WorldWideScience

Sample records for fuel treatment options

  1. Spent fuel reprocessing options

    International Nuclear Information System (INIS)

    2008-08-01

    The objective of this publication is to provide an update on the latest developments in nuclear reprocessing technologies in the light of new developments on the global nuclear scene. The background information on spent fuel reprocessing is provided in Section One. Substantial global growth of nuclear electricity generation is expected to occur during this century, in response to environmental issues and to assure the sustainability of the electrical energy supply in both industrial and less-developed countries. This growth carries with it an increasing responsibility to ensure that nuclear fuel cycle technologies are used only for peaceful purposes. In Section Two, an overview of the options for spent fuel reprocessing and their level of development are provided. A number of options exist for the treatment of spent fuel. Some, including those that avoid separation of a pure plutonium stream, are at an advanced level of technological maturity. These could be deployed in the next generation of industrial-scale reprocessing plants, while others (such as dry methods) are at a pilot scale, laboratory scale or conceptual stage of development. In Section Three, research and development in support of advanced reprocessing options is described. Next-generation spent fuel reprocessing plants are likely to be based on aqueous extraction processes that can be designed to a country specific set of spent fuel partitioning criteria for recycling of fissile materials to advanced light water reactors or fast spectrum reactors. The physical design of these plants must incorporate effective means for materials accountancy, safeguards and physical protection. Section four deals with issues and challenges related to spent fuel reprocessing. The spent fuel reprocessing options assessment of economics, proliferation resistance, and environmental impact are discussed. The importance of public acceptance for a reprocessing strategy is discussed. A review of modelling tools to support the

  2. Graphite fuels combustion off-gas treatment options

    International Nuclear Information System (INIS)

    Kirkham, R.J.; Lords, R.E.

    1993-03-01

    Scenarios for burning bulk graphite and for burning crushed fuel particles from graphite spent nuclear fuels have been considered. Particulates can be removed with sintered metal filters. Subsequent cooling would then condense semi-volatile fission products into or onto a particulate. These particulates would be trapped by a second sintered metal filter or downstream packed bed. A packed bed scrub column can be used to eliminate most of the iodine-129 and tritium. A molecular sieve bed is proposed to collect the residual 129 I and other tramp radionuclides downstream (Ruthenium, etc.). Krypton-85 can be recovered, if need be, either by cryogenics or by the KALC process (Krypton Adsorption in Liquid Carbon dioxide). Likewise carbon-14 in the form of carbon dioxide could be collected with a caustic or lime scrub solution and incorporated into a grout. Sulfur dioxide present will be well below regulatory concern level of 4.0 tons per year and most of it would be removed by the scrubber. Carbon monoxide emissions will depend on the choice of burner and start-up conditions. Should the system exceed the regulatory concern level, a catalytic converter in the final packed bed will be provided. Radon and its daughters have sufficiently short half-lives (less than two minutes). If necessary, an additional holdup bed can be added before the final HEPA filters or additional volume can be added to the molecular sieve bed to limit radon emissions. The calculated total effective dose equivalent at the Idaho National Engineering Laboratory boundary from a single release of all the 3 , 14 C, 85 Kr, and 129 I in the total fuel mass if 0.43 mrem/year

  3. Treatment Options

    Science.gov (United States)

    ... one that is tailored to your symptoms. article Protecting your eyesight when taking Plaquenil Some lupus treatments have the potential for eye health side-effects. Know the warning signs. article ​ ...

  4. Treatment Options for Retinoblastoma

    Science.gov (United States)

    ... factors affect prognosis (chance of recovery) and treatment options. The prognosis (chance of recovery ) and treatment options ... or in other places in the body. Treatment Option Overview Key Points There are different types of ...

  5. K Basin spent fuel sludge treatment alternatives study. Volume 2, Technical options

    International Nuclear Information System (INIS)

    Beary, M.M.; Honekemp, J.R.; Winters, N.

    1995-01-01

    Approximately 2100 metric tons of irradiated N Reactor fuel are stored in the KE and KW Basins at the Hanford Site, Richland, Washington. Corrosion of the fuel has led to the formation of sludges, both within the storage canisters and on the basin floors. Concern about the degraded condition of the fuel and the potential for leakage from the basins in proximity to the Columbia River has resulted in DOE's commitment in the Tri-Party Agreement (TPA) to Milestone M-34-00-T08 to remove the fuel and sludges by a December 2002 target date. To support the planning for this expedited removal action, the implications of sludge management under various scenarios are examined. This report, Volume 2 of two volumes, describes the technical options for managing the sludges, including schedule and cost impacts, and assesses strategies for establishing a preferred path

  6. K Basin spent fuel sludge treatment alternatives study. Volume 2, Technical options

    Energy Technology Data Exchange (ETDEWEB)

    Beary, M.M.; Honekemp, J.R.; Winters, N. [Science Applications International Corp., Richland, WA (United States)

    1995-01-01

    Approximately 2100 metric tons of irradiated N Reactor fuel are stored in the KE and KW Basins at the Hanford Site, Richland, Washington. Corrosion of the fuel has led to the formation of sludges, both within the storage canisters and on the basin floors. Concern about the degraded condition of the fuel and the potential for leakage from the basins in proximity to the Columbia River has resulted in DOE`s commitment in the Tri-Party Agreement (TPA) to Milestone M-34-00-T08 to remove the fuel and sludges by a December 2002 target date. To support the planning for this expedited removal action, the implications of sludge management under various scenarios are examined. This report, Volume 2 of two volumes, describes the technical options for managing the sludges, including schedule and cost impacts, and assesses strategies for establishing a preferred path.

  7. K Basin spent fuel sludge treatment alternatives study. Volume 1, Regulatory options

    International Nuclear Information System (INIS)

    Beary, M.M.; Honekemp, J.R.; Winters, N.

    1995-01-01

    Approximately 2100 metric tons of irradiated N Reactor fuel are stored in the KE and KW Basins at the Hanford Site, Richland, Washington. Corrosion of the fuel has led to the formation of sludges, both within the storage canisters and on the basin floors. Concern about the degraded condition of the fuel and the potential for leakage from the basins in proximity to the Columbia River has resulted in DOE's commitment in the Tri-Party Agreement (TPA) to Milestone M-34-00-T08 to remove the fuel and sludges by a December 2002 target date. To support the planning for this expedited removal action, the implications of sludge management under various scenarios are examined. Volume 1 of this two-volume report describes the regulatory options for managing the sludges, including schedule and cost impacts, and assesses strategies for establishing a preferred path

  8. Breast Cancer: Treatment Options

    Science.gov (United States)

    ... Breast Cancer > Breast Cancer: Treatment Options Request Permissions Breast Cancer: Treatment Options Approved by the Cancer.Net Editorial ... can be addressed as quickly as possible. Recurrent breast cancer If the cancer does return after treatment for ...

  9. Spatial analysis of fuel treatment options for chaparral on the Angeles national forest

    Science.gov (United States)

    G. Jones; J. Chew; R. Silverstein; C. Stalling; J. Sullivan; J. Troutwine; D. Weise; D. Garwood

    2008-01-01

    Spatial fuel treatment schedules were developed for the chaparral vegetation type on the Angeles National Forest using the Multi-resource Analysis and Geographic Information System (MAGIS). Schedules varied by the priority given to various wildland urban interface areas and the general forest, as well as by the number of acres treated per decade. The effectiveness of...

  10. Traditional preventive treatment options

    DEFF Research Database (Denmark)

    Longbottom, C; Ekstrand, K; Zero, D

    2009-01-01

    Preventive treatment options can be divided into primary, secondary and tertiary prevention techniques, which can involve patient- or professionally applied methods. These include: oral hygiene (instruction), pit and fissure sealants ('temporary' or 'permanent'), fluoride applications (patient...... options....

  11. Alternative Fuels Data Center: Biodiesel Equipment Options

    Science.gov (United States)

    Equipment Options to someone by E-mail Share Alternative Fuels Data Center: Biodiesel Equipment Options on Facebook Tweet about Alternative Fuels Data Center: Biodiesel Equipment Options on Twitter Bookmark Alternative Fuels Data Center: Biodiesel Equipment Options on Google Bookmark Alternative Fuels

  12. Fuel options for oil sands

    International Nuclear Information System (INIS)

    Wise, T.

    2005-01-01

    This presentation examined fuel options in relation to oil sands production. Options include steam and hydrogen (H 2 ) for upgrading; natural gas by pipeline; bitumen; petroleum coke; and coal. Various cost drivers were also considered for each of the fuel options. It was noted that natural gas has high energy value but the capital cost is low, and that coke's energy value is very low but the capital cost is high. A chart forecasting energy prices was presented. The disposition of Western Canada's northern gas situation was presented. Issues concerning rail transportation for coal were considered. Environmental concerns were also examined. A chart of typical gas requirements for 75,000 B/D oil sands projects was presented. Issues concerning steam generation with gas and mining cogeneration with gas fuel and steam turbines were discussed, as well as cogeneration and H 2 with gas fuels and steam turbines. Various technology and fuel utility options were examined, along with details of equipment and processes. Boiler technologies were reviewed by type as well as fuel and steam quality and pressure. Charts of cogeneration with gas turbine and circulation fluid bed boilers were presented. Gasification processes were reviewed and a supply cost basis was examined. Cost drivers were ranked according to energy, operating considerations and capital investment. Results indicated that fuel costs were significant for gas and coal. Capital costs and capital recovery charge was most significant with coal and gasification technology. Without capital recovery, cash costs favour the use of bitumen and coke. Gasification would need lower capital and lower capital recovery to compete with direct burning. It was concluded that direct burning of bitumen can compete with natural gas. With price volatility anticipated, dual fuel capability for bitumen and gas has merit. Petroleum coke can be produced or retrieved from stockpiles. Utility supply costs of direct burning of coke is

  13. Treatment Options for Wilms Tumor

    Science.gov (United States)

    ... factors affect prognosis (chance of recovery) and treatment options. The prognosis (chance of recovery ) and treatment options ... come back) after it has been treated. Treatment Option Overview Key Points There are different types of ...

  14. Treatment Options for Myelodysplastic Syndromes

    Science.gov (United States)

    ... special light. Certain factors affect prognosis and treatment options. The prognosis (chance of recovery) and treatment options ... age and general health of the patient. Treatment Option Overview Key Points There are different types of ...

  15. Treatment Option Overview (Prostate Cancer)

    Science.gov (United States)

    ... factors affect prognosis (chance of recovery) and treatment options. The prognosis (chance of recovery ) and treatment options ... or in other parts of the body. Treatment Option Overview Key Points There are different types of ...

  16. Treatment Option Overview (Myelodysplastic Syndromes)

    Science.gov (United States)

    ... special light. Certain factors affect prognosis and treatment options. The prognosis (chance of recovery) and treatment options ... age and general health of the patient. Treatment Option Overview Key Points There are different types of ...

  17. Treatment Option Overview (Esophageal Cancer)

    Science.gov (United States)

    ... factors affect prognosis (chance of recovery) and treatment options. The prognosis (chance of recovery ) and treatment options ... or in other parts of the body. Treatment Option Overview Key Points There are different types of ...

  18. Treatment Option Overview (Childhood Rhabdomyosarcoma)

    Science.gov (United States)

    ... factors affect prognosis (chance of recovery) and treatment options. The prognosis (chance of recovery ) and treatment options ... or in other parts of the body. Treatment Option Overview Key Points There are different types of ...

  19. Treatment Option Overview (Penile Cancer)

    Science.gov (United States)

    ... factors affect prognosis (chance of recovery) and treatment options. The prognosis (chance of recovery ) and treatment options ... or in other parts of the body. Treatment Option Overview Key Points There are different types of ...

  20. Treatment Option Overview (Vulvar Cancer)

    Science.gov (United States)

    ... factors affect prognosis (chance of recovery) and treatment options. The prognosis (chance of recovery ) and treatment options ... or in other parts of the body. Treatment Option Overview Key Points There are different types of ...

  1. Treatment Option Overview (Pancreatic Cancer)

    Science.gov (United States)

    ... factors affect prognosis (chance of recovery) and treatment options. The prognosis (chance of recovery ) and treatment options ... or in other parts of the body. Treatment Option Overview Key Points There are different types of ...

  2. Treatment Option Overview (Adrenocortical Carcinoma)

    Science.gov (United States)

    ... affect the prognosis (chance of recovery) and treatment options. The prognosis (chance of recovery ) and treatment options ... or in other parts of the body. Treatment Option Overview Key Points There are different types of ...

  3. Treatment Options for Childhood Rhabdomyosarcoma

    Science.gov (United States)

    ... factors affect prognosis (chance of recovery) and treatment options. The prognosis (chance of recovery ) and treatment options ... or in other parts of the body. Treatment Option Overview Key Points There are different types of ...

  4. Treatment Options for Kaposi Sarcoma

    Science.gov (United States)

    ... factors affect prognosis (chance of recovery) and treatment options. The prognosis (chance of recovery ) and treatment options ... or in other parts of the body. Treatment Option Overview Key Points There are different types of ...

  5. Treatment Options for Childhood Craniopharyngioma

    Science.gov (United States)

    ... factors affect prognosis (chance of recovery) and treatment options. The prognosis (chance of recovery ) and treatment options ... the brain where it was first found. Treatment Option Overview Key Points There are different types of ...

  6. Novel preventive treatment options

    DEFF Research Database (Denmark)

    Longbottom, C; Ekstrand, K; Zero, D

    2009-01-01

    A number of novel preventive treatment options which, as with traditional methods, can be differentiated into 3 categories of prevention (primary, secondary and tertiary), have been and are being currently investigated. Those reviewed are either commercially available or appear relatively close...... of these techniques show considerable promise and dentists should be aware of these developments and follow their progress, the evidence for each of these novel preventive treatment options is currently insufficient to make widespread recommendations. Changes in dental practice should be explored to see how oral...

  7. ATR Spent Fuel Options Study

    International Nuclear Information System (INIS)

    Connolly, Michael James; Bean, Thomas E.; Brower, Jeffrey O.; Luke, Dale E.; Patterson, M. W.; Robb, Alan K.; Sindelar, Robert; Smith, Rebecca E.; Tonc, Vincent F.; Tripp, Julia L.; Winston, Philip L.

    2017-01-01

    The Advanced Test Reactor (ATR) is a materials and fuels test nuclear reactor that performs irradiation services for the U.S. Department of Energy (DOE) Office of Nuclear Energy (NE), Naval Reactors, the National Nuclear Security Administration (NNSA), and other research programs. ATR achieved initial criticality in 1967 and is expected to operate in support of needed missions until the year 2050 or beyond. It is anticipated that ATR will generate approximately 105 spent nuclear fuel (SNF) elements per year through the year 2050. Idaho National Laboratory (INL) currently stores 2,008 ATR SNF elements in dry storage, 976 in wet storage, and expects to have 1,000 elements in wet storage before January 2017. A capability gap exists at INL for long-term (greater than the year 2050) management, in compliance with the Idaho Settlement Agreement (ISA), of ATR SNF until a monitored retrievable geological repository is open. INL has significant wet and dry storage capabilities that are owned by the DOE Office of Environmental Management (EM) and operated and managed by Fluor Idaho, which include the Idaho Nuclear Technology and Engineering Center's (INTEC's) CPP-666, CPP-749, and CPP-603. In addition, INL has other capabilities owned by DOE-NE and operated and managed by Battelle Energy Alliance, LLC (BEA), which are located at the Materials and Fuel Complex (MFC). Additional storage capabilities are located on the INL Site at the Naval Reactors Facility (NRF). Current INL SNF management planning, as defined in the Fluor Idaho contract, shows INTEC dry fuel storage, which is currently used for ATR SNF, will be nearly full after transfer of an additional 1,000 ATR SNF from wet storage. DOE-NE tasked BEA with identifying and analyzing options that have the potential to fulfill this capability gap. BEA assembled a team comprised of SNF management experts from Fluor Idaho, Savannah River Site (SRS), INL/BEA, and the MITRE Corp with an objective of developing and analyzing

  8. ATR Spent Fuel Options Study

    Energy Technology Data Exchange (ETDEWEB)

    Connolly, Michael James [Idaho National Lab. (INL), Idaho Falls, ID (United States); Bean, Thomas E. [Idaho National Lab. (INL), Idaho Falls, ID (United States); Brower, Jeffrey O. [Idaho National Lab. (INL), Idaho Falls, ID (United States); Luke, Dale E. [Idaho National Lab. (INL), Idaho Falls, ID (United States); Patterson, M. W. [Idaho National Lab. (INL), Idaho Falls, ID (United States); Robb, Alan K. [Idaho National Lab. (INL), Idaho Falls, ID (United States); Sindelar, Robert [Idaho National Lab. (INL), Idaho Falls, ID (United States); Smith, Rebecca E. [Idaho National Lab. (INL), Idaho Falls, ID (United States); Tonc, Vincent F. [Idaho National Lab. (INL), Idaho Falls, ID (United States); Tripp, Julia L. [Idaho National Lab. (INL), Idaho Falls, ID (United States); Winston, Philip L. [Idaho National Lab. (INL), Idaho Falls, ID (United States)

    2017-01-01

    The Advanced Test Reactor (ATR) is a materials and fuels test nuclear reactor that performs irradiation services for the U.S. Department of Energy (DOE) Office of Nuclear Energy (NE), Naval Reactors, the National Nuclear Security Administration (NNSA), and other research programs. ATR achieved initial criticality in 1967 and is expected to operate in support of needed missions until the year 2050 or beyond. It is anticipated that ATR will generate approximately 105 spent nuclear fuel (SNF) elements per year through the year 2050. Idaho National Laboratory (INL) currently stores 2,008 ATR SNF elements in dry storage, 976 in wet storage, and expects to have 1,000 elements in wet storage before January 2017. A capability gap exists at INL for long-term (greater than the year 2050) management, in compliance with the Idaho Settlement Agreement (ISA), of ATR SNF until a monitored retrievable geological repository is open. INL has significant wet and dry storage capabilities that are owned by the DOE Office of Environmental Management (EM) and operated and managed by Fluor Idaho, which include the Idaho Nuclear Technology and Engineering Center’s (INTEC’s) CPP-666, CPP-749, and CPP-603. In addition, INL has other capabilities owned by DOE-NE and operated and managed by Battelle Energy Alliance, LLC (BEA), which are located at the Materials and Fuel Complex (MFC). Additional storage capabilities are located on the INL Site at the Naval Reactors Facility (NRF). Current INL SNF management planning, as defined in the Fluor Idaho contract, shows INTEC dry fuel storage, which is currently used for ATR SNF, will be nearly full after transfer of an additional 1,000 ATR SNF from wet storage. DOE-NE tasked BEA with identifying and analyzing options that have the potential to fulfill this capability gap. BEA assembled a team comprised of SNF management experts from Fluor Idaho, Savannah River Site (SRS), INL/BEA, and the MITRE Corp with an objective of developing and analyzing

  9. Fuels planning: science synthesis and integration; environmental consequences fact sheet 06: wildland fire use: the "other" treatment option

    Science.gov (United States)

    Anne Black

    2004-01-01

    Fire suppression has reduced acres burned to an average of 2 million acres a year. An unfortunate result of this has been the accumulation of even more above-normal fuel loads in many areas. This paper discusses (1) the important ecological role of fire, (2) using fire as a fuels treatment, and (2) the benefits and risks of fire.

  10. Treatment Options for Actinic Keratosis

    Science.gov (United States)

    ... factors affect prognosis (chance of recovery) and treatment options. The prognosis (chance of recovery ) depends mostly on ... helped by lip balm or petroleum jelly . Treatment Option Overview Key Points There are different types of ...

  11. Treatment Option Overview (Vaginal Cancer)

    Science.gov (United States)

    ... factors affect prognosis (chance of recovery) and treatment options. The prognosis (chance of recovery ) depends on the ... or in other parts of the body. Treatment Option Overview Key Points There are different types of ...

  12. Treatment Option Overview (Anal Cancer)

    Science.gov (United States)

    ... affect the prognosis (chance of recovery) and treatment options. The prognosis (chance of recovery ) depends on the ... or in other parts of the body. Treatment Option Overview Key Points There are different types of ...

  13. Achalasia: Treatment Options Revisited

    Directory of Open Access Journals (Sweden)

    Willemijntje A Hoogerwerf

    2000-01-01

    Full Text Available The aim of all current forms of treatment of achalasia is to enable the patient to eat without disabling symptoms such as dysphagia, regurgitation, coughing or choking. Historically, this has been accomplished by mechanical disruption of the lower esophageal sphincter fibres, either by means of pneumatic dilation (PD or by open surgical myotomy. The addition of laparoscopic myotomy and botulinum toxin (BTX injection to the therapeutic armamentarium has triggered a recent series of reviews to determine the optimal therapeutic approach. Both PD and BTX have excellent short term (less than three months efficacy in the majority of patients. New data have been published that suggest that PD and BTX (with repeat injections can potentially obtain long term efficacy. PD is still considered the first-line treatment by most physicians; its main disadvantage is risk of perforation. BTX injection is evolving as an excellent, safe option for patients who are considered high risk for more invasive procedures. Laparoscopic myotomy with combined antireflux surgery is an increasingly attractive option in younger patients with achalasia, but long term follow-up studies are required to establish its efficacy and the potential for reflux-related sequelae.

  14. Treatment Option Overview (Kaposi Sarcoma)

    Science.gov (United States)

    ... Treatment Childhood Vascular Tumors Treatment Research Kaposi Sarcoma Treatment (PDQ®)–Patient Version General Information About Kaposi Sarcoma ... Certain factors affect prognosis (chance of recovery) and treatment options. The prognosis (chance of recovery ) and treatment ...

  15. Treatment Options for Narcolepsy.

    Science.gov (United States)

    Barateau, Lucie; Lopez, Régis; Dauvilliers, Yves

    2016-05-01

    Narcolepsy type 1 and narcolepsy type 2 are central disorders of hypersomnolence. Narcolepsy type 1 is characterized by excessive daytime sleepiness and cataplexy and is associated with hypocretin-1 deficiency. On the other hand, in narcolepsy type 2, cerebrospinal fluid hypocretin-1 levels are normal and cataplexy absent. Despite major advances in our understanding of narcolepsy mechanisms, its current management is only symptomatic. Treatment options may vary from a single drug that targets several symptoms, or multiple medications that each treats a specific symptom. In recent years, narcolepsy treatment has changed with the widespread use of modafinil/armodafinil for daytime sleepiness, antidepressants (selective serotonin and dual serotonin and noradrenalin reuptake inhibitors) for cataplexy, and sodium oxybate for both symptoms. Other psychostimulants can also be used, such as methylphenidate, pitolisant and rarely amphetamines, as third-line therapy. Importantly, clinically relevant subjective and objective measures of daytime sleepiness are required to monitor the treatment efficacy and to provide guidance on whether the treatment goals are met. Associated symptoms and comorbid conditions, such as hypnagogic/hypnopompic hallucinations, sleep paralysis, disturbed nighttime sleep, unpleasant dreams, REM- and non REM-related parasomnias, depressive symptoms, overweight/obesity, and obstructive sleep apnea, should also be taken into account and managed, if required. In the near future, the efficacy of new wake-promoting drugs, anticataplectic agents, hypocretin replacement therapy and immunotherapy at the early stages of the disease should also be evaluated.

  16. Pyroprocessing of oxidized sodium-bonded fast reactor fuel - An experimental study of treatment options for degraded EBR-II fuel

    Energy Technology Data Exchange (ETDEWEB)

    Hermann, S.D.; Gese, N.J. [Separations Department, Idaho National Laboratory, P.O. Box 1625, Idaho Falls, ID 83415 (United States); Wurth, L.A. [Zinc Air Inc., 5314-A US Hwy 2 West, Columbia Falls, MT 59912 (United States)

    2013-07-01

    An experimental study was conducted to assess pyrochemical treatment options for degraded EBR-II fuel. As oxidized material, the degraded fuel would need to be converted back to metal to enable electrorefining within an existing electro-metallurgical treatment process. A lithium-based electrolytic reduction process was studied to assess the efficacy of converting oxide materials to metal with a particular focus on the impact of zirconium oxide and sodium oxide on this process. Bench-scale electrolytic reduction experiments were performed in LiCl-Li{sub 2}O at 650 C. degrees with combinations of manganese oxide (used as a surrogate for uranium oxide), zirconium oxide, and sodium oxide. In the absence of zirconium or sodium oxide, the electrolytic reduction of MnO showed nearly complete conversion to metal. The electrolytic reduction of a blend of MnO-ZrO{sub 2} in LiCl - 1 wt% Li{sub 2}O showed substantial reduction of manganese, but only 8.5% of the zirconium was found in the metal phase. The electrolytic reduction of the same blend of MnO-ZrO{sub 2} in LiCl - 1 wt% Li{sub 2}O - 6.2 wt% Na{sub 2}O showed substantial reduction of manganese, but zirconium reduction was even less at 2.4%. This study concluded that ZrO{sub 2} cannot be substantially reduced to metal in an electrolytic reduction system with LiCl - 1 wt% Li{sub 2}O at 650 C. degrees due to the perceived preferential formation of lithium zirconate. This study also identified a possible interference that sodium oxide may have on the same system by introducing a parasitic and cyclic reaction of dissolved sodium metal between oxidation at the anode and reduction at the cathode. When applied to oxidized sodium-bonded EBR-II fuel (e.g., U-10Zr), the prescribed electrolytic reduction system would not be expected to substantially reduce zirconium oxide, and the accumulation of sodium in the electrolyte could interfere with the reduction of uranium oxide, or at least render it less efficient.

  17. Options contracts in the nuclear fuel industry

    International Nuclear Information System (INIS)

    Fuller, D.M.

    1995-01-01

    This article discusses options trading in the nuclear fuels industry. Although there now exists no formal options market in the nuclear industry, flexibilities, or embedded options, are actually quite common in the long-term supply contracts. The value of these flexibilities can be estimated by applying the methods used to evaluate options. The method used is the Black-Scholes Model, and it is applied to a number of examples

  18. Treatment Option Overview (Ewing Sarcoma)

    Science.gov (United States)

    ... Ewing Sarcoma Treatment Osteosarcoma Treatment Research Ewing Sarcoma Treatment (PDQ®)–Patient Version General Information About Ewing Sarcoma ... started or in another part of the body. Treatment Option Overview Key Points There are different types ...

  19. Part 5. Fuel cycle options

    International Nuclear Information System (INIS)

    Lineberry, M.J.; McFarlane, H.F.; Amundson, P.I.; Goin, R.W.; Webster, D.S.

    1980-01-01

    The results of the FBR fuel cycle study that supported US contributions to the INFCE are presented. Fuel cycle technology is reviewed from both generic and historical standpoints. Technology requirements are developed within the framework of three deployment scenarios: the reference international, the secured area, and the integral cycle. Reprocessing, fabrication, waste handling, transportation, and safeguards are discussed for each deployment scenario. Fuel cycle modifications designed to increase proliferation defenses are described and assessed for effectiveness and technology feasibility. The present status of fuel cycle technology is reviewed and key issues that require resolution are identified

  20. Treatment Option Overview (Myelodysplastic/Myeloproliferative Neoplasms)

    Science.gov (United States)

    ... factors affect prognosis (chance of recovery) and treatment options. The prognosis (chance of recovery ) and treatment options ... factors affect prognosis (chance of recovery) and treatment options. The prognosis (chance of recovery ) and treatment options ...

  1. Nuclear spent fuel management. Experience and options

    International Nuclear Information System (INIS)

    1986-01-01

    Spent nuclear fuel can be stored safely for long periods at relatively low cost, but some form of permanent disposal will eventually be necessary. This report examines the options for spent fuel management, explores the future prospects for each stage of the back-end of the fuel cycle and provides a thorough review of past experience and the technical status of the alternatives. Current policies and practices in twelve OECD countries are surveyed

  2. Sustainability Features of Nuclear Fuel Cycle Options

    Directory of Open Access Journals (Sweden)

    Stefano Passerini

    2012-09-01

    Full Text Available The nuclear fuel cycle is the series of stages that nuclear fuel materials go through in a cradle to grave framework. The Once Through Cycle (OTC is the current fuel cycle implemented in the United States; in which an appropriate form of the fuel is irradiated through a nuclear reactor only once before it is disposed of as waste. The discharged fuel contains materials that can be suitable for use as fuel. Thus, different types of fuel recycling technologies may be introduced in order to more fully utilize the energy potential of the fuel, or reduce the environmental impacts and proliferation concerns about the discarded fuel materials. Nuclear fuel cycle systems analysis is applied in this paper to attain a better understanding of the strengths and weaknesses of fuel cycle alternatives. Through the use of the nuclear fuel cycle analysis code CAFCA (Code for Advanced Fuel Cycle Analysis, the impact of a number of recycling technologies and the associated fuel cycle options is explored in the context of the U.S. energy scenario over 100 years. Particular focus is given to the quantification of Uranium utilization, the amount of Transuranic Material (TRU generated and the economics of the different options compared to the base-line case, the OTC option. It is concluded that LWRs and the OTC are likely to dominate the nuclear energy supply system for the period considered due to limitations on availability of TRU to initiate recycling technologies. While the introduction of U-235 initiated fast reactors can accelerate their penetration of the nuclear energy system, their higher capital cost may lead to continued preference for the LWR-OTC cycle.

  3. CANDU fuel cycle options in Korea

    International Nuclear Information System (INIS)

    Boczar, P. G.; Fehrenbach, P. J.; Meneley, D. A.

    1996-01-01

    There are many reasons for countries embarking on a CANDU R program to start with the natural uranium fuel cycle. Simplicity of fuel design, ease of fabrication, and ready availability of natural uranium all help to localize the technology and to reduce reliance on foreign technology. Nonetheless, at some point, the incentives for using natural uranium fuel may be outweighed by the advantages of alternate fuel cycles. The excellent neutron economy, on-line refuelling, and simple fuel-bundle design provide an unsurpassed degree of fuel-cycle flexibility in CANDU reactors. The easiest first step in CANDU fuel-cycle evolution may be the use of slightly enriched uranium (SEU), including recovered uranium from reprocessed LWR spent fuel. Relatively low enrichment (up to 1.2%) will result in a two- to three-fold reduction in the quantity of spent fuel per unit energy production, reductions in fuel-cycle costs, and greater flexibility in the design of new reactors. The CANFLEX (CANDU FLEXible) fuel bundle would be the optimal fuel carrier. A country that has both CANDU and PWR reactors can exploit the natural synergism between these two reactor types to minimize overall waste production, and maximize energy derived from the fuel. This synergism can be exploited through several different fuel cycles. A high burnup CANDU MOX fuel design could be used to utilize plutonium from conventional reprocessing or more advanced reprocessing options (such as co-processing). DUPIC (Direct Use of Spent PWR Fuel In CANDU) represents a recycle option that has a higher degree of proliferation resistance than dose conventional reprocessing, since it uses only dry processes for converting spent PWR fuel into CANDU fuel, without separating the plutonium. Good progress is being made in the current KAERI, AECL, and U. S. Department of State program in demonstrating the technical feasibility of DUPIC. In the longer term, CANDU reactors offer even more dramatic synergistic fuel cycles with PWR or

  4. Burnable poison option for DUPIC fuel

    International Nuclear Information System (INIS)

    Choi, Hang Bok; Cupta, H. P.

    1996-08-01

    The mechanisms of positive coolant void reactivity of CANDU natural uranium and DUPIC fuel have been studied. The design study of DUPIC fuel was performed using the burnable poison material in the center pin to reduce the coolant void reactivity. The amount of burnable poison was determined such that the prompt inverse period of DUPIC fuel upon full coolant voiding is the same as that of natural uranium fuel at equilibrium burnup. A parametric study on various burnable poisons has shown that natural dysprosium has more merit over other materials because it uniformly controls the void reactivity throughout the burnup with reasonable amount of poison. Additional studies on the option of using scattering or absorber material in the center pin position and the option using variable fuel density were performed. In any case of option using variable fuel density were performed. In any case of options to reduce the void reactivity, it was found that either the discharge burnup and/or the relative linear pin power are sacrificed. A preliminary study was performed for the evaluation of reference DUPIC fuel performance especially represented by Stress Corrosion Cracking(SCC) parameters which is mainly influenced by the refueling operations. For the reference 2-bundle shift refueling scheme, the predicted ramped power and power increment of the reference DUPIC fuel are below the SCC thresholds of CANDU natural uranium fuel. For a 4-bundle shift refueling scheme, the envelopes of element ramped power and power increment upon refueling are 8% and 44% higher than those of a 2-bundle shift refueling scheme on the average, respectively, but still have margins to the failure thresholds of natural uranium fuel. 23 tabs., 25 figs., 20 refs. (Author)

  5. Spent fuel storage options: a critical appraisal

    International Nuclear Information System (INIS)

    Singh, K.P.; Bale, M.G.

    1990-01-01

    The delayed decisions on nuclear fuel reprocessing strategies in the USA and other countries have forced the development of new long-term irradiated fuel storage techniques, to allow a larger volume of fuel to be held on the nuclear station site after removal from the reactor. The nuclear power industry has responded to the challenge by developing several viable options for long-term onsite storage, which can be employed individually or in tandem. They are: densification of storage in the existing spent fuel pool; building another fuel pool facility at the plant site; onsite cask park, and on site vault clusters. Desirable attributes of a storage option are: Safety: minimise the number of fuel handling steps; Economy: minimise total installed, and O and M cost; Security: protection from anti-nuclear protesters; Site adaptability: available site space, earthquake characteristics of the region and so on; Non-intrusiveness: minimise required modifications to existing plant systems; Modularisation: afford the option to adapt a modular approach for staged capital outlays; and Maturity: extent of industry experience with the technology. A critical appraisal is made of each of the four aforementioned storage options in the light of these criteria. (2 figures, 1 table, 4 references) (Author)

  6. Treatment Options by Stage (Chronic Lymphocytic Leukemia)

    Science.gov (United States)

    ... examination under a microscope. Certain factors affect treatment options and prognosis (chance of recovery). Treatment options depend ... that does not get better with treatment. Treatment Option Overview Key Points There are different types of ...

  7. Treatment Option Overview (Chronic Lymphocytic Leukemia)

    Science.gov (United States)

    ... examination under a microscope. Certain factors affect treatment options and prognosis (chance of recovery). Treatment options depend ... that does not get better with treatment. Treatment Option Overview Key Points There are different types of ...

  8. Hairy Cell Leukemia Treatment Option Overview

    Science.gov (United States)

    ... or a swollen spleen. Certain factors affect treatment options and prognosis (chance of recovery). The treatment options ... cell leukemia has not responded to treatment. Treatment Option Overview Key Points There are different types of ...

  9. Treatment Options for Gastrointestinal Carcinoid Tumors

    Science.gov (United States)

    ... factors affect prognosis (chance of recovery) and treatment options. The prognosis (chance of recovery ) and treatment options ... body. Has not gotten better with treatment. Treatment Option Overview Key Points There are different types of ...

  10. Alopecia areata: Treatment options

    Directory of Open Access Journals (Sweden)

    E. Kasumagić-Halilović

    2006-02-01

    Full Text Available Alopecia areata (AA is a common cause of reversible hair loss afflictingapproximately1-2%ofthegeneralpopulation. It commonly present as round patches of hair loss which can be the firstmanifestationofamoreseverealopecia totalis or universalis. The cause of AA is unknown although most evidence supports the hypothesis that AA is an immunologically mediated disease. Treatment of AA may be divided into four different categories of widely accepted therapeutic modalities: immune inhibitors (steroid or psoralen and UVA light- PUVA, topicalsensitizers (squaric acid dibutylester and diphenylcyclopropenone, non-specificirritants(anthralinandthevasodilatator minoxidil. Improved future treatments may be immunosuppressive or immunomodulatory or they may otherwise protect hair follicles from the injurious effects of inflammation.Theaimofthisarticleistoreviewavailable data on current and potential agents for the treatment of AA.

  11. Hand Eczema: Treatment options

    DEFF Research Database (Denmark)

    Lund, Tamara Theresia; Agner, Tove

    2017-01-01

    Hand eczema is a common disease, it affects young people, is often work-related, and the burden of the disease is significant for the individual as well as for society. Factors to be considered when choosing a treatment strategy are, among others, whether the eczema is acute or chronic, the sever...

  12. Treatment Options in Kleptomania

    Directory of Open Access Journals (Sweden)

    Lut Tamam

    2009-06-01

    Full Text Available Kleptomania is a rare disorder with inability or great difficulty in resisting impulses of stealing. People with this disorder are compelled to steal things, generally things of little or no value. This disorder usually begins during puberty and usually last until late adulthood; in some cases lasts throughout the person's life. People with this disorder are likely to have a comorbid conditions like mood disorders. Individuals with the disorder are usually referred for treatment due to the comorbid psychiatric complaints rather than kleptomanic behaviour per se. On the other hand literature lacks of studies about the treatment of kleptomania. A wide variety of therapeutic strategies have been proposed for its treatment, among them psychoanalytic oriented psychotherapy, behavioral therapy and pharmacotherapy. Some medications that are used for people diagnosed with kleptomania are selective serotonin reuptake inhibitors, mood stabilizers and opioid antagonists. There is evidence from numerous case studies that a variety of cognitive behavioral therapy techniques are effective in the treatment of kleptomania and it is favored over other approaches such as psychodynamic and psychoanalytic therapies. Studies to date suggest that cognitive behavioral therapy when used in combination with medication, is more effective than medication alone.

  13. IBS Treatment Options

    Science.gov (United States)

    ... 01 July 2017 Print A short bout of abdominal pain and diarrhea or constipation now and then is not unusual. But long-term or recurring symptoms are not normal. They may signal irritable bowel syndrome (IBS) – and are generally treatable. IBS Treatments Depend ...

  14. CANDU fuel cycle options in Korea

    International Nuclear Information System (INIS)

    Boczar, P.G.; Fehrenbach, P.J.; Meneley, D.A.

    1996-04-01

    The easiest first step in CANDU fuel-cycle evolution may be the use of slightly enriched uranium (SEU), including recovered uranium from reprocessed LWR spent fuel. Relatively low enrichment (up to 1.2%) will result in a twoto three-fold reduction in the quantity of spent fuel per unit energy production, reductions in fuel-cycle costs, and greater flexibility in the design of new reactors. The CANFLEX (CANDU FLEXible) fuel bundle would be the optimal fuel carrier. A country that has both CANDU and PWR reactors can exploit the natural synergism between these two reactor types to minimize overall waste production, and maximize energy derived from the fuel. This synergism can be exploited through several different fuel cycles. A high burnup CANDU MOX fuel design could be used to utilize plutonium from conventional reprocessing or more advanced reprocessing options (such as co-processing). DUPIC (Direct Use of Spent PWR Fuel In CANDU) represents a recycle option that has a higher degree of proliferation resistance than does conventional reprocessing, since it uses only dry processes for converting spent PWR fuel into CANDU fuel, without separating the plutonium. Good progress is being made in the current KAERI, AECL, and U.S. Department of State program in demonstrating the technical feasibility of DUPIC. In the longer term, CANDU reactors offer even more dramatic synergistic fuel cycles with PWR or FBR reactors. If the objective of a national fuel-cycle program is the minimization of actinide waste or destruction of long-lived fission products, then studies have shown the superiority of CANDU reactors in meeting this objective. Long-term energy security can be assured either through the thorium cycle or through a CANDU 1 FBR system, in which the FBR would be operated as a 'fuel factory,' providing the fissile material to power a number of lower-cost, high efficiency CANDU reactors. In summary, the CANDU reactor's simple fuel design, high neutron economy, and on

  15. MIDLINE DIASTEMA: TREATMENT OPTIONS

    OpenAIRE

    Sunil Kumar; Pradnya; Varsha; Sumeet; Fareedi

    2012-01-01

    ABSTRACT : Maxillary midline diastema is a common esthetic problem in mixed and permanent dentition. The space can occur either as a transient malocclusion or created by developmental, pathological or iatrogenic factors. Many innovative therapies are available from restorative procedures such as composite build-up to surgery (fr enectomies) and Orthodontics is available. Treatment depends upon the correct diagnosis of its etiology and early intervention relevant ...

  16. 77 FR 19278 - Informational Meeting on Nuclear Fuel Cycle Options

    Science.gov (United States)

    2012-03-30

    ... DEPARTMENT OF ENERGY Informational Meeting on Nuclear Fuel Cycle Options AGENCY: Office of Fuel... activities leading to a comprehensive evaluation and screening of nuclear fuel cycle options in 2013. At this... fuel cycle options developed for the evaluation and screening provides a comprehensive representation...

  17. Treatment Options by Stage (Pancreatic Cancer)

    Science.gov (United States)

    ... factors affect prognosis (chance of recovery) and treatment options. The prognosis (chance of recovery ) and treatment options ... or in other parts of the body. Treatment Option Overview Key Points There are different types of ...

  18. Treatment Options by Stage (Esophageal Cancer)

    Science.gov (United States)

    ... factors affect prognosis (chance of recovery) and treatment options. The prognosis (chance of recovery ) and treatment options ... or in other parts of the body. Treatment Option Overview Key Points There are different types of ...

  19. Treatment Options by Stage (Vulvar Cancer)

    Science.gov (United States)

    ... factors affect prognosis (chance of recovery) and treatment options. The prognosis (chance of recovery ) and treatment options ... or in other parts of the body. Treatment Option Overview Key Points There are different types of ...

  20. Treatment Options by Stage (Penile Cancer)

    Science.gov (United States)

    ... factors affect prognosis (chance of recovery) and treatment options. The prognosis (chance of recovery ) and treatment options ... or in other parts of the body. Treatment Option Overview Key Points There are different types of ...

  1. Treatment Options for Non-Hodgkin Lymphoma

    Science.gov (United States)

    ... factors affect prognosis (chance of recovery) and treatment options. The prognosis (chance of recovery ) and treatment options ... lymphoma may come back as indolent lymphoma. Treatment Option Overview Key Points There are different types of ...

  2. Treatment Options for Adult Soft Tissue Sarcoma

    Science.gov (United States)

    ... reacts to the light. Certain factors affect treatment options and prognosis (chance of recovery). The treatment options ... or in other parts of the body. Treatment Option Overview Key Points There are different types of ...

  3. Treatment Options by Stage (Merkel Cell Carcinoma)

    Science.gov (United States)

    ... factors affect prognosis (chance of recovery) and treatment options. The prognosis (chance of recovery ) and treatment options ... common for Merkel cell carcinoma to recur. Treatment Option Overview Key Points There are different types of ...

  4. Treatment Options by Stage (Prostate Cancer)

    Science.gov (United States)

    ... factors affect prognosis (chance of recovery) and treatment options. The prognosis (chance of recovery ) and treatment options ... or in other parts of the body. Treatment Option Overview Key Points There are different types of ...

  5. Treatment Options by Stage (Adrenocortical Carcinoma)

    Science.gov (United States)

    ... affect the prognosis (chance of recovery) and treatment options. The prognosis (chance of recovery ) and treatment options ... or in other parts of the body. Treatment Option Overview Key Points There are different types of ...

  6. Treatment Options for Childhood Hodgkin Lymphoma

    Science.gov (United States)

    ... factors affect prognosis (chance of recovery) and treatment options. The prognosis (chance of recovery ) and treatment options ... the lungs , liver , bones, or bone marrow . Treatment Option Overview Key Points There are different types of ...

  7. Treatment Options for Adult Hodgkin Lymphoma

    Science.gov (United States)

    ... factors affect prognosis (chance of recovery) and treatment options. The prognosis (chance of recovery ) and treatment options ... or in other parts of the body. Treatment Option Overview Key Points There are different types of ...

  8. Treatment Options for Hodgkin Lymphoma during Pregnancy

    Science.gov (United States)

    ... factors affect prognosis (chance of recovery) and treatment options. The prognosis (chance of recovery ) and treatment options ... or in other parts of the body. Treatment Option Overview Key Points There are different types of ...

  9. Treatment Option Overview (Adult Soft Tissue Sarcoma)

    Science.gov (United States)

    ... reacts to the light. Certain factors affect treatment options and prognosis (chance of recovery). The treatment options ... or in other parts of the body. Treatment Option Overview Key Points There are different types of ...

  10. Treatment Option Overview (Small Intestine Cancer)

    Science.gov (United States)

    ... factors affect prognosis (chance of recovery) and treatment options. The prognosis (chance of recovery ) and treatment options ... or in other parts of the body. Treatment Option Overview Key Points There are different types of ...

  11. Treatment Option Overview (Adult Hodgkin Lymphoma)

    Science.gov (United States)

    ... factors affect prognosis (chance of recovery) and treatment options. The prognosis (chance of recovery ) and treatment options ... or in other parts of the body. Treatment Option Overview Key Points There are different types of ...

  12. Treatment Option Overview (Merkel Cell Carcinoma)

    Science.gov (United States)

    ... factors affect prognosis (chance of recovery) and treatment options. The prognosis (chance of recovery ) and treatment options ... common for Merkel cell carcinoma to recur. Treatment Option Overview Key Points There are different types of ...

  13. Treatment Option Overview (Childhood Hodgkin Lymphoma)

    Science.gov (United States)

    ... factors affect prognosis (chance of recovery) and treatment options. The prognosis (chance of recovery ) and treatment options ... the lungs , liver , bones, or bone marrow . Treatment Option Overview Key Points There are different types of ...

  14. Treatment Option Overview (Small Cell Lung Cancer)

    Science.gov (United States)

    ... factors affect prognosis (chance of recovery) and treatment options. The prognosis (chance of recovery ) and treatment options ... or in other parts of the body. Treatment Option Overview Key Points There are different types of ...

  15. Treatment Option Overview (Adult Acute Lymphoblastic Leukemia)

    Science.gov (United States)

    ... factors affect prognosis (chance of recovery) and treatment options. The prognosis (chance of recovery ) and treatment options ... marrow , or other parts of the body. Treatment Option Overview Key Points There are different types of ...

  16. Treatment Options for AIDS-Related Lymphoma

    Science.gov (United States)

    ... factors affect prognosis (chance of recovery) and treatment options. The prognosis (chance of recovery ) and treatment options ... nervous system is not primary CNS lymphoma. Treatment Option Overview Key Points There are different types of ...

  17. Treatment Options for Adult Acute Lymphoblastic Leukemia

    Science.gov (United States)

    ... factors affect prognosis (chance of recovery) and treatment options. The prognosis (chance of recovery ) and treatment options ... marrow , or other parts of the body. Treatment Option Overview Key Points There are different types of ...

  18. Treatment Options for Renal Cell Cancer

    Science.gov (United States)

    ... factors affect prognosis (chance of recovery) and treatment options. The prognosis (chance of recovery ) and treatment options ... or in other parts of the body. Treatment Option Overview Key Points There are different types of ...

  19. Treatment Options by Stage (Gastric Cancer)

    Science.gov (United States)

    ... factors affect prognosis (chance of recovery) and treatment options. The prognosis (chance of recovery ) and treatment options ... such as the liver or lymph nodes . Treatment Option Overview Key Points There are different types of ...

  20. Treatment Options by Stage (Thyroid Cancer)

    Science.gov (United States)

    ... factors affect prognosis (chance of recovery) and treatment options. The prognosis (chance of recovery ) and treatment options ... or in other parts of the body. Treatment Option Overview Key Points There are different types of ...

  1. Treatment Options for Chronic Myelogenous Leukemia

    Science.gov (United States)

    ... factors affect prognosis (chance of recovery) and treatment options. The prognosis (chance of recovery ) and treatment options ... of blast cells increases after a remission . Treatment Option Overview Key Points There are different types of ...

  2. Treatment Options for Adult Acute Myeloid Leukemia

    Science.gov (United States)

    ... factors affect prognosis (chance of recovery) and treatment options. The prognosis (chance of recovery ) and treatment options ... back in the blood or bone marrow . Treatment Option Overview Key Points There are different types of ...

  3. Nuclear Fuel Cycle Evaluation and Real Options

    Directory of Open Access Journals (Sweden)

    L. Havlíček

    2008-01-01

    Full Text Available The first part of this paper describes the nuclear fuel cycle. It is divided into three parts. The first part, called Front-End, covers all activities connected with fuel procurement and fabrication. The middle part of the cycle includes fuel reload design activities and the operation of the fuel in the reactor. Back-End comprises all activities ensuring safe separation of spent fuel and radioactive waste from the environment. The individual stages of the fuel cycle are strongly interrelated. Overall economic optimization is very difficult. Generally, NPV is used for an economic evaluation in the nuclear fuel cycle. However the high volatility of uranium prices in the Front-End, and the large uncertainty of both economic and technical parameters in the Back-End, make the use of NPV difficult. The real option method is able to evaluate the value added by flexibility of decision making by a company under conditions of uncertainty. The possibility of applying this method to the nuclear fuel cycle evaluation is studied. 

  4. Treatment Option Overview (Ovarian Germ Cell Tumors)

    Science.gov (United States)

    ... Germ Cell Tumors Treatment (PDQ®)–Patient Version Treatment Option Overview Go to Health Professional Version Key Points ... and restore) the body’s blood cells. New treatment options Combination chemotherapy (the use of more than one ...

  5. Treatment Option Overview (Childhood Acute Lymphoblastic Leukemia)

    Science.gov (United States)

    ... factors affect prognosis (chance of recovery) and treatment options. The prognosis (chance of recovery ) depends on: How ... cancer that does not respond to treatment. Treatment Option Overview Key Points There are different types of ...

  6. [Treatment options for patellar tendinopathy].

    Science.gov (United States)

    Duthon, V B; Borloz, S; Ziltener, J-L

    2012-07-25

    Patellar tendinopathy is also called jumper's knee because of its high incidence in athletes with jumping or cutting activities as soccer, basketball, volleyball. Many different treatment methods have been described. However, no consensus exists regarding the optimal treatment for this condition. According to the literature, eccentric exercise-based physical therapy should be proposed first because of its strong scientific evidence. Shockwave therapy and injections may be useful but their real efficacy still has to be proven by randomized controlled study. For patients recalcitrant to more conservative options, operative management may be indicated.

  7. Cyanobacterial Treatment Options: Permanganate and ...

    Science.gov (United States)

    This presentation will begin with a brief overview of drinking water treatment options for cyanobacteria and their toxins. The treatment discussion will focus on the impacts of permanganate addition to suspensions of toxin-producing Microcystis aeruginosa, followed by powdered activated carbon (PAC) addition. Results will be presented that show changes in toxin concentrations, chlorophyll-a concentrations and cell membrane integrity. The EPA Small Systems Webinar Presentations allow the dissemination of the latest Agency guidance and research to a large geographically dispersed audience while minimizing taxpayer expense

  8. Treatment options for hepatocellular carcinoma.

    Science.gov (United States)

    Sandhu, Dalbir S; Tharayil, Vivek S; Lai, Jin-Ping; Roberts, Lewis R

    2008-02-01

    Hepatocellular carcinoma (HCC) is frequently diagnosed at advanced stages and has a high mortality rate. With improved survival of patients with cirrhotic liver disease and increased prevalence of chronic hepatitis C viral infections, a rise in the number of HCC cases is being reported worldwide. Early diagnosis and treatment can significantly improve the prognosis of patients with HCC. Although surgical resection is an important potentially curative therapy for liver tumors, in appropriately selected patients, liver transplantation has been shown to achieve excellent survival rates for a solid tumor. Locally ablative and locoregional therapies in the form of percutaneous ethanol injection, radiofrequency ablation, transcatheter arterial chemoembolization and transcatheter arterial radioembolization (TheraSphere) are viable options in patients with unresectable HCC. Unfortunately, the role of systemic therapy has been very limited in the treatment of these patients. Novel treatment options based on an improved understanding of the molecular pathogenesis of HCC are being explored. These targeted molecular therapies are aimed at growth factors and their receptors, intracellular signal transduction and cell cycle control. A substantial improvement in outcomes of intermediate and advanced stage HCC is expected with the advent of these targeted therapies, used in combination with surgical or locoregional therapies. Recent positive results from a large Phase III study of the receptor tyrosine kinase inhibitor, sorafenib, hold great promise in the treatment of HCC.

  9. Treatment Options by Stage (Vaginal Cancer)

    Science.gov (United States)

    ... factors affect prognosis (chance of recovery) and treatment options. The prognosis (chance of recovery ) depends on the ... or in other parts of the body. Treatment Option Overview Key Points There are different types of ...

  10. Treatment Options for Chronic Myeloproliferative Neoplasms

    Science.gov (United States)

    ... factors affect prognosis (chance of recovery) and treatment options for primary myelofibrosis. Prognosis (chance of recovery ) depends ... factors affect prognosis (chance of recovery) and treatment options for essential thrombocythemia. Prognosis (chance of recovery ) and ...

  11. Treatment Options for Nonmelanoma Skin Cancer

    Science.gov (United States)

    ... factors affect prognosis (chance of recovery) and treatment options. The prognosis (chance of recovery ) depends mostly on ... helped by lip balm or petroleum jelly . Treatment Option Overview Key Points There are different types of ...

  12. Treatment Option Overview (Chronic Myeloproliferative Neoplasms)

    Science.gov (United States)

    ... factors affect prognosis (chance of recovery) and treatment options for primary myelofibrosis. Prognosis (chance of recovery ) depends ... factors affect prognosis (chance of recovery) and treatment options for essential thrombocythemia. Prognosis (chance of recovery ) and ...

  13. Nuclear Fuel Cycle Options Catalog: FY16 Improvements and Additions

    Energy Technology Data Exchange (ETDEWEB)

    Price, Laura L. [Sandia National Lab. (SNL-NM), Albuquerque, NM (United States); Barela, Amanda Crystal [Sandia National Lab. (SNL-NM), Albuquerque, NM (United States); Schetnan, Richard Reed [Sandia National Lab. (SNL-NM), Albuquerque, NM (United States); Walkow, Walter M. [Sandia National Lab. (SNL-NM), Albuquerque, NM (United States)

    2016-08-31

    The United States Department of Energy, Office of Nuclear Energy, Fuel Cycle Technology Program sponsors nuclear fuel cycle research and development. As part of its Fuel Cycle Options campaign, the DOE has established the Nuclear Fuel Cycle Options Catalog. The catalog is intended for use by the Fuel Cycle Technologies Program in planning its research and development activities and disseminating information regarding nuclear energy to interested parties. The purpose of this report is to document the improvements and additions that have been made to the Nuclear Fuel Cycle Options Catalog in the 2016 fiscal year.

  14. Nuclear Fuel Cycle Options Catalog FY15 Improvements and Additions.

    Energy Technology Data Exchange (ETDEWEB)

    Price, Laura L. [Sandia National Laboratories (SNL-NM), Albuquerque, NM (United States); Barela, Amanda Crystal [Sandia National Laboratories (SNL-NM), Albuquerque, NM (United States); Schetnan, Richard Reed [Sandia National Laboratories (SNL-NM), Albuquerque, NM (United States); Walkow, Walter M. [Sandia National Laboratories (SNL-NM), Albuquerque, NM (United States)

    2015-11-01

    The United States Department of Energy, Office of Nuclear Energy, Fuel Cycle Technology Program sponsors nuclear fuel cycle research and development. As part of its Fuel Cycle Options campaign, the DOE has established the Nuclear Fuel Cycle Options Catalog. The catalog is intended for use by the Fuel Cycle Technologies Program in planning its research and development activities and disseminating information regarding nuclear energy to interested parties. The purpose of this report is to document the improvements and additions that have been made to the Nuclear Fuel Cycle Options Catalog in the 2015 fiscal year.

  15. Current treatment options for meningioma.

    Science.gov (United States)

    Apra, Caroline; Peyre, Matthieu; Kalamarides, Michel

    2018-03-01

    With an annual incidence of 5/100,000, meningioma is the most frequent primary tumor of the central nervous system. Risk factors are radiotherapy and hormone intake. Most meningiomas are grade I benign tumors, but up to 15% are atypical and 2% anaplastic according to the WHO 2016 histological criteria. Areas covered: This review details the current standard therapy based on international guidelines and recent literature, and describes new approaches developed to treat refractory cases. First-line treatments are observation and surgery, but adjuvant radiotherapy/radiosurgery is discussed for atypical and indicated for anaplastic meningiomas. The most problematic cases include skull base meningiomas that enclose vasculo-nervous structures and surgery- and radiation-refractory tumors that present with significant morbidity and mortality. The treatment of recurrent tumors is based on radiotherapy and repeated surgery. Systematic therapies are not effective in general but several clinical trials are ongoing. Expert commentary: Molecular characterization of the tumors, based on genetic mutations such as NF2, SMO, TERT, TRAF7, and on the methylation profile are developing, completing the histological classification and giving new insights into prognosis and treatment options.

  16. Studies relating to construction materials to be used in different options for head end treatment in reprocessing of mixed carbide fuel of plutonium and uranium

    International Nuclear Information System (INIS)

    Rajan, S.K.; Palamalai, A.; Ravi, T.N.; Sampath, M.; Raman, V.R.; Balasubramanian, G.R.

    1993-01-01

    Mixed carbide of uranium and plutonium has been chosen as the fuel for the first core of Fast Breeder Test Reactor, installed in the Indira Gandhi Centre for Atomic Research. Reprocessing of this fuel is one of the vital steps to prove the viability of the fuel cycle. The head end treatment process introduces constraints in the reprocessing of carbide fuel when compared to the commonly used mixed oxide fuel. Three head end processes, namely direct oxidation, pyrohydrolysis and direct dissolution in nitric acid with oxidation of organic acids were considered for study for exercising the choice. The paper briefly describes the three processes. In each process probable material of construction and related problems are discussed. (author). 3 refs, 5 figs, 7 tabs

  17. Alternative Cancer Treatments: 10 Options to Consider

    Science.gov (United States)

    Alternative cancer treatments: 10 options to consider Alternative cancer treatments can't cure your cancer, but they may provide some ... that may help them, including complementary and alternative cancer treatments. If cancer makes you feel as if you ...

  18. Impact of Nuclear Energy Futures on Advanced Fuel Cycle Options

    International Nuclear Information System (INIS)

    Brent W. Dixon; Steven J. Piet

    2004-01-01

    The Nuclear Waste Policy Act requires the Secretary of Energy to inform Congress before 2010 on the need for a second geologic repository for spent nuclear fuel. By that time, the spent fuel discharged from current commercial reactors will exceed the statutory limit of the first repository (63,000 MTiHM commercial, 7,000 MT non-commercial). There are several approaches to eliminate the need for another repository in this century. This paper presents a high-level analysis of these spent fuel management options in the context of a full range of possible nuclear energy futures. The analysis indicates the best option to implement varies depending on the nuclear energy future selected. The first step in understanding the need for different spent fuel management approaches is to understand the size of potential spent fuel inventories. A full range of potential futures for domestic commercial nuclear energy is considered. These energy futures are as follows: 1. Existing License Completion - Based on existing spent fuel inventories plus extrapolation of future plant-by-plant discharges until the end of each operating license, including known license extensions. 2. Extended License Completion - Based on existing spent fuel inventories plus a plant-by-plant extrapolation of future discharges assuming on all operating plants having one 20-year extension. 3. Continuing Level Energy Generation - Based on extension of the current ∼100 GWe installed commercial base and average spent fuel discharge of 2100 MT/yr through the year 2100. 4. Continuing Market Share Generation - Based on a 1.8% compounded growth of the electricity market through the year 2100, matched by growing nuclear capacity and associated spent fuel discharge. 5. Growing Market Share Generation - Extension of current nuclear capacity and associated spent fuel discharge through 2100 with 3.2% growth representing 1.5% market growth (all energy, not just electricity) and 1.7% share growth. Share growth results in

  19. Accounting treatment of currency options

    Directory of Open Access Journals (Sweden)

    Prošić Danica

    2016-01-01

    Full Text Available Currency options are often used to mitigate currency risk resulting from corporate activities. Their implementation can be complex, and there could be problems if the essential elements and principles are not fully understood. Although they are not the simplest financial products, currency options are interesting and useful to those who are trying to make a step forward in the area of currency risk management. This paper aims to present the general principles and specifics of accounting records and valuation of currency options used for hedging against risk. It is a complex process which, in addition to numerous conditions, also involves the implementation of accounting rules that deviate from the generally accepted accounting principles.

  20. Uranium Resource Availability Analysis of Four Nuclear Fuel Cycle Options

    International Nuclear Information System (INIS)

    Youn, S. R.; Lee, S. H.; Jeong, M. S.; Kim, S. K.; Ko, W. I.

    2013-01-01

    Making the national policy regarding nuclear fuel cycle option, the policy should be established in ways that nuclear power generation can be maintained through the evaluation on the basis of the following aspects. To establish the national policy regarding nuclear fuel cycle option, that must begin with identification of a fuel cycle option that can be best suited for the country, and the evaluation work for that should be proceeded. Like all the policy decision, however, a certain nuclear fuel cycle option cannot be superior in all aspects of sustain ability, environment-friendliness, proliferation-resistance, economics, technologies, which make the comparison of the fuel cycle options very complicated. For such a purpose, this paper set up four different fuel cycle of nuclear power generation considering 2nd Comprehensive Nuclear Energy Promotion Plan(CNEPP), and analyzed material flow and features in steady state of all four of the fuel cycle options. As a result of an analysis on material flow of each nuclear fuel cycle, it was analyzed that Pyro-SFR recycling is most effective on U resource availability among four fuel cycle option. As shown in Figure 3, OT cycle required the most amount of U and Pyro-SFR recycle consumed the least amount of U. DUPIC recycling, PWR-MOX recycling, and Pyro-SFR recycling fuel cycle appeared to consumed 8.2%, 12.4%, 39.6% decreased amount of uranium respectively compared to OT cycle. Considering spent fuel can be recycled as potential energy resources, U and TRU taken up to be 96% is efficiently used. That is, application period of limited uranium natural resources can be extended, and it brings a great influence on stable use of nuclear energy

  1. Treatment options for Primary CNS Lymphoma.

    Science.gov (United States)

    Laghari, Altaf Ali; Ahmed, Syed Ijlal; Jabbar, Adnan; Shamim, Muhammad Shahzad

    2018-03-01

    Primary CNS lymphoma (PCNSL) is a rare and aggressive brain tumour that is uniformly fatal. The rarity of the disease and the poor response to treatment makes it difficult to reach a consensus with regards to treatment options. In this review, the authors have discussed different treatment modalities used in the management of PCNSL including chemotherapy, surgery and radiation, as well as the results of recent clinical trials on treatment options for PCNSL.

  2. Considerations Regarding ROK Spent Nuclear Fuel Management Options

    International Nuclear Information System (INIS)

    Braun, Chaim; Forrest, Robert

    2013-01-01

    In this paper we discuss spent fuel management options in the Republic of Korea (ROK) from two interrelated perspectives: Centralized dry cask storage and spent fuel pyroprocessing and burning in sodium fast reactors (SFRs). We argue that the ROK will run out of space for at-reactors spent fuel storage by about the year 2030 and will thus need to transition centralized dry cask storage. Pyroprocessing plant capacity, even if approved and successfully licensed and constructed by that time, will not suffice to handle all the spent fuel discharged annually. Hence centralized dry cask storage will be required even if the pyroprocessing option is successfully developed by 2030. Pyroprocessing is but an enabling technology on the path leading to fissile material recycling and burning in future SFRs. In this regard we discuss two SFR options under development in the U. S.: the Super Prism and the Travelling Wave Reactor (TWR). We note that the U. S. is further along in reactor development than the ROK. The ROK though has acquired more experience, recently in investigating fuel recycling options for SFRs. We thus call for two complementary joint R and D project to be conducted by U. S. and ROK scientists. One leading to the development of a demonstration centralized away-from-reactors spent fuel storage facility. The other involve further R and D on a combined SFR-fuel cycle complex based on the reactor and fuel cycle options discussed in the paper

  3. Radiological impacts of spent nuclear fuel management options

    International Nuclear Information System (INIS)

    Riotte, H.; Lazo, T.; Mundigl, S.

    2000-01-01

    An important technical study on radiological impacts of spent nuclear fuel management options, recently completed by the NEA, is intended to facilitate informed international discussions on the nuclear fuel cycle. The study compares the radiological impacts on the public and on nuclear workers resulting from two approaches to handling spent fuel from nuclear power plants: - the reprocessing option, that includes the recycling of spent uranium fuel, the reuse of the separated plutonium in MOX fuel, and the direct disposal of spent MOX fuel; and the once-through option, with no reprocessing of spent fuel, and its direct disposal. Based on the detailed research of a group of 18 internationally recognised experts, under NEA sponsorship, the report concludes that: The radiological impacts of both the reprocessing and the non-reprocessing fuel cycles studied are small, well below any regulatory dose limits for the public and for workers, and insignificantly low as compared with exposures caused by natural radiation. The difference in the radiological impacts of the two fuel cycles studied does not provide a compelling argument in favour of one option or the other. The study also points out that other factors, such as resource utilisation efficiency, energy security, and social and economic considerations would tend to carry more weight than radiological impacts in decision-making processes. (authors)

  4. Fuels planning: science synthesis and integration; economic uses fact sheet 04: My Fuel Treatment Planner

    Science.gov (United States)

    Rocky Mountain Research Station USDA Forest Service

    2004-01-01

    In the face of rapidly changing public and political attitudes toward fire and fuel planning, one thing remains constant: the fuel planner is ultimately responsible for making decisions on the land. This fact sheet discusses the options for fuel treatments, and the need, development, and use of the MS Excel-based tool, My Fuel Treatment Planner.

  5. Radiological aspects of postfission waste management for light-water reactor fuel cycle options

    Energy Technology Data Exchange (ETDEWEB)

    Shipler, D B; Nelson, I C [Battelle Pacific Northwest Laboratories, Richland, WA (United States)

    1978-12-01

    A generic environmental impact statement on the management of radioactive postfission wastes from various light-water reactor fuel cycles in the United States has been prepared. The environmental analysis for post-fission waste management includes an examination of radiological impacts related to different waste treatment, storage, transportation, and disposal options at the process level. Effects addressed include effluents from plants, and radiological impacts from facility operation (routine and accidents), and decommissioning. Environmental effects are combined for fuel reprocessing plants, mixed-oxide fuel fabrication plants, and waste repositories. Radiological effects are also aggregated for several fuel cycle options over the period 1980 and 2050. Fuel cycles analyzed are (1) once-through cycle in which spent reactor fuel is cooled in water basins for at least 6-1/2 years and then disposed of in deep geologic repositories; (2) spent fuel reprocessing in which uranium only and uranium and plutonium is recycled and solidified high level waste, fuel residues, and non-high-level transuranic wastes are disposed of in deep geologic repositories; and (3) deferred cycle that calls for storage of spent fuel at Federal spent fuel storage facilities until the year 2000 at which time a decision is made whether to dispose of spent fuel as a waste or to reprocess the fuel to recover uranium and plutonium. Key environmental issues for decision-making related to waste management alternatives and fuel cycle options are highlighted. (author)

  6. Fuel cells - An option for the future

    International Nuclear Information System (INIS)

    Vielstich, W.

    1984-01-01

    The direct conversion of the energy of a fuel into electrical energy in fuel cells avoids the losses inseparable from the indirect conversion via heat and mechanical energy. The idea to use this concept of energy conversion for the application in power stations would offer the following advantages: a slightly better total energy efficiency; no environmental problems; and flexibility in size according to the construction in the battery stacks. The use of acid and alkaline H 2 /O 2 fuel cells in the U.S. space program has demonstrated the high energy per weight data possible with a fuel cell device including tankage. Therefore, the application of fuel cells in electric vehicles seems to be suitable at least from the technical point of view. Kordesch has converted an Austin A-40 to electric propulsion by replacing the gasoline engine by an 8-kW truck motor powered by a 6-kW alkaline hydrogen-air fuel cell/4-kW lead-acid hybrid system. Two severe handicaps that occurred were the use of gas cylinders for the storage of the hydrogen and the voluminous CO 2 scrubber to prevent carbonization of the alkaline electrolyte. The direct conversion of a liquid fuel like methanol would be advantageous

  7. Microwave treatment of BPH: still an option?

    NARCIS (Netherlands)

    de la Rosette, J. J.

    1994-01-01

    Surgery, the gold standard in the treatment of benign prostatic hyperplasia (BPH), is presently performed in the majority of patients who receive treatment. An increasing number of alternative options recently became available for treatment of BPH and especially minimal invasive treatment

  8. Impact of Nuclear Energy Futures on Advanced Fuel Cycle Options

    International Nuclear Information System (INIS)

    Dixon, B.W.; Piet, S.J.

    2004-01-01

    The Nuclear Waste Policy Act requires the Secretary of Energy to inform Congress before 2010 on the need for a second geologic repository for spent nuclear fuel. By that time, the spent fuel discharged from current commercial reactors will exceed the statutory limit of the first repository. There are several approaches to eliminate the need for another repository in this century. This paper presents a high-level analysis of these spent fuel management options in the context of a full range of possible nuclear energy futures. The analysis indicates the best option to implement varies depending on the nuclear energy future selected

  9. Treatment Option Overview (AIDS Related-Lymphoma)

    Science.gov (United States)

    ... and treatment options. AIDS-related lymphoma is a disease in which malignant (cancer) cells form in the ... cord. The sample may also be checked for Epstein-Barr virus . This procedure is also called an LP ...

  10. Treatment Option Overview (Bladder Cancer)

    Science.gov (United States)

    ... above the waist. Tiny tubules in the kidneys filter and clean the blood . They take out waste ... to bladder cancer. Being exposed to paints, dyes, metals, or petroleum products in the workplace. Past treatment ...

  11. Treatment Option Overview (Parathyroid Cancer)

    Science.gov (United States)

    ... the following rare disorders that are inherited (passed down from parent to child): Familial isolated hyperparathyroidism (FIHP). Multiple endocrine neoplasia type 1 (MEN1) syndrome . Treatment with radiation therapy may increase the risk of ...

  12. New options for uveitis treatment

    OpenAIRE

    He, Yu; Jia, Song-Bai; Zhang, Wei; Shi, Jing-Ming

    2013-01-01

    Uveitis is one of the most important causes of blindness worldwide. Its etiology and pathogenesis are complicated and have not been well understood. The treatment for uveitis is predominantly based on steroids and immunosuppressants. However, systemic side effects limit their clinical application. With the advancement of molecular biology, some intravitreal implants and biologic agents have been used for the treatment of uveitis. Additionally, novel techniques such as gene therapy and RNA int...

  13. Accelerators and alternative nuclear fuel management options

    International Nuclear Information System (INIS)

    Harms, A.A.

    1983-01-01

    The development of special accelerators suggests the po tential for new directions in nuclear energy systems evolution. Such directions point towards a more acceptable form of nuclear energy by reason of the consequent accessibility of enhanced fuel management choices. Essential and specifically directed research and development activity needs to be under taken in order to clarify and resolve a number of technical issues

  14. Reforming options for hydrogen production from fossil fuels for PEM fuel cells

    Energy Technology Data Exchange (ETDEWEB)

    Ersoz, Atilla; Olgun, Hayati [TUBITAK Marmara Research Center, Institute of Energy, Gebze, 41470 Kocaeli (Turkey); Ozdogan, Sibel [Marmara University Faculty of Engineering, Goztepe, 81040 Istanbul (Turkey)

    2006-03-09

    PEM fuel cell systems are considered as a sustainable option for the future transport sector in the future. There is great interest in converting current hydrocarbon based transportation fuels into hydrogen rich gases acceptable by PEM fuel cells on-board of vehicles. In this paper, we compare the results of our simulation studies for 100kW PEM fuel cell systems utilizing three different major reforming technologies, namely steam reforming (SREF), partial oxidation (POX) and autothermal reforming (ATR). Natural gas, gasoline and diesel are the selected hydrocarbon fuels. It is desired to investigate the effect of the selected fuel reforming options on the overall fuel cell system efficiency, which depends on the fuel processing, PEM fuel cell and auxiliary system efficiencies. The Aspen-HYSYS 3.1 code has been used for simulation purposes. Process parameters of fuel preparation steps have been determined considering the limitations set by the catalysts and hydrocarbons involved. Results indicate that fuel properties, fuel processing system and its operation parameters, and PEM fuel cell characteristics all affect the overall system efficiencies. Steam reforming appears as the most efficient fuel preparation option for all investigated fuels. Natural gas with steam reforming shows the highest fuel cell system efficiency. Good heat integration within the fuel cell system is absolutely necessary to achieve acceptable overall system efficiencies. (author)

  15. Reforming options for hydrogen production from fossil fuels for PEM fuel cells

    Science.gov (United States)

    Ersoz, Atilla; Olgun, Hayati; Ozdogan, Sibel

    PEM fuel cell systems are considered as a sustainable option for the future transport sector in the future. There is great interest in converting current hydrocarbon based transportation fuels into hydrogen rich gases acceptable by PEM fuel cells on-board of vehicles. In this paper, we compare the results of our simulation studies for 100 kW PEM fuel cell systems utilizing three different major reforming technologies, namely steam reforming (SREF), partial oxidation (POX) and autothermal reforming (ATR). Natural gas, gasoline and diesel are the selected hydrocarbon fuels. It is desired to investigate the effect of the selected fuel reforming options on the overall fuel cell system efficiency, which depends on the fuel processing, PEM fuel cell and auxiliary system efficiencies. The Aspen-HYSYS 3.1 code has been used for simulation purposes. Process parameters of fuel preparation steps have been determined considering the limitations set by the catalysts and hydrocarbons involved. Results indicate that fuel properties, fuel processing system and its operation parameters, and PEM fuel cell characteristics all affect the overall system efficiencies. Steam reforming appears as the most efficient fuel preparation option for all investigated fuels. Natural gas with steam reforming shows the highest fuel cell system efficiency. Good heat integration within the fuel cell system is absolutely necessary to achieve acceptable overall system efficiencies.

  16. Closing the fuel cycle: A superior option for India

    International Nuclear Information System (INIS)

    Balu, K.; Purushotham, D.S.C.; Kakodkar, A.

    1999-01-01

    The closed fuel cycle option with reprocessing and recycle of uranium and plutonium (U and Pu) for power generation allows better utilization of the uranium resources. On its part, plutonium is a unique energy source. During the initial years of nuclear fuel cycle activities, reprocessing and recycle of uranium and plutonium for power generation was perceived by many countries to be among the best of long term strategies for the management of spent fuel. But, over the years, some of the countries have taken a position that once-through fuel cycle is both economical and proliferation-resistant. However, such perceptions do vary as a function of economic growth and energy security of a given country. This paper deals with techno-economic perspectives of reprocessing and recycling in the Indian nuclear power programme. Experience of developing Mixed Oxide UO 2 -PuO 2 (MOX) fuel and its actual use in a power reactor (BWR) is presented. The paper further deals with the use of MOX in PHWRs in the future and current thinking, in the Indian context, in respect of advanced fuel cycles for the future. From environmental safety considerations, the separation of long-lived isotopes and minor actinides from high level waste (HLW) would enhance the acceptability of reprocessing and recycle option. The separated actinides are suitable for recycling with MOX fuel. However, the advanced fuel cycles with such recycling of Uranium and transuranium elements call for additional sophisticated fuel cycle activities which are yet to be mastered. India is interested in both uranium and thorium fuel cycles. This paper describes the current status of the Indian nuclear power scenario with reference to the program on reactors, reprocessing and radioactive waste management, plutonium recycle options, thorium-U233 fuel cycle studies and investigations on partitioning of actinides from Purex HLW as relevant to PHWR spent fuels. (author)

  17. Nail Psoriasis: A Review of Treatment Options.

    Science.gov (United States)

    Pasch, Marcel C

    2016-04-01

    Nail involvement affects 80-90 % of patients with plaque psoriasis, and is even more prevalent in patients with psoriatic arthritis. This review is the result of a systemic approach to the literature and covers topical, intralesional, conventional systemic, and biologic systemic treatments, as well as non-pharmacological treatment options for nail psoriasis. The available evidence suggests that all anti-tumor necrosis factor-α, anti-interleukin (IL)-17, and anti-IL-12/23 antibodies which are available for plaque psoriasis and psoriatic arthritis are highly effective treatments for nail psoriasis. Conventional systemic treatments, including methotrexate, cyclosporine, acitretin, and apremilast, as well as intralesional corticosteroids, can also be effective treatments for nail psoriasis. Topical treatments, including corticosteroids, calcipotriol, tacrolimus, and tazarotene, have also been shown to have a position in the treatment of nail psoriasis, particularly in mild cases. Finally, non-pharmacological treatment options, including phototherapy, photodynamic therapy, laser therapy, and several radiotherapeutic options, are also reviewed but cannot be advised as first-line treatment options. Another conclusion of this review is that the lack of a reliable core set of outcomes measures for trials in nail psoriasis hinders the interpretation of results, and is urgently needed.

  18. Frontal fibrosing alopecia treatment options.

    Science.gov (United States)

    Fertig, Raymond; Tosti, Antonella

    2016-11-01

    Frontal fibrosing alopecia (FFA) is a rare dermatologic disease that causes scarring and hair loss and is increasing in prevalence worldwide. FFA patients typically present with hair loss in the frontal scalp region and eyebrows which may be associated with sensations of itching or burning. FFA is a clinically distinct variant of lichen planopilaris (LPP) that affects predominantly postmenopausal women, although men and premenopausal women may also be affected. Early diagnosis and prompt treatment are necessary to prevent definitive scarring and permanent hair loss. Data from retrospective studies indicate that 5-alpha-reductase inhibitors (5aRIs) are effective in stabilizing the disease. In our clinical experience, we have seen optimal results treating FFA patients with oral finasteride in conjunction with hydroxychloroquine, topical calcineurin inhibitors (tacrolimus) and excimer laser in patients with signs of active inflammation.

  19. Treatment options for carcinoma in situ testis

    DEFF Research Database (Denmark)

    Mortensen, M S; Gundgaard, M.G.; Daugaard, G

    2011-01-01

    countries only offer this to high-risk patients. The treatment options range from orchidectomy and chemotherapy to radiotherapy and in rare cases surveillance. Results of the different treatment strategies are presented in this review. The optimal radiation dose is still not clarified. Most patients have...

  20. Treatment Options by Stage (Small Cell Lung Cancer)

    Science.gov (United States)

    ... factors affect prognosis (chance of recovery) and treatment options. The prognosis (chance of recovery ) and treatment options ... or in other parts of the body. Treatment Option Overview Key Points There are different types of ...

  1. Treatment Option Overview (Mycosis Fungoides and the Sezary Syndrome)

    Science.gov (United States)

    ... factors affect prognosis (chance of recovery) and treatment options. The prognosis (chance of recovery ) and treatment options ... or in other parts of the body. Treatment Option Overview Key Points There are different types of ...

  2. Treatment Option Overview (Wilms Tumor and Other Childhood Kidney Tumors)

    Science.gov (United States)

    ... factors affect prognosis (chance of recovery) and treatment options. The prognosis (chance of recovery ) and treatment options ... come back) after it has been treated. Treatment Option Overview Key Points There are different types of ...

  3. Treatment Option Overview (Adult Non-Hodgkin Lymphoma)

    Science.gov (United States)

    ... factors affect prognosis (chance of recovery) and treatment options. The prognosis (chance of recovery ) and treatment options ... lymphoma may come back as indolent lymphoma. Treatment Option Overview Key Points There are different types of ...

  4. Kleptomania: diagnosis and treatment options.

    Science.gov (United States)

    Durst, R; Katz, G; Teitelbaum, A; Zislin, J; Dannon, P N

    2001-01-01

    Kleptomania--the inability to resist the impulse to steal objects, not for personal use or monetary gain--is currently classified in psychiatric nomenclature as an impulse control disorder. However, some of the principle features of the disorder, which include repetitive intrusion thoughts, inability to resist the compulsion to perform the thievery and the relief of tension following the act, suggest that kleptomania may constitute an obsessive-compulsive spectrum disorder. Kleptomania is commonly under-diagnosed and is often accompanied by other psychiatric conditions, most notably affective, anxiety and eating disorders, and alcohol and substance abuse. Individuals with the disorder are usually referred for treatment due to the comorbid psychiatric complaints rather than kleptomanic behaviour per se. Over the past century there has been a shift from psychotherapeutic to psychopharmacological interventions for kleptomania. Pharmacological management using selective serotonin (5-hydroxytryptamine; 5-HT) reuptake inhibitors (SSRIs) and other antidepressants, mood stabilisers and opioid receptor antagonists, as adjuvants to cognitive-behavioural therapy, has produced promising results.

  5. ENVI Model Development for Korean Nuclear Spent Fuel Options Analysis

    Energy Technology Data Exchange (ETDEWEB)

    Chang, Sunyoung; Jeong, Yon Hong; Han, Jae-Jun; Lee, Aeri; Hwang, Yong-Soo [Korea Institute of Nuclear Nonproliferation and Control, Daejeon (Korea, Republic of)

    2015-10-15

    The disposal facility of the spent nuclear fuel will be operated from 2051. This paper presents the ENVI code developed by GoldSim Software to simulate options for managing spent nuclear fuel (SNF) in South Korea. The ENVI is a simulator to allow decision-makers to assist to evaluate the performance for spent nuclear fuel management. The multiple options for managing the spent nuclear fuel including the storage and transportation are investigated into interim storage, permanent disposal in geological repositories and overseas and domestic reprocessing. The ENVI code uses the GoldSim software to simulate the logistics of the associated activities. The result by the ENVI model not only produces the total cost to compare among the multiple options but also predict the sizes and timings of different facilities required. In order to decide the policy for spent nuclear management this purpose of this paper is to draw the optimum management plan to solve the nuclear spent fuel issue in the economical aspects. This paper is focused on the development of the ENVI's logic and calculations to simulate four options(No Reprocessing, Overseas Reprocessing, Domestic Reprocessing, and Overseas and Domestic Reprocessing) for managing the spent nuclear fuel in South Korea. The time history of the spent nuclear fuel produced from both the existing and future NPP's can be predicted, based on the Goldsim software made available very user friendly model. The simulation result will be used to suggest the strategic plans for the spent nuclear fuel management.

  6. ENVI Model Development for Korean Nuclear Spent Fuel Options Analysis

    International Nuclear Information System (INIS)

    Chang, Sunyoung; Jeong, Yon Hong; Han, Jae-Jun; Lee, Aeri; Hwang, Yong-Soo

    2015-01-01

    The disposal facility of the spent nuclear fuel will be operated from 2051. This paper presents the ENVI code developed by GoldSim Software to simulate options for managing spent nuclear fuel (SNF) in South Korea. The ENVI is a simulator to allow decision-makers to assist to evaluate the performance for spent nuclear fuel management. The multiple options for managing the spent nuclear fuel including the storage and transportation are investigated into interim storage, permanent disposal in geological repositories and overseas and domestic reprocessing. The ENVI code uses the GoldSim software to simulate the logistics of the associated activities. The result by the ENVI model not only produces the total cost to compare among the multiple options but also predict the sizes and timings of different facilities required. In order to decide the policy for spent nuclear management this purpose of this paper is to draw the optimum management plan to solve the nuclear spent fuel issue in the economical aspects. This paper is focused on the development of the ENVI's logic and calculations to simulate four options(No Reprocessing, Overseas Reprocessing, Domestic Reprocessing, and Overseas and Domestic Reprocessing) for managing the spent nuclear fuel in South Korea. The time history of the spent nuclear fuel produced from both the existing and future NPP's can be predicted, based on the Goldsim software made available very user friendly model. The simulation result will be used to suggest the strategic plans for the spent nuclear fuel management

  7. An analysis of international nuclear fuel supply options

    Science.gov (United States)

    Taylor, J'tia Patrice

    As the global demand for energy grows, many nations are considering developing or increasing nuclear capacity as a viable, long-term power source. To assess the possible expansion of nuclear power and the intricate relationships---which cover the range of economics, security, and material supply and demand---between established and aspirant nuclear generating entities requires models and system analysis tools that integrate all aspects of the nuclear enterprise. Computational tools and methods now exist across diverse research areas, such as operations research and nuclear engineering, to develop such a tool. This dissertation aims to develop methodologies and employ and expand on existing sources to develop a multipurpose tool to analyze international nuclear fuel supply options. The dissertation is comprised of two distinct components: the development of the Material, Economics, and Proliferation Assessment Tool (MEPAT), and analysis of fuel cycle scenarios using the tool. Development of MEPAT is aimed for unrestricted distribution and therefore uses publicly available and open-source codes in its development when possible. MEPAT is built using the Powersim Studio platform that is widely used in systems analysis. MEPAT development is divided into three modules focusing on: material movement; nonproliferation; and economics. The material movement module tracks material quantity in each process of the fuel cycle and in each nuclear program with respect to ownership, location and composition. The material movement module builds on techniques employed by fuel cycle models such as the Verifiable Fuel Cycle Simulation (VISION) code developed at the Idaho National Laboratory under the Advanced Fuel Cycle Initiative (AFCI) for the analysis of domestic fuel cycle. Material movement parameters such as lending and reactor preference, as well as fuel cycle parameters such as process times and material factors are user-specified through a Microsoft Excel(c) data spreadsheet

  8. An Integrated Fuel Depletion Calculator for Fuel Cycle Options Analysis

    Energy Technology Data Exchange (ETDEWEB)

    Schneider, Erich [Univ. of Texas, Austin, TX (United States); Scopatz, Anthony [Univ. of Wisconsin, Madison, WI (United States)

    2016-04-25

    Bright-lite is a reactor modeling software developed at the University of Texas Austin to expand upon the work done with the Bright [1] reactor modeling software. Originally, bright-lite was designed to function as a standalone reactor modeling software. However, this aim was refocused t couple bright-lite with the Cyclus fuel cycle simulator [2] to make it a module for the fuel cycle simulator.

  9. Influence of fuel costs on seawater desalination options

    International Nuclear Information System (INIS)

    Methnani, Mabrouk

    2007-01-01

    Reference estimates of seawater desalination costs for recent mega projects are all quoted in the range of US$0.50/m 3 . This however does not reflect the recent trends of escalating fossil fuel costs. In order to analyze the effect of these trends, a recently updated version of the IAEA Desalination Economic Evaluation Program, DEEP-3, has been used to compare fossil and nuclear seawater desalination options, under varied fuel cost and interest rate scenarios. Results presented for a gas combined-cycle and a modular high-temperature gas-cooled reactor design, show clear cost advantages for the latter, for both Multi-Effect Distillation (MED) and Reverse Osmosis (RO). Water production cost estimates for the Brayton cycle nuclear option are hardly affected by fuel costs, while combined cycle seawater desalination costs show an increase of more than 40% when fuel costs are doubled. For all cases run, the nuclear desalination costs are lower and if the current trend in fossil fuel prices continues as predicted by pessimist scenarios and the carbon tax carried by greenhouse emissions is enforced in the future, the cost advantage for nuclear desalination will be even more pronounced. Increasing the interest rate from 5 to 8% has a smaller effect than fuel cost variations. It translates into a water cost increase in the range of 10-20%, with the nuclear option being the more sensitive. (author)

  10. Stereotactic Neurosurgical Treatment Options for Childhood Craniopharyngioma

    Directory of Open Access Journals (Sweden)

    Michael eTrippel

    2012-05-01

    Full Text Available Craniopharyngioma are the most common non glial tumors in childhood. The results of different studies indicate that radical excision surgery is not an appropriate treatment strategy for childhood craniopharyngioma with hypothalamic involvement. Stereotactic neurosurgery provides save, minimal invasive and cost efficient options in the treatment of childhood craniopharyngioma. In this review a summary of the contribution of the stereotactic neurosurgery in the interdisciplinary treatment regime of childhood craniopharyngioma will be given and discussed in detail.

  11. Fuel options for public bus fleets in Sweden

    OpenAIRE

    Xylia, Maria; Silveira, Semida

    2015-01-01

    The Swedish public transport sector has defined two major targets, i.e., to run 90% of the total vehicle kilometers of the fleet on non-fossil fuels and double the volume of travel via public transport by 2020, increasing the share of public transport in relation to the total personal transport in the country . The f3 report Fuel options for public bus fleets in Sweden highlights the challenges and solutions encountered, particularly when it comes to the adoption of renewable fuels in the reg...

  12. Options for the interim storage of spent fuel

    International Nuclear Information System (INIS)

    Kromar, M.; Kurincic, B.

    1995-01-01

    Different concepts for the interim storage of spent fuel arising from operation of a NPP are discussed. We considered at reactor as well as away from reactor storage options. Included are enhancements of existing storage capabilities and construction of a new wet or dry storage facility. (author)

  13. Spent fuel storage - dry storage options and issues

    International Nuclear Information System (INIS)

    Akins, M.J.

    2007-01-01

    The increase in the number of nuclear energy power generation facilities will require the ability to store the spent nuclear fuel for a long period until the host countries develop reprocessing or disposal options. Plants have storage pools which are closely associated with the operating units. These are excellent for short term storage, but require active maintenance and operations support which are not desirable for the long term. Over the past 25 years, dry storage options have been developed and implemented throughout the world. In recent years, protection against terrorist attack has become an increasing source of design objectives for these facilities, as well as the main nuclear plant. This paper explores the current design options of dry storage cask systems and examines some of the current design issues for above ground , in-ground, or below-ground storage of spent fuel in dry casks. (author)

  14. Life cycle assessment of automobile/fuel options.

    Science.gov (United States)

    MacLean, Heather L; Lave, Lester B

    2003-12-01

    We examine the possibilities for a "greener" car that would use less material and fuel, be less polluting, and would have a well-managed end-of-life. Light-duty vehicles are fundamental to our economy and will continue to be for the indefinite future. Any redesign to make these vehicles greener requires consumer acceptance. Consumer desires for large, powerful vehicles have been the major stumbling block in achieving a "green car". The other major barrier is inherent contradictions among social goals such as fuel economy, safety, low emissions of pollutants, and low emissions of greenhouse gases, which has led to conflicting regulations such as emissions regulations blocking sales of direct injection diesels in California, which would save fuel. In evaluating fuel/vehicle options with the potential to improve the greenness of cars [diesel (direct injection) and ethanol in internal combustion engines, battery-powered, gasoline hybrid electric, and hydrogen fuel cells], we find no option dominates the others on all dimensions. The principles of green design developed by Anastas and Zimmerman (Environ. Sci. Technol. 2003, 37, 94A-101A) and the use of a life cycle approach provide insights on the key sustainability issues associated with the various options.

  15. Mass Flow Data Comparison for Comprehensive Fuel Cycle Options

    International Nuclear Information System (INIS)

    Kim, T.K.; Taiwo, T.A.; Wigeland, R.A.; Dixon, B.W.; Gehin, J.C.; Todosow, M.

    2015-01-01

    One of the key objectives stated in the United States Department of Energy, Nuclear Energy R and D road-map is the development of sustainable nuclear fuel cycles that improve natural resource utilisation and provide adequate capability and capacity to manage wastes produced by the fuel cycle. In order to inform this objective, an evaluation and screening of nuclear fuel cycle options has been conducted. As part of that effort, the entire fuel cycle options space was represented by 40 Evaluation Groups (EGs), and mass flow information for each of the EGs was provided by using an Analysis Example (AE). In this paper, the mass flow data of the 40 AEs are compared to inform on trends in the natural resource utilisation and nuclear waste generation. For the AEs that need enriched uranium support, the natural uranium required is high and the natural resource utilisation is generally lower than 2% regardless of the fuel cycle strategy (i.e., once-through, limited recycle, or continuous recycle). However, the utilisation could be improved by avoiding enriched uranium fuel support. The natural resource utilisation increases to more than 80% by recycling the nuclear fuel continuously without enriched uranium support. The combined mass of spent nuclear fuel (SNF) and high-level waste (HLW), i.e., SNF+HLW mass, is lower by using a continuous recycle option compared to a once-through fuel cycle option, because SNF mass is converted to mass of recycled products and only fission products and other process losses need to be disposed. The combined disposed mass of depleted uranium (DU), recovered uranium (RU) and thorium (RTh), i.e. DU+RU+RTh mass, has a similar trend to the uranium utilisation. For the AEs that need enriched uranium fuel, the DU and RU are the major fraction by mass of the DU+RU+RTh, which are two orders of magnitude higher in mass compared to those for the AEs that do not need enriched uranium fuel. (authors)

  16. Fuel cycle options for light water reactors in Germany

    International Nuclear Information System (INIS)

    Broecking, D.; Mester, W.

    1999-01-01

    In Germany 19 nuclear power plants with an electrical output of 22 GWe are in operation. Annually about 450 t of spent fuel are unloaded from the reactors. Currently most of the spent fuel elements are shipped to France and the United Kingdom for reprocessing according to contracts which have been signed since the late 70es. By the amendment of the Atomic Energy Act in 1994 the previous priority for reprocessing of spent nuclear fuel was substituted by a legal equivalency of the reprocessing and direct disposal option. As a consequence some utilities take into consideration the direct disposal of their spent fuel for economical reasons. The separated plutonium will be recycled as MOX fuel in light water reactors. About 30 tons of fissile plutonium will be available to German utilities for recycling by the year 2000. Twelve German reactors are already licensed for the use of MOX fuel, five others have applied for MOX use. Eight reactors are currently using MOX fuel or used it in the past. The spent fuel elements which shall be disposed of without reprocessing will be stored in two interim dry storage facilities at Gorleben and Ahaus. The storage capacities are 3800 and 4200 tHM, respectively. The Gorleben salt dome is currently investigated to prove its suitability as a repository for high level radioactive waste, either in a vitrified form or as conditioned spent fuel. The future development of the nuclear fuel cycle and radioactive waste management depends on the future role of nuclear energy in Germany. According to estimations of the German utilities no additional nuclear power plants are needed in the near future. Around the middle of the next decade it will have to be decided whether existing plants should be substituted by new ones. For the foreseeable time German utilities are interested in a highly flexible approach to the nuclear fuel cycle and waste management keeping open both spent fuel management options: the closed fuel cycle and direct disposal of

  17. Nonsurgical Treatment Options for Basal Cell Carcinoma

    International Nuclear Information System (INIS)

    Lien, M. H.; Sondak, V. K.; Sondak, V. K.

    2011-01-01

    Basal cell carcinoma (BCC) remains the most common form of non melanoma skin cancer (NMSC) in Caucasians, with perhaps as many as 2 million new cases expected to occur in the United States in 2010. Many treatment options, including surgical interventions and nonsurgical alternatives, have been utilized to treat BCC. In this paper, two non-surgical options, imiquimod therapy and photodynamic therapy (PDT), will be discussed. Both modalities have demonstrated acceptable disease control rates, cosmetically superior outcomes, and short-term cost-effectiveness. Further studies evaluating long-term cure rates and long-term cost effectiveness of imiquimod therapy and PDT are needed.

  18. Tradeoffs in fuel cycle performance for most promising options - 15346

    International Nuclear Information System (INIS)

    Taiwo, T.; Kim, T.K.; Feng, B.; Stauff, N.; Hoffman, E.; Ganda, F.; Todosow, M.; Brown, N.; Raitses, G.; Gehin, J.; Powers, J.; Youinou, G.; Hiruta, H.; Wigeland, R.

    2015-01-01

    A recent Evaluation and Screening (E/S) study of nuclear fuel cycle options was conducted by grouping all potential options into 40 Evaluation Groups (EGs) based on similarities in fundamental physics characteristics and fuel cycle performance. Through a rigorous evaluation process considering benefit and challenge metrics, 4 of these EGs were identified by the E/S study as 'most promising'. All 4 involve continuous recycle of U/Pu or U/TRU with natural uranium feed in fast critical reactors. However, these most promising EGs also include fuel cycle groups with variations on feed materials, neutron spectra, and reactor criticality. Therefore, the impacts of the addition of natural thorium fuel feed to a system that originally only used natural uranium fuel feed, using an intermediate spectrum instead of a fast spectrum, and using externally-driven systems versus critical reactors were evaluated. It was found that adding thorium to the natural uranium feed mixture leads to lower burnup, higher mass flows, and degrades fuel cycle benefit metrics (waste management, resource utilization, etc.) for fuel cycles that continuously recycle U/Pu or U/TRU. Adding thorium results in fissions of 233 U instead of just 239 Pu and in turn results in a lower average number of neutrons produced per absorption (η) for the fast reactor system. For continuous recycling systems, the lower η results in lower excess reactivity and subsequently lower achievable fuel burnup. This in turn leads to higher mass flows (fabrication, reprocessing, disposal, etc.) to produce a given amount of energy and subsequent lower metrics performance. The investigated fuel cycle options with intermediate spectrum reactors also exhibited degraded performance in the benefit metrics compared to fast spectrum reactors. Similarly, this is due to lower η values as the spectrum softens. The best externally-driven systems exhibited similar performance as fast critical reactors in terms of mass flows

  19. Assessment of Used Nuclear Fuel Inventory Relative to Disposition Options

    International Nuclear Information System (INIS)

    Wagner, John C.; Peterson, Joshua L.; Mueller, Don; Gehin, Jess C.; Worrall, Andrew; Taiwo, Temitope; Nutt, Mark; Williamson, Mark A.; Todosow, Mike; Wigeland, Roald; Halsey, William; Omberg, Ronald; Swift, Peter; Carter, Joe

    2013-01-01

    This paper presents a technical assessment of the current inventory [∼70,150 metric tons of heavy metal (MTHM) as of 2011] of U.S.-discharged used nuclear fuel (UNF) to support decisions regarding fuel cycle strategies and research, development and demonstration (RD and D) needs. The assessment considered discharged UNF from commercial nuclear electricity generation and defense and research programs and determined that the current UNF inventory can be divided into the following three categories: 1. Disposal - excess material that is not needed for other purposes; 2. Research - material needed for RD and D purposes to support waste management (e.g., UNF storage, transportation, and disposal) and development of alternative fuel cycles (e.g., separations and advanced fuels/reactors); and 3. Recycle/Recovery - material with inherent and/or strategic value. A set of key assumptions and attributes relative to the disposition options was used to categorize the current UNF inventory. Based on consideration of RD and D needs, time frames and material needs for deployment of alternative fuel cycles, characteristics of the current UNF inventory, and possible uses to support national security interests, it was determined that the vast majority of the category, without the need for retrieval for reuse or research purposes. Access to the material in the Research and Recycle/Recovery categories should be retained to support RD and D needs and national security interests. This assessment does not assume any decision about future fuel cycle options or preclude any potential options, including those with potential recycling of commercial UNF, since the ∼2,000 MTHM that is generated annually could provide the feedstock needed for deployment of alternative fuel cycles.

  20. Advances in HTGR spent fuel treatment technology

    International Nuclear Information System (INIS)

    Holder, N.D.; Lessig, W.S.

    1984-08-01

    GA Technologies, Inc. has been investigating the burning of spent reactor graphite under Department of Energy sponsorship since 1969. Several deep fluidized bed burners have been used at the GA pilot plant to develop graphite burning techniques for both spent fuel recovery and volume reduction for waste disposal. Since 1982 this technology has been extended to include more efficient circulating bed burners. This paper includes updates on high-temperature gas-cooled reactor fuel cycle options and current results of spent fuel treatment testing for fluidized and advanced circulating bed burners

  1. A nuclear fuel cycle system dynamic model for spent fuel storage options

    International Nuclear Information System (INIS)

    Brinton, Samuel; Kazimi, Mujid

    2013-01-01

    Highlights: • Used nuclear fuel management requires a dynamic system analysis study due to its socio-technical complexity. • Economic comparison of local, regional, and national storage options is limited due to the public financial information. • Local and regional options of used nuclear fuel management are found to be the most economic means of storage. - Abstract: The options for used nuclear fuel storage location and affected parameters such as economic liabilities are currently a focus of several high level studies. A variety of nuclear fuel cycle system analysis models are available for such a task. The application of nuclear fuel cycle system dynamics models for waste management options is important to life-cycle impact assessment. The recommendations of the Blue Ribbon Committee on America’s Nuclear Future led to increased focus on long periods of spent fuel storage [1]. This motivated further investigation of the location dependency of used nuclear fuel in the parameters of economics, environmental impact, and proliferation risk. Through a review of available literature and interactions with each of the programs available, comparisons of post-reactor fuel storage and handling options will be evaluated based on the aforementioned parameters and a consensus of preferred system metrics and boundary conditions will be provided. Specifically, three options of local, regional, and national storage were studied. The preliminary product of this research is the creation of a system dynamics tool known as the Waste Management Module (WMM) which provides an easy to use interface for education on fuel cycle waste management economic impacts. Initial results of baseline cases point to positive benefits of regional storage locations with local regional storage options continuing to offer the lowest cost

  2. Fuel Cells: Power System Option for Space Research

    Science.gov (United States)

    Shaneeth, M.; Mohanty, Surajeet

    2012-07-01

    Fuel Cells are direct energy conversion devices and, thereby, they deliver electrical energy at very high efficiency levels. Hydrogen and Oxygen gases are electrochemically processed, producing clean electric power with water as the only by product. A typical, Fuel Cell based power system involve a Electrochemical power converter, gas storage and management systems, thermal management systems and relevant control units. While there exists different types of Fuel cells, Proton Exchange Membrane (PEM) Fuel Cells are considered as the most suitable one for portable applications. Generally, Fuel Cells are considered as the primary power system option in space missions requiring high power ( > 5kW) and long durations and also where water is a consumable, such as manned missions. This is primarily due to the advantage that fuel cell based power systems offer, in terms of specific energy. Fuel cells have the potential to attain specific energy > 500Wh/kg, specific power >500W/kg, energy density > 400Whr/L and also power density > 200 W/L. This apart, a fuel cell system operate totally independent of sun light, whereas as battery based system is fully dependent on the same. This uniqueness provides added flexibility and capabilities to the missions and modularity for power system. High power requiring missions involving reusable launch vehicles, manned missions etc are expected to be richly benefited from this. Another potential application of Fuel Cell would be interplanetary exploration. Unpredictable and dusty atmospheres of heavenly bodies limits sun light significantly and there fuel cells of different types, eg, Bio-Fuel Cells, PEMFC, DMFCs would be able to work effectively. Manned or unmanned lunar out post would require continuous power even during extra long lunar nights and high power levels are expected. Regenerative Fuel Cells, a combination of Fuel Cells and Electrolysers, are identified as strong candidate. While application of Fuel Cells in high power

  3. Novel treatment options in depression and psychosis

    Directory of Open Access Journals (Sweden)

    Ceskova E

    2018-03-01

    Full Text Available Eva Ceskova, Petr Silhan Department of Psychiatry, University Hospital Ostrava, Ostrava, Czech Republic Abstract: In spite of tremendous development in central nervous system research, current treatment is suboptimal, especially in severe mental disorders. In medicine, there are two main methods of improving the health care provided: seeking new treatment procedures and perfecting (optimizing the existing ones. Optimization of treatment includes not only practical tools such as therapeutic drug monitoring but also implementation of general trends in the clinical practice. New pharmacological options include new more sophisticated forms of monoaminergic drugs, old drugs rediscovered on the base of a better understanding of pathophysiology of mental illnesses, and drugs aimed at new treatment targets. In depression, treatment resistance to antidepressive pharmacotherapy represents one of the most important clinical challenges. Switching to monotherapy with new multimodal/multifunctional antidepressants and augmentation with new atypical antipsychotics (aripiprazole and brexpiprazole may be promising options. Further, current evidence supports utility and safety of adjunctive treatment of nutraceuticals. Novel approaches being studied include ketamine and opioids. Recent advances in technology and emerging knowledge about dysfunctional brain circuits and neuroplasticity have led to the development of different new neuromodulation techniques usually used as add-on therapy. Antipsychotics are still the cornerstone of the current treatment of schizophrenia. Two new partial dopamine agonists, brexpiprazole and cariprazine, are now available in addition to aripiprazole. Although the mechanisms of action are similar, the two agents differ in terms of their pharmacodynamic profiles. Further, two new formulations of long-acting injections of second-generation antipsychotics (aripiprazole lauroxil and 3-month paliperidone palmitate were introduced into

  4. Technology assessment of various coal-fuel options

    International Nuclear Information System (INIS)

    Coenen, R.; Findling, B.; Klein-Vielhauer, S.; Nieke, E.; Paschen, H.; Tangen, H.; Wintzer, D.

    1991-01-01

    The technology assessment (TA) study of coal-based fuels presented in this report was performed for the Federal Ministry for Research and Technology. Its goal was to support decision-making of the Federal Ministry for Research and Technology in the field of coal conversion. Various technical options of coal liquefaction have been analyzed on the basis of hard coal as well as lignite -- direct liquefaction of coal (hydrogenation) and different possibilities of indirect liquefaction, that is the production of fuels (methanol, gasoline) by processing products of coal gasification. The TA study takes into consideration the entire technology chain from coal mining via coal conversion to the utilization of coal-based fuels in road transport. The analysis focuses on costs of the various options, overall economic effects, which include effects on employment and public budgets, and on environmental consequences compared to the use of liquid fuels derived from oil. Furthermore, requirements of infrastructure and other problems of the introduction of coal-based fuels as well as prospects for the export of technologies of direct and indirect coal liquefaction have been analyzed in the study. 14 figs., 10 tabs

  5. Fibromyalgia Pathogenesis and Treatment Options Update.

    Science.gov (United States)

    Chinn, Steven; Caldwell, William; Gritsenko, Karina

    2016-04-01

    This review article presents and summarizes up-to-date literature on the clinical manifestations, diagnosis, pathophysiological mechanisms, and treatment options for fibromyalgia patients. First, the most recent diagnostic criteria for fibromyalgia, as put forth by the American College of Rheumatology will be summarized. Clinical features, including chronic widespread pain, hyperalgesia, mood disorders, anxiety, and disturbed sleep patterns will be explored in-depth. The pathogenesis and pathophysiology of fibromyalgia involves alterations in multiple ascending and descending central nervous system pathways, as well as peripheral pathways, leading to heightened pain sensitivity. Risk factors have been studied extensively, and the most recent research focuses on various genetic influences and the contributions of stress and poor sleep. Lastly, the discussion in this article focuses on treatment options for fibromyalgia; some have been mainstay options for many years. Pharmacological agents include tricyclic antidepressants, anti-epileptic drugs, selective serotonin reuptake inhibitors, norepinephrine/serotonin reuptake inhibitors, as well as some investigational agents. The evidence behind non-pharmacologic treatments, including massage therapy, exercise, and acupuncture, are discussed.

  6. [Necessary and unnecessary treatment options for hemorrhoids].

    Science.gov (United States)

    Zindel, Joel; Inglin, Roman; Brügger, Lukas

    2014-12-01

    Up to one third of the general population suffers from symptoms caused by hemorrhoids. Conservative treatment comes first unless the patient presents with an acute hemorrhoidal prolapse or a thrombosis. A fiber enriched diet is the primary treatment option, recommended in the perioperative period as well as a long-term prophylaxis. A timely limited application of topical ointments or suppositories and/or flavonoids are further treatment options. When symptoms persist interventional procedures for grade I-II hemorrhoids, and surgery for grade III-IV hemorrhoids should be considered. Rubber band ligation is the interventional treatment of choice. A comparable efficacy using sclerosing or infrared therapy has not yet been demonstrated. We therefore do not recommend these treatment options for the cure of hemorrhoids. Self-treatment by anal insertion of bougies is of lowrisk and may be successful, particularly in the setting of an elevated sphincter pressure. Anal dilation, sphincterotomy, cryosurgery, bipolar diathermy, galvanic electrotherapy, and heat therapy should be regarded as obsolete given the poor or missing data reported for these methods. For a long time, the classic excisional hemorrhoidectomy was considered to be the gold standard as far as surgical procedures are concerned. Primary closure (Ferguson) seems to be superior compared to the "open" version (Milligan Morgan) with respect to postoperative pain and wound healing. The more recently proposed stapled hemorrhoidopexy (Longo) is particularly advisable for circular hemorrhoids. Compared to excisional hemorrhoidectomy the Longo-operation is associated with reduced postoperative pain, shorter operation time and hospital stay as well as a faster recovery, with the disadvantage though of a higher recurrence rate. Data from Hemorrhoidal Artery Ligation (HAL)-, if appropriate in combination with a Recto-Anal Repair (HAL/RAR)-, demonstrates a similar trend towards a better tolerance of the procedure at the

  7. Emerging treatment options for meibomian gland dysfunction

    Directory of Open Access Journals (Sweden)

    Qiao J

    2013-09-01

    Full Text Available Jing Qiao, Xiaoming YanDepartment of Ophthalmology, Peking University First Hospital, Key Laboratory of Vision Loss and Restoration, Ministry of Education, Beijing, People's Republic of ChinaAbstract: Meibomian gland dysfunction (MGD is one of the most common diseases observed in clinics; it influences a great number of people, and is the leading cause of evaporative dry eye. Given the increased recognition of the importance of MGD, a great amount of attention has been paid to therapies targeting this condition. The traditional treatments of MGD consist of warm compresses and lid hygiene for removing an obstructed meibum, as well as antibiotics and anti-inflammatory agents to improve the quality of the meibum. However, each of these treatments has a different shortcoming and the treatment of MGD remains challenging. Despite the numerous possible treatment options for MGD, it is still difficult to obtain complete relief of signs and symptoms. This review focuses on current emerging treatment options for MGD including intraductal meibomian gland probing, emulsion eye drops containing lipids, the LipiFlow® thermal pulsation system, N-acetyl-cysteine, azithromycin, oral supplementation with omega-3 essential fatty acids, and cyclosporine A.Keywords: meibomian gland dysfunction, dry eye, emerging treatment

  8. MHR fuel cycle options for future sustainability of nuclear power

    International Nuclear Information System (INIS)

    Baxter, Alan; Venneri, Francesco; Rodriguez, Carmelo; Fikani, Michael

    2005-01-01

    The future sustainability of the nuclear option is not significantly tied to the level of resources. For example, current high quality uranium reserves (∼3.34x10 6 tons) are enough for more than 55 years at present consumption rates (IAEA estimate). Doubling of the present uranium ore price (∼$26/kg) could create about a tenfold increase in resources, providing more than 550 years of supply at present rates (World Nuclear Association estimate). There are also thorium reserves which are estimated to be about three times those of uranium, and would allow for a significant increase in annual consumption levels. The key to a sustainable nuclear future is really tied to the political and technical problems of long term waste disposal, and the perceived risks of nuclear weapons proliferation. Thus fuel cycle options for a sustainable nuclear future must address and solve these issues. High temperature, Gas-Cooled, Graphite Moderated, reactors (MHRs) have nuclear and operational characteristics to provide multiple fuel cycle options to solve these issues. Three fuel cycles for the MHD are described in this paper, and their capabilities for meeting a sustainable nuclear future in terms of nuclear waste minimization and destruction, and reduction of proliferation risk, are discussed. (author)

  9. Treatment Options By Stage (Ovarian Germ Cell Tumors)

    Science.gov (United States)

    ... Germ Cell Tumors Treatment (PDQ®)–Patient Version Treatment Option Overview Go to Health Professional Version Key Points ... and restore) the body’s blood cells. New treatment options Combination chemotherapy (the use of more than one ...

  10. Treatment Option Overview (Plasma Cell Neoplasms Including Multiple Myeloma)

    Science.gov (United States)

    ... factors affect prognosis (chance of recovery) and treatment options. The prognosis (chance of recovery ) depends on the ... going up even though treatment is given. Treatment Option Overview Key Points There are different types of ...

  11. Neonatal hepatic haemangioendothelioma: treatment options and dilemmas

    International Nuclear Information System (INIS)

    Meijs, Bram B. van der; Merks, Johannes H.M.; Haan, Timo R. de; Tabbers, Merit M.; Rijn, Rick R. van

    2009-01-01

    We describe a case of rapidly progressive neonatal diffuse hepatic haemangioendotheliomas. The clinical picture was characterized by respiratory insufficiency due to gross abdominal enlargement, coagulopathy, and the development of cardiovascular insufficiency during the course of disease. Pharmacological, radiotherapeutic and endovascular treatment options all proved ineffective. We describe our own experience and the steps taken to treat this child. Unfortunately, the child died as a consequence of the disease. As cases like this are rare and are associated with severe morbidity and high mortality, more knowledge needs to be gained on infantile hepatic haemangioendotheliomas and their optimal treatment. The use of a web-based data registry could be beneficial. (orig.)

  12. Economic Analysis of Different Nuclear Fuel Cycle Options

    International Nuclear Information System (INIS)

    Ko, W.; Gao, F.

    2012-01-01

    An economic analysis has been performed to compare four nuclear fuel cycle options: a once-through cycle (OT), DUPIC recycling, thermal recycling using MOX fuel in a pressurized water reactor (PWR-MOX), and sodium fast reactor recycling employing pyro processing (Pyro-SFR). This comparison was made to suggest an economic competitive fuel cycle for the Republic of Korea. The fuel cycle cost (FCC) has been calculated based on the equilibrium material flows integrated with the unit cost of the fuel cycle components. The levelized fuel cycle costs (LFCC) have been derived in terms of mills/kWh for a fair comparison among the FCCs, and the results are as follows: OT 7.35 mills/kWh, DUPIC 9.06 mills/kWh, PUREX-MOX 8.94 mills/kWh, and Pyro-SFR 7.70 mills/kWh. Due to unavoidable uncertainties, a cost range has been applied to each unit cost, and an uncertainty study has been performed accordingly. A sensitivity analysis has also been carried out to obtain the break-even uranium price (215$/kgU) for the Pyro-SFR against the OT, which demonstrates that the deployment of the Pyro-SFR may be economical in the foreseeable future. The influence of pyro techniques on the LFCC has also been studied to determine at which level the potential advantages of Pyro-SFR can be realized.

  13. Impact of minor actinide recycling on sustainable fuel cycle options

    Energy Technology Data Exchange (ETDEWEB)

    Heidet, F.; Kim, T. K.; Taiwo, T. A.

    2017-11-01

    The recent Evaluation and Screening study chartered by the U.S. Department of Energy, Office of Nuclear Energy, has identified four fuel cycle options as being the most promising. Among these four options, the two single-stage fuel cycles rely on a fast reactor and are differing in the fact that in one case only uranium and plutonium are recycled while in the other case minor actinides are also recycled. The two other fuel cycles are two-stage and rely on both fast and thermal reactors. They also differ in the fact that in one case only uranium and plutonium are recycled while in the other case minor actinides are also recycled. The current study assesses the impact of recycling minor actinides on the reactor core design, its performance characteristics, and the characteristics of the recycled material and waste material. The recycling of minor actinides is found not to affect the reactor core performance, as long as the same cycle length, core layout and specific power are being used. One notable difference is that the required transuranics (TRU) content is slightly increased when minor actinides are recycled. The mass flows are mostly unchanged given a same specific power and cycle length. Although the material mass flows and reactor performance characteristics are hardly affected by recycling minor actinides, some differences are observed in the waste characteristics between the two fuel cycles considered. The absence of minor actinides in the waste results in a different buildup of decay products, and in somewhat different behaviors depending on the characteristic and time frame considered. Recycling of minor actinides is found to result in a reduction of the waste characteristics ranging from 10% to 90%. These results are consistent with previous studies in this domain and depending on the time frame considered, packaging conditions, repository site, repository strategy, the differences observed in the waste characteristics could be beneficial and help improve

  14. Treatment options in otitis media with effusion.

    Science.gov (United States)

    Upadhya, Ila; Datar, J

    2014-01-01

    Secretary Otitis media with effusion (OME) is the accumulation of mucus in the middle ear and sometimes in the mastoid air cell system. The main etiological factor is alteration in mucociliary system of middle ear secondary to ET malfunction which may be primary or secondary. OME is the cause of concern due to its occurance in paediatric age group, highest at 2 years of age, presenting as impairment of hearing leading to delayed speech and language development, poor academic performance and behavioral problems. In spite of this there are no confirmed guidelines of treatment to overcome. Many treatment options are available medical as well as surgical. Prospective study conducted to evaluate various treatment options revealed that auto inflation of ET is the main stay of treatment. If the ET malfunction is due to any reasons like adenoids, deviated nasal septum, hypertrophied turbinates or any other cause surgical intervention of the same gives 100% results. Medical management gives good results but recurrence is equally common.

  15. Fuel Transfer Cask; Procedure Option and Radiation Protection during Transferring the Spent Fuel

    International Nuclear Information System (INIS)

    Muhammad Khairul Ariff Mustafa; Nurhayati Ramli; Ahmad Nabil Abdul Rahim; Mohd Fazli Zakaria

    2011-01-01

    Reactor TRIGA PUSPATI (RTP) has been operating almost 30 years. Many components are ageing. Nuclear Malaysia has taken an initiative to manage this ageing problem to prolong the life of the reactor. Hence, reactor upgrading project already commence started with the reactor console. To upgrade the core, all the fuel must be taken out from the core. A conceptual design of fuel transfer cask already done. This paper will discuss about the option of safe working procedure for transferring the fuel to the spent fuel pool for temporary. Hence, radiation protection for operator should be considered during the process. (author)

  16. 24-h Efficacy of Glaucoma Treatment Options.

    Science.gov (United States)

    Konstas, Anastasios G P; Quaranta, Luciano; Bozkurt, Banu; Katsanos, Andreas; Garcia-Feijoo, Julian; Rossetti, Luca; Shaarawy, Tarek; Pfeiffer, Norbert; Miglior, Stefano

    2016-04-01

    Current management of glaucoma entails the medical, laser, or surgical reduction of intraocular pressure (IOP) to a predetermined level of target IOP, which is commensurate with either stability or delayed progression of visual loss. In the published literature, the hypothesis is often made that IOP control implies a single IOP measurement over time. Although the follow-up of glaucoma patients with single IOP measurements is quick and convenient, such measurements often do not adequately reflect the untreated IOP characteristics, or indeed the quality of treated IOP control during the 24-h cycle. Since glaucoma is a 24-h disease and the damaging effect of elevated IOP is continuous, it is logical that we should aim to understand the efficacy of all treatment options throughout the 24-h period. This article first reviews the concept and value of diurnal and 24-h IOP monitoring. It then critically evaluates selected available evidence on the 24-h efficacy of medical, laser and surgical therapy options. During the past decade several controlled trials have significantly enhanced our understanding on the 24-h efficacy of all glaucoma therapy options. Nevertheless, more long-term evidence is needed to better evaluate the 24-h efficacy of glaucoma therapy and the precise impact of IOP characteristics on glaucomatous progression and visual prognosis.

  17. Current Treatment Options for Auricular Hematomas.

    Science.gov (United States)

    MacPhail, Catriona

    2016-07-01

    Ear disease, such as otitis externa, resulting in aggressive head shaking or ear scratching, is the most common cause of the development of aural hematomas in dogs and cats. An underlying immunologic cause has also been proposed to explain cartilage and blood vessel fragility. Numerous options exist for management of aural hematomas, from medical management alone with corticosteroids, to simple hematoma centesis, to surgical intervention. Because this condition is usually secondary to another disease process, regardless of mode of treatment, likelihood of recurrence is low if the underlying condition is managed properly. Copyright © 2016 Elsevier Inc. All rights reserved.

  18. Steam and partial oxidation reforming options for hydrogen production from fossil fuels for PEM fuel cells

    Directory of Open Access Journals (Sweden)

    Yousri M.A. Welaya

    2012-06-01

    Full Text Available Proton exchange membrane fuel cell (PEM generates electrical power from air and from hydrogen or hydrogen rich gas mixtures. Therefore, there is an increasing interest in converting current hydrocarbon based marine fuels such as natural gas, gasoline, and diesel into hydrogen rich gases acceptable to the PEM fuel cells on board ships. Using chemical flow sheeting software, the total system efficiency has been calculated. Natural gas appears to be the best fuel for hydrogen rich gas production due to its favorable composition of lower molecular weight compounds. This paper presents a study for a 250 kW net electrical power PEM fuel cell system utilizing a partial oxidation in one case study and steam reformers in the second. This study has shown that steam-reforming process is the most competitive fuel processing option in terms of fuel processing efficiency. Partial oxidation process has proved to posses the lowest fuel processing efficiency. Among the options studied, the highest fuel processing efficiency is achieved with natural gas steam reforming system.

  19. Current and future treatment options in osteoporosis.

    LENUS (Irish Health Repository)

    Brewer, Linda

    2012-02-01

    PURPOSE: The incidence of osteoporosis-related fractures will increase substantially over the coming decades as the population ages globally. This has important economic and public health implications, contributing substantially to morbidity and excess mortality in this population. METHODS: When prescribing for older patients the effectiveness profile of drugs needs to be balanced against their tolerability in individual patients. RESULTS: Currently we have good anti-fracture data to support the use of many available anti-resorptive and anabolic drugs including bisphosphonates, strontium ranelate and recombinant human parathyroid hormone. We also have evidence to demonstrate the importance of calcium and vitamin D repletion in these patients. However, in recent years our understanding of normal bone physiology and the mechanisms underlying the development of osteoporosis has significantly advanced and this has led to the development of new therapies. Novel agents, particularly denosumab, but also inhibitors of cathepsin K and anabolic agents that act on Wnt signalling, will increase the therapeutic options for clinicians in the coming years. CONCLUSION: This review discusses the evidence supporting the use of currently available treatment options for osteoporosis and potential future advances in drug therapy. Particular consideration should be given when prescribing for certain older patients who have issues with compliance or tolerance and also in those with co-morbidities or levels of frailty that may restrict the choice of therapy. Understanding the evidence for the benefit and possible harm of osteoporosis treatments is critical to appropriate management of this patient population.

  20. Greenhouse gas emissions reduction from fossil fuels: options and prospects

    International Nuclear Information System (INIS)

    McDonald, M.M.

    1999-01-01

    If levels of carbon dioxide in the atmosphere are to be stabilized over the next 50 years, net emissions from the use of fossil fuels have to be reduced. One concept worth exploring is the removal of carbon dioxide from plant flue gases and disposing of it in a manner that sequesters it from the atmosphere. A number of technologies, which are either commercially available or under development, promise to make this concept viable. The question of where to dispose of the carbon dioxide removed is not the limiting factor, given the potential for use in enhanced hydrocarbon production as well as other geological disposal options. In the longer term, fossil fuel use will significantly decline, but these extraction and sequestration technologies can provide the time for the transition to take place in a manner which causes least impact to the economies of the world. (author)

  1. Assessment of bio-fuel options for solid oxide fuel cell applications

    Science.gov (United States)

    Lin, Jiefeng

    Rising concerns of inadequate petroleum supply, volatile crude oil price, and adverse environmental impacts from using fossil fuels have spurred the United States to promote bio-fuel domestic production and develop advanced energy systems such as fuel cells. The present dissertation analyzed the bio-fuel applications in a solid oxide fuel cell-based auxiliary power unit from environmental, economic, and technological perspectives. Life cycle assessment integrated with thermodynamics was applied to evaluate the environmental impacts (e.g., greenhouse gas emission, fossil energy consumption) of producing bio-fuels from waste biomass. Landfill gas from municipal solid wastes and biodiesel from waste cooking oil are both suggested as the promising bio-fuel options. A nonlinear optimization model was developed with a multi-objective optimization technique to analyze the economic aspect of biodiesel-ethanol-diesel ternary blends used in transportation sectors and capture the dynamic variables affecting bio-fuel productions and applications (e.g., market disturbances, bio-fuel tax credit, policy changes, fuel specification, and technological innovation). A single-tube catalytic reformer with rhodium/ceria-zirconia catalyst was used for autothermal reformation of various heavy hydrocarbon fuels (e.g., diesel, biodiesel, biodiesel-diesel, and biodiesel-ethanol-diesel) to produce a hydrogen-rich stream reformates suitable for use in solid oxide fuel cell systems. A customized mixing chamber was designed and integrated with the reformer to overcome the technical challenges of heavy hydrocarbon reformation. A thermodynamic analysis, based on total Gibbs free energy minimization, was implemented to optimize the operating environment for the reformations of various fuels. This was complimented by experimental investigations of fuel autothermal reformation. 25% biodiesel blended with 10% ethanol and 65% diesel was determined to be viable fuel for use on a truck travelling with

  2. Pelvic radiation disease: Updates on treatment options

    Science.gov (United States)

    Frazzoni, Leonardo; La Marca, Marina; Guido, Alessandra; Morganti, Alessio Giuseppe; Bazzoli, Franco; Fuccio, Lorenzo

    2015-01-01

    Pelvic cancers are among the most frequently diagnosed neoplasms and radiotherapy represents one of the main treatment options. The irradiation field usually encompasses healthy intestinal tissue, especially of distal large bowel, thus inducing gastrointestinal (GI) radiation-induced toxicity. Indeed, up to half of radiation-treated patients say that their quality of life is affected by GI symptoms (e.g., rectal bleeding, diarrhoea). The constellation of GI symptoms - from transient to long-term, from mild to very severe - experienced by patients who underwent radiation treatment for a pelvic tumor have been comprised in the definition of pelvic radiation disease (PRD). A correct and evidence-based therapeutic approach of patients experiencing GI radiation-induced toxicity is mandatory. Therapeutic non-surgical strategies for PRD can be summarized in two broad categories, i.e., medical and endoscopic. Of note, most of the studies have investigated the management of radiation-induced rectal bleeding. Patients with clinically significant bleeding (i.e., causing chronic anemia) should firstly be considered for medical management (i.e., sucralfate enemas, metronidazole and hyperbaric oxygen); in case of failure, endoscopic treatment should be implemented. This latter should be considered the first choice in case of acute, transfusion requiring, bleeding. More well-performed, high quality studies should be performed, especially the role of medical treatments should be better investigated as well as the comparative studies between endoscopic and hyperbaric oxygen treatments. PMID:26677440

  3. Status of the back-end optional advanced research reactor fuel development in Korea

    International Nuclear Information System (INIS)

    Kim, Chang-Kyu; Lee, Yoon-Sang; Lee, Don-Bae; Oh, Seuk-Jin; Kim, Ki-Hwan; Chae, Hee-Taek; Park, Jong-Man; Sohn Dong-Seong

    2003-01-01

    U-Mo fuel development has been carried out for a reactor upgrade of HANARO and the back-end option in Korea. The 2nd irradiation test of the U-Mo dispersion rod fuels is underway in HANARO in order to find the optimum uranium loading density and to investigate the applicability of the monolithic U-Mo ring fuel as well as other parameters such as particle size and cladding surface-treatment. The optical observation using an immersion camera showed that the cladding surfaces of the two U 3 Si and U-Mo fuels with a high power rate changed in to the darker color, which is not as severe as those of the driving fuels in HANARO. Presumably it would be acceptable. The other fuels were observed as maintaining their initial good conditions. In connection with monolithic U-Mo fuel development, some achievements such as preliminary U-Mo tube production by a continuous casting process and a successful U-Mo foil production using a roll casting process have been obtained. In addition, some investigation on the surface-treatment of multilayer coating and Zr sputtering coating has showed the possibility of eliminating the problem of a temperature rise due to the corrosion layer formation having quite a low conductivity. The next irradiation test will aim mainly at the qualification of the U-Mo dispersion fuel for HANARO around the end of next year. In the 3rd irradiation fuel bundle, some fuels related to the basic investigation tests for the monolithic U-Mo fuel and surface-treatment for anticorrosion will be loaded. (author)

  4. Used fuel rail shock and vibration testing options analysis

    Energy Technology Data Exchange (ETDEWEB)

    Ross, Steven B. [Pacific Northwest National Lab. (PNNL), Richland, WA (United States); Best, Ralph E. [Pacific Northwest National Lab. (PNNL), Richland, WA (United States); Klymyshyn, Nicholas A. [Pacific Northwest National Lab. (PNNL), Richland, WA (United States); Jensen, Philip J. [Pacific Northwest National Lab. (PNNL), Richland, WA (United States); Maheras, Steven J. [Pacific Northwest National Lab. (PNNL), Richland, WA (United States)

    2014-09-25

    The objective of the rail shock and vibration tests is to complete the framework needed to quantify loads of fuel assembly components that are necessary to guide materials research and establish a technical basis for review organizations such as the U.S. Nuclear Regulatory Commission (NRC). A significant body of experimental and numerical modeling data exists to quantify loads and failure limits applicable to normal conditions of transport (NCT) rail transport, but the data are based on assumptions that can only be verified through experimental testing. The test options presented in this report represent possible paths for acquiring the data that are needed to confirm the assumptions of previous work, validate modeling methods that will be needed for evaluating transported fuel on a case-by-case basis, and inform material test campaigns on the anticipated range of fuel loading. The ultimate goal of this testing is to close all of the existing knowledge gaps related to the loading of used fuel under NCT conditions and inform the experiments and analysis program on specific endpoints for their research. The options include tests that would use an actual railcar, surrogate assemblies, and real or simulated rail transportation casks. The railcar carrying the cradle, cask, and surrogate fuel assembly payload would be moved in a train operating over rail track modified or selected to impart shock and vibration forces that occur during normal rail transportation. Computer modeling would be used to help design surrogates that may be needed for a rail cask, a cask’s internal basket, and a transport cradle. The objective of the design of surrogate components would be to provide a test platform that effectively simulates responses to rail shock and vibration loads that would be exhibited by state-of-the-art rail cask, basket, and/or cradle structures. The computer models would also be used to help determine the placement of instrumentation (accelerometers and strain gauges

  5. Novel treatment options for portal hypertension

    Science.gov (United States)

    Laleman, Wim

    2017-01-01

    Abstract Portal hypertension is most frequently associated with cirrhosis and is a major driver for associated complications, such as variceal bleeding, ascites or hepatic encephalopathy. As such, clinically significant portal hypertension forms the prelude to decompensation and impacts significantly on the prognosis of patients with liver cirrhosis. At present, non-selective β-blockers, vasopressin analogues and somatostatin analogues are the mainstay of treatment but these strategies are far from satisfactory and only target splanchnic hyperemia. In contrast, safe and reliable strategies to reduce the increased intrahepatic resistance in cirrhotic patients still represent a pending issue. In recent years, several preclinical and clinical trials have focused on this latter component and other therapeutic avenues. In this review, we highlight novel data in this context and address potentially interesting therapeutic options for the future. PMID:28533907

  6. [Female sexual dysfunction: Drug treatment options].

    Science.gov (United States)

    Alcántara Montero, A; Sánchez Carnerero, C I

    2016-01-01

    Many women will likely experience a sexual problem in their lifetime. Female sexual dysfunction is a broad term used to describe 3 categories of disorders of a multifactorial nature. Effective, but limited pharmacotherapeutic options exist to address female sexual dysfunction. The FDA recently approved the first agent for treatment of hypoactive sexual desire disorder in pre-menopausal women. Off-label use of hormonal therapies, particularly oestrogen and testosterone, are the most widely employed for female sexual dysfunction, particularly in post-menopausal women. Other drugs currently under investigation include phosphodiesterase inhibitors and agents that modulate dopamine or melanocortin receptors. Copyright © 2016 Sociedad Española de Médicos de Atención Primaria (SEMERGEN). Publicado por Elsevier España, S.L.U. All rights reserved.

  7. Spent fuel management options for research reactors in Latin America

    International Nuclear Information System (INIS)

    2006-06-01

    Research reactors (RRs) have been operated in Latin America since the late 1950s, and a total of 23 RRs have been built in the region. At the time of writing (November 2005), 18 RRs are in operation, 4 have been shut down and 1 has been decommissioned. The number of operating RRs in Latin America represents around 6% of the existing operational RRs worldwide and around 21% of the RRs operating in developing countries. Common to all RRs in the region is a consistent record of safe and successful operation. With the purpose of carrying out a collaborative study of different aspects of the management of spent fuel from RRs, some countries from the region proposed to the IAEA in 2000 the organization of a Regional Project. The project (IAEA TC Regional Project RLA/4/018) that was approved for the biennium 2001-2002 and extended for 2003-2004 included the participation of Argentina, Brazil, Chile, Mexico and Peru. The main objectives of this project were: (a) to define the basic conditions for a regional strategy for managing spent fuel that will provide solutions compatible with the economic and technological realities of the countries involved; and (b) to determine what is needed for the temporary wet and dry storage of spent fuel from the research reactors in the countries of the Latin American region that participated in the project. This TECDOC is based on the results of TC Regional Project RLA/4/018. This project was successful in identifying and assessing a number of viable alternatives for RRSF management in the Latin American region. Options for operational and interim storage, spent fuel conditioning and final disposal have been carefully considered. This report presents the views of Latin American experts on RR spent fuel management and will be useful as reference material for the Latin American RR community, decision making authorities in the region and the public in general

  8. PWR Core II blanket fuel disposition recommendation of storage option study

    International Nuclear Information System (INIS)

    Dana, C.M.

    1995-01-01

    After review of the options available for current storage of T Plant Fuel the recommended option is wet storage without the use of chillers. A test has been completed that verifies the maximum temperature reached is below the industrial standard for storage of spent fuel. This option will be the least costly and still maintain the fuel in a safe environment. The options that were evaluated included dry storage with and without chillers, and wet storage with and without chillers. Due to the low decay heat of the Shippingport Core II Blanket fuel assemblies the fuel pool temperature will not exceed 100 deg. F

  9. Treatment options for polycystic ovary syndrome

    Directory of Open Access Journals (Sweden)

    Ahmed Badawy

    2011-02-01

    Full Text Available Ahmed Badawy1 Abubaker Elnashar21Department of Obstetrics and Gynecology, Mansoura University, Mansoura, Egypt; 2Department of Obstetrics and Gynecology, Benha University, Benha, EgyptAbstract: Polycystic ovary syndrome (PCOS is the most common endocrine disorder in women. The clinical manifestation of PCOS varies from a mild menstrual disorder to severe disturbance of reproductive and metabolic functions. Management of women with PCOS depends on the symptoms. These could be ovulatory dysfunction-related infertility, menstrual disorders, or androgen-related symptoms. Weight loss improves the endocrine profile and increases the likelihood of ovulation and pregnancy. Normalization of menstrual cycles and ovulation could occur with modest weight loss as little as 5% of the initial weight. The treatment of obesity includes modifications in lifestyle (diet and exercise and medical and surgical treatment. In PCOS, anovulation relates to low follicle-stimulating hormone concentrations and the arrest of antral follicle growth in the final stages of maturation. This can be treated with medications such as clomiphene citrate, tamoxifen, aromatase inhibitors, metformin, glucocorticoids, or gonadotropins or surgically by laparoscopic ovarian drilling. In vitro fertilization will remain the last option to achieve pregnancy when others fail. Chronic anovulation over a long period of time is also associated with an increased risk of endometrial hyperplasia and carcinoma, which should be seriously investigated and treated. There are androgenic symptoms that will vary from patient to patient, such as hirsutism, acne, and/or alopecia. These are troublesome presentations to the patients and require adequate treatment. Alternative medicine has been emerging as one of the commonly practiced medicines for different health problems, including PCOS. This review underlines the contribution to the treatment of different symptoms.Keywords: treatment, polycystic ovary

  10. Fuel alternatives for oil sands development - the nuclear option

    Energy Technology Data Exchange (ETDEWEB)

    Bock, D [Atomic Energy of Canada Ltd., Mississauga, ON (Canada); Donnelly, J K

    1996-12-31

    Currently natural gas is the fuel of choice in all oil sand developments. Alberta sources of hydrocarbon based fuels are large but limited. Canadian nuclear technology was studied as a possible alternative for providing steam for the deep commercial in situ oil sand projects which were initiated over ten years ago. Because the in situ technology of that time required steam at pressures in excess of 10 MPa, the nuclear option required the development of new reactor technology, or the use of steam compressors, which was not economical. The current SAGD (steam assisted gravity drainage) technology requires steam at pressures of less than 5 MPa, which is in the reach of existing Canadian nuclear technology. The cost of supplying steam for a SAGD in situ project using a CANDU 3 nuclear reactor was developed. The study indicates that for gas prices in excess of $2.50 per gigajoule, replacing natural gas fuel with a nuclear reactor is economically feasible for in situ projects in excess of 123 thousand barrels per day. (author). 9 refs., 3 tabs., 12 figs.

  11. Fuel alternatives for oil sands development - the nuclear option

    International Nuclear Information System (INIS)

    Bock, D.; Donnelly, J.K.

    1995-01-01

    Currently natural gas is the fuel of choice in all oil sand developments. Alberta sources of hydrocarbon based fuels are large but limited. Canadian nuclear technology was studied as a possible alternative for providing steam for the deep commercial in situ oil sand projects which were initiated over ten years ago. Because the in situ technology of that time required steam at pressures in excess of 10 MPa, the nuclear option required the development of new reactor technology, or the use of steam compressors, which was not economical. The current SAGD (steam assisted gravity drainage) technology requires steam at pressures of less than 5 MPa, which is in the reach of existing Canadian nuclear technology. The cost of supplying steam for a SAGD in situ project using a CANDU 3 nuclear reactor was developed. The study indicates that for gas prices in excess of $2.50 per gigajoule, replacing natural gas fuel with a nuclear reactor is economically feasible for in situ projects in excess of 123 thousand barrels per day. (author). 9 refs., 3 tabs., 12 figs

  12. Fuel management options to extend the IRIS reactor cycle

    International Nuclear Information System (INIS)

    Petrovic, B.; Franceschini, F.

    2004-01-01

    To optimize plant operation, reduce scheduled maintenance outage, and increase capacity factor, IRIS is designed to enable extended cycles of up to four years. However, due to the enrichment licensing limitation (less than 5% enriched uranium oxide) there is a tradeoff between the achievable cycle length and fuel utilization, i.e., the average fuel discharge burnup. The longest individual cycle may be achieved with the single-batch straight burn, but at the expense of a lower burnup. Considering the IRIS basic performance requirements, a cycle length in the range of three to four years is deemed desirable. This paper examines different fuel management options, i.e., the influence of the required cycle length on the corresponding reloading strategy, including a two-batch and a three-batch reloading. A reference two-batch core design has been developed for the first cycle, as well as for the transition cycles leading to equilibrium. Main core performance parameters are evaluated. This core design provides the framework for the safety analyses needed to prepare the IRIS safety evaluations. Alternate designs are also considered.(author)

  13. Impact of advanced fuel cycle options on waste management policies

    International Nuclear Information System (INIS)

    Gordelier, Stan; Cavedon, Jean-Marc

    2006-01-01

    OECD/NEA has performed a study on the impact of advanced fuel cycle options on waste management policies with 33 experts from 12 member countries, 1 non-member country and 2 international organizations. The study extends a series of previous ones on partitioning and transmutation (P and T) issues, focusing on the performance assessments for repositories of high-level waste (HLW) arising from advanced fuel cycles. This study covers a broader spectrum than previous studies, from present industrial practice to fully closed cycles via partially closed cycles (in terms of transuranic elements); 9 fuel cycle schemes and 4 variants. Elements of fuel cycles are considered primarily as sources of waste, the internal mass flows of each scheme being kept for the sake of mass conservation. The compositions, activities and heat loads of all waste flows are also tracked. Their impact is finally assessed on the waste repository concepts. The study result confirms the findings from the previous NEA studies on P and T on maximal reduction of the waste source term and maximal use of uranium resources. In advanced fuel cycle schemes the activity of the waste is reduced by burning first plutonium and then minor actinides and also the uranium consumption is reduced, as the fraction of fast reactors in the park is increased to 100%. The result of the repository performance assessments, analysing the effect of different HLW isotopic composition on repository performance and on repository capacity, shows that the maximum dose released to biosphere at any time in normal conditions remains, for all schemes and for all the repository concepts examined, well below accepted radiation protection thresholds. The major impact is on the detailed concept of the repositories, through heat load and waste volume. Advanced fuel cycles could allow a repository to cover waste produced from 5 to 20 times more electricity generation than PWR once-through cycle. Given the flexibility of the advanced fuel

  14. Treatment options for diabetic foot osteomyelitis.

    Science.gov (United States)

    Senneville, Eric; Robineau, Olivier

    2017-06-01

    Diabetic foot osteomyelitis therapeutical options are based on antibiotic therapy and surgical resection of the infected bone(s). Surgical and medical approaches of patients suffering from a diabetic foot osteomyelitis do not oppose but are complementary and need to be discussed as a tailored manner. Areas covered: The aim of the present article is to discuss data issued from the most recent guidelines of the Infectious Diseases Society of America and the International Working Group on the Diabetic Foot on the management of the diabetic foot infection and from a search in the current literature using the terms diabetic foot osteomyelitis and treatment/therapy/therapeutical in both PubMed and Medline, restricted to the last five years. Expert opinion: Surgical removal of the entire infected bone(s) has been considered in the past as the standard treatment but medical approach of these patients has now proven efficacy in selected situations. The current emergence of bacteria, especially among Gram negative rods, resistant to almost all the available antibiotics gradually augments the complexity of the management of these patients and is likely to decrease the place of the medical approach and to worsen the outcome of these infections in the next future.

  15. Facial Pores: Definition, Causes, and Treatment Options.

    Science.gov (United States)

    Lee, Sang Ju; Seok, Joon; Jeong, Se Yeong; Park, Kui Young; Li, Kapsok; Seo, Seong Jun

    2016-03-01

    Enlarged skin pores refer to conditions that present with visible topographic changes of skin surfaces. Although not a medical concern, enlarged pores are a cosmetic concern for a large number of individuals. Moreover, clear definition and possible causes of enlarged pores have not been elucidated. To review the possible causes and treatment options for skin pores. This article is based on a review of the medical literature and the authors' clinical experience in investigating and treating skin pores. There are 3 major clinical causes of enlarged facial pores, namely high sebum excretion, decreased elasticity around pores, and increased hair follicle volume. In addition, chronic recurrent acne, sex hormones, and skin care regimen can affect pore size. Given the different possible causes for enlarged pores, therapeutic modalities must be individualized for each patient. Potential factors that contribute to enlarged skin pores include excessive sebum, decreased elasticity around pores, and increased hair follicle volume. Because various factors cause enlarged facial pores, it might be useful to identify the underlying causes to be able to select the appropriate treatment.

  16. Health and safety of competing fuel options for fuel cells in the road transport sector

    Energy Technology Data Exchange (ETDEWEB)

    Green, E.; Short, S.; Stutt, E.; Wickramatillake, H.; Harrison, P.

    2000-07-01

    This report presents a critical analysis of the health and safety issues surrounding competing transport fuel options, including those for possible future fuel-cell powered vehicles. The fuels considered in this report are gasoline (unleaded and reformulated), diesel, hydrogen (H{sub 2}), methanol, natural gas and liquefied petroleum gas (LPG). The analysis presented here is based on available information in peer-reviewed, published papers and other sources such as government department or research laboratory reports and websites. An overall evaluation of the fuels in terms of their toxicity and health effects, environmental fate, and fire and explosion safety aspects is presented. The report is based on current knowledge and makes no assumptions as to how fuels may change in the future if they are to be used in fuel-cell vehicles. The report identifies the hazards of the fuels but does not estimate the risks likely to be associated with their eventual use in fuel-cell vehicles. The focus is on the fuels themselves and not their exhaust or reaction products. sNo assessment has been made of the environmental effects data for the fuels. Broad environmental considerations such as ozone forming potential and also global warming are not considered. Basic information on environmental fate is included to provide an understanding of migratory pathways, environmental compartmentalisation and potential routes of human exposure. Other factors such as economics, government incentives or disincentives and public attitudes may have a bearing on which of the fuels are considered most appropriate for future fuel-cell vehicles; these factors are not considered in any detail in this report. (Author)

  17. NPP fuel cycle and assessment of possible options for long-term fuel supply

    International Nuclear Information System (INIS)

    Ignatenko, E.I.; Lebedev, V.M.; Davidenko, N.N.

    1999-01-01

    The purpose of this paper is to present some results of the analysis of the possible options for Russian NPPs fuel supply. In the classical consideration these are four fuel cycles: uranium cycle based on natural uranium, this cycle has several economical advantages with the use of CANDU type reactors with a heavy-water moderator; uranium cycle based on enriched uranium, it is a basis for the current and future nuclear power; uranium-thorium fuel cycle with capabilities which are very promising but unfortunately difficult to implement in practice; plutonium-uranium cycle, in terms of its potential capabilities it is an excellent option, but it is extremely difficult to implement it in practice due to a high activity and toxicity of nuclear materials under recycle. The nuclear power of Russia is currently aimed at using the cheapest fuel resources, that is first of all, uranium reprocessed from industrial reactor fuel and slag-heaps accumulated on the past in isotope-separation plant sites. These resources are enough for the Russian large-scale nuclear power to be developed [ru

  18. Current and potential treatment options for hyperphosphatemia.

    Science.gov (United States)

    Carfagna, Fabio; Del Vecchio, Lucia; Pontoriero, Giuseppe; Locatelli, Francesco

    2018-05-21

    Hyperphosphatemia is common in late stages of chronic kidney disease and is often associated with elevated parathormone levels, abnormal bone mineralization, extra-osseous calcification, and increased risk of cardiovascular events and death. Several classes of oral phosphate binders are available to help control plasma phosphorus levels. Although effective at lowering serum phosphorus, they all have safety, tolerability, and compliance issues that need to be considered when selecting which one to use. Areas covered: This paper reviews the most established treatment options for hyperphosphatemia, in patients with chronic kidney disease, focusing on the new inhibitors of active phosphate absorption. Expert opinion: The prevention and the treatment of hyperphosphatemia is today far to be satisfactory. Nonetheless, an extending range of phosphate binders are now available. Aluminum has potentially serious toxic risks. Calcium-based binders are very effective but can lead to hypercalcemia and/or positive calcium balance and progression of cardiovascular calcification. No long-term data are available for the new calcium acetate/magnesium combination product. Lanthanum is an effective phosphate binder, and long-term effects of tissue deposition seem clinically irrelevant. Sevelamer, appear to have profiles that would lead to pleiotropic effects and reduced progression of vascular calcification, and the main adverse events seen with these agents are gastrointestinal. Iron has a powerful capability of binding phosphate, thus numerous preparations are available, both with and without significant systemic absorption of the iron component. The inhibitors of active intestinal phosphate transport, with their very selective mechanism of action and low pill burden seem the most interesting approach; however, do not seem at present to be effective alone, in reducing serum phosphorus levels.

  19. Reprocessing of research reactor fuel the Dounreay option

    Energy Technology Data Exchange (ETDEWEB)

    Cartwright, P.

    1997-08-01

    Reprocessing is a proven process for the treatment of spent U/Al Research Reactor fuel. At Dounreay 12679 elements have been reprocessed during the past 30 years. For reactors converting to LEU fuel the uranium recovered in reprocessing can be blended down to less than 20% U{sub 235}, enrichment and be fabricated into new elements. For reactors already converted to LEU it is technically possible to reprocess spent silicide fuel to reduce the U{sub 235} burden and present to a repository only stable conditioned waste. The main waste stream from reprocessing which contains the Fission products is collected in underground storage tanks where it is kept for a period of at least five years before being converted to a stable solid form for return to the country of origin for subsequent storage/disposal. Discharges to the environment from reprocessing are low and are limited to the radioactive gases contained in the spent fuel and a low level liquid waste steam. Both of these discharges are independently monitored, and controlled within strict discharge limits set by the UK Government`s Scottish Office. Transportation of spent fuel to Dounreay has been undertaken using many routes from mainland Europe and has utilised over the past few years both chartered and scheduled vessel services. Several different transport containers have been handled and are currently licensed in the UK. This paper provides a short history of MTR reprocessing at Dounreay, and provides information to show reprocessing can satisfy the needs of MTR operators, showing that reprocessing is a valuable asset in non-proliferation terms, offers a complete solution and is environmentally acceptable.

  20. Parametric analyses of single-zone thorium-fueled molten salt reactor fuel cycle options

    International Nuclear Information System (INIS)

    Powers, J.J.; Worrall, A.; Gehin, J.C.; Harrison, T.J.; Sunny, E.E.

    2013-01-01

    Analyses of fuel cycle options based on thorium-fueled Molten Salt Reactors (MSRs) have been performed in support of fuel cycle screening and evaluation activities for the United States Department of Energy. The MSR options considered are based on thermal spectrum MSRs with 3 different separations levels: full recycling, limited recycling, and 'once-through' operation without active separations. A single-fluid, single-zone 2250 MWth (1000 MWe) MSR concept consisting of a fuel-bearing molten salt with graphite moderator and reflectors was used as the basis for this study. Radiation transport and isotopic depletion calculations were performed using SCALE 6.1 with ENDF/B-VII nuclear data. New methodology developed at Oak Ridge National Laboratory (ORNL) enables MSR analysis using SCALE, modeling material feed and removal by taking user-specified parameters and performing multiple SCALE/TRITON simulations to determine the resulting equilibrium operating conditions. Parametric analyses examined the sensitivity of the performance of a thorium MSR to variations in the separations efficiency for protactinium and fission products. Results indicate that self-sustained operation is possible with full or limited recycling but once-through operation would require an external neutron source. (authors)

  1. Treatment Options for Extrahepatic Bile Duct Cancer

    Science.gov (United States)

    ... Treatment Liver Cancer Prevention Liver Cancer Screening Research Bile Duct Cancer (Cholangiocarcinoma) Treatment (PDQ®)–Patient Version Treatment ... are different types of treatment for patients with bile duct cancer. Different types of treatments are available ...

  2. Treatment Option Overview (Extrahepatic Bile Duct Cancer)

    Science.gov (United States)

    ... Treatment Liver Cancer Prevention Liver Cancer Screening Research Bile Duct Cancer (Cholangiocarcinoma) Treatment (PDQ®)–Patient Version Treatment ... are different types of treatment for patients with bile duct cancer. Different types of treatments are available ...

  3. Advanced fuel cycles options for LWRs and IMF benchmark definition

    International Nuclear Information System (INIS)

    Breza, J.; Darilek, P.; Necas, V.

    2008-01-01

    In the paper, different advanced nuclear fuel cycles including thorium-based fuel and inert-matrix fuel are examined under light water reactor conditions, especially VVER-440, and compared. Two investigated thorium based fuels include one solely plutonium-thorium based fuel and the second one plutonium-thorium based fuel with initial uranium content. Both of them are used to carry and burn or transmute plutonium created in the classical UOX cycle. The inert-matrix fuel consist of plutonium and minor actinides separated from spent UOX fuel fixed in Yttria-stabilised zirconia matrix. The article shows analysed fuel cycles and their short description. The conclusion is concentrated on the rate of Pu transmutation and Pu with minor actinides cumulating in the spent advanced thorium fuel and its comparison to UOX open fuel cycle. Definition of IMF benchmark based on presented scenario is given. (authors)

  4. Consolidated fuel reprocessing programme: Analysis of various options for the breeder fuel cycle in the USA

    International Nuclear Information System (INIS)

    Stradley, J.G.; Burch, W.D.; Yook, H.R.

    1986-01-01

    The United States Department of Energy (DOE) has established a programme to develop innovative liquid metal reactor (LMR) designs to assist in developing future U.S. reactor strategy. The paper describes studies in progress to examine various fuel cycle strategies that relate to the reactor strategy. Three potential fuel cycle options that focus on supporting an initial 1300 MW(e) reactor station have been defined: (1) Completion and utilization of the Breeder Reprocessing Engineering Test/Secure Automated Fabrication (BRET/SAF) in the Fuels and Materials Examination Facility (FMEF) at Hanford, Washington; (2) a co-located fuel cycle facility; and (3) delayed closure of the fuel cycle for five to ten years. The BRET, designed as a development facility, has sufficient capacity to service the needs of an initial module at an LMR station. It appears feasible to increase this capacity and to utilize SAF in the FMEF to accommodate the projected output (up to 35 MtHM/year) from the 1300 MW(e) liquid-metal concepts under study. Plans developed within the United States Consolidated Management Office for an initial reactor project have envisioned that cost savings could be realized by delaying the closure of the fuel cycle as long as supplies of plutonium could be obtained relatively inexpensively. This might prove to be only five to ten years, but even that period might be long enough for the fuel cycle costs to be spread over more than one reactor rather than loaded on the initial project. This concept is being explored as is the question of the future coupling of a light water reactor reprocessing industry for plutonium supply to breeder recycle

  5. Completion of Population of and Quality Assurance on the Nuclear Fuel Cycle Options Catalog.

    Energy Technology Data Exchange (ETDEWEB)

    Price, Laura L. [Sandia National Lab. (SNL-NM), Albuquerque, NM (United States); Barela, Amanda Crystal [Sandia National Lab. (SNL-NM), Albuquerque, NM (United States); Walkow, Walter M. [Sandia National Lab. (SNL-NM), Albuquerque, NM (United States); Schetnan, Richard Reed [Sandia National Lab. (SNL-NM), Albuquerque, NM (United States); Arnold, Matthew Brian [Sandia National Lab. (SNL-NM), Albuquerque, NM (United States)

    2015-12-01

    An Evaluation and Screening team supporting the Fuel Cycle Technologies Program Office of the United States Department of Energy, Office of Nuclear Energy is conducting an evaluation and screening of a comprehensive set of fuel cycle options. These options have been assigned to one of 40 evaluation groups, each of which has a representative fuel cycle option [Todosow 2013]. A Fuel Cycle Data Package System Datasheet has been prepared for each representative fuel cycle option to ensure that the technical information used in the evaluation is high-quality and traceable [Kim, et al., 2013]. The information contained in the Fuel Cycle Data Packages has been entered into the Nuclear Fuel Cycle Options Catalog at Sandia National Laboratories so that it is accessible by the evaluation and screening team and other interested parties. In addition, an independent team at Savannah River National Laboratory has verified that the information has been entered into the catalog correctly. This report documents that the 40 representative fuel cycle options have been entered into the Catalog, and that the data entered into the catalog for the 40 representative options has been entered correctly.

  6. Treatment Option Overview (Chronic Myelogenous Leukemia)

    Science.gov (United States)

    ... ALL Treatment Childhood AML Treatment Research Chronic Myelogenous Leukemia Treatment (PDQ®)–Patient Version General Information About Chronic Myelogenous Leukemia Go to Health Professional Version Key Points Chronic ...

  7. Treatment Option Overview (Extragonadal Germ Cell Tumors)

    Science.gov (United States)

    ... Cell Tumors Treatment Testicular Cancer Treatment Age and gender can affect the risk of extragonadal germ cell ... Headache. Change in bowel habits. Feeling very tired. Trouble walking. Trouble in seeing or moving the eyes. ...

  8. Treatment Options for Intraocular (Uveal) Melanoma

    Science.gov (United States)

    ... A to Z List of Cancer Drugs Complementary & Alternative Medicine (CAM) Questions to Ask about Your Treatment Research ... Treatment Side Effects Clinical Trials Cancer Drugs Complementary & Alternative Medicine Coping Feelings & Cancer Adjusting to Cancer Self Image & ...

  9. Treatment Option Overview (Intraocular [Uveal] Melanoma)

    Science.gov (United States)

    ... A to Z List of Cancer Drugs Complementary & Alternative Medicine (CAM) Questions to Ask about Your Treatment Research ... Treatment Side Effects Clinical Trials Cancer Drugs Complementary & Alternative Medicine Coping Feelings & Cancer Adjusting to Cancer Self Image & ...

  10. Eating Disorder Treatment: Know Your Options

    Science.gov (United States)

    ... of the American Dietetic Association. 2011:111:1236. Gabbard GO, ed. Evidence-based psychological treatments for eating disorders. In: Gabbard's Treatments of Psychiatric Disorders. 5th ed. Arlington, Va.: ...

  11. Treatment Option Overview (Renal Cell Cancer)

    Science.gov (United States)

    ... Tumors Treatment Genetics of Kidney Cancer Research Renal Cell Cancer Treatment (PDQ®)–Patient Version General Information About Renal Cell Cancer Go to Health Professional Version Key Points Renal ...

  12. The Northeast heating fuel market: Assessment and options; TOPICAL

    International Nuclear Information System (INIS)

    None

    2000-01-01

    In response to a Presidential request, this study examines how the distillate fuel oil market (and related energy markets) in the Northeast behaved in the winter of 1999-2000, explains the role played by residential, commercial, industrial, and electricity generation sector consumers in distillate fuel oil markets and describes how that role is influenced by the structure of tie energy markets in the Northeast. In addition, this report explores the potential for nonresidential users to move away from distillate fuel oil and how this might impact future prices, and discusses conversion of distillate fuel oil users to other fuels over the next 5 years. Because the President's and Secretary's request focused on converting factories and other large-volume users of mostly high-sulfur distillate fuel oil to other fuels, transportation sector use of low-sulfur distillate fuel oil is not examined here

  13. The Northeast heating fuel market: Assessment and options

    Energy Technology Data Exchange (ETDEWEB)

    None

    2000-07-01

    In response to a Presidential request, this study examines how the distillate fuel oil market (and related energy markets) in the Northeast behaved in the winter of 1999-2000, explains the role played by residential, commercial, industrial, and electricity generation sector consumers in distillate fuel oil markets and describes how that role is influenced by the structure of tie energy markets in the Northeast. In addition, this report explores the potential for nonresidential users to move away from distillate fuel oil and how this might impact future prices, and discusses conversion of distillate fuel oil users to other fuels over the next 5 years. Because the President's and Secretary's request focused on converting factories and other large-volume users of mostly high-sulfur distillate fuel oil to other fuels, transportation sector use of low-sulfur distillate fuel oil is not examined here.

  14. Fuel Cells: A Real Option for Unmanned Aerial Vehicles Propulsion

    OpenAIRE

    González_Espasandín, Oscar; Leo Mena, Teresa de Jesus; Navarro Arevalo, Emilio

    2013-01-01

    The possibility of implementing fuel cell technology in Unmanned Aerial Vehicle (UAV) propulsion systems is considered. Potential advantages of the Proton Exchange Membrane or Polymer Electrolyte Membrane (PEMFC) and Direct Methanol Fuel Cells (DMFC), their fuels (hydrogen and methanol), and their storage systems are revised from technical and environmental standpoints. Some operating commercial applications are described. Main constraints for these kinds of fuel cells are analyzed in order t...

  15. Assessment of Startup Fuel Options for the GNEP Advanced Burner Reactor (ABR)

    Energy Technology Data Exchange (ETDEWEB)

    Jon Carmack (062056); Kemal O. Pasamehmetoglu (103171); David Alberstein

    2008-02-01

    The Global Nuclear Energy Program (GNEP) includes a program element for the development and construction of an advanced sodium cooled fast reactor to demonstrate the burning (transmutation) of significant quantities of minor actinides obtained from a separations process and fabricated into a transuranic bearing fuel assembly. To demonstrate and qualify transuranic (TRU) fuel in a fast reactor, an Advanced Burner Reactor (ABR) prototype is needed. The ABR would necessarily be started up using conventional metal alloy or oxide (U or U, Pu) fuel. Startup fuel is needed for the ABR for the first 2 to 4 core loads of fuel in the ABR. Following start up, a series of advanced TRU bearing fuel assemblies will be irradiated in qualification lead test assemblies in the ABR. There are multiple options for this startup fuel. This report provides a description of the possible startup fuel options as well as possible fabrication alternatives available to the program in the current domestic and international facilities and infrastructure.

  16. The current treatment options for epilepsy

    International Nuclear Information System (INIS)

    Sykora, P.; Svecova, L.

    2014-01-01

    Epilepsy is the most prevalent chronic brain disease manifesting with epileptic seizures. Epilepsy itself is not one nosological entity, it rather includes several diseases with various etiology, clinics, course and therapy. Antiepileptic therapy aims seizure freedom without affecting psychical and physical functions. The therapy is in first line pharmacological. The choice of antiepileptic drug depends not only on the seizure phenomenology, but also on the respective type of epilepsy syndrome. Most patients achieve seizure freedom or at least significant seizure frequency reduction. In 20-30% of the patients is the pharmacotherapy ineffective. In these cases of refractory epilepsy therapeutical options include epilepsy surgery, vagal stimulation or ketogenic diet. Despite recent advances in the diagnostics and therapy, epilepsy remains a serious medical and social issue. (author)

  17. Fuel cells: a real option for Unmanned Aerial Vehicles propulsion.

    Science.gov (United States)

    González-Espasandín, Óscar; Leo, Teresa J; Navarro-Arévalo, Emilio

    2014-01-01

    The possibility of implementing fuel cell technology in Unmanned Aerial Vehicle (UAV) propulsion systems is considered. Potential advantages of the Proton Exchange Membrane or Polymer Electrolyte Membrane (PEMFC) and Direct Methanol Fuel Cells (DMFC), their fuels (hydrogen and methanol), and their storage systems are revised from technical and environmental standpoints. Some operating commercial applications are described. Main constraints for these kinds of fuel cells are analyzed in order to elucidate the viability of future developments. Since the low power density is the main problem of fuel cells, hybridization with electric batteries, necessary in most cases, is also explored.

  18. Fuel Cells: A Real Option for Unmanned Aerial Vehicles Propulsion

    Science.gov (United States)

    2014-01-01

    The possibility of implementing fuel cell technology in Unmanned Aerial Vehicle (UAV) propulsion systems is considered. Potential advantages of the Proton Exchange Membrane or Polymer Electrolyte Membrane (PEMFC) and Direct Methanol Fuel Cells (DMFC), their fuels (hydrogen and methanol), and their storage systems are revised from technical and environmental standpoints. Some operating commercial applications are described. Main constraints for these kinds of fuel cells are analyzed in order to elucidate the viability of future developments. Since the low power density is the main problem of fuel cells, hybridization with electric batteries, necessary in most cases, is also explored. PMID:24600326

  19. Fuel Cells: A Real Option for Unmanned Aerial Vehicles Propulsion

    Directory of Open Access Journals (Sweden)

    Óscar González-Espasandín

    2014-01-01

    Full Text Available The possibility of implementing fuel cell technology in Unmanned Aerial Vehicle (UAV propulsion systems is considered. Potential advantages of the Proton Exchange Membrane or Polymer Electrolyte Membrane (PEMFC and Direct Methanol Fuel Cells (DMFC, their fuels (hydrogen and methanol, and their storage systems are revised from technical and environmental standpoints. Some operating commercial applications are described. Main constraints for these kinds of fuel cells are analyzed in order to elucidate the viability of future developments. Since the low power density is the main problem of fuel cells, hybridization with electric batteries, necessary in most cases, is also explored.

  20. MOX fuel use as a back-end option: Trends, main issues and impacts on fuel cycle management

    International Nuclear Information System (INIS)

    Fukuda, K.; Choi, J.-S.; Shani, R.; Durpel, L. van den; Bertel, E.; Sartori, E.

    2000-01-01

    In the past decades while the FBIULWR fuel cycle concept was zealously being developed, MOX-fuel use in thermal reactors was taken as an alternative back-end policy option. However, the plutonium recycling with LWRs has evolved to industrial level, gaining high maturity through the incubative period while FBR deployment was envisaged. Today, MOX-fuel use in LWRs makes integral part of the fuel cycle for those countries relying on the recycling policy. Developments to improve the fuel cycle performance, including the minimisation of remaining wastes, and the reactor engineering aspects owing to MOX-fuel use, are continued. This paper jointly presented by IAEA and OECD/NEA brings an integrated overview on MOX use as a back-end policy, covering MOX fuel utilisation, fuel performance and technology, economics, licensing, MOX fuel trends in the coming decades. (author)

  1. Hyperthyroidism: a review of the treatment options

    International Nuclear Information System (INIS)

    Chen Danyun; Jing Jin

    2007-01-01

    Hyperthyroidism is commonly treated with anti-thyroid medications, radioactive iodine, or surgery. Three kinds of treatments have their own advantages and disadvantages. Therefore, the treatment of hyperthyroidism is still controversial. With regard to the first choice, strategies vary among different countries. (authors)

  2. Review of Saccharomyces boulardii as a treatment option in IBD

    DEFF Research Database (Denmark)

    Sivananthan, Kavitha; Petersen, Andreas Munk

    2018-01-01

    CONTEXT: Review of the yeast Saccharomyces boulardii as a treatment option for the inflammatory bowel diseases (IBD) ulcerative colitis and Crohn's disease. OBJECTIVE: IBD is caused by an inappropriate immune response to gut microbiota. Treatment options could therefore be prebiotics, probiotics......, antibiotics and/or fecal transplant. In this review, we have looked at the evidence for the yeast S. boulardii as a treatment option. MATERIAL AND METHODS: Searches in PubMed and the Cochrane Library with the MeSH words 'Saccharomyces boulardii AND IBD', 'Saccharomyces boulardii AND Inflammatory Bowel Disease....... Saccharomyces boulardii is, however, a plausible treatment option in the future, but more placebo-controlled clinical studies on both patients with ulcerative colitis and Crohn's disease are needed....

  3. For Some Breast Cancers, New Drug May Be Treatment Option

    Science.gov (United States)

    Results from an international clinical trial suggest that women with metastatic, HER2-positive breast cancer that is no longer responding to the targeted therapy trastuzumab (Herceptin) may soon have a new treatment option.

  4. Desmoid tumors: clinical features and treatment options: a case ...

    African Journals Online (AJOL)

    Desmoid tumors: clinical features and treatment options: a case report and a review of literature. Amel Achour Jenayah, Hajer Bettaieb, Sarra Saoudi, Anissa Gharsa, Ezzeddine Sfar, Fethia Boudaya, Dalenda Chelli ...

  5. My fuel treatment planner: a user guide.

    Science.gov (United States)

    Robin L. Biesecker; Roger D. Fight

    2006-01-01

    My Fuel Treatment Planner (MyFTP) is a tool for calculating and displaying the financial costs and potential revenues associated with forest fuel reduction treatments. It was designed for fuel treatment planners including those with little or no background in economics, forest management, or timber sales. This guide provides the information needed to acquire, load, and...

  6. Treatment Options by Stage (Bladder Cancer)

    Science.gov (United States)

    ... above the waist. Tiny tubules in the kidneys filter and clean the blood . They take out waste ... to bladder cancer. Being exposed to paints, dyes, metals, or petroleum products in the workplace. Past treatment ...

  7. Exploring Treatment Options for Alcohol Use Disorders

    Science.gov (United States)

    ... smartphones to provide patients with information, adherence strategies, decision-making tools, reminders, and social support services in easy- ... can choose among many available alternatives. Programs are making services more ... motivations directly, these programs simply promote rapid treatment entry ...

  8. Treatment options for patients with Gaucher disease

    African Journals Online (AJOL)

    Rabah M. Shawky

    2016-02-28

    Feb 28, 2016 ... has been the mainstay of treatment with its major disadvantage of long life dependency on biweekly ..... Another advantage is that PCT can cross the BBB and can ... Induced pluripotent stem cells are an attractive alternative.

  9. Treatment Option Overview (Childhood Acute Myeloid Leukemia/Other Myeloid Malignancies)

    Science.gov (United States)

    ... factors affect prognosis (chance of recovery) and treatment options. The prognosis (chance of recovery ) and treatment options ... the cancer does not respond to treatment. Treatment Option Overview Key Points There are different types of ...

  10. Advancing treatment options for chronic idiopathic constipation.

    Science.gov (United States)

    Quigley, Eamonn M M; Neshatian, Leila

    2016-01-01

    Chronic constipation is a global problem affecting all ages and associated with considerable morbidity and significant financial burden for society. Though formerly defined on the basis of a single symptom, infrequent defecation; constipation is now viewed as a syndrome encompassing several complaints such as difficulty with defecation, a sense of incomplete evacuation, hard stools, abdominal discomfort and bloating. The expanded concept of constipation has inevitably led to a significant change in outcomes in clinical trials, as well as in patient expectations from new therapeutic interventions. The past decades have also witnessed a proliferation in therapeutic targets for new agents. Foremost among these have been novel prokinetics, a new category, prosecretory agents and innovative approaches such as inhibitors of bile salt transport. In contrast, relatively few effective therapies exist for the management of those anorectal and pelvic floor problems that result in difficult defecation. Though constipation is a common and often troublesome disorder, many of those affected can resolve their symptoms with relatively simple measures. For those with more resistant symptoms a number of novel, effective and safe options now exist. Those with defecatory difficulty (anismus, pelvic floor dysfunction) continue to represent a significant management challenge.

  11. Narcolepsy: current treatment options and future approaches

    Directory of Open Access Journals (Sweden)

    Michel Billiard

    2008-06-01

    Full Text Available Michel BilliardDepartment of Neurology, Gui de Chauliac Hospital, Montpellier, FranceAbstract: The management of narcolepsy is presently at a turning point. Three main avenues are considered in this review: 1 Two tendencies characterize the conventional treatment of narcolepsy. Modafinil has replaced methylphenidate and amphetamine as the first-line treatment of excessive daytime sleepiness (EDS and sleep attacks, based on randomized, double blind, placebo-controlled clinical trials of modafinil, but on no direct comparison of modafinil versus traditional stimulants. For cataplexy, sleep paralysis, and hypnagogic hallucinations, new antidepressants tend to replace tricyclic antidepressants and selective serotonin reuptake inhibitors (SSRIs in spite of a lack of randomized, double blind, placebo-controlled clinical trials of these compounds; 2 The conventional treatment of narcolepsy is now challenged by sodium oxybate, the sodium salt of gammahydroxybutyrate, based on a series of randomized, double-blind, placebo-controlled clinical trials and a long-term open label study. This treatment has a fairly good efficacy and is active on all symptoms of narcolepsy. Careful titration up to an adequate level is essential both to obtain positive results and avoid adverse effects; 3 A series of new treatments are currently being tested, either in animal models or in humans, They include novel stimulant and anticataplectic drugs, endocrine therapy, and, more attractively, totally new approaches based on the present state of knowledge of the pathophysiology of narcolepsy with cataplexy, hypocretine-based therapies, and immunotherapy.Keywords: narcolepsy, treatment, conventional drugs, modafinil, sodium oxybate, future treatments

  12. Narcolepsy: current treatment options and future approaches

    Science.gov (United States)

    Billiard, Michel

    2008-01-01

    The management of narcolepsy is presently at a turning point. Three main avenues are considered in this review: 1) Two tendencies characterize the conventional treatment of narcolepsy. Modafinil has replaced methylphenidate and amphetamine as the first-line treatment of excessive daytime sleepiness (EDS) and sleep attacks, based on randomized, double blind, placebo-controlled clinical trials of modafinil, but on no direct comparison of modafinil versus traditional stimulants. For cataplexy, sleep paralysis, and hypnagogic hallucinations, new antidepressants tend to replace tricyclic antidepressants and selective serotonin reuptake inhibitors (SSRIs) in spite of a lack of randomized, double blind, placebo-controlled clinical trials of these compounds; 2) The conventional treatment of narcolepsy is now challenged by sodium oxybate, the sodium salt of gammahydroxybutyrate, based on a series of randomized, double-blind, placebo-controlled clinical trials and a long-term open label study. This treatment has a fairly good efficacy and is active on all symptoms of narcolepsy. Careful titration up to an adequate level is essential both to obtain positive results and avoid adverse effects; 3) A series of new treatments are currently being tested, either in animal models or in humans, They include novel stimulant and anticataplectic drugs, endocrine therapy, and, more attractively, totally new approaches based on the present state of knowledge of the pathophysiology of narcolepsy with cataplexy, hypocretine-based therapies, and immunotherapy. PMID:18830438

  13. Current and future treatment options for acne.

    NARCIS (Netherlands)

    Kerkhof, P.C.M. van de; Kleinpenning, M.M.; Jong, E.M.G.J. de; Gerritsen, M.J.P.; Dooren-Greebe, R.J. van; Alkemade, J.A.C.

    2006-01-01

    Acne is a frequent skin disease with abnormalities in the process of keratinization, sebaceous gland functioning and inflammation. In this review, our understanding of the pathogenesis of acne has been updated. An overview of efficacy and side effects of available anti-acne treatments is presented.

  14. Retinal vein occlusion: pathophysiology and treatment options

    OpenAIRE

    Karia, Niral

    2010-01-01

    Niral KariaDepartment of Ophthalmology, Southend Hospital, Prittlewell Chase, Westcliff on Sea, Essex, United KingdomAbstract: This paper reviews the current thinking about retinal vein occlusion. It gives an overview of its pathophysiology and discusses the evidence behind the various established and emerging treatment paradigms.Keywords: central, hemispheric, branch, retinal vein occlusion, visual loss

  15. Urinary Incontinence: Management and Treatment Options

    Science.gov (United States)

    Griebling, Tomas L.

    2009-01-01

    Urinary incontinence, defined as the involuntary leakage of urine, is a common health problem in both women and men. Children may also suffer from this condition. Management and treatment of urinary incontinence depends primarily on the specific type of incontinence and the underlying problem causing the leakage for a given patient. Because…

  16. The EBR-II spent fuel treatment program

    International Nuclear Information System (INIS)

    Lineberry, M.J.; McFarlane, H.F.

    1995-01-01

    Argonne National Laboratory has refurbished and equipped an existing hot cell facility for demonstrating a high-temperature electrometallurgical process for treating spent nuclear fuel from the Experimental Breeder Reactor-11. Two waste forms will be produced and qualified for geologic disposal of the fission and activation products. Relatively pure uranium will be separated for storage. Following additional development, transuranium elements will be blended into one of the high-level waste streams. The spent fuel treatment program will help assess the viability of electrometallurgical technology as a spent fuel management option

  17. Options Study Documenting the Fast Reactor Fuels Innovative Design Activity

    Energy Technology Data Exchange (ETDEWEB)

    Jon Carmack; Kemal Pasamehmetoglu

    2010-07-01

    This document provides presentation and general analysis of innovative design concepts submitted to the FCRD Advanced Fuels Campaign by nine national laboratory teams as part of the Innovative Transmutation Fuels Concepts Call for Proposals issued on October 15, 2009 (Appendix A). Twenty one whitepapers were received and evaluated by an independent technical review committee.

  18. Neutronics Study on LEU Nuclear Thermal Rocket Fuel Options

    Energy Technology Data Exchange (ETDEWEB)

    Venneri, Paolo; Kim, Yong Hee [KAIST, Daejeon (Korea, Republic of); Howe, Steven [CSNR, Idaho (United States)

    2014-10-15

    This has resulted in a non-trivial simplification of the tasks needed to develop such an engine and the quick initial development of the concept. There are, however, a series of key core-design choices that are currently under scrutiny in the field that have to be resolved in order for the LEU-NTR to be fully developed. The most important of these is the choice of fuel: carbide composite or tungsten cermet. This study presents a first comparison of the two fuel types specifically in the neutronic application to the LEU-NTR, keeping in mind the unique neutronic environment and the system requirements of the system. The scope of the study itself is limited to a neutronics study of the two fuels and only a cursory overview of the material properties of the fuels themselves... The results of this study have led to two major conclusions. First of all is that the carbide composite fuel is, from a neutronics standpoint, a much better fuel. It has a low absorption cross-section, is inherently a strong moderator, is able to achieve a higher reactivity using smaller amounts of fissile material, and can potentially enable a smaller reactor. Second is that despite its neutronic difficulties (high absorption, inferior moderating abilities, and lower k-infinity values) the tungsten cermet fuel is still able to perform satisfactorily in an LEU-NTR, largely due to its ability to have an extremely high fuel loading.

  19. Patient knowledge on stroke risk factors, symptoms and treatment options.

    Science.gov (United States)

    Faiz, Kashif Waqar; Sundseth, Antje; Thommessen, Bente; Rønning, Ole Morten

    2018-01-01

    Public campaigns focus primarily on stroke symptom and risk factor knowledge, but patients who correctly recognize stroke symptoms do not necessarily know the reason for urgent hospitalization. The aim of this study was to explore knowledge on stroke risk factors, symptoms and treatment options among acute stroke and transient ischemic attack patients. This prospective study included patients admitted to the stroke unit at the Department of Neurology, Akershus University Hospital, Norway. Patients with previous cerebrovascular disease, patients receiving thrombolytic treatment and patients who were not able to answer the questions in the questionnaire were excluded. Patients were asked two closed-ended questions: "Do you believe that stroke is a serious disorder?" and "Do you believe that time is of importance for stroke treatment?". In addition, patients were asked three open-ended questions where they were asked to list as many stroke risk factors, stroke symptoms and stroke treatment options as they could. A total of 173 patients were included, of whom 158 (91.3%) confirmed that they regarded stroke as a serious disorder and 148 patients (85.5%) considered time being of importance. In all, 102 patients (59.0%) could not name any treatment option. Forty-one patients (23.7%) named one or more adequate treatment options, and they were younger ( p options, which may contribute to reduce prehospital delay and onset-to-treatment-time.

  20. [Options for stress management in obesity treatment].

    Science.gov (United States)

    Czeglédi, Edit

    2016-02-14

    Overeating and physical inactivity are of great importance in the etiology of obesity. Psychological factors are often found in the background of life style. Chronic stress can contribute to physical inactivity and behaviors that hinder the keeping of a diet (e.g., irregular eating pattern, emotional eating). Results of randomized controlled trials show that relaxation can reduce emotional eating, improve cognitive restraint, and thereby reduce weight. However, stress management is more than relaxation. It consists of adaptive emotion-focused and problem-focused coping strategies and skills to improve relationships. Deflection skills may help in replacing emotional eating with other behaviors. Cognitive restructuring, saying no, and problem solving help to prevent or manage conflicts and difficulties otherwise would result in overeating due to distress. Developing stress management skills may result in greater compliance with the treatment. The techniques presented in the study can be easily applied by general practitioners or specialists, and provide tools for optimizing obesity treatment.

  1. Treatment options for ocular adnexal lymphoma (OAL

    Directory of Open Access Journals (Sweden)

    Victoria Mary Lendrum Cohen

    2009-11-01

    Full Text Available Victoria Mary Lendrum CohenSt. Bartholomew’s and Moorfields Eye Hospital, London UKAbstract: Most lymphomas that involve the ocular adnexal structure are low grade, B cell, non-Hodgkin’s lymphomas. The treatment depends upon the grade and stage of the disease. High grade lymhoma requires treatment with systemic chemotherapy whereas the localized low grade (extranodal marginal zone lymphoma can be successfully managed with local radiotherapy. Chlamydia psittaci infection is associated with low grade ocular lymphoma; however there is wide geographic variation in the strength of this association. Blanket antibiotic therapy is not advised unless there is proof of an infective agent. The monoclonal antibody, rituximab, may be successful for CD20 positive lymphoma, although it is likely that rituximab will have better long-term results when used in combination with systemic chemotherapy.Keywords: ocular adnexal lymphoma, mucosa associated lymphoid tissue, extranodal marginal zone lymphoma, Chlamydia psittaci, rituximab, radiotherapy, chemotherapy

  2. Perinatal depression: treatment options and dilemmas

    OpenAIRE

    Pearlstein, Teri

    2008-01-01

    The treatment of depression during pregnancy and the postpartum period raises unique concerns about safety for the developing fetus and the infant. An increasing number of studies suggest adverse effects from untreated stress, anxiety and depression as well as adverse effects from antidepressant and other psychotropic medications. Even when studies suggest a lack of short-term adverse effects with some medications, the paucity of systematic longitudinal follow-up studies investigating the dev...

  3. Opiate addiction - current trends and treatment options

    OpenAIRE

    Achal Bhatt; Aminder Gill

    2016-01-01

    Opioids are widely used drugs for treatment of pain and related disorders. Opiate addiction is a major public health concern in the United States causing significant increase in healthcare expenditure. They produce euphoria and sense of well-being which makes them addictive to some people. Used in higher doses they can lead to cardiac or respiratory compromise. They also impair cognition leading to impaired decision making. Opioids exert their effects by acting on three different types of re...

  4. Hemifacial spasm: conservative and surgical treatment options.

    Science.gov (United States)

    Rosenstengel, Christian; Matthes, Marc; Baldauf, Jörg; Fleck, Steffen; Schroeder, Henry

    2012-10-01

    Hemifacial spasm is a neuromuscular movement disorder characterized by brief or persistent involuntary contractions of the muscles innervated by the facial nerve. Its prevalence has been estimated at 11 cases per 100 000 individuals. Among the patients who were operated on by our team, the mean interval from diagnosis to surgery was 8.2 years, and more than half of them learned of the possibility of surgical treatment only through a personal search for information on the condition. These facts motivated us to write this article to raise the awareness of hemifacial spasm and its neurosurgical treatment among physicians who will encounter it. This review article is based on a selective literature search and on our own clinical experience. Hemifacial spasm is usually caused by an artery compressing the facial nerve at the root exit zone of the brainstem. 85-95% of patients obtain moderate or marked relief from local injections of botulinum toxin (BTX), which must be repeated every 3 to 4 months. Alternatively, microvascular decompression has a success rate of about 85%. Local botulinum-toxin injection is a safe and well-tolerated symptomatic treatment for hemifacial spasm. In the long term, however, lasting relief can only be achieved by microvascular decompression, a microsurgical intervention with a relatively low risk and a high success rate.

  5. Assessment of Options for the Treatment of Nitrate Salt Wastes at Los Alamos National Laboratory

    International Nuclear Information System (INIS)

    Robinson, Bruce Alan; Funk, David John; Stevens, Patrice Ann

    2016-01-01

    This paper summarizes the methodology used to evaluate options for treatment of the remediated nitrate salt waste containers at Los Alamos National Laboratory. The method selected must enable treatment of the waste drums, which consist of a mixture of complex nitrate salts (oxidizer) improperly mixed with sWheat Scoop®1, an organic kitty litter and absorbent (fuel), in a manner that renders the waste safe, meets the specifications of waste acceptance criteria, and is suitable for transport and final disposal in the Waste Isolation Pilot Plant located in Carlsbad, New Mexico. A Core Remediation Team was responsible for comprehensively reviewing the options, ensuring a robust, defensible treatment recommendation. The evaluation process consisted of two steps. First, a prescreening process was conducted to cull the list on the basis for a decision of feasibility of certain potential options with respect to the criteria. Then, the remaining potential options were evaluated and ranked against each of the criteria in a consistent methodology. Numerical scores were established by consensus of the review team. Finally, recommendations were developed based on current information and understanding of the scientific, technical, and regulatory situation. A discussion of the preferred options and documentation of the process used to reach the recommended treatment options are presented.

  6. Assessment of Options for the Treatment of Nitrate Salt Wastes at Los Alamos National Laboratory

    Energy Technology Data Exchange (ETDEWEB)

    Robinson, Bruce Alan [Los Alamos National Lab. (LANL), Los Alamos, NM (United States); Funk, David John [Los Alamos National Lab. (LANL), Los Alamos, NM (United States); Stevens, Patrice Ann [Los Alamos National Lab. (LANL), Los Alamos, NM (United States)

    2016-03-17

    This paper summarizes the methodology used to evaluate options for treatment of the remediated nitrate salt waste containers at Los Alamos National Laboratory. The method selected must enable treatment of the waste drums, which consist of a mixture of complex nitrate salts (oxidizer) improperly mixed with sWheat Scoop®1, an organic kitty litter and absorbent (fuel), in a manner that renders the waste safe, meets the specifications of waste acceptance criteria, and is suitable for transport and final disposal in the Waste Isolation Pilot Plant located in Carlsbad, New Mexico. A Core Remediation Team was responsible for comprehensively reviewing the options, ensuring a robust, defensible treatment recommendation. The evaluation process consisted of two steps. First, a prescreening process was conducted to cull the list on the basis for a decision of feasibility of certain potential options with respect to the criteria. Then, the remaining potential options were evaluated and ranked against each of the criteria in a consistent methodology. Numerical scores were established by consensus of the review team. Finally, recommendations were developed based on current information and understanding of the scientific, technical, and regulatory situation. A discussion of the preferred options and documentation of the process used to reach the recommended treatment options are presented.

  7. [Renal denervation as treatment option for hypertension].

    Science.gov (United States)

    Blankestijn, P J; Bots, M L

    2016-01-01

    The rationale behind catheter-based renal denervation is that afferent and efferent renal nerves play a role in the pathogenesis and maintenance of high blood pressure, and that this can be prevented by blocking the function of the renal nerves. Since the introduction of catheter-based renal denervation, several observational and a small number of randomised controlled trials have been conducted. The available evidence does not allow for a definitive conclusion regarding its efficacy. There have been no serious side-effects reported. The development of this treatment concept has not been finalised; new trials have just commenced or will start in the near future.

  8. Superficial femoral artery: current treatment options

    International Nuclear Information System (INIS)

    Tepe, Gunnar; Schmehl, Joerg; Heller, Stephan; Wiesinger, Benjamin; Claussen, Claus D.; Duda, Stephan H.

    2006-01-01

    Treatment of the superficial femoral artery (SFA) has been among the least effective of all endovascular procedures in terms of long-term patency. The relatively small vessel lumen, in conjunction with a high plaque burden, slow flow, and a high frequency of primary occlusions, contributes to a considerable rate of acute technical failures. Because of these technical limitations a much effort has been made during the past years. This manuscript should summarize the hopes and limitations of different approaches such as brachytherapy, cutting balloons, stents and stent grafts, drug-eluting stents, and drug-coated balloons. (orig.)

  9. Evaluation of plate type fuel options for small power reactors

    International Nuclear Information System (INIS)

    Andrzejewski, Claudio de Sa

    2005-01-01

    Plate type fuels are generally used in research reactor. The utilization of this kind of configuration improves significantly the overall performance fuel. The conception of new fuels for small power reactors based in plate-type configuration needs a complete review of the safety criteria originally used to conduce power and research reactor projects. In this work, a group of safety criteria is established for the utilization of plate-type fuels in small power reactors taking into consideration the characteristics of power and research reactors. The performance characteristics of fuel elements are strongly supported by its materials properties and the adopted configuration for its fissile particles. The present work makes an orientated bibliographic investigation searching the best material properties (structural materials and fuel compounds) related to the performance fuel. Looking for good parafermionic characteristics and manufacturing exequibility associated to existing facilities in national research centres, this work proposes several alternatives of plate type fuels, considering its utilization in small power reactors: dispersions of UO 2 in stainless steel, of UO 2 in zircaloy, and of U-Mo alloy in zircaloy, and monolithic plates of U-Mo cladded with zircaloy. Given the strong dependency of radiation damage with temperature increase, the safety criteria related to heat transfer were verified for all the alternatives, namely the DNBR; coolant temperature lower than saturation temperature; peak meat temperature to avoid swelling; peak fuel temperature to avoid meat-matrix reaction. It was found that all alternatives meet the safety criteria including the 0.5 mm monolithic U-Mo plate cladded with zircaloy. (author)

  10. Emerging treatment options for the mucopolysaccharidoses

    Directory of Open Access Journals (Sweden)

    Matte U

    2012-11-01

    Full Text Available Roberto Giugliani,1–6 Andressa Federhen,1,4 André Anjos da Silva,1,5 Camila Matzenbacher Bittar,1,5 Carolina Fischinger Moura de Souza,1 Cristina Brinckmann Oliveira Netto,1 Fabiana Mayer,2,7 Guilherme Baldo,1,2,8 Ursula Matte1–51Medical Genetics Service, 2Gene Therapy Center, Hospital de Clínicas (HCPA, Porto Alegre, RS, Brazil; 3Department of Genetics, 4Postgraduate Program in Child and Adolescent Health, 5Postgraduate Program in Genetics and Molecular Biology, Universidade Federal do Rio Grande do Sul (UFRGS, Porto Alegre, RS, Brazil; 6National Institute of Population Medical Genetics (INAGEMP, Porto Alegre, RS, Brazil; 7Fundação Estadual de Pesquisa Agropecuária (FEPAGRO, Eldorado do Sul, RS, Brazil; 8Department of Biophysics, Universidade Federal do Rio Grande do Sul (UFRGS, Porto Alegre, RS, BrazilAbstract: The mucopolysaccharidoses (MPS are a group of diseases arising from one of eleven different enzyme defects, each one affecting one single step of the degradation pathway of glycosamynoglycans. Several developments in the understanding of the MPS have occurred since the first clinical report about their occurrence in 1917: the nature of the storage product was recognized, a useful biomarker (mucopolysacchariduria was developed, the enzyme defects became identified, and the gene defects were elucidated. The first successful treatment for MPS diseases was bone marrow transplantation, which was introduced for the therapy in 1980. Over the last decade, a whole new set of therapeutic approaches have become available or are currently in development to address MPS. Intravenous enzyme replacement therapy, already approved for MPS I, II, and VI, will possibly be available for MPS IVA and for MPS VII within the next few years. Intrathecal enzyme replacement therapy (tested in animals and already reported in a few patients may become a tool to treat or prevent the central nervous system (CNS manifestations which occur in several MPS

  11. Drug-resistant tuberculosis: emerging treatment options

    Directory of Open Access Journals (Sweden)

    Adhvaryu MR

    2011-12-01

    Full Text Available Meghna Adhvaryu1, Bhasker Vakharia21Department of Biotechnology, SRK Institute of Computer Education and Applied Sciences, 2R&D, Bhuma Research in Ayurvedic and Herbal Medicine, Surat, Gujarat, IndiaAbstract: Multidrug-resistant tuberculosis has emerged worldwide, with an increasing incidence due to failure of implementation of apparently effective first-line antituberculous therapy as well as primary infection with drug-resistant strains. Failure of current therapy is attributed to a long duration of treatment leading to nonadherence and irregular therapy, lack of patient education about the disease, poverty, irregular supply by care providers, drug–drug interactions in patients coinfected with human immunodeficiency virus (HIV, inadequate regulations causing market overlap and irresponsible drug usage in the private sector, and lack of research, with no addition of new drugs in the last four decades. Present standards of care for the treatment of drug-susceptible tuberculosis, multidrug-resistant tuberculosis, tuberculosis-HIV coinfection, and latent tuberculosis infection are all unsatisfactory. Since 2000, the World Health Organization (WHO has focused on drug development for tuberculosis, as well as research in all relevant aspects to discover new regimens by 2015 and to eliminate tuberculosis as a public health concern by 2050. As a result, some 20 promising compounds from 14 groups of drugs have been discovered. Twelve candidates from eight classes are currently being evaluated in clinical trials. Ongoing research should prioritize identification of novel targets and newer application of existing drugs, discovery of multitargeted drugs from natural compounds, strengthening host factors by immunopotentiation with herbal immunomodulators, as well as protective vaccines before and after exposure, consideration of surgical measures when indicated, development of tools for rapid diagnosis, early identification of resistant strains, and

  12. Final Report on Two-Stage Fast Spectrum Fuel Cycle Options

    International Nuclear Information System (INIS)

    Yang, Won Sik; Lin, C. S.; Hader, J. S.; Park, T. K.; Deng, P.; Yang, G.; Jung, Y. S.; Kim, T. K.; Stauff, N. E.

    2016-01-01

    This report presents the performance characteristics of two ''two-stage'' fast spectrum fuel cycle options proposed to enhance uranium resource utilization and to reduce nuclear waste generation. One is a two-stage fast spectrum fuel cycle option of continuous recycle of plutonium (Pu) in a fast reactor (FR) and subsequent burning of minor actinides (MAs) in an accelerator-driven system (ADS). The first stage is a sodium-cooled FR fuel cycle starting with low-enriched uranium (LEU) fuel; at the equilibrium cycle, the FR is operated using the recovered Pu and natural uranium without supporting LEU. Pu and uranium (U) are co-extracted from the discharged fuel and recycled in the first stage, and the recovered MAs are sent to the second stage. The second stage is a sodium-cooled ADS in which MAs are burned in an inert matrix fuel form. The discharged fuel of ADS is reprocessed, and all the recovered heavy metals (HMs) are recycled into the ADS. The other is a two-stage FR/ADS fuel cycle option with MA targets loaded in the FR. The recovered MAs are not directly sent to ADS, but partially incinerated in the FR in order to reduce the amount of MAs to be sent to the ADS. This is a heterogeneous recycling option of transuranic (TRU) elements

  13. Final Report on Two-Stage Fast Spectrum Fuel Cycle Options

    Energy Technology Data Exchange (ETDEWEB)

    Yang, Won Sik [Purdue Univ., West Lafayette, IN (United States); Lin, C. S. [Purdue Univ., West Lafayette, IN (United States); Hader, J. S. [Purdue Univ., West Lafayette, IN (United States); Park, T. K. [Purdue Univ., West Lafayette, IN (United States); Deng, P. [Purdue Univ., West Lafayette, IN (United States); Yang, G. [Purdue Univ., West Lafayette, IN (United States); Jung, Y. S. [Purdue Univ., West Lafayette, IN (United States); Kim, T. K. [Argonne National Lab. (ANL), Argonne, IL (United States); Stauff, N. E. [Argonne National Lab. (ANL), Argonne, IL (United States)

    2016-01-30

    This report presents the performance characteristics of two “two-stage” fast spectrum fuel cycle options proposed to enhance uranium resource utilization and to reduce nuclear waste generation. One is a two-stage fast spectrum fuel cycle option of continuous recycle of plutonium (Pu) in a fast reactor (FR) and subsequent burning of minor actinides (MAs) in an accelerator-driven system (ADS). The first stage is a sodium-cooled FR fuel cycle starting with low-enriched uranium (LEU) fuel; at the equilibrium cycle, the FR is operated using the recovered Pu and natural uranium without supporting LEU. Pu and uranium (U) are co-extracted from the discharged fuel and recycled in the first stage, and the recovered MAs are sent to the second stage. The second stage is a sodium-cooled ADS in which MAs are burned in an inert matrix fuel form. The discharged fuel of ADS is reprocessed, and all the recovered heavy metals (HMs) are recycled into the ADS. The other is a two-stage FR/ADS fuel cycle option with MA targets loaded in the FR. The recovered MAs are not directly sent to ADS, but partially incinerated in the FR in order to reduce the amount of MAs to be sent to the ADS. This is a heterogeneous recycling option of transuranic (TRU) elements

  14. Psoriasis: characteristics, psychosocial effects and treatment options.

    LENUS (Irish Health Repository)

    Ryan, Sheila

    2012-02-01

    Psoriasis is a complex chronic non-infectious inflammatory skin disease with a variety of different presentations. The classic presentation is of well-defined red plaques with silver scale. The characteristic scale makes the disorder highly visible and intrusive on the patient\\'s lifestyle. The visible nature of the disease ensures that psoriasis has both physical and psychosocial effects. In normal skin, epidermal cell reproduction and proliferation takes 28 days. In psoriasis this process is considerably accelerated to approximately 4 days, resulting in the deposit of immature cells on the skin. While the exact cause of this process is unknown, certain environmental and genetic factors are known to be triggers. Disease management depends on disease severity, psychosocial effects and the patient\\'s lifestyle. To effectively treat this disease the nurse must be skilled in psoriasis management, and in patient education and motivation. This article reviews the characteristics, aetiology, psychosocial effects and treatment strategies of psoriasis.

  15. Hilar cholangiocarcinoma: diagnosis, treatment options, and management

    Science.gov (United States)

    Soares, Kevin C.; Kamel, Ihab; Cosgrove, David P.; Herman, Joseph M.

    2014-01-01

    Hilar cholangiocarcinoma (HC) is a rare disease with a poor prognosis which typically presents in the 6th decade of life. Of the 3,000 cases seen annually in the United States, less than one half of these tumors are resectable. A variety of risk factors have been associated with HC, most notably primary sclerosing cholangitis (PSC), biliary stone disease and parasitic liver disease. Patients typically present with abdominal pain, pruritis, weight loss, and jaundice. Computed topography (CT), magnetic resonance imaging (MRI), and ultrasound (US) are used to characterize biliary lesions. Endoscopic retrograde cholangiopancreatography (ERCP) and percutaneous transhepatic cholangiography (PTC) assess local ductal extent of the tumor while allowing for therapeutic biliary drainage. MRCP has demonstrated similar efficacies to PTC and ERCP in identifying anatomic extension of tumors with less complications. Treatment consists of surgery, radiation, chemotherapy and photodynamic therapy. Biliary drainage of the future liver remnant should be performed to decrease bilirubin levels thereby facilitating future liver hypertrophy. Standard therapy consists of surgical margin-negative (R0) resection with extrahepatic bile duct resection, hepatectomy and en bloc lymphadenectomy. Local resection should not be undertaken. Lymph node invasion, tumor grade and negative margins are important prognostic indicators. In instances where curative resection is not possible, liver transplantation has demonstrated acceptable outcomes in highly selected patients. Despite the limited data, chemotherapy is indicated for patients with unresectable tumors and adequate functional status. Five-year survival after surgical resection of HC ranges from 10% to 40% however, recurrence can be as high as 50-70% even after R0 resection. Due to the complexity of this disease, a multi-disciplinary approach with multimodal treatment is recommended for this complex disease. PMID:24696835

  16. Tarapur's nuclear fuel uncertainty and India's policy options

    International Nuclear Information System (INIS)

    Subramanian, R.R.

    1978-01-01

    The Indo-US agreement over the turnkey Project of the Tarapur Atomic Power Station (TAPS) signed in 1963 is being reintepreted by the American Government from 'non-proliferation' aspect, particularly after the Pokharan peaceful nuclear explosion in 1974. With the ratification of the new Non-Proliferation Act by the American Congress, the supply of enriched uranium fuel for the TAPS has become uncertain, as India is not prepared to accept comprehensive safeguards on all domestic nuclear facilities. If the contractual obligations for fuel supply and transport of spent fuel back to U.S. are not fulfilled, it is pointed out, that India will have to start reprocessing spent fuel and recycle plutonium. (K.M.)

  17. The high temperature reactor and its fuel cycle options

    International Nuclear Information System (INIS)

    1979-07-01

    The status of the HTR system in the Federal Republic of Germany as well as the consecutive steps and the probable cost of further development are presented. The considerations are based on a recycling Th/highly enriched uranium (HEU) fuel cycle which has been chosen as the main line of the German HTR R and D efforts. Alternative fuel cycles such as medium-enriched uranium (MEU) and low-enriched uranium (LEU) are discussed as well

  18. Options for treating high-temperature gas-cooled reactor fuel for repository disposal

    Energy Technology Data Exchange (ETDEWEB)

    Lotts, A.L.; Bond, W.D.; Forsberg, C.W.; Glass, R.W.; Harrington, F.E.; Micheals, G.E.; Notz, K.J.; Wymer, R.G.

    1992-02-01

    This report describes the options that can reasonably be considered for disposal of high-temperature gas-cooled reactor (HTGR) fuel in a repository. The options include whole-block disposal, disposal with removal of graphite (either mechanically or by burning), and reprocessing of spent fuel to separate the fuel and fission products. The report summarizes what is known about the options without extensively projecting or analyzing actual performance of waste forms in a repository. The report also summarizes the processes involved in convert spent HTGR fuel into the various waste forms and projects relative schedules and costs for deployment of the various options. Fort St. Vrain Reactor fuel, which utilizes highly-enriched {sup 235}U (plus thorium) and is contained in a prismatic graphite block geometry, was used as the baseline for evaluation, but the major conclusions would not be significantly different for low- or medium-enriched {sup 235}U (without thorium) or for the German pebble-bed fuel. Future US HTGRs will be based on the Fort St. Vrain (FSV) fuel form. The whole block appears to be a satisfactory waste form for disposal in a repository and may perform better than light-water reactor (LWR) spent fuel. From the standpoint of process cost and schedule (not considering repository cost or value of fuel that might be recycled), the options are ranked as follows in order of increased cost and longer schedule to perform the option: (1) whole block, (2a) physical separation, (2b) chemical separation, and (3) complete chemical processing.

  19. Options for treating high-temperature gas-cooled reactor fuel for repository disposal

    International Nuclear Information System (INIS)

    Lotts, A.L.; Bond, W.D.; Forsberg, C.W.; Glass, R.W.; Harrington, F.E.; Micheals, G.E.; Notz, K.J.; Wymer, R.G.

    1992-02-01

    This report describes the options that can reasonably be considered for disposal of high-temperature gas-cooled reactor (HTGR) fuel in a repository. The options include whole-block disposal, disposal with removal of graphite (either mechanically or by burning), and reprocessing of spent fuel to separate the fuel and fission products. The report summarizes what is known about the options without extensively projecting or analyzing actual performance of waste forms in a repository. The report also summarizes the processes involved in convert spent HTGR fuel into the various waste forms and projects relative schedules and costs for deployment of the various options. Fort St. Vrain Reactor fuel, which utilizes highly-enriched 235 U (plus thorium) and is contained in a prismatic graphite block geometry, was used as the baseline for evaluation, but the major conclusions would not be significantly different for low- or medium-enriched 235 U (without thorium) or for the German pebble-bed fuel. Future US HTGRs will be based on the Fort St. Vrain (FSV) fuel form. The whole block appears to be a satisfactory waste form for disposal in a repository and may perform better than light-water reactor (LWR) spent fuel. From the standpoint of process cost and schedule (not considering repository cost or value of fuel that might be recycled), the options are ranked as follows in order of increased cost and longer schedule to perform the option: (1) whole block, (2a) physical separation, (2b) chemical separation, and (3) complete chemical processing

  20. Current options for the treatment of pathological scarring.

    Science.gov (United States)

    Poetschke, Julian; Gauglitz, Gerd G

    2016-05-01

    Scarring is the consequence of surgery, trauma or different skin diseases. Apart from fresh, immature scars,that transform into mature scars over the course of would healing and that do not require further treatment,linear hypertrophic scars, widespread hypertrophic scars, keloids and atrophic scars exist. Symptoms like pruritusand pain, stigmatization as well as functional and aesthetic impairments that are very disturbing for the affected patients can bethe basis for the desire for treatment. Today, a multitude of options for the treatment and prevention of scars exists. Topical agents based on silicone or onion extract, intralesional injections of cristalline glucocorticoids (oftentimes in combinationwith cryotherapy) or 5-Fluorouracil as well as ablative and nonablative laser treatment are used. Current guidelines summarize the multitude of available treatment options and the currently available datafor the treating physicians, allowing them to make clear therapy recommendations for every single scar type. Relieving patients of their discomfort and doing their aesthetic demands justice is thus possible. Apart from scar prevention becoming more and more important, the increased use of modernlaser treatment options constitutes a key point in clinical scar treatment. At the same time the attention is turned to evaluating current therapeutic options with the help of contemporary study designs so as to graduallyimprove the level of evidence in scar treatment. © 2016 Deutsche Dermatologische Gesellschaft (DDG). Published by John Wiley & Sons Ltd.

  1. Cyanobacterial Treatment Options: Permanganate and Powdered Activated Carbon

    Science.gov (United States)

    This presentation will begin with a brief overview of drinking water treatment options for cyanobacteria and their toxins. The treatment discussion will focus on the impacts of permanganate addition to suspensions of toxin-producing Microcystis aeruginosa, followed by powdered ac...

  2. Acute intermittent porphyria: Diagnostic dilemma and treatment options

    Directory of Open Access Journals (Sweden)

    Mohan Deep Kaur

    2015-01-01

    Full Text Available Acute intermittent porphyria (AIP presents with diverse group of symptoms making its early diagnosis difficult. Delaying diagnosis and treatment of AIP can be fatal or can cause long term or permanent neurological damage. We present here a case report of AIP where the diagnosis was missed. The diversity of symptoms and details concerning the treatment options for AIP are discussed.

  3. Acute intermittent porphyria: Diagnostic dilemma and treatment options

    Science.gov (United States)

    Kaur, Mohan Deep; Hazarika, Nita; Saraswat, Namita; Sood, Rajesh

    2015-01-01

    Acute intermittent porphyria (AIP) presents with diverse group of symptoms making its early diagnosis difficult. Delaying diagnosis and treatment of AIP can be fatal or can cause long term or permanent neurological damage. We present here a case report of AIP where the diagnosis was missed. The diversity of symptoms and details concerning the treatment options for AIP are discussed. PMID:26330726

  4. Tooth wear : a systematic review of treatment options

    NARCIS (Netherlands)

    Muts, Erik-Jan; van Pelt, Hans; Edelhoff, Daniel; Krejci, Ivo; Cune, Marco

    2014-01-01

    STATEMENT OF PROBLEM: Treatment of tooth wear is increasing. Because no evidence-based guidelines are available, the clinician may have difficulties deciding which treatment option to choose to resolve complex situations. PURPOSE: The purpose of this systematic review was to identify similarities

  5. New options for conversion of vegetable oils to alternative fuels

    Energy Technology Data Exchange (ETDEWEB)

    Demirbas, A.; Kara, H. [Selcuk University, Konya (Turkey). Department of Chemical Engineering

    2006-05-15

    Biodiesel from transesterification of vegetable oils is an excellent alternative fuel. There is, however, a need to develop a direct process for conversion of vegetable oils into gasoline-competitive biodiesel and other petroleum products. Methyl esters of vegetable oils have several outstanding advantages among other new-renewable and clean engine fuel alternatives. The purpose of the transesterification process is to lower the viscosity of vegetable oil. Compared to No. 2 diesel fuel, all of the vegetable oils are much more viscous, whereas methyl esters of vegetable oils are slightly more viscous. The methyl esters are more volatile than those of the vegetable oils. Conversion of vegetable oils to useful fuels involves the pyrolysis and catalytic cracking of the oils into lower molecular products. Pyrolysis produces more biogasoline than biodiesel fuel. Soap pyrolysis products of vegetable oils can be used as alternative diesel engine fuel. The soaps obtained from the vegetable oils can be pyrolyzed into hydrocarbon-rich products. Zinc chloride catalyst contributed greatly to high amounts of hydrocarbons in the liquid product. The yield of ZnCl2 catalytic conversion of the soybean oil reached the maximum 79.9% at 660 K. (author)

  6. Subclinical hyperthyroidism: clinical features and treatment options.

    Science.gov (United States)

    Biondi, Bernadette; Palmieri, Emiliano Antonio; Klain, Michele; Schlumberger, Martin; Filetti, Sebastiano; Lombardi, Gaetano

    2005-01-01

    Subclinical hyperthyroidism appears to be a common disorder. It may be caused by exogenous or endogenous factors: excessive TSH suppressive therapy with L-thyroxine (L-T4) for benign thyroid nodular disease, differentiated thyroid cancer, or hormone over-replacement in patients with hypothyroidism are the most frequent causes. Consistent evidence indicates that 'subclinical' hyperthyroidism reduces the quality of life, affecting both the psycho and somatic components of well-being, and produces relevant signs and symptoms of excessive thyroid hormone action, often mimicking adrenergic overactivity. Subclinical hyperthyroidism exerts many significant effects on the cardiovascular system; it is usually associated with a higher heart rate and a higher risk of supraventricular arrhythmias, and with an increased left ventricular mass, often accompanied by an impaired diastolic function and sometimes by a reduced systolic performance on effort and decreased exercise tolerance. It is well known that these abnormalities usually precede the onset of a more severe cardiovascular disease, thus potentially contributing to the increased cardiovascular morbidity and mortality observed in these patients. In addition, it is becoming increasingly apparent that subclinical hyperthyroidism may accelerate the development of osteoporosis and hence increased bone vulnerability to trauma, particularly in postmenopausal women with a pre-existing predisposition. Subclinical hyperthyroidism and its related clinical manifestations are reversible and may be prevented by timely treatment.

  7. Emerging treatment options for nasopharyngeal carcinoma

    Directory of Open Access Journals (Sweden)

    Zhang L

    2013-02-01

    Full Text Available Lu Zhang,1,2 Qiu-Yan Chen,1,2 Huai Liu,1,2 Lin-Quan Tang,1,2 Hai-Qiang Mai1,21State Key Laboratory of Oncology in South China, 2Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of ChinaAbstract: Nasopharyngeal carcinoma is endemic in Asia and is etiologically associated with Epstein–Barr virus. Radiotherapy is the primary treatment modality. The role of systemic therapy has become more prominent. Based on multiple phase III studies and meta-analyses, concurrent cisplatin-based chemoradiotherapy is the current standard of care for locally advanced disease (American Joint Committee on Cancer manual [7th edition] stages II–IVb. The reported failure-free survival rates from phase II trials are encouraging for induction + concurrent chemoradiotherapy. Data from ongoing phase III trials comparing induction + concurrent chemoradiotherapy with concurrent chemoradiotherapy will validate the results of these phase II studies. Intensity-modulated radiotherapy techniques are recommended if the resources are available. Locoregional control exceeding 90% and reduced xerostomia-related toxicities can now be achieved using intensity-modulated radiotherapy, although distant control remains the most pressing research problem. The promising results of targeted therapy and Epstein–Barr virus-specific immunotherapy from early clinical trials should be validated in phase III clinical trials. New technology, more effective and less toxic chemotherapy regimens, and targeted therapy offer new opportunities for treating nasopharyngeal carcinoma.Keywords: nasopharyngeal carcinoma, intensity-modulated radiotherapy, chemoradiotherapy, molecular targeted agents, immunotherapy, prognostic markers

  8. Spent-fuel storage: a private sector option

    International Nuclear Information System (INIS)

    Thomas, J.A.; Ross, S.R.

    1983-01-01

    The investigation was performed to delineate the legal and financial considerations for establishing private sector support for the planning and development of an independent spent-fuel storage facility (ISFSF). The preferred institutional structure was found to be one in which a not-for-profit corporation contracts with a limited partnership to handle the spent fuel. The limited partnership acquires the necessary land and constructs the ISFSF facility and then leases the facility to the not-for-profit corporation, which acquires spent-fuel rods from the utilities. The DOE must agree to purchase the spent-fuel rods at the expiration of term and warrant continued operation of the facility if policy changes at the federal level force the removal of the rods prior to completion of the contracted storage cycle. The DOE planning base estimate of spent-fuel storage requirements indicates a market potential adequate to support 10,000 MTU or more of spent-fuel storage prior to the time a government repository is available to accept spent fuel around the turn of the century. The estimated construction cost of a 5000-MTU water basin facility is $552 million. The total capital requirements to finance such a facility are estimated to be $695 million, based on an assumed capital structure of 70 percent debt and 30 percent equity. The estimated total levelized cost of storage, including operating costs, for the assumed 17-year life of the facility is $223 per kilogram of uranium. This is equivalent to a slightly less than one mill per kilowatt-hour increase in nuclear fuel costs at the nuclear power station that was the source of the spent fuel. In conclusion, within the context of the new Nuclear Waste Policy Act of 1982, the study points to both the need for and the advantages of private sector support for one or more ISFSFs and establishes a workable mechanism for the recovery of the costs of owning and operating such facilities. 3 figures, 4 tables

  9. The feasibility study I on the blanket fuel options for the ATW/HYPER

    Energy Technology Data Exchange (ETDEWEB)

    Hwang, Woan; Lee, Byoung Oon; Lee, Bong Sang; Park, Won Seok; Meyer, M.K; Hayes, S.L

    2001-01-01

    The choice of a blanket fuel cycle technology and the fuel type for HYPER/ATW are important to develop an ADS with better economics, performance and safety. Even though several fuel types have been considered as an alternative of the blanket fuels for HYPER/ATW, the metal alloy and the dispersion fuels were selected as the candidate fuels for ADS, and the technical feasibilities for both fuels are evaluated in this report. General performance characteristics, fabrication abilities, technical aspects, safety aspects, economics, and non-proliferation aspects for each fuel type are reviewed and evaluated. And some technological problems are addressed in this report, focused on the development strategy, the roadmaps, and the flexibility to meet the missions and specific designs. This study has been performed at the first stage of conceptual design. Since it is under the lack of physical properties for each fuel material, no an attempt is made to select the best fuel option, but the more better fuel options are recommended.

  10. The feasibility study I on the blanket fuel options for the ATW/HYPER

    International Nuclear Information System (INIS)

    Hwang, Woan; Lee, Byoung Oon; Lee, Bong Sang; Park, Won Seok; Meyer, M.K; Hayes, S.L.

    2001-01-01

    The choice of a blanket fuel cycle technology and the fuel type for HYPER/ATW are important to develop an ADS with better economics, performance and safety. Even though several fuel types have been considered as an alternative of the blanket fuels for HYPER/ATW, the metal alloy and the dispersion fuels were selected as the candidate fuels for ADS, and the technical feasibilities for both fuels are evaluated in this report. General performance characteristics, fabrication abilities, technical aspects, safety aspects, economics, and non-proliferation aspects for each fuel type are reviewed and evaluated. And some technological problems are addressed in this report, focused on the development strategy, the roadmaps, and the flexibility to meet the missions and specific designs. This study has been performed at the first stage of conceptual design. Since it is under the lack of physical properties for each fuel material, no an attempt is made to select the best fuel option, but the more better fuel options are recommended

  11. Fuel cells - an option for decentralized power supply?

    International Nuclear Information System (INIS)

    Ketterer, H.

    1995-01-01

    Development efforts worldwide are made on industrial-scale power stations with high-temperature fuel cells fuelled with coal gas and with off-gases of up to 1000 C, which will improve the high efficiency of the plant even further. As reported at a conference of the VDI-Gesellschaft Energietechnik, it with still take several decades until these base load power station will be in operation. On the other hand, heating power stations with low-temperature fuel cells in the range up to 200 kW have been tested successfully worldwide. (orig.) [de

  12. Progressive Supranuclear Palsy and Corticobasal Degeneration: Pathophysiology and Treatment Options

    OpenAIRE

    Lamb, Ruth; Rohrer, Jonathan D.; Lees, Andrew J.; Morris, Huw R.

    2016-01-01

    Opinion statement There are currently no disease-modifying treatments for progressive supranuclear palsy (PSP) or corticobasal degeneration (CBD), and no approved pharmacological or therapeutic treatments that are effective in controlling their symptoms. The use of most pharmacological treatment options are based on experience in other disorders or from non-randomized historical controls, case series, or expert opinion. Levodopa may provide some improvement in symptoms of Parkinsonism (specif...

  13. Progressive Supranuclear Palsy and Corticobasal Degeneration: Pathophysiology and Treatment Options

    OpenAIRE

    Lamb, R.; Rohrer, J. D.; Lees, A. J.; Morris, H. R.

    2016-01-01

    There are currently no disease-modifying treatments for progressive supranuclear palsy (PSP) or corticobasal degeneration (CBD), and no approved pharmacological or therapeutic treatments that are effective in controlling their symptoms. The use of most pharmacological treatment options are based on experience in other disorders or from non-randomized historical controls, case series, or expert opinion. Levodopa may provide some improvement in symptoms of Parkinsonism (specifically bradykinesi...

  14. 40 CFR 80.552 - What compliance options are available to motor vehicle diesel fuel small refiners?

    Science.gov (United States)

    2010-07-01

    ... to motor vehicle diesel fuel small refiners? 80.552 Section 80.552 Protection of Environment... Motor Vehicle Diesel Fuel; Nonroad, Locomotive, and Marine Diesel Fuel; and ECA Marine Fuel Small Refiner Hardship Provisions § 80.552 What compliance options are available to motor vehicle diesel fuel...

  15. Current options for the back end of the fuel cycle

    International Nuclear Information System (INIS)

    Sue Ion

    2000-01-01

    Two strategic issues facing the nuclear industry are the claimed risks of (a) weapons proliferation, and (b) environmental contamination; both affect the choice between open and closed fuel cycles. The choice for plutonium lies between supposedly permanent disposal and bumming/utilisation as a fuel. Disposal while never irretrievable could create an economically decisive obstacle to constructive use of material of great value for future global energy. Utilisation in energy supply will both restrict access to separated stockpiles and allow the inventory size to be managed with efficient use of this energy resource. Recycling recovers valuable materials for further use and allows the spent fuel stockpile to be managed. However, risk of diversion to weapon proliferation depends not on the extent of plutonium stocks but on access to a minute proportion of them, and would not be directly altered by any foreseeable increase or reduction in the well managed inventory. A key issue is to decide how in future to recover from the fuel cycle the accessible stock required to sustain it. The fear of environmental contamination is principally based on increasingly disputed health risks from radiation well below the variation in natural levels. Neither this nor the proliferation issue appears to justify insisting on the once through cycle and so wasting a finite resource that will almost certainly be needed in the coming decades. (author)

  16. Assessment of Startup Fuel Options for a Test or Demonstration Fast Reactor

    Energy Technology Data Exchange (ETDEWEB)

    Carmack, Jon [Idaho National Lab. (INL), Idaho Falls, ID (United States); Hayes, Steven [Idaho National Lab. (INL), Idaho Falls, ID (United States); Walters, L. C. [Idaho National Lab. (INL), Idaho Falls, ID (United States)

    2015-09-01

    This document explores startup fuel options for a proposed test/demonstration fast reactor. The fuel options considered are the metallic fuels U-Zr and U-Pu-Zr and the ceramic fuels UO2 and UO2-PuO2 (MOX). Attributes of the candidate fuel choices considered were feedstock availability, fabrication feasibility, rough order of magnitude cost and schedule, and the existing irradiation performance database. The reactor-grade plutonium bearing fuels (U-Pu-Zr and MOX) were eliminated from consideration as the initial startup fuels because the availability and isotopics of domestic plutonium feedstock is uncertain. There are international sources of reactor grade plutonium feedstock but isotopics and availability are also uncertain. Weapons grade plutonium is the only possible source of Pu feedstock in sufficient quantities needed to fuel a startup core. Currently, the available U.S. source of (excess) weapons-grade plutonium is designated for irradiation in commercial light water reactors (LWR) to a level that would preclude diversion. Weapons-grade plutonium also contains a significant concentration of gallium. Gallium presents a potential issue for both the fabrication of MOX fuel as well as possible performance issues for metallic fuel. Also, the construction of a fuel fabrication line for plutonium fuels, with or without a line to remove gallium, is expected to be considerably more expensive than for uranium fuels. In the case of U-Pu-Zr, a relatively small number of fuel pins have been irradiated to high burnup, and in no case has a full assembly been irradiated to high burnup without disassembly and re-constitution. For MOX fuel, the irradiation database from the Fast Flux Test Facility (FFTF) is extensive. If a significant source of either weapons-grade or reactor-grade Pu became available (i.e., from an international source), a startup core based on Pu could be reconsidered.

  17. Proposal of guidelines for selecting optimum options in packagings and transportation systems of spent fuel

    International Nuclear Information System (INIS)

    Saegusa, T.; Abe, H.; Fukuda, S.

    1983-01-01

    Type and size of spent fuel shipping packagings and packaging transport ships in spent fuel transport system would have been determined separately in response to technical requirements etc. of reactor sites and reprocessing plants. However, since more and more spent fuel will be generated from world's nuclear power plants and will be transported much frequently to reprocessing plants or storage facilities, the current spent fuel transport system will have to be necessarily reexamined from the operational and economical aspects or an optimum transport system may have to be newly determined in the near future. In the literature, a variety of options are found, particularly of spent fuel packagings. This paper listed and classified options of spent fuel packagings and packaging transport ships in the transportation systems of spent fuel on the basis of literature surveys. These options were discussed from viewpoints of designers and users and compared in terms of transport efficiency. Finally, one way to determine an optimum transport system of spent fuel was indicated considering the total transport system in the light of safety, operational efficiency and economy

  18. Review of Saccharomyces boulardii as a treatment option in IBD.

    Science.gov (United States)

    Sivananthan, Kavitha; Petersen, Andreas Munk

    2018-05-17

    Review of the yeast Saccharomyces boulardii as a treatment option for the inflammatory bowel diseases (IBD) ulcerative colitis and Crohn's disease. IBD is caused by an inappropriate immune response to gut microbiota. Treatment options could therefore be prebiotics, probiotics, antibiotics and/or fecal transplant. In this review, we have looked at the evidence for the yeast S. boulardii as a treatment option. Searches in PubMed and the Cochrane Library with the MeSH words 'Saccharomyces boulardii AND IBD', 'Saccharomyces boulardii AND Inflammatory Bowel Disease', 'Saccharomyces boulardii AND ulcerative colitis' and 'Saccharomyces boulardii AND Crohn's disease' gave total a total of 80 articles. After exclusions because of irrelevance, articles in other languages and some articles that were not available, 16 articles were included in this review. Three of the clinical trials showed a positive effect of S. boulardii in IBD patients (two Crohn's disease, one ulcerative colitis), while there was one trial that didn't prove any effect (Crohn's disease). Included Animal trials and cell assays describes different anti-inflammatory mechanisms of S. boulardii supporting a possible effect when treating IBD patients. The number of studies of S. boulardii as treatment for IBD is limited. Furthermore, the existing trials have small populations and short duration. We do not have enough evidence to prove the effect of S. boulardii in IBD. Saccharomyces boulardii is, however, a plausible treatment option in the future, but more placebo-controlled clinical studies on both patients with ulcerative colitis and Crohn's disease are needed.

  19. National Option of China's Nuclear Energy Systems for Spent Fuel Management

    Energy Technology Data Exchange (ETDEWEB)

    Gao, R.X. [University of Science and Technology, Daejeon (Korea, Republic of); Ko, W. I.; Lee, S. H. [Korea Atomic Energy Research Institute, Daejeon (Korea, Republic of)

    2015-10-15

    Along with safety concerns, these long standing environmental challenges are the major factors influencing the public acceptance of nuclear power. Although nuclear power plays an important role in reducing carbon emissions from energy generation, this could not fully prove it as a sustainable energy source unless we find a consensus approach to treat the nuclear wastes. There are currently no countries that have completed a whole nuclear fuel cycle, and the relative comparison of the reprocessing spent fuel options versus direct disposal option is always a controversial issue. Without exception, nowadays, China is implementing many R and D projects on spent fuel management to find a long-term solution for nuclear fuel cycle system transition, such as deep geological repositories for High Level Waste (HLW), Pu Reduction by Solvent Extraction (PUREX) technology, and fast reactor recycling Mixed U-Pu Oxide (MOX) fuels, etc. This paper integrates the current nation's projects of back-end fuel cycle, analyzes the consequences of potential successes, failures and delays in the project development to future nuclear fuel cycle transition up to 2100. We compared the dynamic results of four scenarios and then assessed relative impact on spent fuel management. The result revealed that the fuel cycle transition of reprocessing and recycling of spent fuel would bring advantages to overall nuclear systems by reducing high level waste inventory, saving natural uranium resources, and reducing plutonium management risk.

  20. Effect of different fuel options on performance of high-temperature PEMFC (proton exchange membrane fuel cell) systems

    International Nuclear Information System (INIS)

    Authayanun, Suthida; Saebea, Dang; Patcharavorachot, Yaneeporn; Arpornwichanop, Amornchai

    2014-01-01

    High-temperature proton exchange membrane fuel cells (HT-PEMFCs) have received substantial attention due to their high CO (carbon monoxide) tolerance and simplified water management. The hydrogen and CO fractions affect the HT-PEMFC performance and different fuel sources for hydrogen production result in different product gas compositions. Therefore, the aim of this study is to investigate the theoretical performance of HT-PEMFCs fueled by the reformate gas derived from various fuel options (i.e., methane, methanol, ethanol, and glycerol). Effects of fuel types and CO poisoning on the HT-PEMFC performance are analyzed. Furthermore, the necessity of a water-gas shift (WGS) reactor as a CO removal unit for pretreating the reformate gas is investigated for each fuel type. The methane steam reforming shows the highest possibility of CO formation, whereas the methanol steam reforming produces the lowest quantity of CO in the reformate gas. The methane fuel processing gives the maximum fraction of hydrogen (≈0.79) when the WGS reactor is included. The most suitable fuel is the one with the lowest CO poisoning effect and the maximum fuel cell performance. It is found that the HT-PEMFC system fueled by methanol without the WGS reactor and methane with WGS reactor shows the highest system efficiency (≈50%). - Highlights: • Performance of HT-PEMFC run on different fuel options is theoretically investigated. • Glycerol, methanol, ethanol and methane are hydrogen sources for the HT-PEMFC system. • Effect of CO poisoning on the HT-PEMFC performance is taken into account. • The suitable fuel for HT-PEMFC system is identified regarding the system efficiency

  1. New options to fuel plate for MTR reactor

    International Nuclear Information System (INIS)

    Macedo, C.R.

    1988-01-01

    The main datas of fuel elements and the new materials for good performance of the MTR reactor are described. A study to verify the possibility of introduction a new element on the alloy is presented. After verification the stages of nucleus fabrication with dispersion cermets of uranium oxide is gave a special emphasis to cermet fabrication of uranium-aluminium alloys. (C.G.C.) [pt

  2. Treatment Options for Primary Nocturnal Enuresis by Parents in a ...

    African Journals Online (AJOL)

    femi oloka

    common treatment option was waking up child at intervals during the night to void by 103 (45.2 ... patient/family education, simple behavioral ... nocturnal enuresis were employing in managing ..... Dental and Medical Sciences 2014;13:41 – 4.

  3. Automobiles and global warming: Alternative fuels and other options for carbon dioxide emissions reduction

    International Nuclear Information System (INIS)

    Sagar, A.D.

    1995-01-01

    Automobiles are a source of considerable pollution at the global level, including a significant fraction of the total greenhouse gas emissions. Alternative fuels have received some attention as potential options to curtail the carbon dioxide emissions from motor vehicles. This article discusses the feasibility and desirability (from a technical as well as a broader environmental perspective) of the large-scale production and use of alternative fuels as a strategy to mitigate automotive carbon dioxide emissions. Other options such as improving vehicle efficiency and switching to more efficient modes of passenger transportation are also discussed. These latter options offer an effective and immediate way to tackle the greenhouse and other pollutant emission from automobiles, especially as the limitations of currently available alternative fuels and the technological and other constraints for potential future alternatives are revealed

  4. U.S. weapons-usable plutonium disposition policy: Implementation of the MOX fuel option

    Energy Technology Data Exchange (ETDEWEB)

    Woods, A.L. [ed.] [Amarillo National Resource Center for Plutonium, TX (United States); Gonzalez, V.L. [Texas A and M Univ., College Station, TX (United States). Dept. of Political Science

    1998-10-01

    A comprehensive case study was conducted on the policy problem of disposing of US weapons-grade plutonium, which has been declared surplus to strategic defense needs. Specifically, implementation of the mixed-oxide fuel disposition option was examined in the context of national and international nonproliferation policy, and in contrast to US plutonium policy. The study reveals numerous difficulties in achieving effective implementation of the mixed-oxide fuel option including unresolved licensing and regulatory issues, technological uncertainties, public opposition, potentially conflicting federal policies, and the need for international assurances of reciprocal plutonium disposition activities. It is believed that these difficulties can be resolved in time so that the implementation of the mixed-oxide fuel option can eventually be effective in accomplishing its policy objective.

  5. U.S. weapons-useable plutonium disposition policy: Implementation of the MOX fuel option

    International Nuclear Information System (INIS)

    Woods, A.L.; Gonzalez, V.L.

    1998-10-01

    A comprehensive case study was conducted on the policy problem of disposing of US weapons-grade plutonium, which has been declared surplus to strategic defense needs. Specifically, implementation of the mixed-oxide fuel disposition option was examined in the context of national and international nonproliferation policy, and in contrast to US plutonium policy. The study reveals numerous difficulties in achieving effective implementation of the mixed-oxide fuel option including unresolved licensing and regulatory issues, technological uncertainties, public opposition, potentially conflicting federal policies, and the need for international assurances of reciprocal plutonium disposition activities. It is believed that these difficulties can be resolved in time so that the implementation of the mixed-oxide fuel option can eventually be effective in accomplishing its policy objective

  6. Current Treatment Options in Challenging Oral Diseases: Burning Mouth Syndrome

    OpenAIRE

    Bilgen Erdoğan; Murat Yılmaz

    2012-01-01

    Burning mouth syndrome is a chronic condition characterized by burning pain without any signs of an oral mucosal pathology, that usually affects postmenopausal women. Burning sensation is often accompanied by dysgeusia and xerostomia. The pathogenesis of the disease is unknown and an effective treatment option for most of the patients has not been defined yet. The aim of this review is to present current pharmacological and physicological treatments of burning mouth syndrome.

  7. Current Treatment Options in Challenging Oral Diseases: Burning Mouth Syndrome

    Directory of Open Access Journals (Sweden)

    Bilgen Erdoğan

    2012-12-01

    Full Text Available Burning mouth syndrome is a chronic condition characterized by burning pain without any signs of an oral mucosal pathology, that usually affects postmenopausal women. Burning sensation is often accompanied by dysgeusia and xerostomia. The pathogenesis of the disease is unknown and an effective treatment option for most of the patients has not been defined yet. The aim of this review is to present current pharmacological and physicological treatments of burning mouth syndrome.

  8. Life cycle assessment integrated with thermodynamic analysis of bio-fuel options for solid oxide fuel cells.

    Science.gov (United States)

    Lin, Jiefeng; Babbitt, Callie W; Trabold, Thomas A

    2013-01-01

    A methodology that integrates life cycle assessment (LCA) with thermodynamic analysis is developed and applied to evaluate the environmental impacts of producing biofuels from waste biomass, including biodiesel from waste cooking oil, ethanol from corn stover, and compressed natural gas from municipal solid wastes. Solid oxide fuel cell-based auxiliary power units using bio-fuel as the hydrogen precursor enable generation of auxiliary electricity for idling heavy-duty trucks. Thermodynamic analysis is applied to evaluate the fuel conversion efficiency and determine the amount of fuel feedstock needed to generate a unit of electrical power. These inputs feed into an LCA that compares energy consumption and greenhouse gas emissions of different fuel pathways. Results show that compressed natural gas from municipal solid wastes is an optimal bio-fuel option for SOFC-APU applications in New York State. However, this methodology can be regionalized within the U.S. or internationally to account for different fuel feedstock options. Copyright © 2012 Elsevier Ltd. All rights reserved.

  9. Effluent treatment options for nuclear thermal propulsion system ground tests

    International Nuclear Information System (INIS)

    Shipers, L.R.; Brockmann, J.E.

    1992-01-01

    A variety of approaches for handling effluent from nuclear thermal propulsion system ground tests in an environmentally acceptable manner are discussed. The functional requirements of effluent treatment are defined and concept options are presented within the framework of these requirements. System concepts differ primarily in the choice of fission-product retention and waste handling concepts. The concept options considered range from closed cycle (venting the exhaust to a closed volume or recirculating the hydrogen in a closed loop) to open cycle (real time processing and venting of the effluent). This paper reviews the strengths and weaknesses of different methods to handle effluent from nuclear thermal propulsion system ground tests

  10. Criteria for proliferation resistance of nuclear fuel cycle options

    International Nuclear Information System (INIS)

    Kiriyama, Eriko; Pickett, Susan; Suzuki, Tatsujiro

    2000-01-01

    In order to understand the concept of nuclear proliferation resistance, this paper examines the technical definitions of proliferation resistance. Although nuclear proliferation resistance is often included as one of the major goals of advanced reactor research and development, the criteria for nuclear proliferation resistance of nuclear fuel cycles is not defined clearly. The implied meaning of proliferation resistance was compared in proposals regarding the nuclear fuel cycle. Discrepancies amongst the proposals regarding the technical definition of proliferation resistance is found. While all these proposals indicate proliferation resistance, few clearly spell out exactly what criteria they are measuring themselves against. However we found there are also common feature in many proposals. They are; (1) Reduction of Pu, (2) Less separated Weapon Usable Materials, (3) Fewer steps, (4) Barrier for Weapon Usable Materials. Recognizing that there are numerous political and infrastructure measures that may also be taken to guard against proliferation risks, we have focused here on the definition of proliferation resistance in terms of technical characteristics. Another important conclusion is that in many proposals proliferation resistance is only one of the important criteria such as energy security, economical efficiency, and safety. (author)

  11. Lack of tolerable treatment options for patients with schizophrenia

    Directory of Open Access Journals (Sweden)

    Citrome L

    2015-12-01

    Full Text Available Leslie Citrome,1 Anna Eramo,2 Clement Francois,2 Ruth Duffy,3 Susan N Legacy,3 Steve J Offord,3 Holly B Krasa,3 Stephen S Johnston,4 Alice Guiraud-Diawara,5 Siddhesh A Kamat,3 Patricia Rohman3 1Department of Psychiatry and Behavioral Sciences, New York Medical College, Valhalla, NY, 2Lundbeck, Deerfield, IL, 3Otsuka America Pharmaceuticals, Princeton, NJ, 4Truven Health Analytics, Bethesda, MD, USA; 5Lundbeck SAS, Issy-les-Moulineaux, France Purpose: Atypical antipsychotics (AAs, an effective treatment for schizophrenia, have a range of pharmacologic properties leading to differences in tolerability as well as heterogeneity in treatment response. Individual patient characteristics must be considered when making treatment choices, especially from an adverse event (AE or tolerability perspective. Despite the availability of numerous AAs, after appraising patient characteristics at the time of treatment selection, physicians may quickly run out of tolerable treatment options. Patients and methods: AE risk factors, defined as having either a prior history of an AE or a risk factor for that AE, were determined for Medicaid-insured and Commercially insured patients using database analysis. Patients receiving AA treatment between January 1, 2010 and December 31, 2012 defined the index date of first observed AA prescription during this period. Nine AAs were evaluated for association with AE risk factors as informed by drug prescribing information from the different manufacturers and published meta-analyses. The proportion of patients with pre-index AE risk factors prescribed an AA associated with that risk factor was then determined. Results: A high proportion of patients (>80% were prescribed an AA associated with extrapyramidal symptoms or akathisia despite experiencing extrapyramidal symptoms or akathisia prior to AA treatment initiation. Similar trends were observed among patients with diabetes (>60% and obesity (>40%. From the nine treatment

  12. Augmented lagrange hopfield network for economic dispatch with multiple fuel options

    International Nuclear Information System (INIS)

    Dieu, Vo Ngoc; Ongsakul, Weerakorn; Polprasert, Jirawadee

    2011-01-01

    This paper proposes an augmented Lagrange Hopfield network (ALHN) for solving economic dispatch (ED) problem with multiple fuel options. The proposed ALHN method is a continuous Hopfield neural network with its energy function based on augmented Lagrangian function. The advantages of ALHN over the conventional Hopfield neural network are easier use, more general applications, faster convergence, better optimal solution, and larger scale of problem implementation. The method solves the problem by directly searching the most suitable fuel among the available fuels of each unit and finding the optimal solution for the problem based on minimization of the energy function of the continuous Hopfield neural network. The proposed method is tested on systems up to 100 units and the obtained results are compared to those from other methods in the literature. The results have shown that the proposed method is efficient for solving the ED problem with multiple fuel options and favorable for implementation in large scale problems.

  13. Performance and fuel cycle cost analysis of one Janus 30 conceptual design for several fuel element design options

    Energy Technology Data Exchange (ETDEWEB)

    Nurdin, Martias [Research Centre for Nuclear Techniques, National Atomic Energy Agency (Indonesia); Matos, J E; Freese, K E [RERTR Program, Argonne National Laboratory (United States)

    1983-09-01

    The performance and fuel cycle costs for a 25 MW, JANUS 30 reactor conceptual design by INTERATOM, Federal Republic of Germany, for BATAN, Republic of Indonesia have been studied using 19.75% enriched uranium in four fuel element design options. All of these fuel element designs have either been proposed by INTERATOM for various reactors or are currently in use with 93% enriched uranium in reactors in the Federal Republic of Germany. Aluminide, oxide, and silicide fuels were studied for selected designs using the range of uranium densities that are either currently qualified or are being developed and demonstrated internationally. These uranium densities include 1.7-2.3 g/cm{sup 3} in aluminide fuel, 1.7-3.2 g/cm{sup 3} in oxide fuel, and 2.9-6.8 g/cm{sup 3} in silicide fuel. As of November 1982) both the aluminide and the oxide fuels with about 1.7 g U/cm{sup 3} are considered to be fully-proven for licensing purposes. Irradiation screening and proof testing of fuels with uranium densities greater than 1.7 g/cm{sup 3} are currently in progress, and these tests need to be completed in order to obtain licensing authorization for routine reactor use. To assess the long-term fuel adaptation strategy as well as the present fuel acceptance, reactor performance and annual fuel cycle costs were computed for seventeen cases based on a representative end-of-cycle excess reactivity and duty factor. In addition, a study was made to provide data for evaluating the trade-off between the increased safety associated with thicker cladding and the economic penalty due to increased fuel consumption. (author)

  14. An update on adjunctive treatment options for bipolar disorder.

    Science.gov (United States)

    Dean, Olivia M; Gliddon, Emma; Van Rheenen, Tamsyn E; Giorlando, Francesco; Davidson, Sandra K; Kaur, Manreena; Ngo, Trung T; Williams, Lana J

    2018-03-01

    Bipolar disorder is a complex illness often requiring combinations of therapies to successfully treat symptoms. In recent years, there have been significant advancements in a number of therapies for bipolar disorder. It is therefore timely to provide an overview of current adjunctive therapeutic options to help treating clinicians to inform their patients and work towards optimal outcomes. Publications were identified from PubMed searches on bipolar disorder and pharmacotherapy, nutraceuticals, hormone therapy, psychoeducation, interpersonal and social rhythm therapy, cognitive remediation, mindfulness, e-Health and brain stimulation techniques. Relevant articles in these areas were selected for further review. This paper provides a narrative review of adjunctive treatment options and is not a systematic review of the literature. A number of pharmacotherapeutic, psychological and neuromodulation treatment options are available. These have varying efficacy but all have shown benefit to people with bipolar disorder. Due to the complex nature of treating the disorder, combination treatments are often required. Adjunctive treatments to traditional pharmacological and psychological therapies are proving useful in closing the gap between initial symptom remission and full functional recovery. Given that response to monotherapy is often inadequate, combination regimens for bipolar disorder are typical. Correspondingly, psychiatric research is working towards a better understanding of the disorder's underlying biology. Therefore, treatment options are changing and adjunctive therapies are being increasingly recognized as providing significant tools to improve patient outcomes. Towards this end, this paper provides an overview of novel treatments that may improve clinical outcomes for people with bipolar disorder. © 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

  15. Effects of SO2 emission regulations and fuel prices on levellized energy costs for industrial steam generation options

    International Nuclear Information System (INIS)

    Ozdogan, Sibel; Arikol, Mahir

    1992-01-01

    We discuss the impacts of SO 2 emission regulations and fuel prices on levellized energy costs of industrial steam generation options. A computer model called INDUSTEAM has been utilized. The steam-supply options comprise conventional grate-firing, bubbling and circulating fluidized beds, fuel-oil, and natural-gas-fired systems. Fuels of different SO 2 pollution potential have been evaluated assuming six environmental scenarios and varying fuel prices. A capacity range of 10-90 MW th is covered. (author)

  16. Specialists' meeting on gas-cooled reactor fuel development and spent fuel treatment

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1985-07-01

    Topics covered during the 'Specialists' meeting on gas-cooled reactor fuel development and spent fuel treatment' were as follows: Selection of constructions and materials, fuel element development concepts; Fabrication of spherical coated fuel particles and fuel element on their base; investigation of fuel properties; Spent fuel treatment and storage; Head-end processing of HTGR fuel elements; investigation of HTGR fuel regeneration process; applicability of gas-fluorine technology of regeneration of spent HTGR fuel elements.

  17. Specialists' meeting on gas-cooled reactor fuel development and spent fuel treatment

    International Nuclear Information System (INIS)

    1985-01-01

    Topics covered during the 'Specialists' meeting on gas-cooled reactor fuel development and spent fuel treatment' were as follows: Selection of constructions and materials, fuel element development concepts; Fabrication of spherical coated fuel particles and fuel element on their base; investigation of fuel properties; Spent fuel treatment and storage; Head-end processing of HTGR fuel elements; investigation of HTGR fuel regeneration process; applicability of gas-fluorine technology of regeneration of spent HTGR fuel elements

  18. Analysis of fuel options for the breakeven core configuration of the Advanced Recycling Reactor

    Energy Technology Data Exchange (ETDEWEB)

    Stauff, N.E.; Klim, T.K.; Taiwo, T.A. [Argonne National Laboratory, Argonne, IL (United States); Fiorina, C. [Politecnico di Milano, Milan (Italy); Franceschini, F. [Westinghouse Electric Company LLC., Cranberry Township, Pennsylvania (United States)

    2013-07-01

    A trade-off study is performed to determine the impacts of various fuel forms on the core design and core physics characteristics of the sodium-cooled Toshiba- Westinghouse Advanced Recycling Reactor (ARR). The fuel forms include oxide, nitride, and metallic forms of U and Th. The ARR core configuration is redesigned with driver and blanket regions in order to achieve breakeven fissile breeding performance with the various fuel types. State-of-the-art core physics tools are used for the analyses. In addition, a quasi-static reactivity balance approach is used for a preliminary comparison of the inherent safety performances of the various fuel options. Thorium-fueled cores exhibit lower breeding ratios and require larger blankets compared to the U-fueled cores, which is detrimental to core compactness and increases reprocessing and manufacturing requirements. The Th cores also exhibit higher reactivity swings through each cycle, which penalizes reactivity control and increases the number of control rods required. On the other hand, using Th leads to drastic reductions in void and coolant expansion coefficients of reactivity, with the potential for enhancing inherent core safety. Among the U-fueled ARR cores, metallic and nitride fuels result in higher breeding ratios due to their higher heavy metal densities. On the other hand, oxide fuels provide a softer spectrum, which increases the Doppler effect and reduces the positive sodium void worth. A lower fuel temperature is obtained with the metallic and nitride fuels due to their higher thermal conductivities and compatibility with sodium bonds. This is especially beneficial from an inherent safety point of view since it facilitates the reactor cool-down during loss of power removal transients. The advantages in terms of inherent safety of nitride and metallic fuels are maintained when using Th fuel. However, there is a lower relative increase in heavy metal density and in breeding ratio going from oxide to metallic

  19. Spent fuel treatment in Japan

    International Nuclear Information System (INIS)

    Takahashi, K.

    1999-01-01

    In Japan, 52 nuclear power reactors are operating with a total power generation capacity of 45 GWe. The cumulative amount of spent fuel arising, as of March 1998, is about 14,700 W. Spent fuel is reprocessed and recovered nuclear materials are to be recycled in LWRs and FBRs. Pu utilization in LWRs will commence in 1999. In January 1997, short-term policy measures were announced by the Atomic Energy Commission, which addressed promotion of the reprocessing programme in Rokkasho, plutonium utilization in LWRs, spent fuel management, back-end measures and FBR development. With regard to the spent fuel management, the policy measures included expansion of spent fuel storage capacity at reactor sites and a study on spent fuel storage away-from-reactor sites, considering the increasing amount of spent fuel arising. Valuable experience was been accumulated at the Tokai Reprocessing Plant (TRP), from the start of hot operation in 1977 up to now. The role of the TRP will be changed from an operation-oriented to a more R and D oriented facility, when PNC is reorganized into the new organization JNC. The Rokkasho reprocessing plant is under construction and is expected to commence operation in 2003. R and D of future recycling technologies is also continued for the establishment of a nuclear fuel cycle based on FBRs and LWRs. (author)

  20. Electrometallurgical treatment of oxide spent fuels

    International Nuclear Information System (INIS)

    Karell, E. J.

    1999-01-01

    The Department of Energy (DOE) inventory of spent nuclear fuel contains a wide variety of oxide fuel types that may be unsuitable for direct repository disposal in their current form. The molten-salt electrometallurgical treatment technique developed by Argonne National Laboratory (ANL) has the potential to simplify preparing and qualifying these fuels for disposal by converting them into three uniform product streams: uranium metal, a metal waste form, and a ceramic waste form. This paper describes the major steps in the electrometallurgical treatment process for oxide fuels and provides the results of recent experiments performed to develop and scale up the process

  1. Spent fuel treatment at ANL-West

    International Nuclear Information System (INIS)

    Goff, K.M.; Benedict, R.W.; Levinskas, D.

    1994-01-01

    At Argonne National Laboratory-West (ANL-West) there are several thousand kilograms of metallic spent nuclear fuel containing bond sodium. This fuel will be treated in the Fuel Cycle Facility at ANL-West to produce stable waste forms for storage and disposal. The treatment operations will employ a pyrochemical process that also has applications for treating most of the fuel types within the Department of Energy complex. The treatment equipment is in its last stage of readiness, and operations will begin in the Fall of 1994

  2. Electrometallurgical treatment of aluminum-matrix fuels

    International Nuclear Information System (INIS)

    Willit, J.L.; Gay, E.C.; Miller, W.E.; McPheeters, C.C.; Laidler, J.J.

    1996-01-01

    The electrometallurgical treatment process described in this paper builds on our experience in treating spent fuel from the Experimental Breeder Reactor (EBR-II). The work is also to some degree, a spin-off from applying electrometallurgical treatment to spent fuel from the Hanford single pass reactors (SPRs) and fuel and flush salt from the Molten Salt Reactor Experiment (MSRE) in treating EBR-II fuel, we recover the actinides from a uranium-zirconium fuel by electrorefining the uranium out of the chopped fuel. With SPR fuel, uranium is electrorefined out of the aluminum cladding. Both of these processes are conducted in a LiCl-KCl molten-salt electrolyte. In the case of the MSRE, which used a fluoride salt-based fuel, uranium in this salt is recovered through a series of electrochemical reductions. Recovering high-purity uranium from an aluminum-matrix fuel is more challenging than treating SPR or EBR-II fuel because the aluminum- matrix fuel is typically -90% (volume basis) aluminum

  3. Fuel options for the fuel cell vehicle: hydrogen, methanol or gasoline?

    International Nuclear Information System (INIS)

    Thomas, C.E.; James, B.D.; Lomax, F.D. Jr.; Kuhn, I.F. Jr.

    2000-01-01

    Fuel cell vehicles can be powered directly by hydrogen or, with an onboard chemical processor, other liquid fuels such as gasoline or methanol. Most analysts agree that hydrogen is the preferred fuel in terms of reducing vehicle complexity, but one common perception is that the cost of a hydrogen infrastructure would be excessive. According to this conventional wisdom, the automobile industry must therefore develop complex onboard fuel processors to convert methanol, ethanol or gasoline to hydrogen. We show here, however, that the total fuel infrastructure cost to society including onboard fuel processors may be less for hydrogen than for either gasoline or methanol, the primary initial candidates currently under consideration for fuel cell vehicles. We also present the local air pollution and greenhouse gas advantages of hydrogen fuel cell vehicles compared to those powered by gasoline or methanol. (Author)

  4. Cost-Effective Fuel Treatment Planning

    Science.gov (United States)

    Kreitler, J.; Thompson, M.; Vaillant, N.

    2014-12-01

    The cost of fighting large wildland fires in the western United States has grown dramatically over the past decade. This trend will likely continue with growth of the WUI into fire prone ecosystems, dangerous fuel conditions from decades of fire suppression, and a potentially increasing effect from prolonged drought and climate change. Fuel treatments are often considered the primary pre-fire mechanism to reduce the exposure of values at risk to wildland fire, and a growing suite of fire models and tools are employed to prioritize where treatments could mitigate wildland fire damages. Assessments using the likelihood and consequence of fire are critical because funds are insufficient to reduce risk on all lands needing treatment, therefore prioritization is required to maximize the effectiveness of fuel treatment budgets. Cost-effectiveness, doing the most good per dollar, would seem to be an important fuel treatment metric, yet studies or plans that prioritize fuel treatments using costs or cost-effectiveness measures are absent from the literature. Therefore, to explore the effect of using costs in fuel treatment planning we test four prioritization algorithms designed to reduce risk in a case study examining fuel treatments on the Sisters Ranger District of central Oregon. For benefits we model sediment retention and standing biomass, and measure the effectiveness of each algorithm by comparing the differences among treatment and no treat alternative scenarios. Our objective is to maximize the averted loss of net benefits subject to a representative fuel treatment budget. We model costs across the study landscape using the My Fuel Treatment Planner software, tree list data, local mill prices, and GIS-measured site characteristics. We use fire simulations to generate burn probabilities, and estimate fire intensity as conditional flame length at each pixel. Two prioritization algorithms target treatments based on cost-effectiveness and show improvements over those

  5. Steam and partial oxidation reforming options for hydrogen production from fossil fuels for PEM fuel cells

    OpenAIRE

    Yousri M.A. Welaya; Mohamed M. El Gohary; Nader R. Ammar

    2012-01-01

    Proton exchange membrane fuel cell (PEM) generates electrical power from air and from hydrogen or hydrogen rich gas mixtures. Therefore, there is an increasing interest in converting current hydrocarbon based marine fuels such as natural gas, gasoline, and diesel into hydrogen rich gases acceptable to the PEM fuel cells on board ships. Using chemical flow sheeting software, the total system efficiency has been calculated. Natural gas appears to be the best fuel for hydrogen rich gas productio...

  6. Core design options for high conversion BWRs operating in Th–233U fuel cycle

    International Nuclear Information System (INIS)

    Shaposhnik, Y.; Shwageraus, E.; Elias, E.

    2013-01-01

    Highlights: • BWR core operating in a closed self-sustainable Th– 233 U fuel cycle. • Seed blanket optimization that includes assembly size array and axial dimensions. • Fully coupled MC with fuel depletion and thermo-hydraulic feedback modules. • Thermal-hydraulic analysis includes MCPR observation. -- Abstract: Several options of fuel assembly design are investigated for a BWR core operating in a closed self-sustainable Th– 233 U fuel cycle. The designs rely on an axially heterogeneous fuel assembly structure consisting of a single axial fissile zone “sandwiched” between two fertile blanket zones, in order to improve fertile to fissile conversion ratio. The main objective of the study was to identify the most promising assembly design parameters, dimensions of fissile and fertile zones, for achieving net breeding of 233 U. The design challenge, in this respect, is that the fuel breeding potential is at odds with axial power peaking and the core minimum critical power ratio (CPR), hence limiting the maximum achievable core power rating. Calculations were performed with the BGCore system, which consists of the MCNP code coupled with fuel depletion and thermo-hydraulic feedback modules. A single 3-dimensional fuel assembly having reflective radial boundaries was modeled applying simplified restrictions on the maximum centerline fuel temperature and the CPR. It was found that axially heterogeneous fuel assembly design with a single fissile zone can potentially achieve net breeding, while matching conventional BWR core power rating under certain restrictions to the core loading pattern design

  7. Annex 34 : task 1 : analysis of biodiesel options : biomass-derived diesel fuels : final report

    Energy Technology Data Exchange (ETDEWEB)

    McGill, R [Oak Ridge National Laboratory, TN (United States); Aakko-Saksa, P; Nylund, N O [TransEnergy Consulting Ltd., Helsinki (Finland)

    2009-06-15

    Biofuels are derived from woody biomass, non-woody biomass, and organic wastes. The properties of vegetable oil feedstocks can have profound effects on the properties of the finished biodiesel product. However, all biodiesel fuels have beneficial effects on engine emissions. This report discussed the use of biodiesel fuels as replacements for part of the diesel fuel consumed throughout the world. Biodiesel fuels currently being produced from fatty acid esters today were reviewed, as well as some of the more advanced diesel replacement fuels. The report was produced as part of the International Energy Agency (IEA) Advanced Motor Fuels (AMF) Implementing Agreement Annex 34, and was divided into 14 sections: (1) an introduction, (2) biodiesel and biomass, (3) an explanation of biodiesel, (4) properties of finished biodiesel fuels, (5) exhaust emissions of finished biodiesel fuels and blends, (6) life-cycle emissions and energy, (7) international biodiesel (FAME) technical standards and specifications, (8) growth in production and use of biodiesel fuels, (9) biofuel refineries, (10) process technology, (11) development and status of biorefineries, (12) comparison of options to produce biobased diesel fuels, (13) barriers and gaps in knowledge, and (14) references. 113 refs., 37 tabs., 74 figs.

  8. Enhanced CANDU6: Reactor and fuel cycle options - Natural uranium and beyond

    International Nuclear Information System (INIS)

    Ovanes, M.; Chan, P. S. W.; Mao, J.; Alderson, N.; Hopwood, J. M.

    2012-01-01

    The Enhanced CANDU 6 R (ECo R ) is the updated version of the well established CANDU 6 family of units incorporating improved safety characteristics designed to meet or exceed Generation III nuclear power plant expectations. The EC6 retains the excellent neutron economy and fuel cycle flexibility that are inherent in the CANDU reactor design. The reference design is based on natural uranium fuel, but the EC6 is also able to utilize additional fuel options, including the use of Recovered Uranium (RU) and Thorium based fuels, without requiring major hardware upgrades to the existing control and safety systems. This paper outlines the major changes in the EC6 core design from the existing C6 design that significantly enhance the safety characteristics and operating efficiency of the reactor. The use of RU fuel as a transparent replacement fuel for the standard 37-el NU fuel, and several RU based advanced fuel designs that give significant improvements in fuel burnup and inherent safety characteristics are also discussed in the paper. In addition, the suitability of the EC6 to use MOX and related Pu-based fuels will also be discussed. (authors)

  9. Alternative fuel cycle options: performance characteristics and impact on nuclear power growth potential

    International Nuclear Information System (INIS)

    Chang, Y.I.; Till, C.E.; Rudolph, R.R.; Deen, J.R.; King, M.J.

    1977-09-01

    The fuel utilization characteristics for LWR, SSCR, CANDU and LMFBR reactor concepts are quantified for various fuel cycle options, including once-through cycles, thorium cycles, and denatured cycles. The implications of various alternative reactor deployment strategies on the long-term nuclear power growth potential are then quantified in terms of the maximum nuclear capacity that can be achieved and the growth pattern over time, subject to the constraint of a fixed uranium-resource base. The overall objective of this study is to shed light on any large differences in the long-term potential that exist between various alternative reactor/fuel cycle deployment strategies

  10. Treatment options for patellofemoral instability in sports traumatology

    Directory of Open Access Journals (Sweden)

    Philippe M. Tscholl

    2013-09-01

    Full Text Available Patellofemoral instability not only involves lateral patellar dislocation, patellar mal-tracking or subluxation but can also cause a limiting disability for sports activities. Its underlying causes are known as morphological anomalies of the patellofemoral joint or the mechanical axis, femorotibial malrotation, variants of the knee extensor apparatus, and ligamentous insufficiencies often accompanied by poor proprioception. Athletes with such predisposing factors are either suffering from unspecific anterior knee pain or from slightly traumatic or recurrent lateral patellar dislocation Treatment options of patellar instability are vast, and need to be tailored individually depending on the athlete’s history, age, complaints and physical demands. Different conservative and surgical treatment options are reviewed and discussed, especially limited expectations after surgery.

  11. Angina pectoris: current therapy and future treatment options.

    Science.gov (United States)

    Parikh, Raj; Kadowitz, Philip J

    2014-02-01

    Angina pectoris is the consequence of an inequality between the demand and supply of blood to the heart. Angina manifests itself as chest pain or discomfort and is a common complaint of patients in the hospital and in the clinic. There are, in fact, roughly half a million new cases of angina per year. Chest pain, while having many etiologies, is generally considered to be most lethal when related to a cardiac cause. In this review, the authors outline the current medical and surgical therapies that are used in the management of angina. Highlights of the various clinical trials that have assisted in the investigation of these therapies are summarized also. Then, the authors provide a focused review of the novel therapy options for angina that are currently being explored. From new medical treatments to revised surgical techniques to the discovery of stem cell therapy, many innovative options are being investigated for the treatment of angina.

  12. Cost reductions of fuel cells for transport applications: fuel processing options

    Energy Technology Data Exchange (ETDEWEB)

    Teagan, W P; Bentley, J; Barnett, B [Arthur D. Little, Inc., Cambridge, MA (United States)

    1998-03-15

    The highly favorable efficiency/environmental characteristics of fuel cell technologies have now been verified by virtue of recent and ongoing field experience. The key issue regarding the timing and extent of fuel cell commercialization is the ability to reduce costs to acceptable levels in both stationary and transport applications. It is increasingly recognized that the fuel processing subsystem can have a major impact on overall system costs, particularly as ongoing R and D efforts result in reduction of the basic cost structure of stacks which currently dominate system costs. The fuel processing subsystem for polymer electrolyte membrane fuel cell (PEMFC) technology, which is the focus of transport applications, includes the reformer, shift reactors, and means for CO reduction. In addition to low cost, transport applications require a fuel processor that is compact and can start rapidly. This paper describes the impact of factors such as fuel choice operating temperature, material selection, catalyst requirements, and controls on the cost of fuel processing systems. There are fuel processor technology paths which manufacturing cost analyses indicate are consistent with fuel processor subsystem costs of under $150/kW in stationary applications and $30/kW in transport applications. As such, the costs of mature fuel processing subsystem technologies should be consistent with their use in commercially viable fuel cell systems in both application categories. (orig.)

  13. Spent Nuclear Fuel Option Study on Hybrid Reactor for Waste Transmutation

    International Nuclear Information System (INIS)

    Hong, Seong Hee; Kim, Myung Hyun

    2016-01-01

    DUPIC nuclear fuel can be used in hybrid reactor by compensation of subcritical level through (U-10Zr) fuel. Energy production performance of Hyb-WT with DUPIC is grateful because it has high EM factor and performs waste transmutation at the same time. However, waste transmutation performance should be improved by different fissile fuel instead of (U-10Zr) fuel. SNF (Spent Nuclear Fuel) disposal is one of the problems in the nuclear industry. FFHR (Fusion-Fission Hybrid Reactor) is one of the most attractive option on reuse of SNF as a waste transmutation system. Because subcritical system like FFHR has some advantages compared to critical system. Subcritical systems have higher safety potential than critical system. Also, there is suppressed excess reactivity at BOC (Beginning of Cycle) in critical system, on the other hand there is no suppressed reactivity in subcritical system. Our research team could have designed FFHR for waste transmutation; Hyb-WT. Various researches have been conducted on fuel and coolant option for optimization of transmutation performance. However, Hyb-WT has technical disadvantage. It is required fusion power (Pfus) which is the key design parameter in FFHR is increased for compensation of decreasing subcritical level. As a result, structure material integrity is damaged under high irradiation condition by increasing Pfus. Also, deep burn of reprocessed SNF is limited by weakened integrity of structure material. Therefore, in this research, SNF option study will be conducted on DUPIC (Direct Use of Spent PWR Fuel in CANDU Reactor) fuel, TRU fuel and DUPIC + TRU mixed fuel for optimization of Hyb-WT performance. Goal of this research is design check for low required fusion power and high waste transmutation. In this paper, neutronic analysis is conducted on Hyb-WT with DUPIC nuclear fuel. When DUPIC nuclear fuel is loaded in fast neutron system, supplement fissile materials need to be loaded together for compensation of low criticality

  14. Spent Nuclear Fuel Option Study on Hybrid Reactor for Waste Transmutation

    Energy Technology Data Exchange (ETDEWEB)

    Hong, Seong Hee; Kim, Myung Hyun [Kyung Hee University, Yongin (Korea, Republic of)

    2016-05-15

    DUPIC nuclear fuel can be used in hybrid reactor by compensation of subcritical level through (U-10Zr) fuel. Energy production performance of Hyb-WT with DUPIC is grateful because it has high EM factor and performs waste transmutation at the same time. However, waste transmutation performance should be improved by different fissile fuel instead of (U-10Zr) fuel. SNF (Spent Nuclear Fuel) disposal is one of the problems in the nuclear industry. FFHR (Fusion-Fission Hybrid Reactor) is one of the most attractive option on reuse of SNF as a waste transmutation system. Because subcritical system like FFHR has some advantages compared to critical system. Subcritical systems have higher safety potential than critical system. Also, there is suppressed excess reactivity at BOC (Beginning of Cycle) in critical system, on the other hand there is no suppressed reactivity in subcritical system. Our research team could have designed FFHR for waste transmutation; Hyb-WT. Various researches have been conducted on fuel and coolant option for optimization of transmutation performance. However, Hyb-WT has technical disadvantage. It is required fusion power (Pfus) which is the key design parameter in FFHR is increased for compensation of decreasing subcritical level. As a result, structure material integrity is damaged under high irradiation condition by increasing Pfus. Also, deep burn of reprocessed SNF is limited by weakened integrity of structure material. Therefore, in this research, SNF option study will be conducted on DUPIC (Direct Use of Spent PWR Fuel in CANDU Reactor) fuel, TRU fuel and DUPIC + TRU mixed fuel for optimization of Hyb-WT performance. Goal of this research is design check for low required fusion power and high waste transmutation. In this paper, neutronic analysis is conducted on Hyb-WT with DUPIC nuclear fuel. When DUPIC nuclear fuel is loaded in fast neutron system, supplement fissile materials need to be loaded together for compensation of low criticality

  15. Treatment options for permanent teeth with deep caries

    OpenAIRE

    Marending, Monika; Attin, Thomas; Zehnder, Matthias

    2016-01-01

    The goal of this narrative review was to summarize and compare treatment options for permanent teeth carious lesions that are radiographically close to the pulp chamber. Thanks to adhesive restorative materials, minimally invasive approaches are possible. In this context, the old question arises as to whether caries must be excavated completely, i.e., down to hard dentin, or whether it could be advantageous to leave some soft dentin, or even merely seal the whole lesion. To answer this questi...

  16. CANFLEX-RU fuel development programs as one option of advanced fuel cycles in Korea

    International Nuclear Information System (INIS)

    Suk, Ho Chun; Sim, Ki-Seob; Chung, Jang Hwan

    1999-01-01

    As one of the possible fuel cycles in Korea, RU (Recycled Uranium) fuel offers a very attractive alternative to the use of NU (Natural Uranium) and SEU in the CANDU reactors, because Korea is a unique country having both PWR and CANDU reactors. Korea can therefore exploit the natural synergism between the two reactor types to minimise overall waste production, and maximise energy derived from the fuel, by burning the spent fuel from its PWR reactors in CANDU reactors. Potential benefits can be derived from a number of stages in the fuel cycle: no enrichment required, no enrichment tails, direct conversion to UO 2 lower sensitivity to 234 U and 236 U absorption in the CANDU reactor, expected lower cost relative to NU and SEU. These benefits all fit well with the PWR-CANDU fuel cycle synergy. RU arising from the reprocessing of European and Japanese oxide spent fuel by 2000 is projected to be approaching 25,000 te. The use of RU fuel in a CANDU-6 reactor should result in no serious radiological difficulties and no requirements for special precautions and should not require any new technologies for the fuel fabrication and handling. A KAERI's feasibility shows that the use of the CANFLEX bundle as the carrier for RU will be compatible with the reactor design, current safety and operational requirements, and there will be no significant fuel performance difference from the CANDU 37-element NU fuel bundle. Compared with the 37-element NU bundle, the RU fuel has significantly improved fuel cycle economics derived from increased burnups, a large reduction in fuel requirements and spent fuel arisings and the potential lower cost for RU material. There is the potential for annual fuel cost savings to be in the range of one-third to two-thirds, with enhanced operating margins using RU in the CANFLEX bundle design. These benefits provide the rationale for justifying R and D effort on the use of RU fuel for advanced fuel cycles in the CANDU reactors of Korea. The RU fuel

  17. Recycling and transmutation of spent fuel as a sustainable option for the nuclear energy development

    International Nuclear Information System (INIS)

    Maiorino, Jose R.; Moreira, Joao M.L.

    2013-01-01

    The objective of this paper is to discuss the option of recycling and transmutation of radioactive waste against Once-through Fuel Cycle (OTC) based on uranium feed under the perspective of sustainability. We use a qualitative analysis to compare OTC with closed fuel cycles based on studies already performed such as the Red Impact Project and the comparative study on accelerator driven systems and fast reactors for advanced fuel cycles performed by the Nuclear Energy Agency. The results show that recycling and transmutation fuel cycles are more attractive than the OTC from the point of view of sustainability. The main conclusion is that the decision about the construction of a deep geological repository for spent fuel disposal must be reevaluated. (author)

  18. Current status in the treatment options for esophageal achalasia.

    Science.gov (United States)

    Chuah, Seng-Kee; Chiu, Chien-Hua; Tai, Wei-Chen; Lee, Jyong-Hong; Lu, Hung-I; Changchien, Chi-Sin; Tseng, Ping-Huei; Wu, Keng-Liang

    2013-09-07

    Recent advances in the treatment of achalasia include the use of high-resolution manometry to predict the outcome of patients and the introduction of peroral endoscopic myotomy (POEM). The first multicenter randomized, controlled, 2-year follow-up study conducted by the European Achalasia Trial group indicated that laparoscopic Heller myotomy (LHM) was not superior to pneumatic dilations (PD). Publications on the long-term success of laparoscopic surgery continue to emerge. In addition, laparoscopic single-site surgery is applicable to advanced laparoscopic operations such as LHM and anterior fundoplication. The optimal treatment option is an ongoing matter of debate. In this review, we provide an update of the current progress in the treatment of esophageal achalasia. Unless new conclusive data prove otherwise, LHM is considered the most durable treatment for achalasia at the expense of increased reflux-associated complications. However, PD is the first choice for non-surgical treatment and is more cost-effective. Repeated PD according to an "on-demand" strategy based on symptom recurrence can achieve long-term remission. Decision making should be based on clinical evidence that identifies a subcategory of patients who would benefit from specific treatment options. POEM has shown promise but its long-term efficacy and safety need to be assessed further.

  19. Current and emerging treatment options for myopic choroidal neovascularization

    Directory of Open Access Journals (Sweden)

    El Matri L

    2015-04-01

    Full Text Available Leila El Matri, Ahmed Chebil, Fedra Kort Department B of Ophthalmology, Hedi Rais Institute of Ophthalmology, Faculty of Medicine of Tunis, University of El Manar, Tunis, Tunisia Abstract: Choroidal neovascularization (CNV is the main cause of visual impairment in highly myopic patients younger than 50 years of age. There are different treatments for myopic CNV (mCNV, with 5- to 10-year outcomes currently. Chorioretinal atrophy is still the most important determinant factor for visual outcome. The purpose of this study is to provide an overview of the current treatments for mCNV, including laser, surgical management, verteporfin photodynamic therapy, and mainly anti-vascular endothelial growth factor therapy. Emerging treatment options are also discussed. Keywords: myopia, choroidal neovascularization, current treatment, emerging treatment

  20. Look at potential options for the fast reactor fuel cycle in the United States

    International Nuclear Information System (INIS)

    Burch, W.D.

    1984-01-01

    This paper reviews the status and plans for the fast reactor fuel cycle in the United States, presents some options that are under consideration, and describes how these options are being evaluated at the present time. The United States will undertake some far-reaching examinations of the entire breeder program strategy in the coming year, and the outcome of these reviews cannot be predicted today. In other papers at this conference you have heard various perspectives from both government and industry representatives. The proposed studies to examine the associated fuel cycle strategies as they relate to the overall emerging breeder strategy are described. The present status of and recent developments in the fuel cycle R and D programs will also be summarized and updated in order to present an overall picture of the United States situation

  1. Radiological impacts of spent nuclear fuel management options. A comparative study

    International Nuclear Information System (INIS)

    2000-01-01

    Given its potential significance for public health and the environment, the impact of radioactive releases during important steps of nuclear energy production must be considered when selecting among different fuel cycles. With this in mind, the OECD Nuclear Energy Agency (NEA) has undertaken a comparative study to the radiological impacts of two main fuel cycle options : one with and one without reprocessing of spent nuclear fuel. The study compares the respective impacts of the two options based on generic models and assumptions as well as actual data. It concludes that the difference between them is not significant. A wealth of recent data assembled and evaluated by an international expert team is provided in annex. (authors)

  2. Integrated model of Korean spent fuel and high level waste disposal options - 16091

    International Nuclear Information System (INIS)

    Hwang, Yongsoo; Miller, Ian

    2009-01-01

    This paper describes an integrated model developed by the Korean Atomic Energy Research Institute (KAERI) to simulate options for disposal of spent nuclear fuel (SNF) and reprocessing products in South Korea. A companion paper (Hwang and Miller, 2009) describes a systems-level model of Korean options for spent nuclear fuel (SNF) management in the 21. century. The model addresses alternative design concepts for disposal of SNF of different types (Candu, PWR), high level waste, and fission products arising from a variety of alternative fuel cycle back ends. It uses the GoldSim software to simulate the engineered system, near-field and far-field geosphere, and biosphere, resulting in long-term dose predictions for a variety of receptor groups. The model's results allow direct comparison of alternative repository design concepts, and identification of key parameter uncertainties and contributors to receptor doses. (authors)

  3. 40 CFR 270.235 - Options for incinerators, cement kilns, lightweight aggregate kilns, solid fuel boilers, liquid...

    Science.gov (United States)

    2010-07-01

    ... 40 Protection of Environment 26 2010-07-01 2010-07-01 false Options for incinerators, cement kilns... Technology (MACT) Standards § 270.235 Options for incinerators, cement kilns, lightweight aggregate kilns... incinerator, cement kiln, lightweight aggregate kiln, solid fuel boiler, liquid fuel boiler, or hydrochloric...

  4. Current options for palliative treatment in patients with pancreatic cancer.

    Science.gov (United States)

    Ridwelski, K; Meyer, F

    2001-01-01

    Palliative treatment is often the only remaining option in the management of pancreatic carcinoma, but its efficacy is poor due to low tumor sensitivity and inadequate treatment protocols. There are several options of palliative treatment with antitumor or supportive intention. Classical end points of palliative treatment are survival, tumor response, and quality of life. A decade ago, palliative chemotherapy consisted mainly of 5-fluorouracil as the standard agent in combination with either other agents and/or radiotherapy. Only the new antineoplastic drug gemcitabine, which was introduced simultaneously with the definition of novel end points of chemotherapy such as clinical benefit, allowed to achieve some progress. However, while gemcitabine monotherapy appeared to be superior to 5-fluorouracil and improved important parameters of quality of life, it could not provide a significant improvement of survival. A novel concept, therefore, is to improve this beneficial cytostatic response in pancreatic carcinoma using a gemcitabine-based protocol by combining it with antineoplastic drugs such as taxanes or platin analogs. This strategy may have the potential to improve the outcome in palliative chemotherapy of pancreatic carcinoma patients with advanced tumor growth or metastases. Best supportive care in pancreatic cancer consists of the treatment of symptoms, such as pain, jaundice, duodenal obstruction, weight loss, exocrine pancreatic insufficiency, and tumor-associated depression. Copyright 2001 S. Karger AG, Basel

  5. Basic principles of forest fuel reduction treatments

    Science.gov (United States)

    James K. Agee; Carl N. Skinner

    2005-01-01

    Successful fire exclusion in the 20th century has created severe fire problems across the West. Not every forest is at risk of uncharacteristically severe wildfire, but drier forests are in need of active management to mitigate fire hazard. We summarize a set of simple principles important to address in fuel reduction treatments: reduction of surface fuels, increasing...

  6. The generation of denatured reactor plutonium by different options of the fuel cycle

    Energy Technology Data Exchange (ETDEWEB)

    Broeders, C.H.M.; Kessler, G. [Inst. for Neutron Physics and Reactor Technology, Research Center Karlsruhe (Germany)

    2006-11-15

    Denatured (proliferation resistant) reactor plutonium can be generated in a number of different fuel cycle options. First denatured reactor plutonium can be obtained if, instead of low enriched U-235 PWR fuel, re-enriched U-235/U-236 from reprocessed uranium is used (fuel type A). Also the envisaged existing 2,500 t of reactor plutonium (being generated world wide up to the year 2010), mostly stored in intermediate fuel storage facilities at present, could be converted during a transition phase into denatured reactor plutonium by the options fuel type B and D. Denatured reactor plutonium could have the same safeguards standard as present low enriched (<20% U-235) LWR fuel. It could be incinerated by recycling once or twice in PWRs and subsequently by multi-recycling in FRs (CAPRA type or IFRs). Once denatured, such reactor plutonium could remain denatured during multiple recycling. In a PWR, e.g., denatured reactor plutonium could be destroyed at a rate of about 250 kg/GWey. While denatured reactor plutonium could be recycled and incinerated under relieved IAEA safeguards, neptunium would still have to be monitored by the IAEA in future for all cases in which considerable amounts of neptunium are produced. (orig.)

  7. Transport and supply logistics of biomass fuels: Vol. 1. Supply chain options for biomass fuels

    Energy Technology Data Exchange (ETDEWEB)

    Allen, J; Browne, M; Palmer, H; Hunter, A; Boyd, J

    1996-10-01

    The study which forms part of a wider project funded by the Department of Trade and Industry, looks at the feasibility of generating electricity from biomass-fuelled power stations. Emphasis is placed on supply availabilty and transport consideration for biomass fuels such as wood wastes from forestry, short rotation coppice products, straw, miscanthus (an energy crop) and farm animal slurries. The study details the elements of the supply chain for each fuel from harvesting to delivery at the power station. The delivered cost of each fuel, the environmental impact of the biomass fuel supply and other relevant non-technical issues are addressed. (UK)

  8. Current options for the treatment of facial angiofibromas.

    Science.gov (United States)

    Salido-Vallejo, R; Garnacho-Saucedo, G; Moreno-Giménez, J C

    2014-01-01

    Facial angiofibromas are hamartomatous growths that are closely associated with tuberous sclerosis complex and, in fact, they constitute one of the main diagnostic criteria for that disease. These lesions composed of blood vessels and fibrous tissue appear on the face at an early age. Since they have important physical and psychological repercussions for patients, several treatment options have been used to remove them or improve their appearance. However, the lack of treatment guidelines prevents us from developing a common protocol for patients with this condition. The present article aims to review the treatments for facial angiofibromas used to date and to propose a new evidence-based treatment protocol. Copyright © 2012 Elsevier España, S.L. and AEDV. All rights reserved.

  9. Current treatment options for the management of patent ductus arteriosus

    Directory of Open Access Journals (Sweden)

    Takeuchi K

    2013-03-01

    Full Text Available Koh Takeuchi,1 Atsushi Hirota,2 Sachito Minegishi,1 Jotaro Kobayashi,1 Keiji Tsuchiya3 1Division of Cardiovascular Surgery, 2Department of Neonatology, 3Department of Pediatrics, Japanese Red Cross Medical Center, Shibuya, Tokyo, Japan Abstract: Pharmacological and/or surgical closure of a hemodynamically significant patent ductus arteriosus (PDA in the very premature infant has been the standard of care over the past few decades. However, the rationale for closure of PDA has recently been challenged. In this article, three ways of approaching the closure of PDA including pharmacological treatment, catheter intervention, and surgical intervention, are reviewed in detail. In addition, the different treatment strategies applied in clinical care are evaluated with a focus on the discussion of the available evidence of PDA treatment in the literature. Keywords: patent ductus arteriosus, premature infant, treatment option

  10. Managing AVN following internal fixation: treatment options and clinical results.

    Science.gov (United States)

    Hoskinson, Simon; Morison, Zachary; Shahrokhi, Shahram; Schemitsch, Emil H

    2015-03-01

    Avascular necrosis (AVN) after internal fixation of intracapsular hip fractures is a progressive multifactorial disease that ultimately results in local ischemia with ensuing osteocyte necrosis and structural compromise. This disease can cause significant clinical morbidity and affects patients of any age, including young and active patients. Effective treatment of this condition among young adults is challenging due to their high functional demands. The aim of managing AVN is to relieve pain, preserve range of movement and improve function. Treatment methods vary depending on the stage of the disease and can be broadly categorised into two options, hip preserving surgery and hip arthroplasty. Although, hip preserving techniques are attractive in the young adult, they may alter the morphology of the proximal femur and make subsequent arthroplasty more challenging. Conversely, arthroplasty in the young adult may require repeat revision procedures throughout the patient's life. Current evidence suggests that modifications of prevailing treatments, in addition to new technologies, have led to the development of management strategies that may be able to alter the course of femoral head osteonecrosis. This review aims to summarise the options available for treatment of AVN in the young adult and review the clinical results. Copyright © 2014 Elsevier Ltd. All rights reserved.

  11. Investigation into fuel pin reshuffling options in PWR in-core fuel management for enhancement of efficient use of nuclear fuel

    Energy Technology Data Exchange (ETDEWEB)

    Daing, Aung Tharn, E-mail: atdaing@khu.ac.kr; Kim, Myung Hyun, E-mail: mhkim@khu.ac.kr

    2014-07-01

    Highlights: • This paper discusses an alternative option, fuel pin reshuffling for maximization of cycle energy production. • The prediction results of isotopic compositions of each burnt pin are verified. • The operating performance is analyzed at equilibrium core with fuel pin reshuffling. • The possibility of reuse of spent fuel pins for reduction of fresh fuel assemblies is investigated. - Abstract: An alternative way to enhance efficient use of nuclear fuel is investigated through fuel pin reshuffling options within PWR fuel assembly (FA). In modeling FA with reshuffled pins, as prerequisite, the single pin calculation method is proposed to estimate the isotopic compositions of each pin of burnt FA in the core-wide environment. Subsequently, such estimation has been verified by comparing with the neutronic performance of the reference design. Two scenarios are concerned, i.e., first scenario was targeted on the improvement of the uniform flux spatial distribution and on the enhancement of neutron economy by simply reshuffling the existing fuel pins in once-burnt fuel assemblies, and second one was focused on reduction of fresh fuel loading and discharged fuel assemblies with more economic incentives by reusing some available spent fuel pins still carrying enough reactivity that are mechanically sound ascertained. In scenario-1, the operating time was merely somewhat increased for few minutes when treating eight FAs by keeping enough safety margins. The scenario-2 was proved to reduce four fresh FAs loading without largely losing any targeted parameters from the safety aspect despite loss of 14 effective full power days for operation at reference plant full rated power.

  12. Vaccines against drugs of abuse: a viable treatment option?

    Science.gov (United States)

    Kantak, Kathleen M

    2003-01-01

    Drug addiction is a chronically relapsing brain disorder. There is an urgent need for new treatment options for this disease because the relapse rate among drug abusers seeking treatment is quite high. During the past decade, many groups have explored the feasibility of using vaccines directed against drugs of abuse as a means of eliminating illicit drug use as well as drug overdose and neurotoxicity. Vaccines work by inducing drug-specific antibodies in the bloodstream that bind to the drug of abuse and prevent its entry into the brain. The majority of work in this area has been conducted with vaccines and antibodies directed against cocaine and nicotine. On the basis of preclinical work, vaccines for cocaine and nicotine are now in clinical trials because they can offer long-term protection with minimal treatment compliance. In addition, vaccines and antibodies for phencyclidine, methamphetamine and heroin abuse are currently under development. An underlying theme in this research is the need for high concentrations of circulating drug-specific antibodies to reduce drug-seeking and drug-taking behaviour when the drug is repeatedly available, especially in high doses. Although vaccines against drugs of abuse may become a viable treatment option, there are several drawbacks that need to be considered. These include: a lack of protection against a structurally dissimilar drug that produces the same effects as the drug of choice;a lack of an effect on drug craving that predisposes an addict to relapse; and tremendous individual variability in antibody formation. Forced or coerced vaccination is not likely to work from a scientific perspective, and also carries serious legal and ethical concerns. All things considered, vaccination against a drug of abuse is likely to work best with individuals who are highly motivated to quit using drugs altogether and as part of a comprehensive treatment programme. As such, the medical treatment of drug abuse will not be radically

  13. Ragweed-induced allergic rhinoconjunctivitis: current and emerging treatment options

    Directory of Open Access Journals (Sweden)

    Ihler F

    2015-02-01

    Full Text Available Friedrich Ihler, Martin CanisDepartment of Otorhinolaryngology, University Medical Center Göttingen, Göttingen, GermanyAbstract: Ragweed (Ambrosia spp. is an annually flowering plant whose pollen bears high allergenic potential. Ragweed-induced allergic rhinoconjunctivitis has long been seen as a major immunologic condition in Northern America with high exposure and sensitization rates in the general population. The invasive occurrence of ragweed (A. artemisiifolia poses an increasing challenge to public health in Europe and Asia as well. Possible explanations for its worldwide spread are climate change and urbanization, as well as pollen transport over long distances by globalized traffic and winds. Due to the increasing disease burden worldwide, and to the lack of a current and comprehensive overview, this study aims to review the current and emerging treatment options for ragweed-induced rhinoconjunctivitis. Sound clinical evidence is present for the symptomatic treatment of ragweed-induced allergic rhinoconjunctivitis with oral third-generation H1-antihistamines and leukotriene antagonists. The topical application of glucocorticoids has also been efficient in randomized controlled clinical trials. Combined approaches employing multiple agents are common. The mainstay of causal treatment to date, especially in Northern America, is subcutaneous immunotherapy with the focus on the major allergen, Amb a 1. Beyond this, growing evidence from several geographical regions documents the benefit of sublingual immunotherapy. Future treatment options promise more specific symptomatic treatment and fewer side effects during causal therapy. Novel antihistamines for symptomatic treatment are aimed at the histamine H3-receptor. New adjuvants with toll-like receptor 4 activity or the application of the monoclonal anti-immunoglobulin E antibody, omalizumab, are supposed to enhance conventional immunotherapy. An approach targeting toll-like receptor 9 by

  14. Economic analysis of fuel treatments

    Science.gov (United States)

    D. Evan Mercer; Jeffrey P. Prestemon

    2012-01-01

    The economics of wildfire is complicated because wildfire behavior depends on the spatial and temporal scale at which management decisions made, and because of uncertainties surrounding the results of management actions. Like the wildfire processes they seek to manage, interventions through fire prevention programs, suppression, and fuels management are scale dependent...

  15. Potential External (non-DOE) Constraints on U.S. Fuel Cycle Options

    Energy Technology Data Exchange (ETDEWEB)

    Steven J. Piet

    2012-07-01

    The DOE Fuel Cycle Technologies (FCT) Program will be conducting a screening of fuel cycle options in FY2013 to help focus fuel cycle R&D activities. As part of this screening, performance criteria and go/no-go criteria are being identified. To help ensure that these criteria are consistent with current policy, an effort was initiated to identify the status and basis of potentially relevant regulations, laws, and policies that have been established external to DOE. As such regulations, laws, and policies may be beyond DOE’s control to change, they may constrain the screening criteria and internally-developed policy. This report contains a historical survey and analysis of publically available domestic documents that could pertain to external constraints on advanced nuclear fuel cycles. “External” is defined as public documents outside DOE. This effort did not include survey and analysis of constraints established internal to DOE.

  16. Options for Healthcare Waste Management and Treatment in China

    Institute of Scientific and Technical Information of China (English)

    2006-01-01

    Healthcare waste management and treatment is one of the national priority tasks of China's Tenth Five-Year Plan.Numerous installations disposing medical waste have already operated the project or under construction to the operation in 2006. This paper focuses on the assessment of existing and fu~re options to handle medical waste (MW). Internationally available and so far in China applied technologies and management practice are analysed, including the problems how to materials. Non-hazardous MW can be managed and treated in analogue to municipal solid waste (MSW). In most of the European countries decentralised hospital incinerators have been, because of high operation costs and pollution problems,widely banned and replaced by pre-treatment technologies at the source and centralised incineration plants for hazardous MW.Information for adapting and further developing MW management solutions and treatment technologies in China and applying the most appropriate MWM practice is provided.

  17. Spent fuel from RA reactor inspection of state and options for management

    International Nuclear Information System (INIS)

    Aden, V.G.; Bulkin, S. Yu.; Sokolov, A. V.; Matausek, M.V.; Vukadin, Z.

    2001-01-01

    About five thousand spent fuel elements from RA reactor have been stored for over 30 years in sealed aluminum barrels in the spent fuel storage pool. This way of storage does not provide complete information about the state of spent fuel elements or the medium inside the barrels, like pressure or radioactivity. The technology has been developed and the equipment has been manufactured to inspect the state of the spent fuel and to reduce eventual internal pressure inside the aluminum barrels. The realization of this technology was started in 1999 but due to political and financial difficulties was not completed. In September the year 2000 the work was restarted. Two different ways of RA reactor spent fuel elements preparation for transportation or long-term storage are considered: 'all fuel elements canning without leak-tightness testing' and 'all fuel elements leak-tightness testing'. It is believed that the first option offers several distinct advantages, which can be summarized as: greater reliability in the course of transportation or dry storage. Higher safety for workers. Lower expenditures for non-standard equipment manufacturing. Shorter duration of work. (author)

  18. Fuel particles in the Chernobyl cooling pond: current state and prediction for remediation options

    International Nuclear Information System (INIS)

    Bulgakov, A.; Konoplev, A.; Smith, J.; Laptev, G.; Voitsekhovich, O.

    2009-01-01

    During the coming years, a management and remediation strategy for the Chernobyl cooling pond (CP) will be implemented. Remediation options include a controlled reduction in surface water level of the cooling pond and stabilisation of exposed sediments. In terrestrial soils, fuel particles deposited during the Chernobyl accident have now almost completely disintegrated. However, in the CP sediments the majority of 90 Sr activity is still in the form of fuel particles. Due to the low dissolved oxygen concentration and high pH, dissolution of fuel particles in the CP sediments is significantly slower than in soils. After the planned cessation of water pumping from the Pripyat River to the Pond, significant areas of sediments will be drained and exposed to the air. This will significantly enhance the dissolution rate and, correspondingly, the mobility and bioavailability of radionuclides will increase with time. The rate of acidification of exposed bottom sediments was predicted on the basis of acidification of similar soils after liming. Using empirical equations relating the fuel particle dissolution rate to soil and sediment pH allowed prediction of fuel particle dissolution and 90 Sr mobilisation for different remediation scenarios. It is shown that in exposed sediments, fuel particles will be almost completely dissolved in 15-25 years, while in parts of the cooling pond which remain flooded, fuel particle dissolution will take about a century

  19. New treatment options for fibromyalgia: critical appraisal of duloxetine

    Directory of Open Access Journals (Sweden)

    Nurcan Üçeyler

    2008-06-01

    Full Text Available Nurcan Üçeyler1, Martin Offenbächer2, Frank Petzke3, Winfried Häuser4, Claudia Sommer11Department of Neurology, University of Würzburg, Germany; 2GRP – Generation Research Program, Human Science Center, University of Munich, Germany; 3Department of Anesthesiology, University of Cologne, Germany; 4Center of Pain Therapy, Klinikum Saarbrücken gGmbH, Winterberg 1, Saarbrücken, GermanyAbstract: Fibromyalgia syndrome (FMS is a chronic condition characterized by widespread pain, tender points, fatigue, and sleep disturbance. FMS leads to high disability levels, poor quality of life, and extensive use of medical care. Effective pharmacological treatment options are rare, and treatment effects are often of limited duration. Duloxetine is a new selective serotonin and norepinephrine reuptake inhibitor that is licensed for the treatment of pain in diabetic neuropathy. So far two randomized, placebo-controlled trials have investigated the short-term safety and efficacy of duloxetine 60 mg/day and 120 mg/day in patients suffering from FMS over a period of 12 weeks. Both dosages were superior to placebo in pain relief, and improvement in quality of life and depressive symptoms. The analgesic effect was largely independent of the antidepressant action of duloxetine. The higher dose of 120 mg/day further reduced the tender point count and elevated the tender point pain thresholds. Only mild to moderate adverse effects were reported. Duloxetine 60 mg/day and 120 mg/day has proven to be beneficial in the treatment of FMS symptoms. As true for other antidepressants further studies are needed to assess the long-term efficacy and safety of duloxetine as an additional pharmacological treatment option in FMS.Keywords: fibromyalgia syndrome, duloxetine, antidepressant, review, SNRI

  20. Evaluation of fuel cycle options for plutonium utilization: 1977 study. Final report

    International Nuclear Information System (INIS)

    Pardue, W.M.; Madia, W.J.; Pobereskin, M.; Tripplett, M.B.; Waddell, J.D.

    1977-05-01

    This is the third in a series of three reports on the analysis of plutonium recycle. Analyses are based upon an October, 1976, middle case ERDA forecast of nuclear growth which predicts 510 GWe of nuclear capacity in the year 2000. Four fuel cycle options were reviewed, ranging from no LWR recycle of uranium of plutonium to recycle options both with and without breeder reactors. A special effort was devoted to the review of various estimates of the costs of reprocessing nuclear fuels, with a resulting value of $190/kg of heavy metal (deflated 1975 dollars). The associated range is estimated to $125/kg to $250/kg. Sensitivity analysis of reprocessing costs, uranium consumption, average generation costs, and total discounted costs of electricity indicate that the long-term economic advantages of plutonium recycle are quite conclusive. Nuclear scenarios which project low growth rates and which delay the start of recycle and introduction of a breeder reactor postpone the apparent economic advantages

  1. Current options for the treatment of optic neuritis

    Directory of Open Access Journals (Sweden)

    Pula JH

    2012-07-01

    Full Text Available John H Pula,1 Christopher J MacDonald21Division of Neuro-ophthalmology, University of Illinois College of Medicine at Peoria, Peoria; 2University of Illinois College of Medicine at Urbana-Champaign, Champaign, IL, USAAbstract: Optic neuritis can be defined as typical (associated with multiple sclerosis, improving independent of steroid treatment, or atypical (not associated with multiple sclerosis, steroid-dependent improvement. Causes of atypical optic neuritis include connective tissue diseases (eg, lupus, vasculitis, sarcoidosis, or neuromyelitis optica. In this manuscript, updated treatment options for both typical and atypical optic neuritis are reviewed. Conventional treatments, such as corticosteroids, therapeutic plasma exchange, and intravenous immunoglobulin therapy are all discussed with commentary regarding evidence-based outcomes. Less commonly used treatments and novel purported therapies for optic neuritis are also reviewed. Special scenarios in the treatment of optic neuritis – pediatric optic neuritis, acute demyelinating encephalomyelitis, and optic neuritis occurring during pregnancy – are specifically examined.Keywords: optic neuritis, optic neuropathy, treatment, neuroophthalmology

  2. Gastroparesis: a review of current and emerging treatment options

    Directory of Open Access Journals (Sweden)

    Enweluzo C

    2013-09-01

    Full Text Available Chijioke Enweluzo, Fahad AzizHospital Medicine, Department of Internal Medicine, Wake Forest School of Medicine, Winston Salem, NC, USAAbstract: Gastroparesis is a motility disorder of the stomach causing delay in food emptying from the stomach without any evidence of mechanical obstruction. The majority of cases are idiopathic. Patients need to be diagnosed properly by formal testing, and the evaluation of the severity of the gastroparesis may assist in guiding therapy. Initially, dietary modifications are encouraged, which include frequent and small semisolid-based meals. Promotility medications, like erythromycin, and antiemetics, like prochlorperazine, are offered for symptom relief. In patients who are refractory to pharmacologic treatment, more invasive options, such as intrapyloric botulinum toxin injections, placement of a jejunostomy tube, or implantation of a gastric stimulator, can be considered. Hemin therapy and gastric electric stimulation are emerging treatment options that are still at different stages of research. Regenerative medicine and stem cell-based therapies also hold promise for gastroparesis in the near future.Keywords: Gastroparesis, gastric emptying, gastric electrical stimulation, hemin

  3. Treatment options for permanent teeth with deep caries.

    Science.gov (United States)

    Marending, Monika; Attin, Thomas; Zehnder, Matthias

    The goal of this narrative review was to summarize and compare treatment options for permanent teeth carious lesions that are radiographically close to the pulp chamber. Thanks to adhesive restorative materials, minimally invasive approaches are possible. In this context, the old question arises as to whether caries must be excavated completely, i.e., down to hard dentin, or whether it could be advantageous to leave some soft dentin, or even merely seal the whole lesion. To answer this question, the microbiological aspects of the lesion must be considered, along with the immunological response in the dental pulp, with the concurrent possible negative outcomes for the patient. Both aspects are considered in this review, and clinical studies comparing different treatment modalities are discussed. Situations in which calcium silicate cements could be advantageous over the gold standard calcium hydroxide preparations for covering the dentin/pulp wound are also discussed.

  4. Evaluation of retention and disposal options for tritium in fuel reprocessing

    International Nuclear Information System (INIS)

    Grimes, W.R.; Hampson, D.C.; Larkin, D.J.; Skolrud, J.O.; Benjamin, R.W.

    1982-08-01

    Five options were evaluated as means of retaining tritium released from light-water reactor or fast breeder reactor fuel during the head-end steps of a typical Purex reprocessing scheme. Cost estimates for these options were compared with a base case in which no retention of tritium within the facility was obtained. Costs were also estimated for a variety of disposal methods of the retained tritium. The disposal costs were combined with the retention costs to yield total costs (capital plus operating) for retention and disposal of tritium under the conditions envisioned. The above costs were converted to an annual basis and to a dollars per curie retained basis. This then was used to estimate the cost in dollars per man-rem saved by retaining the tritium. Only the options that used the least expensive disposal costs could approach the $1000/man-rem cost used as a guide by the Nuclear Regulatory Commission

  5. North American natural gas outlook : does gas remain a fuel option for oil sands?

    International Nuclear Information System (INIS)

    George, R.R.

    2003-01-01

    This paper presents a North America natural gas outlook from Purvin and Gertz, an international energy consulting firm that has 30 years experience in providing strategic, commercial and technical advice to the petroleum industry. In particular, this presentation focuses on natural gas market fundamentals and how they may impact on oil sands development. It includes charts and graphs depicting NYMEX natural gas outlooks to July, 2009 and examines how supply will react to major changes in Canada's supply portfolio. It was noted that oil sands development is a driver for natural gas demand in Alberta. The existing regional gas pipeline infrastructure was presented and the market impact on upgrader options was discussed. The author suggests that if gas prices are too high, there are other fuel options for steam and power generation. These include bitumen, asphalt, coke, coal and nuclear. However, these options have additional costs, uncertainties and environmental issues. A key factor for success would be to have a clear understanding of the benefits and risks between these fuel options. 1 tab., 9 figs

  6. Safety of treatment options for spondyloarthritis: a narrative review.

    Science.gov (United States)

    D'Angelo, Salvatore; Carriero, Antonio; Gilio, Michele; Ursini, Francesco; Leccese, Pietro; Palazzi, Carlo

    2018-05-01

    Spondyloarthritis (SpA) are chronic inflammatory diseases with overlapping pathogenic mechanisms and clinical features. Treatment armamentarium against SpA includes non-steroidal anti-inflammatory drugs, glucocorticoids, conventional disease-modifying antirheumatic drugs (DMARDs, including sulfasalazine, methotrexate, leflunomide, cyclosporine), targeted synthetic DMARDs (apremilast) and biological DMARDs (TNF inhibitors, anti-IL 12/23 and anti-IL-17 agents). Areas covered: A narrative review of published literature on safety profile of available SpA treatment options was performed. Readers will be provided with a comprehensive overview on frequent and rare adverse events associated with each drug listed in current SpA treatment recommendations. Expert opinion: The overall safety profile of such molecules is good and serious adverse events are rare but need to be promptly recognized and treated. However, the monitoring of adverse events is a major challenge for clinicians because it is not adequately addressed by current treatment recommendations. A tailored treatment is crucial and rheumatologists must accurately select patients in order to identify those more susceptible to develop adverse events.

  7. Current and emerging treatment options for Peyronie's disease

    Directory of Open Access Journals (Sweden)

    Gokce A

    2013-01-01

    Full Text Available Ahmet Gokce, Julie C Wang, Mary K Powers, Wayne JG HellstromDepartment of Urology, Tulane University – School of Medicine, New Orleans, LA, USAAbstract: Peyronie's disease (PD is a condition of the penis, characterized by the presence of localized fibrotic plaque in the tunica albuginea. PD is not an uncommon disorder, with recent epidemiologic studies documenting a prevalence of 3–9% of adult men affected. The actual prevalence of PD may be even higher. It is often associated with penile pain, anatomical deformities in the erect penis, and difficulty with intromission. As the definitive pathophysiology of PD has not been completely elucidated, further basic research is required to make progress in the understanding of this enigmatic condition. Similarly, research on effective therapies is limited. Currently, nonsurgical treatments are used for those men who are in the acute stage of PD, whereas surgical options are reserved for men with established PD who cannot successfully penetrate. Intralesional treatments are growing in clinical popularity as a minimally invasive approach in the initial treatment of PD. A surgical approach should be considered when men with PD do not respond to conservative, medical, or minimally invasive therapies for approximately 1 year and cannot have satisfactory sexual intercourse. As scientific breakthroughs in the understanding of the mechanisms of this disease process evolve, novel treatments for the many men suffering with PD are anticipated.Keywords: oral therapy, intralesional treatment, topical therapy, extracorporeal shockwave therapy, traction devices, plication, incision and grafting, penile prosthesis.

  8. Electrometallurgical treatment of TMI-2 fuel debris

    International Nuclear Information System (INIS)

    Karell, E.J.; Gourishankar, K.V.; Johnson, G.K.

    1997-01-01

    Argonne National Laboratory (ANL) has developed an electrometallurgical treatment process suitable for conditioning DOE oxide spent fuel for long-term storage or disposal. The process consists of an initial oxide reduction step that converts the actinide oxides to a metallic form, followed by an electrochemical separation of uranium from the other fuel constituents. The final product of the process is a uniform set of stable waste forms suitable for long-term storage or disposal. The suitability of the process for treating core debris from the Three Mile Island-2 (TMI-2) reactor is being evaluated. This paper reviews the results of preliminary experimental work performed using simulated TMI-2 fuel debris

  9. The application of systems engineering principles to the prioritization of sustainable nuclear fuel cycle options

    International Nuclear Information System (INIS)

    Price, Robert R.; Singh, Bhupinder P.; MacKinnon, Robert J.; David Sevougian, S.

    2013-01-01

    We investigate the implementation of the principles of systems engineering in the U.S. Department of Energy’s Fuel Cycle Technologies (FCT) Program to provide a framework for achieving its long-term mission of demonstrating and deploying sustainable nuclear fuel cycle options. A fuel cycle “screening” methodology is introduced that provides a systematic, objective, and traceable method for evaluating and categorizing nuclear fuel cycles according to their performance in meeting sustainability objectives. The goal of the systems engineering approach is to transparently define and justify the research and development (R and D) necessary to deploy sustainable fuel cycle technologies for a given set of national policy objectives. The approach provides a path for more efficient use of limited R and D resources and facilitates dialog among a variety of stakeholder groups interested in U.S. energy policy. Furthermore, the use of systems engineering principles will allow the FCT Program to more rapidly adapt to future policy changes, including any decisions based on recommendations of the Blue Ribbon Commission on America’s Nuclear Future. Specifically, if the relative importance of policy objectives changes, the FCT Program will have a structured process to rapidly determine how this impacts potential fuel cycle performance and the prioritization of needed R and D for associated technologies. - Highlights: ► Systems engineering principles applied in U.S. DOE-NE Fuel Cycle Technology Program. ► Use of decision analysis methods for determining promising nuclear fuel cycles. ► A new screening methodology to help communicate and prioritize U.S. DOE R and D needs. ► Fuel cycles categorized by performance/risk in meeting FCT Program objectives. ► Systems engineering allows DOE-NE to more rapidly adapt to future policy changes

  10. Financial analysis of fuel treatments.

    Science.gov (United States)

    Fight; Roger D.; R. James. Barbour

    2005-01-01

    The purpose of this paper is to provide information and discussion that will be helpful in promoting thoughtful design of fire hazard reduction treatments to meet the full range of management objectives. Thoughtful design requires an understanding of the costs and potential revenues of applying variations of fire hazard reduction treatments in a wide range of stand...

  11. Current and emerging treatment options for nasopharyngeal carcinoma

    Directory of Open Access Journals (Sweden)

    Spratt DE

    2012-10-01

    Full Text Available Daniel E Spratt, Nancy LeeDepartment of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY, USAAbstract: In this article, we focus on the current and emerging treatments in nasopharyngeal cancer (NPC. A detailed evolution of the current standard of care, and new techniques and treatment options will be reviewed. Intergroup 0099 established the role for chemoradiotherapy (chemo-RT in the treatment of nasopharyngeal carcinoma. Multiple randomized Phase III trials have shown the benefit of chemo-RT; however, none of these studies utilized modern radiotherapy (RT techniques of intensity-modulated radiation therapy (IMRT. IMRT has the ability to deliver high doses of radiation to the target structures while sparing adjacent bystander healthy tissues, and has now become the preferred RT treatment modality. Chemotherapy also has had a shifting paradigm of induction and/or adjuvant chemotherapy combined with RT alone, to the investigation with concurrent chemo-RT. New treatment options including targeted monoclonal antibodies and small molecule tyrosine kinase inhibitors are being studied in NPC. These new biologic therapies have promising in vitro activity for NPC, and emerging clinical studies are beginning to define their role. RT continues to expand its capabilities, and since IMRT and particle therapy, specifically intensity-modulated proton therapy (IMPT, has reports of impressive dosimetric efficacy in-silica. Adaptive RT is attempting to reduce toxicity while maintaining treatment efficacy, and the clinical results are still in their youth. Lastly, Epstein–Barr virus (EBV DNA has recently been studied for prediction of tumor response and its use as a biomarker is increasingly promising to aid in early detection as well as supplementing the current staging system. RT with or without chemotherapy remains the standard of care for nasopharyngeal carcinoma. Advances in RT technique, timing of chemotherapy, biologically

  12. Conversion and standardization of university reactor fuels using low-enrichment uranium - Options and costs

    International Nuclear Information System (INIS)

    Harris, D.R.; Matos, J.E.; Young, H.H.

    1985-01-01

    The highly-enriched uranium (HEU) fuel used in twenty United States university reactors can be viewed as contributing to the risk of theft or diversion of weapons-useable material. The U.S. Nuclear Regulatory Commission has issued a policy statement expressing its concern and has published a proposed rule on limiting the use of HEU in NRC-licensed non-power reactors. The fuel options, functional impacts, licensing, and scheduling of conversion and standardization of these reactor fuels to use of low-enrichment uranium (LEU) have been assessed. The university reactors span a wide range in form and function, from medium-power intense neutron sources where HEU fuel may be required, to low-power training and research facilities where HEU fuel is unnecessary. Conversion provides an opportunity to standardize university reactor fuels and improve reactor utilization in some cases. The entire program is estimated to cost about $10 million and to last about five years. Planning for conversion and standardization is facilitated by the U.S. Department of Energy. (author)

  13. Conversion and standardization of university reactor fuels using low-enrichment uranium - options and costs

    International Nuclear Information System (INIS)

    Harris, D.R.; Matos, J.E.; Young, H.H.

    1985-01-01

    The highly-enriched uranium (HEU) fuel used in twenty United States university reactors can be viewed as contributing to the risk of theft or diversion of weapons-useable material. The US Nuclear Regulatory Commission has issued a policy statement expressing its concern and has published a proposed rule on limiting the use of HEU in NRC-licensed non-power reactors. The fuel options, functional impacts, licensing, and scheduling of conversion and standardization of these reactor fuels to use of low-enrichment uranium (LEU) have been assessed. The university reactors span a wide range in form and function, from medium-power intense neutron sources where HEU fuel may be required, to low-power training and research facilities where HEU fuel is unnecessary. Conversion provides an opportunity to standardize university reactor fuels and improve reactor utilization in some cases. The entire program is estimated to cost about $10 million and to last about five years. Planning for conversion and standardization is facilitated by the US Department of Energy. 20 refs., 1 tab

  14. R and D for back-end options for irradiated research reactor fuel in Germany

    International Nuclear Information System (INIS)

    Bruecher, H.; Curtius, H.; Fachinger, J.

    2001-01-01

    Out of 11.5 t of irradiated fuel arising from German research reactors until the end of this decade, 3.9 t are intended to be returned to the USA, and 2.3 t are expected to be recycled for reuse of uranium. The remaining 5.3 t, as well as the fuel irradiated after the year 2010, will have to follow the domestic back-end option of extended dry interim storage in Castor-type casks, followed by disposal in a deep geological repository. R and D is going on in the Research Centre Juelich to investigate the long-term behaviour of U-Al based fuel in a salt repository. First results from leaching experiments show I) a fast dissolution of the fuel with mobilization of its radionuclide inventory, and 2) the following formation of amorphous Al-Mg-hydroxide phases. Long-lived actinides from the fuel were shown to be fixed in these phases and hence immobilized. Future R and D will be to investigate the nature and stability of these phases for long-term safety assessments. Investigations will have to be extended to cover alternative disposal sites (granite clay) as well as different (e.g. silicon based) fuels. (author)

  15. Analysis of radwaste material management options for experimental DUPIC fuel fabrication process

    Energy Technology Data Exchange (ETDEWEB)

    Lee, H. H.; Park, J. J.; Yang, M. S.; Kim, K. H.; Shin, J. M.; Lee, H. S.; Ko, W. I.; Lee, J. W.; Yim, S. P.; Hong, D. H.; Lee, J. Y.; Baik, S. Y.; Song, W. S.; Yoo, B. O.; Lee, E. P.; Kang, I. S. [Korea Atomic Energy Research Institute, Taejeon (Korea)

    2000-03-01

    This report is desirable to review management options in advance for radioactive waste generated from manufacturing experiment of DUPIC nuclear fuel as well as residual nuclear material and dismantled equipment. This report was written for helping researchers working in related facilities to DUPIC project understanding management of DUPIC radioactive waste as well as fellows in DUPIC project. Also, it will be used as basic material to prove transparency and safeguardability of DUPIC fuel cycle. In order to meet these purposes, this report includes basic experiment plan for manufacturing DUPIC nuclear fuel, outlines for DUPIC manufacturing facility and equipment, arising source and estimated amount of radioactive waste, waste classification and packing, transport cask, transport procedures. 15 refs., 31 figs., 11 tabs. (Author)

  16. Laryngeal manifestations of relapsing polychondritis and a novel treatment option.

    Science.gov (United States)

    Childs, Lesley F; Rickert, Scott; Wengerman, Oscar C; Lebovics, Robert; Blitzer, Andrew

    2012-09-01

    Laryngotracheal involvement in relapsing polychondritis (RP) is rare. However, it is one of the most common causes of death in this patient population. We present three patients who primarily presented with laryngeal manifestations of RP and a novel treatment option for bamboo nodules. Retrospective chart review and comprehensive review of the literature. Two patients first presented to an otolaryngologist because of hoarseness and chronic cough that eventually progressed to dyspnea upon exertion. Laryngeal examination revealed subglottic stenoses. Upon rheumatologic workup both were diagnosed with RP. After treatment with steroids and immunosuppressive drugs, one of the patient's laryngeal symptoms improved, whereas the other required dilation procedures. Neither patient had classic auricular or nasal symptoms upon initial presentation. The third patient was being treated for spasmodic dysphonia and was noted to have bamboo nodules with accompanying dysphonia. Rheumatologic workup revealed RP and systemic treatment ensued. Unfortunately, her symptoms of hoarseness persisted despite systemic treatment. A pulsed-potassium-titanyl-phosphate (KTP) laser was applied to the bilateral bamboo nodules, which eventually caused resolution of her vocal fold lesions and dysphonia. We present three patients with RP, all of whom sought health care by an otolaryngologist primarily. Awareness of this disease entity and the possibility for early laryngeal involvement is crucial for proper care of those with this life-threatening disease. Copyright © 2012 The Voice Foundation. Published by Mosby, Inc. All rights reserved.

  17. The safety of treatment options available for gout.

    Science.gov (United States)

    Schlesinger, Naomi

    2017-04-01

    Gout is the most common inflammatory arthritis in humans. Gout treatment includes rapid initiation of anti-inflammatory medications for acute attacks and chronically treating with urate lowering drugs as well as chronic anti-inflammatory prophylaxis. Areas covered: This review aims to provide an overview and discussion of the safety concerns of current treatment options available for gout. Expert opinion: Gout is a curable disease with appropriate treatment. The advent of new therapies provides encouraging opportunities to improve gout management. However, clinicians should be aware of some of the safety concerns of medications used to treat acute and chronic gout. When prescribing medications for gout one has to be mindful of the presence of comorbidities commonly affecting gout patients that may affect drug safety and efficacy, especially in the elderly and in patients treated with multiple drugs. The benefits of gout drugs, usually, outweigh their safety concerns. Studies are needed in gout patients with chronic kidney disease and/or cardiovascular disease, so that escalation of dosing /combination of anti-inflammatory drugs needed to suppress gouty inflammation as well as escalation of dosing/combination of urate lowering drugs needed to achieve target serum urate level will lead to better understanding of gout treatment safety issues.

  18. Social Cost Assessment for Nuclear Fuel Cycle Options in the Republic of Korea

    Energy Technology Data Exchange (ETDEWEB)

    Joo, Ji-eun; Yim, Man-Sung [KAIST, Daejeon (Korea, Republic of)

    2016-10-15

    This paper will investigate the vast array of economic factors to estimate the true cost of the nuclear power. There are many studies addressing the external costs of energy production. However, it is only since the 1990s that the external costs of nuclear powered electricity production has been studied in detail. Each investigation has identified their own set of external costs and developed formulas and models using a variety of statistical techniques. The objective of this research is to broaden the scope of the parameters currently consider by adding new areas and expanding on the types of situations considered. Previously the approach to evaluating the external cost of nuclear power did not include various fuel cycle options and influencing parameters. Cost has always been a very important factor in decision-making, in particular for policy choices evaluating the alternative energy sources and electricity generation technologies. Assessment of external costs in support of decision-making should reflect timely consideration of important country specific policy objective. PWR-MOX and FR-Pyro are the best fuel cycle in parameter of environment impacts, but OT or OT-ER is proper than FR-Pyro in human beings. Using the OT fuel cycle is better than FR-Pyro to reduce the conflict cost. When energy supply is deficient, FR-Pyro fuel cycle stands longer than other fuel cycles. Proliferation resistance is shown as 'high' in all fuel cycles, so there are no difference between fuel cycles. When the severe accident occurs, FR-Pyro cycle is economical than other OT based fuel cycles.

  19. Maturity onset diabetes of the young: Diagnosis and treatment options

    Directory of Open Access Journals (Sweden)

    Serghei Covanțev

    2016-12-01

    Full Text Available Diabetes is a complicated disease, so multiple factors are involved in its development. Nevertheless some of the patients with type 1 and 2 diabetes mellitus have a monogenic form of this disease which has different treatment options and usually fewer complications. It is estimated that about 5% of patients with type 2 diabetes melitus (T2DM and about 10% of type 1 diabetes melitus (T1DM are misdiagnosed and have maturity onset diabetes of the young (MODY. We present a review study of the management of most frequent monogenic forms of diabetes such as MODY 1, 2 and 3 and the possibilities of their diagnosis including in resource limited situations.

  20. Direct visual internal urethrotomy: Is it a durable treatment option?

    Science.gov (United States)

    Pal, Dilip Kumar; Kumar, Sanjay; Ghosh, Bastab

    2017-01-01

    To evaluate the long-term success rate of direct vision internal urethrotomy as a treatment for anterior urethral strictures. We retrospectively analyzed the results for patients who underwent internal urethrotomy from January 2009 to January 2014 for anterior urethral strictures. Patients were followed till January 2016. Patients with complicated urethral strictures with a history of previous urethroplasty, hypospadias repair, or previous radiation were excluded from the study, as anticipated low success rate of direct visual internal urethrotomy (DVIU) in these patients. The Kaplan-Meier method was used to analyze stricture-free probability after the first, second, and third urethrotomy. A total of 186 patients were included in this study. Stricture-free rates after first, second, and third urethrotomy were 29.66%, 22.64%, and 13.33%, respectively. Although DVIU may be a management option for anterior urethral stricture disease, it seems that long-term results are disappointing.

  1. Antenatal Hydronephrosis: Differential Diagnosis, Evaluation, and Treatment Options

    Science.gov (United States)

    Herndon, C.D. Anthony

    2006-01-01

    The diagnosis, evaluation and management of antenatal hydronephrosis has undergone a two stage paradigm shift since the advent of prenatal ultrasonography in the early 1980s. Initially the identification of a large number of asymptomatic infants appeared to afford the surgeon the opportunity for preemptive intervention. However, it has now become apparent that antenatal hydronephrosis (AH) is far more difficult to interpret thanoriginally perceived. The initial enthusiasm for surgery has now been replaced by a much more conservative approach to ureteropelvic junction(UPJ) obstruction, multi-cystic dysplastic kidney(MCDK), vesicoureteral reflux and the non-refluxing megaureter. This review will highlight the postnatal evaluation of AH and include an overview of the Society for Fetal Urology grading system for hydronephrosis. The differential diagnosis and treatment options for UPJ obstruction, vesicoureteral reflux, MCDK, duplication anomalies, megaureter, and posterior urethral valves will be discussed. PMID:17619702

  2. Acupuncture as a therapeutic treatment option for threatened miscarriage

    Directory of Open Access Journals (Sweden)

    Betts Debra

    2012-03-01

    Full Text Available Abstract Background Threatened miscarriage involves vaginal bleeding in a pregnancy that remains viable. This is a common early pregnancy complication with increased risk factors for early pregnancy loss, preterm premature rupture of membranes (PPROM, preterm delivery, low birth weight babies and maternal antepartum haemorrhage. Currently there are no recommended medical treatment options, rather women receive advice that centres on a 'wait and see' approach. For women with a history of unexplained recurrent miscarriage providing supportive care in a subsequent pregnancy improves live birthing outcomes, but the provision of supportive care to women experiencing threatened miscarriage has to date not been examined. Discussion While it is known that 50-70% of miscarriages occur due to chromosomal abnormalities, the potential for therapeutic intervention amongst the remaining percentage of women remains unknown. Complementary and alternative medicine (CAM therapies have the potential to provide supportive care for women presenting with threatened miscarriage. Within fertility research, acupuncture demonstrates beneficial hormonal responses with decreased miscarriage rates, raising the possibility acupuncture may promote specific beneficial effects in early pregnancy. With the lack of current medical options for women presenting with threatened miscarriage it is timely to examine the possible treatment benefits of providing CAM therapies such as acupuncture. Summary Despite vaginal bleeding being a common complication of early pregnancy there is often reluctance from practitioners to discuss with women and medical personal how and why CAM may be beneficial. In this debate article, the physiological processes of early pregnancy together with the concept of providing supportive care and acupuncture are examined. The aim is to raise awareness and promote discussion as to the beneficial role CAM may have for women presenting with threatened miscarriage.

  3. New and current preventive treatment options in actinic keratosis.

    Science.gov (United States)

    Arenberger, P; Arenbergerova, M

    2017-09-01

    Actinic keratosis (AK) is a characteristic skin lesion on skin areas of subjects with mainly phototype I and phototype II, or with specific genetic factors and who are exposed to prolonged ultraviolet radiation. AK may be considered a precursor of in situ squamous cell carcinoma (SCC), a type of non-melanoma skin cancer (NMSC). However, it is still not possible to predict which AK lesions will develop into SCC. Early treatment of AK is therefore recommended. Despite the increasing number of patients with AK developing into SCC, to date, there is still no clear suggestion of therapeutic strategy for AK. Current treatment consists of a multitude of topical lesion-directed or field-directed therapies or a combination of both. Recently, orally administered nicotinamide has shown to significantly reduce rates of new NMSC and AK in high-risk patients. This study aims to provide an update on the most relevant information about AK and to provide an insight into current and new treatment options. © 2017 European Academy of Dermatology and Venereology.

  4. Transepidermal drug delivery: a new treatment option for areata alopecia?

    Science.gov (United States)

    Issa, Maria Claudia Almeida; Pires, Marianna; Silveira, Priscilla; Xavier de Brito, Esther; Sasajima, Cristiane

    2015-02-01

    Transepidermal drug delivery (TED) is a new potential method in dermatology. Permeability alterations induced by ablative fractional resurfacing have been described with the aim to increasing the delivery of different substances into the skin. To evaluate clinical response and side effects of TED in areata alopecia (AA) treatment using ablative fractional methods associated with acoustic pressure ultrasound (US) to deliver triamcinolone solution into the skin. Five cases of AA underwent treatment which comprised of 3 steps: 1) Ablative fractioned RF or CO2 laser 2) topical application of triamcinolone 3) acoustic pressure wave US. The number of sessions varied according to the clinical response, ranging from one to six sessions. All patients had complete recovery of the area treated. Two of them treated with ablative fractional RF + triamcinolone + US had complete response after three and six sessions. The other two treated with ablative fractional CO2 + triamcinolone + US had complete response after one session. Fractioned ablative resurfacing associated with acoustic pressure wave US is a new option to areata alopecia treatment with good clinical result and low incidence of side effects.

  5. Long-term issues associated with spent nuclear power fuel management options

    International Nuclear Information System (INIS)

    Jae-Sol, Lee; Kosaku, Fukuda; Burcl, R.; Bell, M.

    2003-01-01

    Spent fuel management is perceived as one of the crucial issues to be resolved for sustainable utilisation of nuclear power. In the last decades, spent fuel management policies have shown diverging tendencies among the nuclear power production countries - a group has adhered to reprocessing- recycle and another has turned to direct disposal, while the rest of the countries have not taken decision yet, often with ''wait and see'' position. Both the closed and open fuel cycle options for spent fuel management have been subject to a number of debates with pros and cons on various issues such as proliferation risk, environmental impact, etc. The anticipation for better technical solutions that would mitigate those issues has given rise to the renewal of interest in partitioning and transmutation of harmful nuclides to be disposed of, and in a broader context, the recent initiatives for development of innovative nuclear systems. The current trend toward globalization of market economy, which has already brought important impacts on nuclear industry, might have a stimulating effect on regional-international co-operations for cost-effective efforts to mitigate some of those long-term issues associated with spent fuel management. (author)

  6. Thorium Fuel Options for Sustained Transuranic Burning in Pressurized Water Reactors - 12381

    Energy Technology Data Exchange (ETDEWEB)

    Rahman, Fariz Abdul; Lee, John C. [University of Michigan, Ann Arbor, MI (United States); Franceschini, Fausto; Wenner, Michael [Westinghouse Electric Company LLC, Cranberry Township, PA (United States)

    2012-07-01

    As described in companion papers, Westinghouse is proposing the adoption of a thorium-based fuel cycle to burn the transuranics (TRU) contained in the current Used Nuclear Fuel (UNF) and transition towards a less radio-toxic high level waste. A combination of both light water reactors (LWR) and fast reactors (FR) is envisaged for the task, with the emphasis initially posed on their TRU burning capability and eventually to their self-sufficiency. Given the many technical challenges and development times related to the deployment of TRU burners fast reactors, an interim solution making best use of the current resources to initiate burning the legacy TRU inventory while developing and testing some technologies of later use is desirable. In this perspective, a portion of the LWR fleet can be used to start burning the legacy TRUs using Th-based fuels compatible with the current plants and operational features. This analysis focuses on a typical 4-loop PWR, with 17x17 fuel assembly design and TRUs (or Pu) admixed with Th (similar to U-MOX fuel, but with Th instead of U). Global calculations of the core were represented with unit assembly simulations using the Linear Reactivity Model (LRM). Several assembly configurations have been developed to offer two options that can be attractive during the TRU transmutation campaign: maximization of the TRU transmutation rate and capability for TRU multi-recycling, to extend the option of TRU recycling in LWR until the FR is available. Homogeneous as well as heterogeneous assembly configurations have been developed with various recycling schemes (Pu recycle, TRU recycle, TRU and in-bred U recycle etc.). Oxide as well as nitride fuels have been examined. This enabled an assessment of the potential for burning and multi-recycling TRU in a Th-based fuel PWR to compare against other more typical alternatives (U-MOX and variations thereof). Results will be shown indicating that Th-based PWR fuel is a promising option to multi-recycle and

  7. Ovarian failure due to cancer treatment and fertility preservation options

    Directory of Open Access Journals (Sweden)

    Soheila Aminimoghaddam

    2016-04-01

    Full Text Available Primary ovarian insufficiency (POI, commonly referred to premature ovarian failure, is defined as ovarian failure before the age of 40 years. It is the loss of ovarian function caused by a process directly affecting ovaries. Cancer therapy which includes surgery, radiotherapy, and chemotherapy influence ovarian function, leading to premature menopause and loss of fertility. POI is idiopathic in most cases (74-90%. The known causes, in addition to anticancer treatment, are other processes like chromosomal abnormalities, autoimmunity, and natural aging can result in secondary ovarian failure, which is detected by an increase in serum gonadotropin levels (FSH and LH. There are evident risks of POI in women treated for cancer. Those who receive anticancer treatments have an increased risk of developing POI. There by, anticancer drugs and radiation therapy are considered as the most common toxins of ovaries. Although cancer incidence rates in women less than 50 years old continue to increase during recent years, mortality rates are dramatically decreasing due to modern advances in treatment. Increasing numbers of survivors are now confronted with the long-term consequences of exposure to these treatments. The pool of primordial follicles in the ovary is fixed and any injury to the ovary can potentially reduce this ovarian reserve, effectively advancing the patient’s reproductive age, thus narrowing the window of reproductive opportunity. Ovarian failure occurs in a significant percentage of childhood cancer survivors and many of them will seek care for reproductive dysfunction. Nevertheless, Embryo cryopreservation, oocyte cryopreservation, ovary tissue cryopreservation, ovarian suppression and oophoro-pexy are some options to preserve fertility in these groups. As a result, having foreknowledge of potential treatment related ovarian failure will allow the physician to give a better counsel to patients and their family regarding the importance and

  8. Fuel price and technological uncertainty in a real options model for electricity planning

    International Nuclear Information System (INIS)

    Fuss, Sabine; Szolgayova, Jana

    2010-01-01

    Electricity generation is an important source of total CO 2 emissions, which in turn have been found to relate to an acceleration of global warming. Given that many OECD countries have to replace substantial portions of their electricity-generating capacity over the next 10-20 years, investment decisions today will determine the CO 2 -intensity of the future energy mix. But by what type of power plants will old (mostly fossil-fuel-fired) capacity be replaced? Given that modern, less carbon-intensive technologies are still expensive but can be expected to undergo improvements due to technical change in the near future, they may become more attractive, especially if fossil fuel price volatility makes traditional technologies more risky. At the same time, technological progress is an inherently uncertain process itself. In this paper, we use a real options model with stochastic technical change and stochastic fossil fuel prices in order to investigate their impact on replacement investment decisions in the electricity sector. We find that the uncertainty associated with the technological progress of renewable energy technologies leads to a postponement of investment. Even the simultaneous inclusion of stochastic fossil fuel prices in the same model does not make renewable energy competitive compared to fossil-fuel-fired technology in the short run based on the data used. This implies that policymakers have to intervene if renewable energy is supposed to get diffused more quickly. Otherwise, old fossil-fuel-fired equipment will be refurbished or replaced by fossil-fuel-fired capacity again, which enforces the lock-in of the current system into unsustainable electricity generation. (author)

  9. Reactor-based management of used nuclear fuel: assessment of major options.

    Science.gov (United States)

    Finck, Phillip J; Wigeland, Roald A; Hill, Robert N

    2011-01-01

    This paper discusses the current status of the ongoing Advanced Fuel Cycle Initiative (AFCI) program in the U.S. Department of Energy that is investigating the potential for using the processing and recycling of used nuclear fuel to improve radioactive waste management, including used fuel. A key element of the strategies is to use nuclear reactors for further irradiation of recovered chemical elements to transmute certain long-lived highly-radioactive isotopes into less hazardous isotopes. Both thermal and fast neutron spectrum reactors are being studied as part of integrated nuclear energy systems where separations, transmutation, and disposal are considered. Radiotoxicity is being used as one of the metrics for estimating the hazard of used fuel and the processing of wastes resulting from separations and recycle-fuel fabrication. Decay heat from the used fuel and/or wastes destined for disposal is used as a metric for use of a geologic repository. Results to date indicate that the most promising options appear to be those using fast reactors in a repeated recycle mode to limit buildup of higher actinides, since the transuranic elements are a key contributor to the radiotoxicity and decay heat. Using such an approach, there could be much lower environmental impact from the high-level waste as compared to direct disposal of the used fuel, but there would likely be greater generation of low-level wastes that will also require disposal. An additional potential waste management benefit is having the ability to tailor waste forms and contents to one or more targeted disposal environments (i.e., to be able to put waste in environments best-suited for the waste contents and forms). Copyright © 2010 Health Physics Society

  10. Nuclear fuel cycle in France: today's situation and long term options

    International Nuclear Information System (INIS)

    Boullis, B.; Drevon, C.; Pays, M.

    2015-01-01

    In France plutonium and uranium are recycled as MOX fuel (used in 22 reactors) and URE (enriched uranium from spent fuel). Fission products and minor actinides, that composed ultimate wastes, are vitrified and cast in stainless steel containers. Fuel recycling has reached industrial maturity and about 30.000 tonnes of spent fuels have been processed. This strategy has allowed France to save about 17% of its annual consumption of uranium and to get a least volume of high-level radioactive wastes. This strategy can be pushed forwards by introducing a multi-recycling option in which plutonium and uranium from spent MOX fuels are recycled. Multi-recycling produces a nuclear fuel that is polluted with remainders of actinides and fission products and to compensate this deterioration of its neutronic properties a higher concentration of fissile materials is required. For safety reasons the concentration of plutonium in MOX fuels is limited to 12% so multi-recycling is not a strategy for a fleet of PWRs only. Fast neutron reactors use uranium and plutonium in a more efficiently way and can be a solution for multi-recycling. The study shows that for a constant output of 420 TWh a year a fleet of PWRs need 7600 tonnes of natural uranium. If mono-recycling is allowed this consumption decreases to 6300 tonnes a year and if multi-recycling is allowed by integrating fast reactors in the proportion of 40% of the fleet, this consumption drops to 2700 tonnes a year. The study also shows the changes in the production of wastes in relation with multi-recycling. (A.C.)

  11. Nuclear fuel cycle. Which way forward for multilateral approaches? An international expert group examines options

    International Nuclear Information System (INIS)

    Pellaud, Bruno

    2005-01-01

    For several years now, the debate on the proliferation of nuclear weapons has been dominated by individuals and countries that violate rules of good behaviour - as sellers or acquirers of clandestine nuclear technology. As a result, the 1968 Treaty on the Non-Proliferation of Nuclear Weapons (NPT) has been declared to be 'inadequate' by some, 'full of loopholes' by others. Two basic approaches have been put forward to tighten up the NPT; both seek to ensure that the nuclear non-proliferation regime maintains its authority and credibility in the face of these very real challenges. One calls for non-nuclear weapon States to accept a partial denial of technology through a reinterpretation of the NPT's provisions governing the rights of access to nuclear technologies. The unwillingness of most non-nuclear-weapon States to accept additional restrictions under the NPT makes this approach difficult. The other approach would apply multinational alternatives to the national operation of uranium-enrichment and plutonium-separation technologies, and to the disposal of spent nuclear fuel. In this perspective, IAEA Director General Mohamed ElBaradei proposed in 2003 to revisit the concept of multilateral nuclear approaches (MNA) that was intensively discussed several decades ago. Several such approaches were adopted at that time in Europe, which became the true homeland of MNAs. Nonetheless, MNAs have failed so far to materialise outside Europe due to different political and economic perceptions. In June 2004, the Director General appointed an international group of experts to consider possible multilateral approaches to the nuclear fuel cycle. The overall purpose was to assess MNAs in the framework of a double objective: strengthening the international nuclear non-proliferation regime and making the peaceful uses of nuclear energy more economical and attractive. In the report submitted to the Director General in February 2005, the Group identified a number of options - options

  12. Taxing Options: Do Ceos Respond To Favorable Tax Treatment Of Stock Options?

    OpenAIRE

    Martin Gritsch; Tricia Coxwell Snyder

    2007-01-01

    CEO stock option compensation increased tremendously during the 1990s. During this period, the spread between the marginal income and capital gains tax rates increased substantially, creating the potential for tax avoidance. Using ExecuComp data from 1992-2000, we estimate CEOs’ responsiveness to changes in these tax rates. Our findings show that an increase in the marginal income and a decrease in the capital gains tax rate create a significant increase in stock option compensation. Furtherm...

  13. Nuclear fuel treatment facility for 'Mutsu'

    International Nuclear Information System (INIS)

    Kanazawa, Toshio; Fujimura, Kazuo; Horiguchi, Eiji; Kobayashi, Tetsuji; Tamekiyo, Yoshizou

    1989-01-01

    A new fixed mooring harbor in Sekinehama and surrounding land facilities to accommodate a test voyage for the nuclear-powered ship 'Mutsu' in 1990 were constructed by the Japan Atomic Energy Research Institute. Kobe Steel took part in the construction of the nuclear fuel treatment process in various facilities, beginning in October, 1988. This report describes the outline of the facility. (author)

  14. Interspinous Process Decompression: Expanding Treatment Options for Lumbar Spinal Stenosis

    Directory of Open Access Journals (Sweden)

    Pierce D. Nunley

    2016-01-01

    Full Text Available Interspinous process decompression is a minimally invasive implantation procedure employing a stand-alone interspinous spacer that functions as an extension blocker to prevent compression of neural elements without direct surgical removal of tissue adjacent to the nerves. The Superion® spacer is the only FDA approved stand-alone device available in the US. It is also the only spacer approved by the CMS to be implanted in an ambulatory surgery center. We computed the within-group effect sizes from the Superion IDE trial and compared them to results extrapolated from two randomized trials of decompressive laminectomy. For the ODI, effect sizes were all very large (>1.0 for Superion and laminectomy at 2, 3, and 4 years. For ZCQ, the 2-year Superion symptom severity (1.26 and physical function (1.29 domains were very large; laminectomy effect sizes were very large (1.07 for symptom severity and large for physical function (0.80. Current projections indicate a marked increase in the number of patients with spinal stenosis. Consequently, there remains a keen interest in minimally invasive treatment options that delay or obviate the need for invasive surgical procedures, such as decompressive laminectomy or fusion. Stand-alone interspinous spacers may fill a currently unmet treatment gap in the continuum of care and help to reduce the burden of this chronic degenerative condition on the health care system.

  15. An overview of seasonal affective disorder and its treatment options.

    Science.gov (United States)

    Howland, Robert H

    2009-12-01

    Seasonal affective disorder (SAD) is defined as a history of major depressive episodes that recur regularly at a particular time of year. Depending on the diagnostic instruments and criteria available, the reported prevalence (1%-10%) varies. Neurotransmitter abnormalities have been implicated in the pathophysiology, but they do not necessarily explain the seasonal pattern or the known chronobiological abnormalities in SAD compared with nonseasonal depression. Circadian rhythm abnormalies have been hypothesized to account for these aspects of SAD, and they provide a rationale for the therapeutic use of light therapy. Family history, twin, and molecular genetics studies suggest that hereditary factors are also involved. Light therapy and antidepressant medication are effective treatment options, with limited evidence for the efficacy of psychotherapy. Some studies demonstrate that narrow-band short wavelength "blue" light, naturalistic dawn simulation, and high-density negative air ionization are effective. Patients should be informed of the benefits of diet and exercise. Light therapy should be clinically monitored in the same manner, as it is done for other antidepressant treatments.

  16. Cachexia and pancreatic cancer: Are there treatment options?

    Science.gov (United States)

    Mueller, Tara C; Burmeister, Marc A; Bachmann, Jeannine; Martignoni, Marc E

    2014-01-01

    Cachexia is frequently described in patients with pancreatic ductal adenocarcinoma (PDAC) and is associated with reduced survival and quality of life. Unfortunately, the therapeutic options of this multi-factorial and complex syndrome are limited. This is due to the fact that, despite extensive preclinical and clinical research, the underlying pathological mechanisms leading to PDAC-associated cachexia are still not fully understood. Furthermore, there is still a lack of consensus on the definition of cachexia, which complicates the standardization of diagnosis and treatment as well as the analysis of the current literature. In order to provide an efficient therapy for cachexia, an early and reliable diagnosis and consistent monitoring is required, which can be challenging especially in obese patients. Although many substances have been tested in clinical and preclinical settings, so far none of them have been proven to have a long-term effect in ameliorating cancer-associated cachexia. However, recent studies have demonstrated that multidimensional therapeutic modalities are able to alleviate pancreatic cancer-associated cachexia and ultimately improve patients’ outcome. In this current review, we propose a stepwise and pragmatic approach to facilitate and standardize the treatment of cachexia in pancreatic cancer patients. This strategy consists of nutritional, dietary, pharmacological, physical and psychological methods. PMID:25071331

  17. Biocidal treatment and preservation of liquid fuels

    Energy Technology Data Exchange (ETDEWEB)

    Siegert, W.

    1995-05-01

    Strict microbiological limit values are the result of damage caused by microorganisms in fuels. With MAR 71, a biocide based on methylenebisoxazolidine, a product is available which has been tested and approved by leading car manufacturers, the mineral oil industry, and NATO. Depending on the degree of microbiological contamination, different decontamination concepts are presented, and recommendations for the treatment of fuels which are contaminated when purchased are given. In order to avoid recontamination, planning principles or the new design of tanks are necessary. The possibility of convenient, economical and regular drainage is a key factor.

  18. Management of patients with resistant hypertension: current treatment options

    Directory of Open Access Journals (Sweden)

    Kumar N

    2013-10-01

    Full Text Available Nilay Kumar,1 David A Calhoun,2 Tanja Dudenbostel21Department of Medicine, 2Division of Cardiovascular Disease, Hypertension and Vascular Biology Program, University of Alabama at Birmingham, Birmingham, AL, USAAbstract: Resistant hypertension (RHTN is an increasingly common clinical problem that is often heterogeneous in etiology, risk factors, and comorbidities. It is defined as uncontrolled blood pressure on optimal doses of three antihypertensive agents, ideally one being a diuretic. The definition also includes controlled hypertension with use of four or more antihypertensive agents. Recent observational studies have advanced the characterization of patients with RHTN. Patients with RHTN have higher rates of cardiovascular events and mortality compared with patients with more easily controlled hypertension. Secondary causes of hypertension, including obstructive sleep apnea, primary aldosteronism, renovascular disease, are common in patients with RHTN and often coexist in the same patient. In addition, RHTN is often complicated by metabolic abnormalities. Patients with RHTN require a thorough evaluation to confirm the diagnosis and optimize treatment, which typically includes a combination of lifestyle adjustments, and pharmacologic and interventional treatment. Combination therapy including a diuretic, a long-acting calcium channel blocker, an angiotensin-converting enzyme inhibitor, a beta blocker, and a mineralocorticoid receptor antagonist where warranted is the classic regimen for patients with treatment-resistant hypertension. Mineralocorticoid receptor antagonists like spironolactone or eplerenone have been shown to be efficacious in patients with RHTN, heart failure, chronic kidney disease, and primary aldosteronism. Novel interventional therapies, including baroreflex activation and renal denervation, have shown that both of these methods may be used to lower blood pressure safely, thereby providing exciting and promising new

  19. Analysis of Technology Options to Reduce the Fuel Consumption of Idling Trucks; FINAL

    International Nuclear Information System (INIS)

    Stodolsky, F.; Gaines, L.; Vyas, A.

    2000-01-01

    Long-haul trucks idling overnight consume more than 838 million gallons (20 million barrels) of fuel annually. Idling also emits pollutants. Truck drivers idle their engines primarily to (1) heat or cool the cab and/or sleeper, (2) keep the fuel warm in winter, and (3) keep the engine warm in the winter so that the engine is easier to start. Alternatives to overnight idling could save much of this fuel, reduce emissions, and cut operating costs. Several fuel-efficient alternatives to idling are available to provide heating and cooling: (1) direct-fired heater for cab/sleeper heating, with or without storage cooling; (2) auxiliary power units; and (3) truck stop electrification. Many of these technologies have drawbacks that limit market acceptance. Options that supply electricity are economically viable for trucks that are idled for 1,000-3,000 or more hours a year, while heater units could be used across the board. Payback times for fleets, which would receive quantity discounts on the prices, would be somewhat shorter

  20. Biofuels Fuels Technology Pathway Options for Advanced Drop-in Biofuels Production

    Energy Technology Data Exchange (ETDEWEB)

    Kevin L Kenney

    2011-09-01

    Advanced drop-in hydrocarbon biofuels require biofuel alternatives for refinery products other than gasoline. Candidate biofuels must have performance characteristics equivalent to conventional petroleum-based fuels. The technology pathways for biofuel alternatives also must be plausible, sustainable (e.g., positive energy balance, environmentally benign, etc.), and demonstrate a reasonable pathway to economic viability and end-user affordability. Viable biofuels technology pathways must address feedstock production and environmental issues through to the fuel or chemical end products. Potential end products include compatible replacement fuel products (e.g., gasoline, diesel, and JP8 and JP5 jet fuel) and other petroleum products or chemicals typically produced from a barrel of crude. Considering the complexity and technology diversity of a complete biofuels supply chain, no single entity or technology provider is capable of addressing in depth all aspects of any given pathway; however, all the necessary expert entities exist. As such, we propose the assembly of a team capable of conducting an in-depth technology pathway options analysis (including sustainability indicators and complete LCA) to identify and define the domestic biofuel pathways for a Green Fleet. This team is not only capable of conducting in-depth analyses on technology pathways, but collectively they are able to trouble shoot and/or engineer solutions that would give industrial technology providers the highest potential for success. Such a team would provide the greatest possible down-side protection for high-risk advanced drop-in biofuels procurement(s).

  1. The option study of air shipment of DUPIC fuel elements to Canada

    International Nuclear Information System (INIS)

    Lee, H. H.; Park, J. J.; Shin, J. M.; Kim, J. H.; Yang, M. S.; Koo, J. H.

    2003-01-01

    KAERI developed a DUPIC nuclear fuel with the refabrication of spent PWR fuel discharged from domestic nuclear power plant by a dry process at M6 hot-cell in IMEF. To verify the performance of DUPIC nuclear fuel, irradiation test at operating conditions of commercially operating power plant is essential. Since the HANARO research reactor of KAERI does not have Fuel Test Loop(FTL) for irradiating nuclear fuel under high temperature and high pressure conditions, DUPIC fuel cannot be irradiated in the FTL of HANARO until about 2008. In the 13-th PRM among Korea, Canada, USA and IAEA, AECL proposed that KAERI fabricated DUPIC fuel can be irradiated in the FTL of the NRU research reactor without charge of neutrons. The transportation quantity of DUPIC fuel to Canada is 10 elements(about 6 kg). This transportation package is classified as the 7-th class according to 'recommendation on the transport of dangerous goods' made by the United Nations. Air shipment was investigated as a promising option because it is generally understood that air shipment is more appropriate than ship shipment for transportation of small quantity of nuclear materials from the perspectives of cost and transportation period. In case of air shipment, the IATA regulations have been more intensified since the July of 2001. To make matters worse, it becomes more difficult to get the ratification of corresponding authorities due to 9.11 terror. It was found that at present there is no proper air transportation cask for DUPIC fuel. So, air transportation is considered to be impossible. An alternative of using the exemption limit of fissile material was reviewed. Its results showed that in case of going via USA territory, approvals from US DOT should be needed. The approvals include shipping and cask approvals on technical cask testing. Furthermore, since passes through territories of Japan and Russia have to be done in case of using a regular air cargo from Korea to Canada, approvals from Russia and

  2. Arsenic contaminated groundwater and its treatment options in Bangladesh.

    Science.gov (United States)

    Jiang, Jia-Qian; Ashekuzzaman, S M; Jiang, Anlun; Sharifuzzaman, S M; Chowdhury, Sayedur Rahman

    2012-12-20

    Arsenic (As) causes health concerns due to its significant toxicity and worldwide presence in drinking water and groundwater. The major sources of As pollution may be natural process such as dissolution of As-containing minerals and anthropogenic activities such as percolation of water from mines, etc. The maximum contaminant level for total As in potable water has been established as 10 µg/L. Among the countries facing As contamination problems, Bangladesh is the most affected. Up to 77 million people in Bangladesh have been exposed to toxic levels of arsenic from drinking water. Therefore, it has become an urgent need to provide As-free drinking water in rural households throughout Bangladesh. This paper provides a comprehensive overview on the recent data on arsenic contamination status, its sources and reasons of mobilization and the exposure pathways in Bangladesh. Very little literature has focused on the removal of As from groundwaters in developing countries and thus this paper aims to review the As removal technologies and be a useful resource for researchers or policy makers to help identify and investigate useful treatment options. While a number of technological developments in arsenic removal have taken place, we must consider variations in sources and quality characteristics of As polluted water and differences in the socio-economic and literacy conditions of people, and then aim at improving effectiveness in arsenic removal, reducing the cost of the system, making the technology user friendly, overcoming maintenance problems and resolving sludge management issues.

  3. Arsenic Contaminated Groundwater and Its Treatment Options in Bangladesh

    Directory of Open Access Journals (Sweden)

    Sayedur Rahman Chowdhury

    2012-12-01

    Full Text Available Arsenic (As causes health concerns due to its significant toxicity and worldwide presence in drinking water and groundwater. The major sources of As pollution may be natural process such as dissolution of As-containing minerals and anthropogenic activities such as percolation of water from mines, etc. The maximum contaminant level for total As in potable water has been established as 10 µg/L. Among the countries facing As contamination problems, Bangladesh is the most affected. Up to 77 million people in Bangladesh have been exposed to toxic levels of arsenic from drinking water. Therefore, it has become an urgent need to provide As-free drinking water in rural households throughout Bangladesh. This paper provides a comprehensive overview on the recent data on arsenic contamination status, its sources and reasons of mobilization and the exposure pathways in Bangladesh. Very little literature has focused on the removal of As from groundwaters in developing countries and thus this paper aims to review the As removal technologies and be a useful resource for researchers or policy makers to help identify and investigate useful treatment options. While a number of technological developments in arsenic removal have taken place, we must consider variations in sources and quality characteristics of As polluted water and differences in the socio-economic and literacy conditions of people, and then aim at improving effectiveness in arsenic removal, reducing the cost of the system, making the technology user friendly, overcoming maintenance problems and resolving sludge management issues.

  4. Keratosis lichenoides chronica: Case-based review of treatment options.

    Science.gov (United States)

    Pistoni, Federica; Peroni, Anna; Colato, Chiara; Schena, Donatella; Girolomoni, Giampiero

    2016-08-01

    Keratosis lichenoides chronica (KLC) is a rare dermatological condition characterized by keratotic papules arranged in a parallel linear or reticular pattern and facial lesions resembling seborrheic dermatitis or rosacea. The clinical, histological and therapeutic information on 71 patients with KLC retrieved through a PubMed search plus one our new case were analyzed. KLC affects patients of all ages, with a modest male predominance. Pediatric cases represent about one quarter of patients. Diagnosis is usually delayed and histologically confirmed. All patients have thick, rough and scaly papules and plaques arranged in a linear or reticular pattern, on limbs (>80%) and trunk (about 60%). Face involvement is described in two-thirds of patients. Lesions are usually asymptomatic or mildly pruritic. Other manifestations, such as palmoplantar keratoderma, mucosal involvement, ocular manifestations, nail dystrophy, are reported in 20-30% of patients. Children present more frequently alopecia. No controlled trials are available. Results from small case series or single case reports show that the best treatment options are phototherapy and systemic retinoids, alone or in combination, with nearly half of patients reaching complete remission. Systemic corticosteroids as well as antibiotics and antimalarials are not effective.

  5. Arsenic Contaminated Groundwater and Its Treatment Options in Bangladesh

    Science.gov (United States)

    Jiang, Jia-Qian; Ashekuzzaman, S. M.; Jiang, Anlun; Sharifuzzaman, S. M.; Chowdhury, Sayedur Rahman

    2012-01-01

    Arsenic (As) causes health concerns due to its significant toxicity and worldwide presence in drinking water and groundwater. The major sources of As pollution may be natural process such as dissolution of As-containing minerals and anthropogenic activities such as percolation of water from mines, etc. The maximum contaminant level for total As in potable water has been established as 10 µg/L. Among the countries facing As contamination problems, Bangladesh is the most affected. Up to 77 million people in Bangladesh have been exposed to toxic levels of arsenic from drinking water. Therefore, it has become an urgent need to provide As-free drinking water in rural households throughout Bangladesh. This paper provides a comprehensive overview on the recent data on arsenic contamination status, its sources and reasons of mobilization and the exposure pathways in Bangladesh. Very little literature has focused on the removal of As from groundwaters in developing countries and thus this paper aims to review the As removal technologies and be a useful resource for researchers or policy makers to help identify and investigate useful treatment options. While a number of technological developments in arsenic removal have taken place, we must consider variations in sources and quality characteristics of As polluted water and differences in the socio-economic and literacy conditions of people, and then aim at improving effectiveness in arsenic removal, reducing the cost of the system, making the technology user friendly, overcoming maintenance problems and resolving sludge management issues. PMID:23343979

  6. [Established treatment options for male stress urinary incontinence].

    Science.gov (United States)

    Hampel, C; Gillitzer, R; Wiesner, C; Thüroff, J W

    2007-03-01

    Nowadays, male stress urinary incontinence is rare and almost always of iatrogenic origin (radiotherapy, pelvic surgery). However, the prognosis of urinary incontinence following surgery is good and can be improved by pelvic floor muscle exercises in combination with biofeedback systems. For the remaining patient cohort with persistent urinary incontinence, several established surgical treatment options are available. Suburothelial injections of bulking agents can easily be performed in an ambulatory setting. However, regardless of the material used, long-term results are disappointing. Moreover, the residual urethral function deteriorates due to cicatrization of the suburothelial plexus with consequent loss of urethral elasticity. The fascial sling procedure in males has to be performed in preoperated areas and is as technically demanding for the surgeon as it is burdening for the patient. Alloplastic material is not used, thus minimizing risks for arrosion or infection. Since the sling tension can neither be standardized nor postoperatively readjusted, the risk of overcorrection is considerable and the success of the procedure is heavily dependent on the surgeon's experience. Despite wear and high revision rates, the technically mature artificial sphincter produces excellent continence results and has become the gold standard in the therapy of male stress urinary incontinence. The circumferential and continuous urethral compression by the cuff is highly effective, but at the price of an almost inevitable urethral atrophy. To overcome this problem, various surgical techniques have been developed (tandem cuff, cuff downsizing, transcorporal cuff placement). However, the expensive artificial sphincter is not a nostrum for every incontinent man, since it requires certain minimal cognitive and manual capabilities. Therefore, the search for less demanding treatment alternatives seems to be necessary, even if one has to accept lower continence rates.

  7. Options for converting excess plutonium to feed for the MOX fuel fabrication facility

    Energy Technology Data Exchange (ETDEWEB)

    Watts, Joe A [Los Alamos National Laboratory; Smith, Paul H [Los Alamos National Laboratory; Psaras, John D [Los Alamos National Laboratory; Jarvinen, Gordon D [Los Alamos National Laboratory; Costa, David A [Los Alamos National Laboratory; Joyce, Jr., Edward L [Los Alamos National Laboratory

    2009-01-01

    The storage and safekeeping of excess plutonium in the United States represents a multibillion-dollar lifecycle cost to the taxpayers and poses challenges to National Security and Nuclear Non-Proliferation. Los Alamos National Laboratory is considering options for converting some portion of the 13 metric tons of excess plutonium that was previously destined for long-term waste disposition into feed for the MOX Fuel Fabrication Facility (MFFF). This approach could reduce storage costs and security ri sks, and produce fuel for nuclear energy at the same time. Over the course of 30 years of weapons related plutonium production, Los Alamos has developed a number of flow sheets aimed at separation and purification of plutonium. Flow sheets for converting metal to oxide and for removing chloride and fluoride from plutonium residues have been developed and withstood the test oftime. This presentation will address some potential options for utilizing processes and infrastructure developed by Defense Programs to transform a large variety of highly impure plutonium into feedstock for the MFFF.

  8. Progressive Supranuclear Palsy and Corticobasal Degeneration: Pathophysiology and Treatment Options.

    Science.gov (United States)

    Lamb, Ruth; Rohrer, Jonathan D; Lees, Andrew J; Morris, Huw R

    2016-09-01

    There are currently no disease-modifying treatments for progressive supranuclear palsy (PSP) or corticobasal degeneration (CBD), and no approved pharmacological or therapeutic treatments that are effective in controlling their symptoms. The use of most pharmacological treatment options are based on experience in other disorders or from non-randomized historical controls, case series, or expert opinion. Levodopa may provide some improvement in symptoms of Parkinsonism (specifically bradykinesia and rigidity) in PSP and CBD; however, evidence is conflicting and where present, benefits are often negligible and short lived. In fact, "poor" response to levodopa forms part of the NINDS-SPSP criteria for the diagnosis of PSP and consensus criteria for the diagnosis of CBD (Lang Mov Disord. 20 Suppl 1:S83-91, 2005; Litvan et al. Neurology. 48:119-25, 1997; Armstrong et al. Neurology. 80(5):496-503, 2013). There is some evidence that intrasalivery gland botulinum toxin is useful in managing problematic sialorrhea and that intramuscular botulinum toxin and baclofen are helpful in reducing dystonia, including blepharospasm. Benzodiazepines may also be useful in managing dystonia. Myoclonus may be managed using levetiracetam and benzodiazepines. Pharmacological agents licensed for Alzheimer's disease (such as acetylcholinesterase inhibitors and N-Methyl-D-aspartate receptor antagonists) have been used off-label in PSP, CBD, and other tauopathies with the aim of improving cognition; however, there is limited evidence that they are effective and risk of adverse effects may outweigh benefits. The use of atypical antipsychotics for behavioural symptoms is not recommended in the elderly or those with demetia associated conditions and most antipsychotics will worsen Parkinsonism. Antidepressants may be useful for behavioral symptoms and depression but are often poorly tolerated due to adverse effects. In the absence of an effective drug treatment to target the underlying cause of

  9. A comparative review of the options for treatment of erectile dysfunction: which treatment for which patient?

    Science.gov (United States)

    Hatzimouratidis, Konstantinos; Hatzichristou, Dimitrios G

    2005-01-01

    The field of erectile dysfunction (ED) has been revolutionised over the last two decades. Several treatment options are available today, most of which are associated with high efficacy rates and favourable safety profiles. A MEDLINE search was undertaken in order to evaluate all currently available data on treatment modalities for ED. Phosphodiesterase type 5 (PDE5) inhibitors (sildenafil, tadalafil, vardenafil) are currently the first-choice of most physicians and patients for the treatment of ED. PDE5 inhibitors have differences in their pharmacological profiles, the most obvious being the long duration of action of tadalafil, but there are no data supporting superiority for any one of them in terms of efficacy or safety. Sublingual apomorphine has limited efficacy compared with the PDE5 inhibitors, and its use is limited to patients with mild ED. Treatment failures with oral drugs may be due to medication, clinician and patient issues. The physician needs to address all of these issues in order to identify true treatment failures. Patients who are truly unresponsive to oral drugs may be offered other treatment options.Intracavernous injections of alprostadil alone, or in combination with other vasoactive agents (papaverine and phentolamine), remain an excellent treatment option, with proven efficacy and safety over time. Topical pharmacotherapy is appealing in nature, but currently available formulations have limited efficacy. Vacuum constriction devices may be offered mainly to elderly patients with occasional intercourse attempts, as younger patients show limited preference because of the unnatural erection that is associated with this treatment modality. Penile prostheses are generally the last treatment option offered, because of invasiveness, cost and non-reversibility; however, they are associated with high satisfaction rates in properly selected patients. All treatment options are associated with particular strengths and weaknesses. A patient

  10. Fusion option to dispose of spent nuclear fuel and transuranic elements

    International Nuclear Information System (INIS)

    Gohar, Y.

    2000-01-01

    The fusion option is examined to solve the disposition problems of the spent nuclear fuel and the transuranic elements. The analysis of this report shows that the top rated solution, the elimination of the transuranic elements and the long-lived fission products, can be achieved in a fusion reactor. A 167 MW of fusion power from a D-T plasma for sixty years with an availability factor of 0.75 can transmute all the transuranic elements and the long-lived fission products of the 70,000 tons of the US inventory of spent nuclear fuel generated up to the year 2015. The operating time can be reduced to thirty years with use of 334 MW of fusion power, a system study is needed to define the optimum time. In addition, the fusion solution eliminates the need for a geological repository site, which is a major advantage. Meanwhile, such utilization of the fusion power will provide an excellent opportunity to develop fusion energy for the future. Fusion blankets with a liquid carrier for the transuranic elements can achieve a transmutation rate for the transuranic elements up to 80 kg/MW.y of fusion power with k eff of 0.98. In addition, the liquid blankets have several advantages relative to the other blanket options. The energy from this transmutation is utilized to produce revenue for the system. Molten salt (Flibe) and lithium-lead eutectic are identified as the most promising liquids for this application, both materials are under development for future fusion blanket concepts. The Flibe molten salt with transuranic elements was developed and used successfully as nuclear fuel for the molten salt breeder reactor in the 1960's

  11. Excited delirium syndrome (ExDS): treatment options and considerations.

    Science.gov (United States)

    Vilke, Gary M; Bozeman, William P; Dawes, Donald M; Demers, Gerard; Wilson, Michael P

    2012-04-01

    and initiate appropriate stabilizing treatment. ExDS patients will generally require transfer to an emergency department (ED) for further management, evaluation, and definitive care. In this paper, we present a typical ExDS case and then review existing literature for current treatment options. Copyright © 2011 Elsevier Ltd and Faculty of Forensic and Legal Medicine. All rights reserved.

  12. Treatment options and outcomes for glioblastoma in the elderly patient

    Directory of Open Access Journals (Sweden)

    Arvold ND

    2014-02-01

    options include best supportive care, TMZ alone, hypofractionated RT alone, or whole brain RT for symptomatic patients needing to start treatment urgently. Given the balance between short survival and quality of life in this patient population, optimal management of elderly GBM patients must be made individually according to patient age, MGMT methylation status, performance score, and patient preferences. Keywords: glioblastoma, elderly, radiotherapy, hypofractionated, temozolomide, MGMT

  13. Radioactive waste management and spent nuclear fuel storing. Options and priorities

    International Nuclear Information System (INIS)

    Popescu, Ion

    2001-01-01

    As a member of the states' club using nuclear energy for peaceful applications, Romania approaches all the activities implied by natural uranium nuclear fuel cycle, beginning with uranium mining and ending with electric energy generation. Since, in all steps of the nuclear fuel cycle radioactive wastes are resulting, in order to protect the environment and the life, the correct and competent radioactive waste management is compulsory. Such a management implies: a. Separating the radioisotopes in all the effluences released into environment; b. Treating separately the radioisotopes to be each properly stored; c. Conditioning waste within resistant matrices ensuring long term isolation of the radioactive waste destined to final disposal; d. Building radioactive waste repositories with characteristics of isolation guaranteed for long periods of time. To comply with the provisions of the International Convention concerning the safety of the spent nuclear fuel and radioactive waste management, signed on 5 September 1997, Romania launched its program 'Management of Radioactive Wastes and Dry Storing of Spent Nuclear Fuel' having the following objectives: 1. Establishing the technology package for treating and conditioning the low and medium active waste from Cernavoda NPP to prepare them for final disposal; 2. Geophysical and geochemical investigations of the site chosen for the low and medium active final disposal (DFDSMA); 3. Evaluating the impact on environment and population of the DFDSMA; 4. Providing data necessary in the dry intermediate storing of spent nuclear fuel and the continuous and automated surveillance; 5. Establishing multiple barriers for spent nuclear fuel final disposal in order to establish the repository in granitic rocks and salt massives; 6. Designing and testing containers for final disposal of spent nuclear fuel guaranteeing the isolation over at least 500 years; 7. Computational programs for evaluation of radionuclide leakage in environment in

  14. Back-end of the nuclear fuel cycle. A comparison of the direct disposal and reprocessing options

    International Nuclear Information System (INIS)

    Allan, C.J.; Baumgartner, P.

    1997-01-01

    Based on the need to address public concerns, the need to ensure long-term safety and an ethical concern for future generations, many countries are developing technology to dispose of nuclear fuel waste. The waste substances in used fuel can be disposed of either by directly disposing of the used fuel assemblies themselves, or by disposing of the long-lived waste from fuel reprocessing. The basic thesis of this paper is that the direct disposal of either used fuel or of the long-lived heat-generating and non-heat generating waste that arise from reprocessing is technically and economically feasible and that both options will meet the fundamental objectives of protecting human health and the environment. Decisions about whether, or when, to reprocess used fuel, or about whether to dispose of used fuel directly, are not fundamentally waste management issues. (author)

  15. Closed Fuel Cycle Waste Treatment Strategy

    Energy Technology Data Exchange (ETDEWEB)

    Vienna, J. D. [Pacific Northwest National Lab. (PNNL), Richland, WA (United States); Collins, E. D. [Oak Ridge National Lab. (ORNL), Oak Ridge, TN (United States); Crum, J. V. [Pacific Northwest National Lab. (PNNL), Richland, WA (United States); Ebert, W. L. [Argonne National Lab. (ANL), Argonne, IL (United States); Frank, S. M. [Idaho National Lab. (INL), Idaho Falls, ID (United States); Garn, T. G. [Idaho National Lab. (INL), Idaho Falls, ID (United States); Gombert, D. [Pacific Northwest National Lab. (PNNL), Richland, WA (United States); Jones, R. [Savannah River Site (SRS), Aiken, SC (United States). Savannah River National Lab. (SRNL); Jubin, R. T. [Oak Ridge National Lab. (ORNL), Oak Ridge, TN (United States); Maio, V. C. [Idaho National Lab. (INL), Idaho Falls, ID (United States); Marra, J. C. [Savannah River Site (SRS), Aiken, SC (United States). Savannah River National Lab. (SRNL); Matyas, J. [Pacific Northwest National Lab. (PNNL), Richland, WA (United States); Nenoff, T. M. [Sandia National Lab. (SNL-NM), Albuquerque, NM (United States); Riley, B. J. [Pacific Northwest National Lab. (PNNL), Richland, WA (United States); Sevigny, G. J. [Pacific Northwest National Lab. (PNNL), Richland, WA (United States); Soelberg, N. R. [Idaho National Lab. (INL), Idaho Falls, ID (United States); Strachan, D. M. [Pacific Northwest National Lab. (PNNL), Richland, WA (United States); Thallapally, P. K. [Pacific Northwest National Lab. (PNNL), Richland, WA (United States); Westsik, J. H. [Pacific Northwest National Lab. (PNNL), Richland, WA (United States)

    2015-02-01

    This study is aimed at evaluating the existing waste management approaches for nuclear fuel cycle facilities in comparison to the objectives of implementing an advanced fuel cycle in the U.S. under current legal, regulatory, and logistical constructs. The study begins with the Global Nuclear Energy Partnership (GNEP) Integrated Waste Management Strategy (IWMS) (Gombert et al. 2008) as a general strategy and associated Waste Treatment Baseline Study (WTBS) (Gombert et al. 2007). The tenets of the IWMS are equally valid to the current waste management study. However, the flowsheet details have changed significantly from those considered under GNEP. In addition, significant additional waste management technology development has occurred since the GNEP waste management studies were performed. This study updates the information found in the WTBS, summarizes the results of more recent technology development efforts, and describes waste management approaches as they apply to a representative full recycle reprocessing flowsheet. Many of the waste management technologies discussed also apply to other potential flowsheets that involve reprocessing. These applications are occasionally discussed where the data are more readily available. The report summarizes the waste arising from aqueous reprocessing of a typical light-water reactor (LWR) fuel to separate actinides for use in fabricating metal sodium fast reactor (SFR) fuel and from electrochemical reprocessing of the metal SFR fuel to separate actinides for recycle back into the SFR in the form of metal fuel. The primary streams considered and the recommended waste forms include; Tritium in low-water cement in high integrity containers (HICs); Iodine-129: As a reference case, a glass composite material (GCM) formed by the encapsulation of the silver Mordenite (AgZ) getter material in a low-temperature glass is assumed. A number of alternatives with distinct advantages are also considered including a fused silica waste form

  16. Proceedings of the GLOBAL 2009 congress - The Nuclear Fuel Cycle: Sustainable Options and Industrial Perspectives

    International Nuclear Information System (INIS)

    2009-06-01

    TOP FUEL / Water Reactor Fuel Performance which shares some common technical sessions. The exhibition is the same for the two meetings. Intended participants and audiences include personnel working on all aspects of the NFC, such as scientific and technical topics, design challenges, industrial implementation, societal and institutional issues (including regulatory framework), and policy questions. The technical Program includes the following topical areas: 1 - Front End of the Fuel Cycle; 2 - Current Spent Nuclear Fuel Recycling; 3 - Waste Management Technologies And Strategies; 4 - Concepts for Transportation and Interim Storage of Spent Fuels and Conditioned Waste or Other Radioactive Materials; 5 - Nuclear Waste Repository Developments; 6 - Advanced Technologies for Fuel Recycling Including Partitioning of Specific Radionuclides; 7 - Advances in Reactor Cores Design and In-core Fuel Management; 8 - Transmutation Systems for Long Lived Radio Nuclides; 9 - Developments in Nuclear Non-Proliferation Technology, Policy and Implementation; 10 - Sustainable Fuel Cycle Options and Nuclear Material Management; 11 - Dismantling, Decommissioning and Material Management; 12 - Crosscutting Issues, Policies and Programs; 13 - Plenary Sessions

  17. Proceedings of the GLOBAL 2009 congress - The Nuclear Fuel Cycle: Sustainable Options and Industrial Perspectives

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    2009-06-15

    TOP FUEL / Water Reactor Fuel Performance which shares some common technical sessions. The exhibition is the same for the two meetings. Intended participants and audiences include personnel working on all aspects of the NFC, such as scientific and technical topics, design challenges, industrial implementation, societal and institutional issues (including regulatory framework), and policy questions. The technical Program includes the following topical areas: 1 - Front End of the Fuel Cycle; 2 - Current Spent Nuclear Fuel Recycling; 3 - Waste Management Technologies And Strategies; 4 - Concepts for Transportation and Interim Storage of Spent Fuels and Conditioned Waste or Other Radioactive Materials; 5 - Nuclear Waste Repository Developments; 6 - Advanced Technologies for Fuel Recycling Including Partitioning of Specific Radionuclides; 7 - Advances in Reactor Cores Design and In-core Fuel Management; 8 - Transmutation Systems for Long Lived Radio Nuclides; 9 - Developments in Nuclear Non-Proliferation Technology, Policy and Implementation; 10 - Sustainable Fuel Cycle Options and Nuclear Material Management; 11 - Dismantling, Decommissioning and Material Management; 12 - Crosscutting Issues, Policies and Programs; 13 - Plenary Sessions.

  18. Deployment evaluation methodology for the electrometallurgical treatment of DOE-EM spent nuclear fuel

    International Nuclear Information System (INIS)

    Dahl, C.A.; Adams, J.P.; Ramer, R.J.

    1998-07-01

    Part of the Department of Energy (DOE) spent nuclear fuel (SNF) inventory may require some type of treatment to meet acceptance criteria at various disposition sites. The current focus for much of this spent nuclear fuel is the electrometallurgical treatment process under development at Argonne National Laboratory. Potential flowsheets for this treatment process are presented. Deployment of the process for the treatment of the spent nuclear fuel requires evaluation to determine the spent nuclear fuel program need for treatment and compatibility of the spent nuclear fuel with the process. The evaluation of need includes considerations of cost, technical feasibility, process material disposition, and schedule to treat a proposed fuel. A siting evaluation methodology has been developed to account for these variables. A work breakdown structure is proposed to gather life-cycle cost information to allow evaluation of alternative siting strategies on a similar basis. The evaluation methodology, while created specifically for the electrometallurgical evaluation, has been written such that it could be applied to any potential treatment process that is a disposition option for spent nuclear fuel. Future work to complete the evaluation of the process for electrometallurgical treatment is discussed

  19. Nonalcoholic steatohepatitis: emerging targeted therapies to optimize treatment options

    Directory of Open Access Journals (Sweden)

    Milic S

    2015-08-01

    Full Text Available Sandra Milic,1 Ivana Mikolasevic,1,2 Irena Krznaric-Zrnic,1 Marija Stanic,3 Goran Poropat,1 Davor Stimac,1 Vera Vlahovic-Palcevski,4 Lidija Orlic2 1Department of Gastroenterology, UHC Rijeka, Rijeka, Croatia; 2Department of Nephrology, Dialysis and Kidney Transplantation, UHC Rijeka, Rijeka, Croatia; 3Department of Hematology, UHC Rijeka, Rijeka, Croatia; 4Department for Clinical Pharmacology, University of Rijeka Medical School, UHC Rijeka, Rijeka, Croatia Abstract: Diet and lifestyle changes have led to worldwide increases in the prevalences of obesity and metabolic syndrome, resulting in substantially greater incidence of nonalcoholic fatty liver disease (NAFLD. NAFLD is considered a hepatic manifestation of metabolic syndrome and is related to diabetes, insulin resistance, central obesity, hyperlipidemia, and hypertension. Nonalcoholic steatohepatitis (NASH is an entity that describes liver inflammation due to NAFLD. Growing evidence suggests that NAFLD is a multisystem disease with a clinical burden that is not only confined to liver-related morbidity and mortality, but that also affects several extra-hepatic organs and regulatory pathways. Thus, NAFLD is considered an important public health issue, but there is currently no effective therapy for all NAFLD patients in the general population. Studies seeking optimal therapy for NAFLD and NASH have not yet led to development of a universal protocol for treating this growing problem. Several pharmacological agents have been studied in an effort to improve insulin resistance and the proinflammatory mediators that may be responsible for NASH progression. Cardiovascular risk factors are highly prevalent among NASH patients, and the backbone of treatment regimens for these patients still comprises general lifestyle interventions, including dietary changes and increased physical activity. Vitamin E and thiazolidinedione derivatives are currently the most evidence-based therapeutic options, but only

  20. The option value of innovative treatments in the context of chronic myeloid leukemia.

    Science.gov (United States)

    Sanchez, Yuri; Penrod, John R; Qiu, Xiaoli Lily; Romley, John; Thornton Snider, Julia; Philipson, Tomas

    2012-11-01

    To quantify in the context of chronic myeloid leukemia (CML) the additional value patients receive when innovative treatments enable them to survive until the advent of even more effective future treatments (ie, the "option value"). Observational study using data from the Surveillance, Epidemiology and End Results (SEER) cancer registry comprising all US patients with CML diagnosed between 2000 and 2008 (N = 9,760). We quantified the option value of recent breakthroughs in CML treatment by first conducting retrospective survival analyses on SEER data to assess the effectiveness of TKI treatments, and then forecasting survival from CML and other causes to measure expected future medical progress. We then developed an analytical framework to calculate option value of innovative CML therapies, and used an economic model to value these gains. We calculated the option value created both by future innovations in CML treatment and by medical progress in reducing background mortality. For a recently diagnosed CML patient, the option value of innovative therapies from future medical innovation amounts to 0.76 life-years. This option value is worth $63,000, equivalent to 9% of the average survival gains from existing treatments. Future innovations in CML treatment jointly account for 96% of this benefit. The option value of innovative treatments has significance in the context of CML and, more broadly, in disease areas with rapid innovation. Incorporating option value into traditional valuations of medical innovations is both a feasible and a necessary practice in health technology assessment.

  1. The Effects of Accounting Treatment and Financial Crisis on the Stock Option Plans of Italian Companies

    Directory of Open Access Journals (Sweden)

    Francesco Avallone

    2014-03-01

    Full Text Available Many studies state that favourable accounting treatment has been one of the main reasons behind employee stock options. In addition, stock options have recently been the target of growing criticism with a possible influence on incentive effectiveness and outrage costs. In such a perspective, the main purpose of the paper is to explore the impact of IFRS 2 and of the recent financial crisis on stock option compensation. Empirical evidence suggests that: (i IFRS 2 did not have a significant effect on stock option granting, (ii the issue of stock options is less likely to occur during the financial crisis.

  2. Treatment options for active removal of renal stones

    NARCIS (Netherlands)

    Warmerdam, G.J.J.; Laet, De K.; Wijn, R.P.W.F.; Wijn, P.F.F.

    2012-01-01

    This study provides an update on the technological aspects of the methods for active removal of renal stones. Currently, extracorporeal shock wave lithotripsy (ESWL), ureteroscopy (URS) and percutaneous nephrolithotomy (PCNL) are the available options. Findings are based upon recent literature from

  3. Advanced Reactor Technology Options for Utilization and Transmutation of Actinides in Spent Nuclear Fuel

    International Nuclear Information System (INIS)

    2009-09-01

    Renewed interest in the potential of nuclear energy to contribute to a sustainable worldwide energy mix is strengthening the IAEA's statutory role in fostering the peaceful uses of nuclear energy, in particular the need for effective exchanges of information and collaborative research and technology development among Member States on advanced nuclear power technologies (Articles III-A.1 and III-A.3). The major challenges facing the long term development of nuclear energy as a part of the world's energy mix are improvement of the economic competitiveness, meeting increasingly stringent safety requirements, adhering to the criteria of sustainable development, and public acceptability. The concern linked to the long life of many of the radioisotopes generated from fission has led to increased R and D efforts to develop a technology aimed at reducing the amount of long lived radioactive waste through transmutation in fission reactors or accelerator driven hybrids. In recent years, in various countries and at an international level, more and more studies have been carried out on advanced and innovative waste management strategies (i.e. actinide separation and elimination). Within the framework of the Project on Technology Advances in Fast Reactors and Accelerator Driven Systems (http://www.iaea.org/inisnkm/nkm/aws/fnss/index.html), the IAEA initiated a number of activities on utilization of plutonium and transmutation of long lived radioactive waste, accelerator driven systems, thorium fuel options, innovative nuclear reactors and fuel cycles, non-conventional nuclear energy systems, and fusion/fission hybrids. These activities are implemented under the guidance and with the support of the IAEA Nuclear Energy Department's Technical Working Group on Fast Reactors (TWG-FR). This publication compiles the analyses and findings of the Coordinated Research Project (CRP) on Studies of Advanced Reactor Technology Options for Effective Incineration of Radioactive Waste (2002

  4. An approach for assessing development and deployment risks in the DOE fuel cycle options evaluation and screening study - 5267

    International Nuclear Information System (INIS)

    Gehin, J.C.; Worrall, A.; Oakley, B.; Jenni, K.; Taiwo, T.; Wigeland, R.

    2015-01-01

    One of the key objectives of the U.S. Department of Energy (DOE) Nuclear Energy Research/development road-map is the development of sustainable nuclear fuel cycles that can improve natural resource utilization and provide solutions to the management of nuclear wastes. Recently, an evaluation and screening (ES) of fuel cycle systems has been conducted to identify those options that provide the best opportunities for obtaining such improvements and also to identify the required research and development activities that can support the development of advanced fuel cycle options. In order to evaluate and screen fuel cycle systems in the ES study, nine criteria were used including Development and Deployment Risk (DDR). More specifically, this criterion was represented by the following metrics: Development time, development cost, deployment cost from prototypic validation to first-of-a-kind commercial, compatibility with the existing nuclear fuel cycle infrastructure, existence of regulations for the fuel cycle and familiarity with licensing, and existence of market incentives and/or barriers to commercial implementation of fuel cycle processes. Given the comprehensive nature of the study, a systematic approach was needed to determine metric data for the DDR criterion. As would be expected, the Evaluation Group representing the once-through use of uranium in thermal reactors is always the highest ranked fuel cycle Evaluation Group for this DDR criterion. Evaluation Groups that consist of once-through fuel cycles that use existing reactor types are consistently ranked very high. The highest ranked limited and continuous recycle fuel cycle Evaluation Groups are those that recycle Pu in thermal reactors. The lowest ranked fuel cycles are predominately continuous recycle single stage and multi-stage fuel cycles that involve TRU and/or U 233 recycle. (authors)

  5. Fuel accumulation and forest structure change following hazardous fuel reduction treatments throughout California

    Science.gov (United States)

    Nicole M. Vaillant; Erin K. Noonan-Wright; Alicia L. Reiner; Carol M. Ewell; Benjamin M. Rau; Josephine A. Fites-Kaufman; Scott N. Dailey

    2015-01-01

    Altered fuel conditions coupled with changing climate have disrupted fire regimes of forests historically characterised by high-frequency and low-to-moderate-severity fire. Managers use fuel treatments to abate undesirable fire behaviour and effects. Short-term effectiveness of fuel treatments to alter fire behaviour and effects is well documented; however, long-term...

  6. Fuels planning: science synthesis and integration; economic uses fact sheet 03: economic impacts of fuel treatments

    Science.gov (United States)

    Rocky Mountain Research Station USDA Forest Service

    2004-01-01

    With increased interest in reducing hazardous fuels in dry inland forests of the American West, agencies and the public will want to know the economic impacts of fuel reduction treatments. This fact sheet discusses the economic impact tool, a component of My Fuel Treatment Planner, for evaluating economic impacts.

  7. Deployment Evaluation Methodology for the Electrometallurgical Treatment of DOE-EM Spent Nuclear Fuel

    International Nuclear Information System (INIS)

    Dahl, C.A.; Adams, J.P.; Rynearson, M.A.; Ramer, R.J.

    1999-01-01

    The Department of Energy - Environmental Management (DOE-EM) National Spent Nuclear Fuel Program (NSNFP) is charged with the disposition of legacy spent nuclear fuel (SNF). While direct repository disposal of the SNF is the preferred disposition option, some DOE SNF may need treatment to meet acceptance criteria at various disposition sites. The treatments may range from electrometallurgical treatment (EMT) and chemical dissolution to engineering controls. As a planning basis, a need is assumed for a treatment process, either as a primary or backup technology, that is compatible with, and cost-effective for, this portion of the DOE-EM inventory. The current planning option for treating this SNF, pending completion of development work and National Environmental Policy Act (NEPA) analysis, is the EMT process under development by Argonne National Laboratory - West (ANL-W). A decision on the deployment of the EMT is pending completion of an engineering scale demonstration currently in progress at ANL-W. For this study, a set of questions was developed for the EMT process for fuels at several locations. The set of questions addresses all issues associated with design, construction, and operation of a production facility. A matrix table was developed to determine questions applicable to various fuel treatment options. A work breakdown structure (WBS) was developed to identify a treatment process and costs from initial design to shipment of treatment products to final disposition. Costs were applied to determine the life-cycle cost of each option. This technique can also be applied to other treatment techniques for treating SNF

  8. Hyaluronic acid and other conservative treatment options for osteoarthritis of the ankle

    NARCIS (Netherlands)

    Witteveen, Angelique G. H.; Hofstad, Cheriel J.; Kerkhoffs, Gino M. M. J.

    2015-01-01

    Background The cause of ankle osteoarthritis (OA) is usually trauma. Patients are relatively young, since ankle trauma occurs at a relatively young age. Several conservative treatment options are available, evidence of the benefits and harms of these options are lacking. Objectives To assess the

  9. Approved and Off-Label Uses of Obesity Medications, and Potential New Pharmacologic Treatment Options

    Directory of Open Access Journals (Sweden)

    Fernando Cordido

    2010-01-01

    Full Text Available Available anti-obesity pharmacotherapy options remain very limited and development of more effective drugs has become a priority. The potential strategies to achieve weight loss are to reduce energy intake by stimulating anorexigenic signals or by blocking orexigenic signals, and to increase energy expenditure. This review will focus on approved obesity medications, as well as potential new pharmacologic treatment options.

  10. The methods and options of the treatment for hyperthyroidism

    International Nuclear Information System (INIS)

    Tang Jianlin; Li Yuying; Gao Liuyan; Tang Xiuping; Hu Hongyong

    2009-01-01

    Hyperthyroidism is a frequently-occurring endocrine disease. Aantithyroid drugs, surgery and radioactive iodine therapy are currently accepted and effective methods of treatment for hyperthyroidism. Years of clinical practices and a lot o[ researches on each of the three treatment methods to further deepen the understanding of the characteristics, the choice of treatment for hyperthyroidism tend to have a new change. After comparing and evaluating the three treatments for hyperthyroidism, most scholars believe that radioactive iodine therapy to treat hyperthyroidism will maintain its unique position before the physiological treatment for hyperthyroidism is uncertainly discoveried in the future. (authors)

  11. Mobile Melt-Dilute Treatment for Russian Spent Nuclear Fuel

    International Nuclear Information System (INIS)

    Peacock, H.

    2002-01-01

    Treatment of spent Russian fuel using a Melt-Dilute (MD) process is proposed to consolidate fuel assemblies into a form that is proliferation resistant and provides critically safety under storage and disposal configurations. Russian fuel elements contain a variety of fuel meat and cladding materials. The Melt-Dilute treatment process was initially developed for aluminum-based fuels so additional development is needed for several cladding and fuel meat combinations in the Russian fuel inventory (e.g. zirconium-clad, uranium-zirconium alloy fuel). A Mobile Melt-Dilute facility (MMD) is being proposed for treatment of spent fuels at reactor site storage locations in Russia; thereby, avoiding the costs of building separate treatment facilities at each site and avoiding shipment of enriched fuel assemblies over the road. The MMD facility concept is based on laboratory tests conducted at the Savannah River Technology Center (SRTC), and modular pilot-scale facilities constructed at the Savannah River Site for treatment of US spent fuel. SRTC laboratory tests have shown the feasibility of operating a Melt-Dilute treatment process with either a closed system or a filtered off-gas system. The proposed Mobile Melt-Dilute process is presented in this paper

  12. Deployment Evaluation Methodology for the Electrometallurgical Treatment of DOE-EM Spent Nuclear Fuel

    International Nuclear Information System (INIS)

    Ramer, Ronald James; Adams, James Paul; Rynearson, Michael Ardel; Dahl, Christian Adam

    1999-01-01

    The Department of Energy - Environmental Management (DOE-EM) National Spent Nuclear Fuel Program (NSNFP) is charged with the disposition of legacy Spent Nuclear Fuel (SNF). The NSNFP, conducted by Lockheed Martin Idaho Technology Co. (LMITCO) at the Idaho National Engineering and Environmental Laboratory (INEEL), is evaluating final disposition of SNF in the DOE complex. While direct repository disposal of the SNF is the preferred disposition option, some DOE SNF may need treatment to meet acceptance criteria at various disposition sites. Evaluations of treatment needs and options have been previously prepared, and further evaluations are ongoing activities in the DOE-EM NSNFP. The treatments may range from electrometallurgical treatment (EMT) and chemical dissolution to engineering controls. As a planning basis, a need is assumed for a treatment process, either as a primary or backup technology, that is compatible with, and cost-effective for, this portion of the DOE-EM inventory. The current planning option for treating this SNF, pending completion of development work and National Environmental Policy Act (NEPA) analysis, is the EMT process under development by Argonne National Laboratory - West (ANL-W). A decision on the deployment of the EMT is pending completion of an engineering scale demonstration currently in progress at ANL-W. Treatment options and treatment locations will depend on fuel type and location of the fuel. One of the first steps associated with selecting one or more sites for treating SNF in the DOE complex is to determine the cost of each option. An economic analysis will assist in determining which fuel treatment alternative attains the optimum disposition of SNF at the lowest possible cost to the government and the public. One of the major issues associated with SNF treatment is final disposition of treatment products and associated waste streams. During conventional SNF treatment, various chemicals are added that may increase the product

  13. Molten salt burner fuel behaviour and treatment

    International Nuclear Information System (INIS)

    Ignatiev, V.V.; Zakirov, R.Y.; Grebenkine, K.F.

    2001-01-01

    The objective of this paper is to discuss the feasibility of molten salt reactor technology for treatment of Pu, minor actinides and fission products, when the reactor and fission product clean-up unit are planned as an integral system. This contribution summarises the available R and D which led to selection of the fuel compositions for the molten salt reactor of the TRU burner type (MSB). Special characteristics of behaviour of TRUs and fission products during power operation of MSB concepts are presented. The present paper briefly reviews the processing developments underlying the prior molten salt reactor programmes and relates them to the separation requirements of the MSB concept, including the permissible range of processing cycle times and removal times. Status and development needs in the thermodynamic properties of fluorides, fission product clean-up methods and container materials compatibility with the working fluids for the fission product clean-up unit are discussed. (authors)

  14. Engineered Option Treatment of Remediated Nitrate Salts: Surrogate Batch-Blending Testing

    Energy Technology Data Exchange (ETDEWEB)

    Anast, Kurt Roy [Los Alamos National Lab. (LANL), Los Alamos, NM (United States)

    2016-03-11

    This report provides results from batch-blending test work for remediated nitrate salt (RNS) treatment. Batch blending was identified as a preferred option for blending RNS and unremediated nitrate salt (UNS) material with zeolite to effectively safe the salt/Swheat material identified as ignitable (U.S. Environmental Protection Agency code D001). Blending with zeolite was the preferred remediation option identified in the Options Assessment Report and was originally proposed as the best option for remediation by Clark and Funk in their report, Chemical Reactivity and Recommended Remediation Strategy for Los Alamos Remediated Nitrate Salt (RNS) Wastes, and also found to be a preferred option in the Engineering Options Assessment Report: Nitrate Salt Waste Stream Processing. This test work evaluated equipment and recipe alternatives to achieve effective blending of surrogate waste with zeolite.

  15. Down patients with Eisenmenger syndrome: Is bosentan treatment an option?

    NARCIS (Netherlands)

    Duffels, Mariëlle G. J.; Vis, Jeroen C.; van Loon, Rosa L. E.; Berger, Rolf M. F.; Hoendermis, Elke S.; van Dijk, Arie P. J.; Bouma, Berto J.; Mulder, Barbara J. M.

    2009-01-01

    Background: Favorable results of treatment with bosentan in patients with Eisenmenger syndrome are available. However, data in Down patients are lacking. In this study, we evaluate the therapeutic role of bosentan treatment in Down patients with Eisenmenger syndrome. Methods: In this open-label

  16. Down patients with Eisenmenger syndrome : Is bosentan treatment an option?

    NARCIS (Netherlands)

    Duffels, Marielle G. J.; Vis, Jeroen C.; van Loon, Rosa L. E.; Berger, Rolf M. F.; Hoendermis, Elke S.; van Dijk, Arie P. J.; Bouma, Berto J.; Mulder, Barbara J. M.

    2009-01-01

    Background: Favorable results of treatment with bosentan in patients with Eisenmenger syndrome are available. However, data in Down patients are lacking. In this study, we evaluate the therapeutic role of bosentan treatment in Down patients with Eisenmenger syndrome. Methods: In this open-label

  17. Down patients with Eisenmenger syndrome: Is bosentan treatment an option?

    NARCIS (Netherlands)

    Duffels, M.G.; Vis, J.C.; Loon, R.L. van; Berger, R.M.; Hoendermis, E.S.; Dijk, A.P.J. van; Bouma, B.J.; Mulder, B.J.

    2009-01-01

    BACKGROUND: Favorable results of treatment with bosentan in patients with Eisenmenger syndrome are available. However, data in Down patients are lacking. In this study, we evaluate the therapeutic role of bosentan treatment in Down patients with Eisenmenger syndrome. METHODS: In this open-label

  18. Economic assessment of preeclampsia : Screening, diagnosis, treatment options, and long term outcomes, a systematic review

    NARCIS (Netherlands)

    Zakiyah, N.; Van Asselt, A.; Baker, P.; Postma, M.J.

    2014-01-01

    Objectives: To provide a comprehensive overview of the existing evidence on the health economics of screening, diagnosis, and treatment options in preeclampsia. Methods: A systematic literature search was undertaken using three electronic databases (MEDLINE, Embase, Cochrane) to identify all English

  19. Economic assessment of preeclampsia : Screening, diagnosis, treatment options, and long term outcomes - A systematic review

    NARCIS (Netherlands)

    Zakiyah, Neily; Van Asselt, Antoinette D.; Baker, Philip N.; Postma, Maarten J.

    OBJECTIVES: Provide a comprehensive overview of the existing evidence on the health economics of screening, diagnosis, and treatment options in preeclampsia. METHODS: A systematic literature search was undertaken using three electronic databases (MEDLINE, Embase, Cochrane) to identify all English

  20. Options for Management of Spent Fuel and Radioactive Waste for Countries Developing New Nuclear Power Programmes

    International Nuclear Information System (INIS)

    2013-01-01

    start a nuclear power programme. The IAEA has published guidance on particular elements of radioactive waste and spent fuel management, such as establishing nuclear technical and regulatory infrastructure, relevant financing schemes, national policy and strategies, multinational approaches and other aspects linked to building nuclear power plants. The present publication is intended to provide a concise summary of key issues related to the development of a sound radioactive waste and spent nuclear fuel management system. It is designed to brief countries with small or newly established nuclear power programmes about the challenges of, and to describe current and potential alternatives for, managing spent fuel and radioactive waste arising during operation and decommissioning of nuclear power plants. The publication deals primarily with current technical options, but also considers possible future developments and discusses relevant legal, political, technical and safety issues. It identifies the role of, and potential actions to be adopted by, the international community, including the IAEA, in order to support the responsible introduction of nuclear power in interested countries

  1. ArcFuels: an ArcMap toolbar for fuel treatment planning and wildfire risk assessment

    Science.gov (United States)

    Nicole M. Vaillant; Alan A. Ager

    2014-01-01

    Fire behavior modeling and geospatial analysis can provide tremendous insight to land managers in defining both the benefits and potential impacts of fuel treatments in the context of land management goals and public expectations. ArcFuels is a streamlined fuel management planning and wildfire risk assessment system that creates a trans-scale (stand to large landscape...

  2. Mechanical mastication as a fuels treatment in southeastern forests

    Science.gov (United States)

    Jesse K. Kreye; J. Morgan Varner; Leda N. Kobziar

    2016-01-01

    Mastication is an increasingly common fuels treatment that redistributes ‘‘ladder’’ fuels to the forest floor to reduce vertical fuel continuity, crown fire potential, and fireline intensity. Despite its widespread adoption, it remains unclear how mastication impacts fuels, fire behavior, or plant communities  across Southeastern forest ecosystems. We evaluated these...

  3. Treatment for Problem Drinking: What Are the Options?

    Science.gov (United States)

    ... limited disruption to their home and professional lives. Addiction experts have refined behavioral treatments that deal with ... involved in mitochondrial repair and muscle regeneration. Smartphone Technology Helps People Cut Down on Drinking People using ...

  4. Treatment Options for Plasma Cell Neoplasms (Including Multiple Myeloma)

    Science.gov (United States)

    ... cancer treatment is also called biotherapy or immunotherapy. Immunomodulators are a type of biologic therapy. Thalidomide , lenalidomide , and pomalidomide are immunomodulators used to treat multiple myeloma and other plasma ...

  5. Delayed conifer mortality after fuel reduction treatments: Interactive effects of fuel, fire intensity, and bark beetles

    Science.gov (United States)

    Youngblood, A.; Grace, J.B.; Mciver, J.D.

    2009-01-01

    Many low-elevation dry forests of the western United States contain more small trees and fewer large trees, more down woody debris, and less diverse and vigorous understory plant communities compared to conditions under historical fire regimes. These altered structural conditions may contribute to increased probability of unnaturally severe wildfires, susceptibility to uncharacteristic insect outbreaks, and drought-related mortality. Broad-scale fuel reduction and restoration treatments are proposed to promote stand development on trajectories toward more sustainable structures. Little research to date, however, has quantified the effects of these treatments on the ecosystem, especially delayed and latent tree mortality resulting directly or indirectly from treatments. In this paper, we explore complex hypotheses relating to the cascade of effects that influence ponderosa pine (Pinus ponderosa) and Douglas-fir (Pseudotsuga menziesii) mortality using structural equation modeling (SEM). We used annual census and plot data through six growing seasons after thinning and four growing seasons after burning from a replicated, operational-scale, completely randomized experiment conducted in northeastern Oregon, USA, as part of the national Fire and Fire Surrogate study. Treatments included thin, burn, thin followed by burn (thin+burn), and control. Burn and thin+burn treatments increased the proportion of dead trees while the proportion of dead trees declined or remained constant in thin and control units, although the density of dead trees was essentially unchanged with treatment. Most of the new mortality (96%) occurred within two years of treatment and was attributed to bark beetles. Bark beetle-caused tree mortality, while low overall, was greatest in thin + burn treatments. SEM results indicate that the probability of mortality of large-diameter ponderosa pine from bark beetles and wood borers was directly related to surface fire severity and bole charring, which in

  6. Psychosocial Treatment Options for Major Depressive Disorder in Older Adults.

    Science.gov (United States)

    Renn, Brenna N; Areán, Patricia A

    2017-03-01

    Late-life depression (LLD) is a public health concern with deleterious effects on overall health, cognition, quality of life, and mortality. Although LLD is relatively common, it is not a normal part of aging and is often under-recognized in older adults. However, psychotherapy is an effective treatment for LLD that aligns with many patients' preferences and can improve health and functioning. This review synthesized the current literature on evidence-based psychotherapies for the treatment of depression in older adults. Findings suggest that active, skills-based psychotherapies (cognitive behavioral therapy [CBT] and problem-solving therapy [PST]) may be more effective for LLD than non-directive, supportive counseling. PST may be particularly relevant for offsetting skill deficit associated with LLD, such as in instances of cognitive impairment (especially executive dysfunction) and disability. Emerging treatments also consider contextual factors to improve treatment delivery, such as personalized care, access, and poverty. Tele-mental health represents one such exciting new way of improving access and uptake of treatment by older adults. Although these strategies hold promise, further investigation via randomized controlled trials and comparative effectiveness are necessary to advance our treatment of LLD. Priority should be given to recruiting and training the geriatric mental health workforce to deliver evidence-based psychosocial interventions for LLD.

  7. Hypertension in pregnancy: natural history and treatment options.

    Science.gov (United States)

    Foo, L; Tay, J; Lees, C C; McEniery, C M; Wilkinson, I B

    2015-05-01

    Hypertensive disorders of pregnancy affect approximately 5-10% of all maternities and are major contributors of maternal and neonatal morbidity and mortality worldwide. This group of disorders encompasses chronic hypertension, as well as conditions that arise de novo in pregnancy: gestational hypertension and pre-eclampsia. The latter group is thought to be part of the same continuum but with arbitrary division. Research into the aetiology of hypertension in pregnancy have largely been focused on pre-eclampsia, with a majority of studies exploring either pregnancy-associated factors such as placental-derived or immunologic responses to pregnancy tissue, or maternal constitutional factors such as cardiovascular health and endothelial dysfunction. The evidence base for the pathophysiology and progression of hypertensive disorders in pregnancy, particularly pre-eclampsia, is reviewed. Clinical algorithms and pharmacological agents for the management of hypertension in pregnancy are summarised, with a brief focus on post-partum considerations and long-term health implications. Novel therapeutic options for the management of pre-eclampsia are also explored.

  8. [Tibial plateau fractures in winter sports. Current treatment options].

    Science.gov (United States)

    Zimmermann, V

    2014-01-01

    Tibial plateau fractures overall and especially in winter sports are rare. However, the incidence in recent years is increasing. In a retrospective study from 2009-2012, we found 52 injuries affiliated with winter sports. Noticeable was the high rate of severe injury patterns. In 20 of the 52 cases, there were complete articular or bicondylar fractures (38 %). In 25 cases (48 %), fragment dislocation corresponding to the Moore classification was observed. The operative algorithm was based on the initial soft tissue damage and the type of fracture. A two or more stage procedure with first line soft tissue management and temporary external fixation stabilization was performed 12 times. The final internal osteosynthesis was based on the morphology of the fracture, i.e., direct exposition and stabilization of relevant fracture patterns. In 24 cases (46 %), there was a need for two (or more) approaches. In the anterior aspect of the tibial head, customary implants were used; posterior pathologies were stabilized with low-dimension implants. Summarizing with regard to the literature, there is a more discriminating view of tibial plateau fractures, regarding all relevant fracture patterns. Thus, different options in operative access and choice of implants can be made.

  9. 40 CFR 80.554 - What compliance options are available to NRLM diesel fuel small refiners?

    Science.gov (United States)

    2010-07-01

    ... an approved motor vehicle diesel fuel small refiner under § 80.550(a) but does not qualify as a NRLM... to NRLM diesel fuel small refiners? 80.554 Section 80.554 Protection of Environment ENVIRONMENTAL PROTECTION AGENCY (CONTINUED) AIR PROGRAMS (CONTINUED) REGULATION OF FUELS AND FUEL ADDITIVES Motor Vehicle...

  10. TREATMENT OPTIONS FOR DISPLACED FRACTURE OF THE CALCANEAL TUBEROSITY

    Directory of Open Access Journals (Sweden)

    Siva G. Prasad

    2016-12-01

    Full Text Available BACKGROUND The aim of the study is to compare the outcome following conservative or surgical treatment for displaced fracture of the medial process of the calcaneal tuberosity. MATERIALS AND METHODS 14 men and 4 women aged 20 to 44 years chose to undergo conservative (9 feet or surgical (10 feet treatment by a single surgeon for closed displaced fracture of the medial process of the calcaneal tuberosity. The injury mechanism was a fall from a height of <1.5 m; the mean time from injury to treatment was 3 (range 1-7 days. Conservative treatment comprised immobilisation in a plaster cast. Surgical treatment involved fixation with a half thread cannulated screw for large fragments (in 6 feet or a mini-plate for comminuted fragments (in 4 feet. At the final follow-up, the American Orthopaedic Foot and Ankle Society (AOFAS ankle and hind foot score was evaluated. RESULTS The conservative and surgery groups were comparable in terms of age, gender and fracture displacement. The mean follow-up duration was 20 (range, 14-24 months. All patients had bone union; none had implant loosening or breakage. One patient with surgical treatment developed skin numbness at the medial aspect of the heel that resolved following neurotrophic drug treatment for 3 months. The surgery group achieved earlier full weight bearing (5.8 vs. 7.5 weeks, p<0.001 and return to work (5.9 vs. 8.2 weeks, p=0.048, but comparable AOFAS score (89.0 vs. 88.2, p=0.4. CONCLUSION Surgery for displaced fracture of the medial process of the calcaneal tuberosity enabled earlier full weight bearing and return to work, but comparable AOFAS score.

  11. Acute aortic syndromes: definition, prognosis and treatment options.

    Science.gov (United States)

    Carpenter, S W; Kodolitsch, Y V; Debus, E S; Wipper, S; Tsilimparis, N; Larena-Avellaneda, A; Diener, H; Kölbel, T

    2014-04-01

    Acute aortic syndromes (AAS) are life-threatening vascular conditions of the thoracic aorta presenting with acute pain as the leading symptom in most cases. The incidence is approximately 3-5/100,000 in western countries with increase during the past decades. Clinical suspicion for AAS requires immediate confirmation with advanced imaging modalities. Initial management of AAS addresses avoidance of progression by immediate medical therapy to reduce aortic shear stress. Proximal symptomatic lesions with involvement of the ascending aorta are surgically treated in the acute setting, whereas acute uncomplicated distal dissection should be treated by medical therapy in the acute period, followed by surveillance and repeated imaging studies. Acute complicated distal dissection requires urgent invasive treatment and thoracic endovascular aortic repair has become the treatment modality of choice because of favorable outcomes compared to open surgical repair. Intramural hematoma, penetrating aortic ulcers, and traumatic aortic injuries of the descending aorta harbor specific challenges compared to aortic dissection and treatment strategies are not as uniformly defined as in aortic dissection. Moreover these lesions have a different prognosis. Once the acute period of aortic syndrome has been survived, a lifelong medical treatment and close surveillance with repeated imaging studies is essential to detect impending complications which might need invasive treatment within the short-, mid- or long-term.

  12. Understanding lupus nephritis: diagnosis, management, and treatment options

    Directory of Open Access Journals (Sweden)

    Mok CC

    2012-05-01

    Full Text Available Chi Chiu MokDepartment of Medicine, Tuen Mun Hospital and Center for Assessment and Treatment of Rheumatic Diseases, Pok Oi Hospital, Hong Kong, ChinaAbstract: Systemic lupus erythematosus (SLE predominantly affects women in their reproductive years. Renal disease (glomerulonephritis is one of the most frequent and serious manifestations of SLE. Of the various histological types of lupus glomerulonephritis, diffuse proliferative nephritis carries the worst prognosis. Combined with high-dose prednisone, mycophenolate mofetil (MMF has emerged as a first-line immunosuppressive treatment, although data regarding the efficacy of MMF on the long-term preservation of renal function are forthcoming. Cyclophosphamide is reserved for more severe forms of lupus nephritis, such as crescentic glomerulonephritis with rapidly deteriorating renal function, patients with significant renal function impairment at presentation, and refractory renal disease. Evidence for the calcineurin inhibitors in the treatment of lupus nephritis is weaker, and it concerns patients who are intolerant or recalcitrant to other agents. While further controlled trials are mandatory, B cell modulation therapies, such as rituximab, belimumab and epratuzumab are confined to refractory disease. Non-immunosuppressive measures, such as angiotensin-converting enzyme inhibitors, vigorous blood pressure control, prevention and treatment of hyperlipidemia and osteoporosis, are equally important.Keywords: lupus, nephritis, nephropathy, glomerulonephritis, treatment, therapy, women

  13. Psychiatric manifestations of Graves' hyperthyroidism: pathophysiology and treatment options.

    Science.gov (United States)

    Bunevicius, Robertas; Prange, Arthur J

    2006-01-01

    Graves' disease is an autoimmune disorder that is the most common cause of hyperthyroidism. Other symptoms associated with the disease are goitre, ophthalmopathy, and psychiatric manifestations such as mood and anxiety disorders and, sometimes, cognitive dysfunction. Graves' hyperthyroidism may result in these latter manifestations via the induction of hyperactivity of the adrenergic nervous system. This review addresses the psychiatric presentations, and their pathophysiology and treatment, in patients with hyperthyroidism, based on literature identified by a PubMed/MEDLINE database search. Although the focus is on mental symptoms associated with Graves' disease, it is not always clear from the literature whether patients had Graves' disease: in some studies, the patients were thought to have Graves' disease based on clinical findings such as diffuse goitre or ophthalmopathy or on measurements of thyroid antibodies in serum; however, in other studies, no distinction was made between Graves' hyperthyroidism and hyperthyroidism from other causes. Antithyroid drugs combined with beta-adrenoceptor antagonists are the treatments of choice for hyperthyroidism, as well as for the psychiatric disorders and mental symptoms caused by hyperthyroidism. A substantial proportion of patients have an altered mental state even after successful treatment of hyperthyroidism, suggesting that mechanisms other than hyperthyroidism, including the Graves' autoimmune process per se and ophthalmopathy, may also be involved. When psychiatric disorders remain after restoration of euthyroidism and after treatment with beta-adrenoceptor antagonists, specific treatment for the psychiatric symptoms, especially psychotropic drugs, may be needed.

  14. Quality of life issues relating to endocrine treatment options

    DEFF Research Database (Denmark)

    Iversen, P

    1999-01-01

    Recent interest has focused on the use of hormone therapy in prostate cancer for both the management of patients with non-metastatic disease and as a neoadjuvant or adjuvant to curative therapies. This has resulted in patients with fewer symptoms being treated for longer periods of time. Endocrine...... treatments for prostate cancer, such as castration, combined androgen blockade and non-steroidal antiandrogen monotherapy, have shown similar results in terms of time to progression and survival. The main difference between these treatments is their impact on patients' quality of life. Instruments...... for measuring health-related quality of life should assess both overall and disease-specific quality of life. Data from two large studies of bicalutamide monotherapy show that this non-steroidal antiandrogen is associated with significant health-related quality of life advantages in the treatment of patients...

  15. Preoperative staging and treatment options in T1 rectal adenocarcinoma

    DEFF Research Database (Denmark)

    Baatrup, Gunnar; Endreseth, Birger H; Isaksen, Vidar

    2009-01-01

    . Results. Local treatment of T1 cancers combined with close follow-up, early salvage surgery or later radical resection of local recurrences or with chemo-radiation may lead to fewer severe complications and comparable, or even better, long-term survival. Accurate preoperative staging and careful selection...... of patients for local or non-operative treatment are mandatory. As preoperative staging, at present, is not sufficiently accurate, strategies for completion, salvage or rescue surgery is important, and must be accepted by the patient before local treatment for cure is initiated. Recommendations......Background. Major rectal resection for T1 rectal cancer offers more than 95% cancer specific five-year survival to patients surviving the first 30 days after surgery. A significant further improvement by development of the surgical technique may not be possible. Improvements in the total survival...

  16. Gorlin-Goltz Syndrome: Diagnosis and Treatment Options

    Directory of Open Access Journals (Sweden)

    João Mendes-Abreu

    2017-05-01

    Full Text Available The Gorlin-Goltz syndrome is a rare autosomal dominant hereditary condition, with complete penetrance and variable expressivity. Characterized by the appearance of multiple basaliomas, and often the development of keratocyst, it can also express itself by the presence of palmar/plantar depressions, calcification of brain sickle, and skeletal birth defects, although less frequently. This article presents two cases involving direct relatives, referred after the identification of several basaliomas and jaw cysts. After establishing the diagnosis, given the identification of three major criteria, the treatment consisted in the excision of the lesions followed, in one case, with vismodegib treatment resulting in complete remission. Gorlin-Goltz syndrome is therefore a multidisciplinary challenge, whose variable morbidity and high risk of recurrence make treatment and surveillance critical. However, new molecular targeted therapies have brought a new hope in treating these patients.

  17. [Gorlin-Goltz Syndrome: Diagnosis and Treatment Options].

    Science.gov (United States)

    Mendes-Abreu, João; Pinto-Gouveia, Miguel; Tavares-Ferreira, Cátia; Brinca, Ana; Vieira, Ricardo

    2017-05-31

    The Gorlin-Goltz syndrome is a rare autosomal dominant hereditary condition, with complete penetrance and variable expressivity. Characterized by the appearance of multiple basaliomas, and often the development of keratocyst, it can also express itself by the presence of palmar/plantar depressions, calcification of brain sickle, and skeletal birth defects, although less frequently. This article presents two cases involving direct relatives, referred after the identification of several basaliomas and jaw cysts. After establishing the diagnosis, given the identification of three major criteria, the treatment consisted in the excision of the lesions followed, in one case, with vismodegib treatment resulting in complete remission. Gorlin-Goltz syndrome is therefore a multidisciplinary challenge, whose variable morbidity and high risk of recurrence make treatment and surveillance critical. However, new molecular targeted therapies have brought a new hope in treating these patients.

  18. Orthodontic Camouflage: A Treatment Option – A Clinical Case Report

    Science.gov (United States)

    Mazzini, William Ubilla; Torres, Fátima Mazzini

    2017-01-01

    Orthodontic camouflage provides an alternative treatment for angle III malocclusion since patients with limited economic resources cannot opt for orthognathic surgery, it being clear that correction will be achieved at the dental level and not at the bone complex. Objective: To determine an alternative treatment for patients who do not have the possibility of having orthognathic surgery. Clinical case: A 13-year-old female patient, dolico facial biotype with slightly concave profile, with Class III Skeletal by mandibular prognathism, anterior crossbite, anterior diastema, and large mandibular body, molar class, and canine III. Alexander technique brackets were placed; premolar extraction was not planned. Once the case was completed, the correction of the anterior crossbite was achieved, thanks to the use of the spaces that existed at the beginning of the treatment and also that a correct distalization of canines and retraction of the lower anterior segment were performed. PMID:29326524

  19. Orthodontic Camouflage: A Treatment Option - A Clinical Case Report.

    Science.gov (United States)

    Mazzini, William Ubilla; Torres, Fátima Mazzini

    2017-01-01

    Orthodontic camouflage provides an alternative treatment for angle III malocclusion since patients with limited economic resources cannot opt for orthognathic surgery, it being clear that correction will be achieved at the dental level and not at the bone complex. To determine an alternative treatment for patients who do not have the possibility of having orthognathic surgery. A 13-year-old female patient, dolico facial biotype with slightly concave profile, with Class III Skeletal by mandibular prognathism, anterior crossbite, anterior diastema, and large mandibular body, molar class, and canine III. Alexander technique brackets were placed; premolar extraction was not planned. Once the case was completed, the correction of the anterior crossbite was achieved, thanks to the use of the spaces that existed at the beginning of the treatment and also that a correct distalization of canines and retraction of the lower anterior segment were performed.

  20. Treatment options for hypertriglyceridemia: from risk reduction to pancreatitis

    Science.gov (United States)

    Berglund, Lars; Brunzell, John D.; Goldberg, Anne C.; Goldberg, Ira J.; Stalenhoef, Anton

    2013-01-01

    While there has been considerable focus on the role and treatment of LDL cholesterol levels, a definitive role of triglycerides in the management of cardiovascular disease has been uncertain. Notably, with increasing triglyceride levels, there is a parallel increase in cholesterol levels carried by triglyceride-rich lipoproteins, which has prompted interest in the use of non-HDL cholesterol levels as a tool guiding interventions. Recent studies have provided evidence for an independent role of triglyceride levels as a cardiovascular risk factor, and recently, an Endocrine Society guideline was published for treatment of hypertriglyceridemia. In contrast to the relative uncertainty regarding triglycerides and cardiovascular disease, a role of very high triglyceride levels as a risk factor for pancreatitis has been well known. The present paper summarizes the underlying evidence for a risk role for triglyceride levels in cardiovascular disease and pancreatitis, current treatment recommendations and areas of future research. PMID:24840268

  1. Mycoplasma genitalium infections: current treatment options and resistance issues

    Directory of Open Access Journals (Sweden)

    Sethi S

    2017-09-01

    Full Text Available Sunil Sethi, Kamran Zaman, Neha Jain Department of Medical Microbiology, Postgraduate Institute of Medical Education and Research, Chandigarh, India Abstract: Mycoplasma genitalium is one of the important causes of non-gonococcal urethritis. Rising incidence and emerging antimicrobial resistance are a major concern these days. The poor clinical outcomes with doxycycline therapy led to the use of azithromycin as the primary drug of choice. Single-dose azithromycin regimen over a period of time was changed to extended regimen following studies showing better clinical cures and less risk of resistance development. However, emerging macrolide resistance, either due to transmission of resistance or drug pressure has further worsened the management of this infection. The issues of drug resistance and treatment failures also exist in cases of M. genitalium infection. At present, the emergence of multidrug-resistant (MDR M. genitalium strains is an alarming sign for its treatment and the associated public health impact due to its complications. However, newer drugs like pristinamycin, solithromycin, sitafloxacin, and others have shown a hope for the clinical cure, but need further clinical trials to optimize the therapeutic dosing schedules and formulate appropriate treatment regimens. Rampant and inappropriate use of these newer drugs will further sabotage future attempts to manage MDR strains. There is currently a need to formulate diagnostic algorithms and etiology-based treatment regimens rather than the syndromic approach, preferably using combination therapy instead of a monotherapy. Awareness about the current guidelines and recommended treatment regimens among clinicians and local practitioners is of utmost importance. Antimicrobial resistance testing and global surveillance are required to assess the efficacy of current treatment regimens and for guiding future research for the early detection and management of MDR M. genitalium infections

  2. Tourette Syndrome and comorbid ADHD: current pharmacological treatment options.

    Science.gov (United States)

    Rizzo, Renata; Gulisano, Mariangela; Calì, Paola V; Curatolo, Paolo

    2013-09-01

    Attention Deficit Hyperactivity Disorder (ADHD) is the most common co-morbid condition encountered in people with tics and Tourette Syndrome (TS). The co-occurrence of TS and ADHD is associated with a higher psychopathological, social and academic impairment and the management may represent a challenge for the clinicians. To review recent advances in management of patients with tic, Tourette Syndrome and comorbid Attention Deficit Hyperactivity Disorder. We searched peer reviewed and original medical publications (PUBMED 1990-2012) and included randomized, double-blind, controlled trials related to pharmacological treatment for tic and TS used in children and adolescents with comorbid ADHD. "Tourette Syndrome" or "Tic" and "ADHD", were cross referenced with the words "pharmacological treatment", "α-agonist", "psychostimulants", "selective norepinephrine reuptake inhibitor", "antipsychotics". Three classes of drugs are currently used in the treatment of TS and comorbid ADHD: α-agonists (clonidine and guanfacine), stimulants (amphetamine enantiomers, methylphenidate enantiomers or slow release preparation), and selective norepinephrine reuptake inhibitor (atomoxetine). It has been recently suggested that in a few selected cases partial dopamine agonists (aripiprazole) could be useful. Level A of evidence supported the use of noradrenergic agents (clonidine). Reuptake inhibitors (atomoxetine) and stimulants (methylphenidate) could be, also used for the treatment of TS and comorbid ADHD. Taking into account the risk-benefit profile, clonidine could be used as the first line treatment. However only few studies meet rigorous quality criteria in terms of study design and methodology; most trials have low statistical power due to small sample size or short duration. Treatment should be "symptom targeted" and personalized for each patient. Copyright © 2013 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.

  3. Acne Scarring—Pathogenesis, Evaluation, and Treatment Options

    Science.gov (United States)

    Connolly, Deirdre; Vu, Ha Linh; Mariwalla, Kavita

    2017-01-01

    Acne vulgaris is a ubiquitous problem affecting 80 percent of people ages 11 to 30 years, with many patients experiencing some degree of scarring. This review focuses on atrophic scars, the most common type of acne scar. We briefly address the cellular sequelae that lead to scar formation and the initial evaluation of patients with acne scars. We then discuss an algorithmic approach to the treatment of acne scarring based on the classification of scars into erythematous and atrophic types. Lastly, we discuss the future treatment of acne scars and ongoing clinical trials. PMID:29344322

  4. Emerging treatment options for refractory angina pectoris: ranolazine, shock wave treatment, and cell-based therapies.

    Science.gov (United States)

    Gennari, Marco; Gambini, Elisa; Bassetti, Beatrice; Capogrossi, Maurizio; Pompilio, Giulio

    2014-01-01

    A challenge of modern cardiovascular medicine is to find new, effective treatments for patients with refractory angina pectoris, a clinical condition characterized by severe angina despite optimal medical therapy. These patients are not candidates for surgical or percutaneous revascularization. Herein we review the most up-to-date information regarding the modern approach to the patient with refractory angina pectoris, from conventional medical management to new medications and shock wave therapy, focusing on the use of endothelial precursor cells (EPCs) in the treatment of this condition. Clinical limitations of the efficiency of conventional approaches justify the search for new therapeutic options. Regenerative medicine is considered the next step in the evolution of organ replacement therapy. It is driven largely by the same health needs as transplantation and replacement therapies, but it aims further than traditional approaches, such as cell-based therapy. Increasing knowledge of the role of circulating cells derived from bone marrow (EPCs) on cardiovascular homeostasis in physiologic and pathologic conditions has prompted the clinical use of these cells to relieve ischemia. The current state of therapeutic angiogenesis still leaves many questions unanswered. It is of paramount importance that the treatment is delivered safely. Direct intramyocardial and intracoronary administration has demonstrated acceptable safety profiles in early trials, and may represent a major advance over surgical thoracotomy. The combined efforts of bench and clinical researchers will ultimately answer the question of whether cell therapy is a suitable strategy for treatment of patients with refractory angina.

  5. Treatment options for patients with Gaucher disease | Shawky ...

    African Journals Online (AJOL)

    Gaucher disease is the most common lysosomal storage disorder due to deficiency of ß-glucocerebrosidase. Since the introduction of Ceredase in 1991, enzyme replacement therapy has been the mainstay of treatment with its major disadvantage of long life dependency on biweekly IV therapy. It was more than a decade ...

  6. Quality of life issues relating to endocrine treatment options

    DEFF Research Database (Denmark)

    Iversen, P

    1999-01-01

    for measuring health-related quality of life should assess both overall and disease-specific quality of life. Data from two large studies of bicalutamide monotherapy show that this non-steroidal antiandrogen is associated with significant health-related quality of life advantages in the treatment of patients...

  7. Endodontic-periodontic bifurcation lesions: a novel treatment option.

    Science.gov (United States)

    Lin, Shaul; Tillinger, Gabriel; Zuckerman, Offer

    2008-05-01

    The purpose of this preliminary clinical report is to suggest a novel treatment modality for periodontal bifurcation lesions of endodontic origin. The study consisted of 11 consecutive patients who presented with periodontal bifurcation lesions of endodontic origin (endo-perio lesions). All patients were followed-up for at least 12 months. Treatment included calcium hydroxide with iodine-potassium iodide placed in the root canals for 90 days followed by canal sealing with gutta-percha and cement during a second stage. Dentin bonding was used to seal the furcation floor to prevent the ingress of bacteria and their by-products to the furcation root area through the accessory canals. A radiographic examination showed complete healing of the periradicular lesion in all patients. Probing periodontal pocket depths decreased to 2 to 4 mm (mean 3.5 mm), and resolution of the furcation involvement was observed in post-operative clinical evaluations. The suggested treatment of endo-perio lesions may result in complete healing. Further studies are warranted. This treatment method improves both the disinfection of the bifurcation area and the healing process in endodontically treated teeth considered to be hopeless.

  8. Pazopanib, a promising option for the treatment of aggressive fibromatosis

    NARCIS (Netherlands)

    Szucs, Z.; Messiou, C.; Wong, H.H.; Hatcher, H.; Miah, A.; Zaidi, S.; Graaf, W.T.A. van der; Judson, I.; Jones, R.L.; Benson, C.

    2017-01-01

    Desmoid tumour/aggressive fibromatosis (DT/AF) is a rare soft-tissue neoplasm that is locally aggressive but does not metastasize. There is no standard systemic treatment for symptomatic patients, although a number of agents are used. Tyrosine kinase inhibitors have recently been reported to show

  9. Short-lasting headache syndromes and treatment options.

    Science.gov (United States)

    Rozen, Todd D

    2004-08-01

    A number of primary headache syndromes are marked by their short duration of pain. Many of these syndromes have their own unique treatment, so they must be recognized by practicing physicians. In this article, a number of the short-lasting headache disorders are reviewed, including chronic paroxysmal hemicrania, SUNCT syndrome, hypnic headache, exploding head syndrome, primary stabbing headache, and cough headache.

  10. Hazardous fuel treatments, suppression cost impacts, and risk mitigation

    Science.gov (United States)

    Matthew P. Thompson; Michael S. Hand; Julie W. Gilbertson-Day; Nicole M. Vaillant; Darek J. Nalle

    2013-01-01

    Land management agencies face uncertain tradeoffs regarding investments in preparedness and fuels management versus future suppression costs and impacts to valued resources and assets. Prospective evaluation of fuel treatments allows for comparison of alternative treatment strategies in terms of socioeconomic and ecological impacts, and can facilitate tradeoff analysis...

  11. Direct visual internal urethrotomy: Is it a durable treatment option?

    OpenAIRE

    Pal, Dilip Kumar; Kumar, Sanjay; Ghosh, Bastab

    2017-01-01

    Objective: To evaluate the long-term success rate of direct vision internal urethrotomy as a treatment for anterior urethral strictures. Materials and Methods: We retrospectively analyzed the results for patients who underwent internal urethrotomy from January 2009 to January 2014 for anterior urethral strictures. Patients were followed till January 2016. Patients with complicated urethral strictures with a history of previous urethroplasty, hypospadias repair, or previous radiation were e...

  12. Treatment options for tank farms long-length contaminated equipment

    International Nuclear Information System (INIS)

    Josephson, W.S.

    1995-01-01

    This study evaluated a variety of treatment and disposal technologies for mixed waste (MW) meeting the following criteria: 1. Single-Shell and Double-Shell Tank System (tank farms) equipment and other debris; 2. length greater than 12 feet; and contaminated with listed MW from the tank farms. This waste stream, commonly referred to as tank farms long-length contaminated equipment (LLCE), poses a unique and costly set of challenges during all phases of the waste management lifecycle

  13. Biomedicines?Moving Biologic Agents into Approved Treatment Options

    OpenAIRE

    Cornetta, Kenneth

    2013-01-01

    The development of biologic agents for therapeutic purposes, or biomedicines, has seen an active area of research both at the bench and in clinical trials. There is mounting evidence that biologic products can provide effective therapy for diseases that have been unresponsive to traditional pharmacologic approaches. Monoclonal antibody therapy for cancer and rheumatologic diseases has become a well accepted part of disease treatment plans. Gene therapy products have been approved in China and...

  14. Alcohol addiction - the safety of available approved treatment options.

    Science.gov (United States)

    Antonelli, Mariangela; Ferrulli, Anna; Sestito, Luisa; Vassallo, Gabriele A; Tarli, Claudia; Mosoni, Carolina; Rando, Maria M; Mirijello, Antonio; Gasbarrini, Antonio; Addolorato, Giovanni

    2018-02-01

    Alcohol Use Disorders (AUD) is a leading cause of mortality and morbidity worldwide. At present disulfiram, naltrexone and acamprosate are approved for the treatment of AUD in U.S. and Europe. Nalmefene is approved in Europe and sodium oxybate is approved in Italy and Austria only. Baclofen received a 'temporary recommendation for use' in France. Areas covered: The safety of the above mentioned medications on liver, digestive system, kidney function, nervous system, pregnancy and lactation and their possible side effects are described and discussed. Expert opinion: Mechanism of action and metabolism of these drugs as well as patients' clinical characteristics can affect the safety of treatment. All approved medications are valid tools for the treatment of AUD in patients without advanced liver disease. For some drugs, attention should be paid to patients with renal failure and medications may be used with caution, adjusting the dosage according to kidney function. In patients with AUD and advanced liver disease, at present only baclofen has been formally tested in randomized controlled trials showing its safety in this population.

  15. Rucaparib: a new treatment option for ovarian cancer.

    Science.gov (United States)

    Sabatucci, Ilaria; Maltese, Giuseppa; Lepori, Stefano; Tripodi, Elisa; Bogani, Giorgio; Lorusso, Domenica

    2018-05-01

    Approximately 50% of high-grade serous ovarian cancers present a deficiency in the pathways involved in homologous recombination (HR). PARP inhibitors prevent single-strand DNA damage repair and determine a progression of the defect towards double-strand breaks, which results in a process known as 'synthetic lethality'. Areas covered: In this review, the authors discuss the efficacy and toxicity of rucaparib either as a single agent or as a maintenance treatment for ovarian cancer. This includes the NGS Foundation Medicine evaluation of the role of this drug in the treatment algorithm of ovarian cancer. Moreover, perspectives on the future development of this drug are presented. Expert opinion: The FDA has approved this drug for the treatment of recurrent BRCA-mutated ovarian cancers, which were previously treated with at least two chemotherapies and has accepted the supplemental new drug application for maintenance use in patients who respond to platinum-based chemotherapy via the Prescription Drug User Fee Act (PDUFA) on 6 April 2018. European Medicines Agency (EMA) approval in the same setting is awaited. The possibility of using PARP inhibitors as a maintenance therapy, as a front-line therapy to combat recurrence, and in combination with anti-angiogenic agents and immune-therapies appears to be of particular interest.

  16. Moving forward with treatment options for HIV-infected children.

    Science.gov (United States)

    Beghin, Jean-Christophe; Yombi, Jean Cyr; Ruelle, Jean; Van der Linden, Dimitri

    2018-01-01

    Current international guidelines recommend to treat all HIV-1 infected patients regardless of CD4 cell count. Despite the remarkable worldwide progress for universal access to antiretroviral during the last decade, the pediatric population remains fragile due to lack of randomized studies, inappropriate antiretroviral formulations, adherence difficulties, drug toxicity and development of resistance. Areas covered: This review summarizes the latest recommendations and advances for the treatment of HIV-infected children and highlights the potential complications of a lifelong antiretroviral treatment initiated early in life. Expert opinion: International guidelines recommend to start combination antiretroviral therapy (cART) as fast as possible in all children diagnosed with HIV-1. The principal goal is to improve survival and reduce mortality as well as rapidly decrease HIV reservoirs. This remains a challenge in resource-limited settings were diagnostic tools and treatment access may be limited. Different new strategies are in the pipeline such as immunotherapy in combination with very early cART initiation to seek remission or functional cure. For the time being and awaiting for long term remission or cure, there is a need for further pharmacokinetics studies, more pediatric formulations with improved palatability and implementation of randomized trials for the newer antiretroviral drugs.

  17. Current and emerging treatment options in the management of lupus

    Science.gov (United States)

    Jordan, Natasha; D’Cruz, David

    2016-01-01

    Systemic lupus erythematosus (SLE) is a complex autoimmune disease with variable clinical manifestations. While the clearest guidelines for the treatment of SLE exist in the context of lupus nephritis, patients with other lupus manifestations such as neuropsychiatric, hematologic, musculoskeletal, and severe cutaneous lupus frequently require immunosuppression and/or biologic therapy. Conventional immunosuppressive agents such as mycophenolate mofetil, azathioprine, and cyclophosphamide are widely used in the management of SLE with current more rationalized treatment regimens optimizing the use of these agents while minimizing potential toxicity. The advent of biologic therapies has advanced the treatment of SLE particularly in patients with refractory disease. The CD20 monoclonal antibody rituximab and the anti-BLyS agent belimumab are now widely in use in clinical practice. Several other biologic agents are in ongoing clinical trials. While immunosuppressive and biologic agents are the foundation of inflammatory disease control in SLE, the importance of managing comorbidities such as cardiovascular risk factors, bone health, and minimizing susceptibility to infection should not be neglected. PMID:27529058

  18. Vitiligo: An Update on Pathophysiology and Treatment Options.

    Science.gov (United States)

    Speeckaert, Reinhart; van Geel, Nanja

    2017-12-01

    The pathophysiology of vitiligo is becoming increasingly clarified. In non-segmental vitiligo, early factors include activation of innate immunity, inflammasome activation, oxidative stress, and loss of melanocyte adhesion. Nonetheless, the main mechanism leading to non-segmental vitiligo involves an immune-mediated destruction of melanocytes. Anti-melanocyte-specific cytotoxic T cells exert a central role in the final effector stage. Genetic research revealed a multi-genetic inheritance displaying an overlap with other autoimmune disorders. However, some melanocyte-specific genes were also affected. Segmental vitiligo carries a different pathogenesis with most evidence indicating a mosaic skin disorder. Current management includes topical corticosteroids and immunomodulators. Narrow-band ultraviolet B can be used in patients not responding to topical treatment or in patients with extensive disease. Pigment cell transplantation offers an alternative for the treatment of segmental vitiligo or stable non-segmental lesions. Recent findings have revealed new targets for treatment that could lead to more efficient therapies. Targeted immunotherapy may halt the active immune pathways, although combination therapy may still be required to induce satisfying repigmentation. A recently established core set of outcome measures, new measurement instruments, and biomarker research pave the way for future standardized clinical trials.

  19. Emerging pharmacologic treatment options for fragile X syndrome

    Science.gov (United States)

    Schaefer, Tori L; Davenport, Matthew H; Erickson, Craig A

    2015-01-01

    Fragile X syndrome (FXS) is the most common single gene cause of intellectual disability and autism spectrum disorder. Caused by a silenced fragile X mental retardation 1 gene and the subsequent deficiency in fragile X mental retardation protein, patients with FXS experience a range of physical, behavioral, and intellectual debilitations. The FXS field, as a whole, has recently met with some challenges, as several targeted clinical trials with high expectations of success have failed to elucidate significant improvements in a variety of symptom domains. As new clinical trials in FXS are planned, there has been much discussion about the use of the commonly used clinical outcome measures, as well as study design considerations, patient stratification, and optimal age range for treatment. The evidence that modification of these drug targets and use of these failed compounds would prove to be efficacious in human clinical study were rooted in years of basic and translational research. There are questions arising as to the use of the mouse models for studying FXS treatment development. This issue is twofold: many of the symptom domains and molecular and biochemical changes assessed and indicative of efficacy in mouse model study are not easily amenable to clinical trials in people with FXS because of the intolerability of the testing paradigm or a lack of noninvasive techniques (prepulse inhibition, sensory hypersensitivity, startle reactivity, or electrophysiologic, biochemical, or structural changes in the brain); and capturing subtle yet meaningful changes in symptom domains such as sociability, anxiety, and hyperactivity in human FXS clinical trials is challenging with the currently used measures (typically parent/caregiver rating scales). Clinicians, researchers, and the pharmaceutical industry have all had to take a step back and critically evaluate the way we think about how to best optimize future investigations into pharmacologic FXS treatments. As new clinical

  20. Polyvalent fuel treatment facility (TCP): shearing and dissolution of used fuel at La Hague facility

    Energy Technology Data Exchange (ETDEWEB)

    Brueziere, J.; Tribout-Maurizi, A.; Durand, L.; Bertrand, N. [Recycling Business Unit, AREVA, 1 place de la coupole, 92084 Paris La defense Cedex (France)

    2013-07-01

    Although many used nuclear fuel types have already been recycled, recycling plants are generally optimized for Light Water Reactor (LWR) UO{sub x} fuel. Benefits of used fuel recycling are consequently restricted to those fuels, with only limited capacity for the others like LWR MOX, Fast Reactor (FR) MOX or Research and Test Reactor (RTR) fuel. In order to recycle diverse fuel types, an innovative and polyvalent shearing and dissolving cell is planned to be put in operation in about 10 years at AREVA's La Hague recycling plant. This installation, called TCP (French acronym for polyvalent fuel treatment) will benefit from AREVA's industrial feedback, while taking part in the next steps towards a fast reactor fuel cycle development using innovative treatment solutions. Feasibility studies and R/Development trials on dissolution and shearing are currently ongoing. This new installation will allow AREVA to propose new services to its customers, in particular in term of MOX fuel, Research Test Reactors fuel and Fast Reactor fuel treatment. (authors)

  1. Current and emerging treatment options for hairy cell leukemia

    Directory of Open Access Journals (Sweden)

    López-Rubio M

    2015-08-01

    Full Text Available Montserrat López-Rubio,1 Jose Antonio Garcia-Marco2 1Department of Hematology, Hospital Universitario Príncipe de Asturias, Alcalá de Henares, 2Department of Hematology, Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda, Madrid, Spain Abstract: Hairy cell leukemia (HCL is a lymphoproliferative B-cell disorder characterized by pancytopenia, splenomegaly, and characteristic cytoplasmic hairy projections. Precise diagnosis is essential in order to differentiate classic forms from HCL variants, such as the HCL-variant and VH4-34 molecular variant, which are more resistant to available treatments. The current standard of care is treatment with purine analogs (PAs, such as cladribine or pentostatin, which provide a high rate of long-lasting clinical remissions. Nevertheless, ~30%–40% of the patients relapse, and moreover, some of these are difficult-to-treat refractory cases. The use of the monoclonal antibody rituximab in combination with PA appears to produce even higher responses, and it is often employed to minimize or eliminate residual disease. Currently, research in the field of HCL is focused on identifying novel therapeutic targets and potential agents that are safe and can universally cure the disease. The discovery of the BRAF mutation and progress in understanding the biology of the disease has enabled the scientific community to explore new therapeutic targets. Ongoing clinical trials are assessing various treatment strategies such as the combination of PA and anti-CD20 monoclonal antibodies, recombinant immunotoxins targeting CD22, BRAF inhibitors, and B-cell receptor signal inhibitors. Keywords: hairy cell leukemia, purine analogs, rituximab, immunotoxins, vemurafenib, ibrutinib

  2. Diacerein: a treatment option in painful primary knee osteoarthritis

    International Nuclear Information System (INIS)

    Akhter, N.; Khan, A.A.; Ayaz, S.B.; Afzal, A.

    2015-01-01

    To identify the efficacy and side effects of Diacerein in patients with mild to moderate knee osteoarthritis. Study Design: Quasi experimental study. Place and Duration of Study: Outpatient Department of Armed Forces Institute of Rehabilitation Medicine, Rawalpindi from June 2012 to June 2013. Material and Methods: Ninety cases fulfilling American College of Rheumatology criteria for diagnosis of Knee Osteoarthritis and falling in Grades III of Kellgren-Lawrence Radiological Classification for Knee Osteoarthritis were included. Pre-treatment associated symptoms, complete blood count, renal and liver function tests were documented. After a baseline pain assessment on a 10-Point Visual Analogue Scale, 50 mg of Diacerein was given orally for 4 months followed by pain assessment and inquiry about adverse effects at 6th week, 3rd and 6th months. Post-treatment labs were repeated. Reduction in pain was analyzed by paired-sample t-test using SPSS version 17. Chi-Square test was used to assess the frequency of adverse effects. A p-value < 0.05 was considered significant. Results: Mean age was 61.5 ± 7.8 years. Majority 77 (85.6%) were females. Mean Visual Analogue Scale at start was 6.1 ± 0.87. Significant pain reduction measured on Visual Analogue Scale was observed at six weeks (4.6 ± 1.2) (p < 0.001), three months (2.37 ± 0.91) (p < 0.001) and six months (2.2 ± 0.85) (p < 0.001). Very few patients developed diarrhea 3.3% and nausea 4.4%. Conclusion: Diacerein is effective drug with minimal side effects for treatment of mild to moderate painful Knee Osteoarthritis. (author)

  3. DIABETES MELLITUS IN PATIENTS WITH LIVER CIRRHOSIS: NEW TREATMENT OPTIONS

    Directory of Open Access Journals (Sweden)

    L. Yu. Morgunov

    2017-01-01

    Full Text Available In economically developed countries, cirrhosis is one of the six leading causes of death at the age of 35–60 years and ranges from 14 to 30 cases per 100000 population. In the world 40 million people die of cirrhosis each year. At 6% of the population of the Russian Federation there is a diabetes mellitus. The combination of diabetes mellitus in patients with cirrhosis of the liver is a common comorbid pathology. Diabetes mellitusis a risk factor for the development of liver cirrhosis, and the incidence of combination of both diseases is quite high, although the frequency of occurrence varies. About 80% of patients with LC may have impaired glucose metabolism, and 30% have diabetes mellitus. Prospective studies have shown that diabetes is associated with an increased risk of developing hepatic complications and death in patients with cirrhosis of the liver. Diabetes mellitus increases the risk of complications of liver cirrhosis of any etiology (varicose veins of the esophagus, hepatic encephalopathy, hepatic-cell insufficiency and subsequent survival. The incidence, frequency of hospitalizations and mortality from this combined pathology are very high. There are common mechanisms that provoke metabolic and autoimmune disorders in the development of chronic hepatitis and cirrhosis, leading to steatosis, insulin resistance, impaired glucose tolerance and the development of diabetes mellitus. There are certain features of the evaluation of the compensation of carbohydrate metabolism in patients with cirrhosis of the liver, anemia and impaired protein metabolism. Effective control of glycemia can have a beneficial effect on the treatment of these patients. However, few studies have evaluated the efficacy and safety of antidiabetic drugs and the effect of diabetes treatment on morbidity and mortality in patients with cirrhosis. Previously it was believed that in the presence of cirrhosis the only treatment remains insulin. At present, in

  4. Current and Emerging Treatment Options in Diabetes Care

    DEFF Research Database (Denmark)

    Clemmensen, Christoffer; Müller, Timo D; Finan, Brian

    2016-01-01

    in elevated plasma glucose. In the last three decades, a set of new medicines built upon a deeper understanding of physiology and diabetic pathology have emerged to enhance the clinical management of the disease and related disorders. Recent insights into insulin-dependent and insulin-independent molecular...... events have accelerated the generation of a series of novel medicinal agents, which hold the promise for further advances in the management of diabetes. In this chapter, we provide a historical context for what has been accomplished to provide perspective for future research and novel emerging treatment...

  5. Urinary tract infections: epidemiology, mechanisms of infection and treatment options

    Science.gov (United States)

    Flores-Mireles, Ana L.; Walker, Jennifer N.; Caparon, Michael; Hultgren, Scott J.

    2015-01-01

    Urinary tract infections (UTIs) are a severe public health problem and are caused by a range of pathogens, but most commonly by Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Enterococcus faecalis and Staphylococcus saprophyticus. High recurrence rates and increasing antimicrobial resistance among uropathogens threaten to greatly increase the economic burden of these infections. In this Review, we discuss how basic science studies are elucidating the molecular details of the crosstalk that occurs at the host–pathogen interface, as well as the consequences of these interactions for the pathophysiology of UTIs. We also describe current efforts to translate this knowledge into new clinical treatments for UTIs. PMID:25853778

  6. Biomedicines—Moving Biologic Agents into Approved Treatment Options

    Directory of Open Access Journals (Sweden)

    Kenneth Cornetta

    2013-03-01

    Full Text Available The development of biologic agents for therapeutic purposes, or biomedicines, has seen an active area of research both at the bench and in clinical trials. There is mounting evidence that biologic products can provide effective therapy for diseases that have been unresponsive to traditional pharmacologic approaches. Monoclonal antibody therapy for cancer and rheumatologic diseases has become a well accepted part of disease treatment plans. Gene therapy products have been approved in China and Europe. Bioengineering of new agents capitalizing on microRNA biology, nanoparticle technology, stem cell biology, and an increasing understanding of immunology predict a rich future for product development. [...

  7. Outline of a fuel treatment facility in NUCEF

    International Nuclear Information System (INIS)

    Sugikawa, Susumu; Umeda, Miki; Kokusen, Junya

    1997-03-01

    This report presents outline of the nuclear fuel treatment facility for the purpose of preparing solution fuel used in Static Experiment Critical Facility (STACY) and Transient Experiment Critical Facility (TRACY) in Nuclear Fuel Cycle Safety Engineering Research Facility (NUCEF), including descriptions of process conditions and dimensions of major process equipments on dissolution system of oxide fuel, chemical adjustment system, purification system, acid recovery system, solution fuel storage system, and descriptions of safety design philosophy such as safety considerations of criticality, solvent fire, explosion of hydrogen and red-oil and so on. (author)

  8. Managing plutonium in Britain. Current options[Mixed oxide nuclear fuels; Nuclear weapons

    Energy Technology Data Exchange (ETDEWEB)

    NONE

    1998-09-01

    This is the report of a two day meeting to discuss issues arising from the reprocessing of plutonium and production of mixed oxide nuclear fuels in Britain. It was held at Charney Manor, near Oxford, on June 25 and 26, 1998, and was attended by 35 participants, including government officials, scientists, policy analysts, representatives of interested NGO's, journalists, a Member of Parliament, and visiting representatives from the US and Irish governments. The topic of managing plutonium has been a consistent thread within ORG's work, and was the subject of one of our previous reports, CDR 12. This particular seminar arose out of discussions earlier in the year between Dr. Frank Barnaby and the Rt. Hon. Michael Meacher MP, Minister for the Environment. With important decisions about the management of plutonium in Britain pending, ORG undertook to hold a seminar at which all aspects of the subject could be aired. A number of on-going events formed the background to this initiative. The first was British Nuclear Fuels' [BNFL] application to the Environment Agency to commission a mixed oxide fuel [MOX] plant at Sellafield. The second was BNFL's application to vary radioactive discharge limits at Sellafield. Thirdly, a House of Lords Select Committee was in process of taking evidence, on the disposal of radioactive waste. Fourthly, the Royal Society, in a recent report entitled Management of Separated Plutonium, recommended that 'the Government should commission a comprehensive review... of the options for the management of plutonium'. Four formal presentations were made to the meeting, on the subjects of Britain's plutonium policy, commercial prospects for plutonium use, problems of plutonium accountancy, and the danger of nuclear terrorism, by experts from outside the nuclear industry. It was hoped that the industry's viewpoint would also be heard, and BNFL were invited to present a paper, but declined on the grounds that they

  9. Modeling studies of water consumption for transportation fuel options: Hawaii, US-48

    Science.gov (United States)

    King, C. W.; Webber, M. E.

    2011-12-01

    flow restoration that has already been ordered requires that an additional 18.5 Mgal/d from East Maui streams and 12.5 Mgal/d from West Maui streams not be diverted for irrigation or other uses. Further environmental flow requirements based on a habitat-protective standard enumerated by the Department of Aquatic Resources could be an additional 45 Mgal/d. Thus, it is conceivable that over the next several years a total of 76 Mgal/d, which is 20%-30% of the irrigation water at existing sugarcane farms, could be appropriated away from agriculture on Maui. Many locals have never viewed the large-scale diversion of stream flow for agriculture as legitimate. Now that much of the plantation agriculture in Hawai'i has shut down due to lack of competitive economics, the discussion of the priority for use of 'old' agricultural water is prompting more water to be left in streams. At the same time, Hawai'i has goals for energy sustainability that include producing biofuels. Thus, Maui is a microcosm of the struggle for energy and water sustainability. Brief discussions of other studies on the water needs for transportation fuel options for the continental 48 U.S. states will also be presented.

  10. Lung abscess-etiology, diagnostic and treatment options.

    Science.gov (United States)

    Kuhajda, Ivan; Zarogoulidis, Konstantinos; Tsirgogianni, Katerina; Tsavlis, Drosos; Kioumis, Ioannis; Kosmidis, Christoforos; Tsakiridis, Kosmas; Mpakas, Andrew; Zarogoulidis, Paul; Zissimopoulos, Athanasios; Baloukas, Dimitris; Kuhajda, Danijela

    2015-08-01

    Lung abscess is a type of liquefactive necrosis of the lung tissue and formation of cavities (more than 2 cm) containing necrotic debris or fluid caused by microbial infection. It can be caused by aspiration, which may occur during altered consciousness and it usually causes a pus-filled cavity. Moreover, alcoholism is the most common condition predisposing to lung abscesses. Lung abscess is considered primary (60%) when it results from existing lung parenchymal process and is termed secondary when it complicates another process, e.g., vascular emboli or follows rupture of extrapulmonary abscess into lung. There are several imaging techniques which can identify the material inside the thorax such as computerized tomography (CT) scan of the thorax and ultrasound of the thorax. Broad spectrum antibiotic to cover mixed flora is the mainstay of treatment. Pulmonary physiotherapy and postural drainage are also important. Surgical procedures are required in selective patients for drainage or pulmonary resection. In the current review we will present all current information from diagnosis to treatment.

  11. Reviewing the options for local estrogen treatment of vaginal atrophy

    Directory of Open Access Journals (Sweden)

    Lindahl SH

    2014-03-01

    Full Text Available Sarah H Lindahl Sutter East Bay Medical Foundation, SEBMF – Diablo Division, Castro Valley, CA, USA Background: Vaginal atrophy is a chronic condition with symptoms that include vaginal dryness, pain during sex, itching, irritation, burning, and discharge, as well as various urinary problems. Up to 45% of postmenopausal women may be affected, but it often remains underreported and undertreated. This article aims to review the current recommendations for treatment of vaginal atrophy, and current data on the effectiveness and safety of local vaginal estrogen therapies. Methods: Literature regarding vaginal atrophy (2007–2012 was retrieved from PubMed and summarized, with emphasis on data related to the treatment of vaginal atrophy with local vaginal estrogen therapy. Results: Published data support the effectiveness and endometrial safety of low-dose local estrogen therapies. These results further support the general recommendation by the North American Menopause Society that a progestogen is not needed for endometrial protection in patients using low-dose local vaginal estrogen. Benefits of long-term therapy for vaginal atrophy include sustained relief of symptoms as well as physiological improvements (eg, decreased vaginal pH and increased blood flow, epithelial thickness, secretions. Conclusion: Currently available local vaginal estrogen therapies are well tolerated and effective in relieving symptoms of vaginal atrophy. Recent data support the endometrial safety of low-dose regimens for up to 1 year. Keywords: menopause, estrogen, local estrogen therapy, vaginal atrophy

  12. Dosimetric Study of Current Treatment Options for Radiotherapy in Retinoblastoma

    Energy Technology Data Exchange (ETDEWEB)

    Eldebawy, Eman [Department of Radiation Oncology, McGill University Health Centre, Montreal, Quebec (Canada); Department of Radiation Oncology, Children' s Cancer Hospital, Cairo (Egypt); Parker, William, E-mail: william.parker@mcgill.ca [Department of Medical Physics, McGill University Health Centre, Montreal, Quebec (Canada); Abdel Rahman, Wamied [Department of Medical Physics, McGill University Health Centre, Montreal, Quebec (Canada); Freeman, Carolyn R. [Department of Radiation Oncology, McGill University Health Centre, Montreal, Quebec (Canada)

    2012-03-01

    Purpose: To determine the best treatment technique for patients with retinoblastoma requiring radiotherapy to the whole eye. Methods and Materials: Treatment plans for 3 patients with retinoblastoma were developed using 10 radiotherapy techniques including electron beams, photon beam wedge pair (WP), photon beam three-dimensional conformal radiotherapy (3D-CRT), fixed gantry intensity-modulated radiotherapy (IMRT), photon volumetric arc therapy (VMAT), fractionated stereotactic radiotherapy, and helical tomotherapy (HT). Dose-volume analyses were carried out for each technique. Results: All techniques provided similar target coverage; conformity was highest for VMAT, nine-field (9F) IMRT, and HT (conformity index [CI] = 1.3) and lowest for the WP and two electron techniques (CI = 1.8). The electron techniques had the highest planning target volume dose gradient (131% of maximum dose received [D{sub max}]), and the CRT techniques had the lowest (103% D{sub max}) gradient. The volume receiving at least 20 Gy (V{sub 20Gy}) for the ipsilateral bony orbit was lowest for the VMAT and HT techniques (56%) and highest for the CRT techniques (90%). Generally, the electron beam techniques were superior in terms of brain sparing and delivered approximately one-third of the integral dose of the photon techniques. Conclusions: Inverse planned image-guided radiotherapy delivered using HT or VMAT gives better conformity index, improved orbital bone and brain sparing, and a lower integral dose than other techniques.

  13. An Overview of Autism Spectrum Disorder, Heterogeneity and Treatment Options

    Institute of Scientific and Technical Information of China (English)

    Anne Masi; Marilena M.DeMayo; Nicholas Glozier; Adam J.Guastella

    2017-01-01

    Since the documented observations of Kanner in 1943,there has been great debate about the diagnoses,the sub-types,and the diagnostic threshold that relates to what is now known as autism spectrum disorder (ASD).Reflecting this complicated history,there has been continual refinement from DSM-Ⅲ with ‘Infantile Autism’ to the current DSM-Ⅴ diagnosis.The disorder is now widely accepted as a complex,pervasive,heterogeneous condition with multiple etiologies,sub-types,and developmental trajectories.Diagnosis remains based on observation of atypical behaviors,with criteria of persistent deficits in social communication and restricted and repetitive patterns of behavior.This review provides a broad overview of the history,prevalence,etiology,clinical presentation,and heterogeneity of ASD.Factors contributing to heterogeneity,including genetic variability,comorbidity,and gender are reviewed.We then explore current evidencebased pharmacological and behavioral treatments for ASD and highlight the complexities of conducting clinical trials that evaluate therapeutic efficacy in ASD populations.Finally,we discuss the potential of a new wave of research examining objective biomarkers to facilitate the evaluation of sub-typing,diagnosis,and treatment response in ASD.

  14. Treatment options for nonalcoholic steatohepatitis - a safety evaluation.

    Science.gov (United States)

    Issa, Danny; Wattacheril, Julia; Sanyal, Arun J

    2017-08-01

    There is an urgent as yet unmet need to develop highly effective and safe therapeutics for nonalcoholic fatty liver disease (NAFLD). The remarkable progress in understanding NAFLD pathogenesis allowed the identification of injury pathways which may be recruited as therapy targets. Areas covered: This article reviews the safety and tolerability data of the NAFLD therapies and explains the mechanistic basis for each of the established and investigational drugs. Treatment targets include: weight loss, anti-metabolic agents such as lipid lowering and anti-diabetic drugs, inflammation, fibrosis and others such as targeting gut microbiota, immune modulation and apoptosis. Expert opinion: Current therapies continue to remain suboptimal. Weight loss is effective but hard to achieve. Traditional and endoscopic bariatric procedures are promising although more randomized trials are needed and the long-term safety remains to be established. Clinical trials have demonstrated the efficacy of several drugs for the treatment of NASH. Of these, there remains some uncertainty about the long-term safety of vitamin E. Pioglitazone is associated with osteopenia, fluid retention and weight gain. Obeticholic acid causes pruritus in a substantial proportion of subjects and elafibranor has been associated with transient rises in creatinine. Several exciting therapies are under development and results of clinical and post-marketing trials will help elucidate their safety.

  15. New Topical Treatment Options for Actinic Keratosis: A Systematic Review.

    Science.gov (United States)

    Stockfleth, Eggert; Sibbring, Gillian C; Alarcon, Ivette

    2016-01-01

    This systematic review compared the relative efficacy of 5-fluorouracil 0.5% in salicylic acid 10% (5-FU/SA), ingenol mebutate (IMB) and imiquimod 2.5%/3.75% (IMI) for actinic keratosis on the face, forehead or scalp. Only 11 publications, relating to 7 randomised controlled trials, met inclusion criteria and it was only possible to compare the effect of all 3 treatments on complete clinical clearance, and the effect of 5-FU/SA and IMB on actinic keratosis recurrence rate. Despite a higher vehicle response rate for 5-FU/SA, complete clinical clearance was higher than IMB and IMI (55.4, 42.2, and 25.0-30.6/34.0-35.6%, [corrected] respectively). 5-FU/SA was also associated with lower actinic keratosis recurrence rate than IMB at 12 months post-treatment (32.7 vs. 53.9%). Although qualitative assessment suggested a numerical advantage of 5-FU/SA over IMB and IMI in terms of complete clinical clearance and sustained clearance, clinical data from longer term trials, with comparable outcome measures, are required to corroborate these findings.

  16. Clostridium difficile infection: current, forgotten and emerging treatment options.

    Science.gov (United States)

    Drekonja, Dimitri M

    2014-09-01

    Clostridium difficile infection (CDI) has increased in incidence and severity, and is now among the most common nosocomial infections. Several agents are available for the initial treatment of CDI, some of which are rarely used, and none of which is clearly superior for initial clinical cure. Fidaxomicin appears to offer a benefit in terms of preventing recurrent disease, although the cost-benefit ratio is debated. Recurrent CDI is a major challenge, occurring after 15-30% of initial episodes. The treatment of recurrent CDI is difficult, with sparse evidence available to support any particular agent. Fecal microbiota therapy, also known as 'stool transplantation', appears to be highly effective, although availability is currently limited, and the regulatory environment is in flux. Synthetic stool products and an orally available fecal microbiota therapy product are both under investigation, which may address the problem of availability. As with most infectious diseases, an effective vaccine would be a welcome addition to our armamentarium, but none is currently available.

  17. Depression in Parkinson's disease: impediments to recognition and treatment options.

    Science.gov (United States)

    Poewe, W; Luginger, E

    1999-01-01

    By some estimates, nearly half of patients with PD also suffer depression. Because features of PD frequently overlap with typical manifestations of major affective disorder (or mild dysthymia), both diagnosis and treatment of this comorbidity are challenging. Some of these interactive features include cognitive and speech deficits and impairments in emotional expression (e.g., PD-related facial masking) or processing. Parkinsonian depression probably is caused by an independent abnormality rather than as a maladaptive response to disease, in that the degree of depression is not correlated with PD severity. Prognostically, depressive features (e.g., introversion, inflexibility) may represent a subtle premorbid state heralding the onset of PD or an accelerated cognitive decline thereafter. Therapeutic mainstays for parkinsonian depression include psychosocial counseling at the time of PD diagnosis (and during advanced stages of PD) as well as appropriate medication regimens, the relative clinical efficacy of which remain a matter of ongoing clinical inquiry: levodopa, dopamine agonists, selegilene, tricyclic antidepressants, and selective serotonin reuptake inhibitors). This review formulates a rational treatment algorithm to assist in clinical management of parkinsonian depression, an enormously complex clinical entity.

  18. Aggression in autism spectrum disorder: presentation and treatment options

    Directory of Open Access Journals (Sweden)

    Fitzpatrick SE

    2016-06-01

    Full Text Available Sarah E Fitzpatrick, Laura Srivorakiat, Logan K Wink, Ernest V Pedapati, Craig A Erickson Cincinnati Children’s Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, OH, USA Abstract: Autism spectrum disorder (ASD is a neurodevelopmental disorder characterized by persistent difficulties in social communication and social interaction, coupled with restricted, repetitive patterns of behavior or interest. Research indicates that aggression rates may be higher in individuals with ASD compared to those with other developmental disabilities. Aggression is associated with negative outcomes for children with ASD and their caregivers, including decreased quality of life, increased stress levels, and reduced availability of educational and social support. Therapeutic strategies including functional behavioral assessment, reinforcement strategies, and functional communication training may have a significant impact in reducing the frequency and intensity of aggressive behavior in individuals with ASD. Pharmacologic treatments, particularly the use of second-generation antipsychotics, may also be of some benefit in reducing aggression in individuals with ASD. With the ever-increasing rate of ASD diagnosis, development of effective therapeutic and pharmacologic methods for preventing and treating aggression are essential to improving outcomes in this disorder. Keywords: autism, autism spectrum disorder, aggression, treatment, antipsychotics, applied behavior analysis

  19. Thorium based fuel options for the generation of electricity: Developments in the 1990s

    International Nuclear Information System (INIS)

    2000-05-01

    The IAEA has maintained an interest in the thorium fuel cycle and its worldwide utilization within its framework of activities. Periodic reviews have assessed the current status of this fuel cycle, worldwide applications, economic benefits, and perceived advantages with respect to other nuclear fuel cycles. Since 1994, the IAEA convened a number of technical meetings on the thorium fuel cycle and related issues. Between 1995 and 1997 individual contributions on the thorium fuel cycle were elicited from experts from France, Germany, India, Japan, the Russian Federation and the USA. These contributions included evaluations of the status of the thorium fuel cycle worldwide; the new incentives to use thorium due to large stockpiles of plutonium produced in nuclear reactors; new reactor concepts utilizing thorium; strategies for thorium use; and an evaluation of toxicity of the thorium fuel cycle waste compared to that from other fuel cycles. The results of this updated evaluation are summarized in this publication

  20. Pediatric Crohn's disease: epidemiology and emerging treatment options

    Directory of Open Access Journals (Sweden)

    Kansal S

    2014-07-01

    Full Text Available Shivani Kansal,1–3 Anthony G Catto-Smith1,2 1Department of Paediatrics, University of Melbourne, 2Department of Gastroenterology, The Royal Children's Hospital Melbourne, 3Murdoch Children's Research Institute, Melbourne, VIC, Australia Abstract: There has been a dramatic increase in the incidence of Crohn's disease over the last two to three decades worldwide, which has affected both the developed world and increasingly also the developing world. Crohn's disease is a disease of youth and can have a profound effect on the growing child, both in terms of growth and skeletal health as well psychosocial maturation. Environmental risk factors appear to be crucially important, but it is not clear at present whether improved hygiene, especially in childhood, influences immunological conditioning, or whether there is a direct impact on the gut from a disturbed gut microbiota. Genetic variation appears to relate to how the host interacts with its microbiota, determining susceptibility rather than causation. The outcome is a sustained immune response, clinically presenting as a relapsing/remitting disease process. There is no current cure for Crohn's disease; treatments are designed to reduce symptoms and control inflammation, initially by inducing a remission, then trying to maintain it. Historical therapies have included 5-aminosalicylic acid-based drugs, corticosteroids, and immunomodulators. Two approaches which are gaining increasing interest are the use of exclusive enteral nutrition and biologicals. Enteral nutrition is a remarkably effective approach, though there is a limited understanding of its mechanism and difficulties in acceptance among the medical community. Biologicals are a class of drugs which specifically target molecules and pathways central to the inflammatory process; they are also very effective, but patients can develop a secondary loss of response as a result of antibodies to the biological agent. Infection and the development

  1. Assessing environmental and health impact of the nuclear fuel cycle. Methodology and application to prospective actinides recycling options

    International Nuclear Information System (INIS)

    Garzenne, Claude; Grouiller, Jean-Paul; Le Boulch, Denis

    2005-01-01

    French Industrial Companies: EDF, AREVA (COGEMA and FRAMATOME-ANP), associated with ANDRA, the organization in charge of the waste management in France, and Public Research Institute CEA and IRSN, involved in the nuclear waste management, have developed in collaboration a methodology intended to assess the environmental and health impact of the nuclear fuel cycle. This methodology, based on fuel cycle simulation, Life Cycle Analysis, and Impact Studies of each fuel cycle facilities, has been applied to a set of nuclear scenarios covering a very contrasted range of waste management options, in order to characterize the effect of High Level Waste transmutation, and to estimate to what extent it could contribute to reduce their overall impact on health and environment. The main conclusion we could draw from this study is that it is not possible to discriminate, as far as health and environmental impacts are concerned, nuclear scenarios implementing very different levels of HLW transmutation, representative of the whole range of available options. The main limitation of this work is due to the hypothesis of normal behavior of all fuel cycle facilities: main future improvement of the methodology would be to take the accidental risk into account. (author)

  2. A review of treatment options for Graves' disease: why total thyroidectomy is a viable option in selected patients.

    Science.gov (United States)

    Mohan, Vinuta; Lind, Robert

    2016-01-01

    Graves' disease is the most common cause of hyperthyroidism. If left untreated, patients may have multiple systemic complications such as cardiac, reproductive, and skeletal disease. Thionamides, such as methimazole and propylthiouracil, and I(131) iodine ablation are the most commonly prescribed treatment for Graves' disease. Total thyroidectomy is often overlooked for treatment and is usually only offered if the other options have failed. In our case, we discuss a patient who was admitted to our medical center with symptomatic hyperthyroidism secondary to long-standing Graves' disease. She had a history of non-compliance with medications and medical clinic follow-up. The risks and benefits of total thyroidectomy were explained and she consented to surgery. A few months after the procedure, she was biochemically and clinically euthyroid on levothyroxine. She had no further emergency room visits or admissions for uncontrolled thyroid disease. Here we review the advantages and disadvantages of the more typically prescribed treatments, thionamides and I(131)iodine ablation. We also review the importance of shared decision making and the benefits of total thyroidectomy for the management of Graves' disease. Given the improvement in surgical techniques over the past decade and a significant reduction of complications, we suggest total thyroidectomy be recommended more often for patients with Graves' disease.

  3. Current options and new developments in the treatment of haemophilia.

    Science.gov (United States)

    Wong, Trisha; Recht, Michael

    2011-02-12

    Haemophilia A and B are X-linked bleeding disorders due to the inherited deficiency of factor VIII or factor IX, respectively. Of the approximately 1 per 5000-10000 male births affected by haemophilia, 80% are deficient in factor VIII and 20% are deficient in factor IX. Haemophilia is characterized by spontaneous and provoked joint, muscle, gastrointestinal and CNS bleeding leading to major morbidity and even mortality if left untreated or under-treated. The evolution of haemophilia management has been marked by tragedy and triumph over recent decades. Clotting factors and replacement strategies continue to evolve for patients without inhibitors. For patients with an inhibitor, factor replacement for acute bleeding episodes and immune tolerance, immune modulation and extracorporeal methods for inhibitor reduction are the cornerstone of care. In addition, adjuvant therapies such as desmopressin, antifibrinolytics and topical agents also contribute to improved outcomes for patients with and without inhibitors. The future direction of haemophilia care is promising with new longer-acting clotting factors and genetic therapies, including gene transfer and premature termination codon suppressors. With these current and future treatment modalities, the morbidity and mortality rates in patients with haemophilia certainly will continue to improve.

  4. Acinetobacter baumannii: Evolution of Antimicrobial Resistance—Treatment Options

    Science.gov (United States)

    Doi, Yohei; Murray, Gerald L.; Peleg, Anton Y.

    2015-01-01

    The first decade of the 20th century witnessed a surge in the incidence of infections due to several highly antimicrobial-resistant bacteria in hospitals worldwide. Acinetobacter baumannii is one such organism that turned from an occasional respiratory pathogen into a major nosocomial pathogen. An increasing number of A. baumannii genome sequences have broadened our understanding of the genetic makeup of these bacteria and highlighted the extent of horizontal transfer of DNA. Animal models of disease combined with bacterial mutagenesis have provided some valuable insights into mechanisms of A. baumannii pathogenesis. Bacterial factors known to be important for disease include outer membrane porins, surface structures including capsule and lipopolysaccharide, enzymes such as phospholipase D, iron acquisition systems, and regulatory proteins. A. baumannii has a propensity to accumulate resistance to various groups of antimicrobial agents. In particular, carbapenem resistance has become commonplace, accounting for the majority of A. baumannii strains in many hospitals today. Carbapenem-resistant strains are often resistant to all other routinely tested agents. Treatment of carbapenem-resistant A. baumannii infection therefore involves the use of combinations of last resort agents such as colistin and tigecycline, but the efficacy and safety of these approaches are yet to be defined. Antimicrobial-resistant A. baumannii has high potential to spread among ill patients in intensive care units. Early recognition and timely implementation of appropriate infection control measures is crucial in preventing outbreaks. PMID:25643273

  5. Pramipexole Extended Release: A Novel Treatment Option in Parkinson's Disease

    Directory of Open Access Journals (Sweden)

    Wolfram Eisenreich

    2010-01-01

    Full Text Available Pramipexole, the most commonly prescribed dopamine agonist worldwide, meanwhile serves as a reference substance for evaluation of new drugs. Based on numerous clinical data and vast experiences, efficacy and safety profiles of this non-ergoline dopamine agonist are well characterized. Since October 2009, an extended-release formulation of pramipexole has been available for symptomatic treatment of Parkinson's disease. Pramipexole administration can be cut down from three times to once a day due to the newly developed extended-release formulation. This is considerable progress in regard to minimizing pill burden and enhancing compliance. Moreover, the 24 h continuous drug release of the once-daily extended-release formulation results in fewer fluctuations in plasma concentrations over time compared to immediate-release pramipexole, given three times daily. The present study summarizes pharmacokinetics and all essential pharmacological and clinical characteristics of the extended-release formulation. In addition, it provides all study data, available so far, with regard to transition and de-novo administration of extended-release formulation for patients with Parkinson's disease. It further compares efficacy and safety data of immediate-release pramipexole with the extended-release formulation of pramipexole.

  6. Targeting Gonadotropins: An Alternative Option for Alzheimer Disease Treatment

    Directory of Open Access Journals (Sweden)

    Gemma Casadesus

    2006-01-01

    Full Text Available Recent evidence indicates that, alongside oxidative stress, dysregulation of the cell cycle in neurons susceptible to degeneration in Alzheimer disease may play a crucial role in the initiation of the disease. As such, the role of reproductive hormones, which are closely associated with the cell cycle both during development and after birth, may be of key import. While estrogen has been the primary focus, the protective effects of hormone replacement therapy on cognition and dementia only during a “crucial period” led us to expand the study of hormonal influences to other members of the hypothalamic pituitary axis. Specifically, in this review, we focus on luteinizing hormone, which is not only increased in the sera of patients with Alzheimer disease but, like estrogen, is modulated by hormone replacement therapy and also influences cognitive behavior and pathogenic processing in animal models of the disease. Targeting gonadotropins may be a useful treatment strategy for disease targeting multiple pleiotropic downstream consequences.

  7. LANGERHANS CELL HISTIOCYTOSIS OF THE SCAPULA - DIAGNOSIS & TREATMENT OPTIONS

    Directory of Open Access Journals (Sweden)

    ROHIT PANDEY

    Full Text Available ABSTRACT Langerhans cell histiocytosis (LCH is characterised by an abnormal histiocytic accumulation in tissues such as the lung, spleen, bone marrow, skin, central nervous system, liver and lymph nodes, causing focal or systemic effects. No specific clinical & radiographic presentation of LCH is described in literature. This poses a diagnostic dilemma for surgeons. The scapula is the site of 3% of bone tumours, while for LCH it is the least common site. In a 10-year-old boy with isolated lesion of the scapula with no other systemic involvement, and no specific finding in MRI or CT scan of scapula, diagnosis was confirmed on biopsy. Division into single and multi-system disease is paramount in treatment, given that it is a single system disease. The patient improved clinically on follow-up of 2 years. The scapula is one of the rarest site of LCH, and because various lesions mimic each other, a biopsy is always required, with immunohistochemistry for CD68 & S-100. This was only a single system disease, so conservative management was performed, and the patent improved clinically.

  8. Treatment options for low-level radiologically contaminated ORNL filtercake

    International Nuclear Information System (INIS)

    Lee, Hom-Ti; Bostick, W.D.

    1996-04-01

    Water softening sludge (>4000 stored low level contaminated drums; 600 drums per year) generated by the ORNL Process Waste Treatment Plant must be treated, stabilized, and placed in safe storage/disposal. The sludge is primarily CaCO 3 and is contaminated by low levels of 90 Sr and 137 Cs. In this study, microwave sintering and calcination were evaluated for treating the sludge. The microwave melting experiments showed promise: volume reductions were significant (3-5X), and the waste form was durable with glass additives (LiOH, fly ash). A commercial vendor using surrogate has demonstrated a melt mineralization process that yields a dense monolithic waste form with a volume reduction factor (VR) of 7.7. Calcination of the sludge at 850-900 C yielded a VR of 2.5. Compaction at 4500 psi increased the VR to 4.2, but the compressed form is not dimensionally stable. Addition of paraffin helped consolidate fines and yielded a VR of 3.5. In conclusion, microwave melting or another form of vitrification is likely to be the best method; however for immediate implementation, the calculation/compaction/waxing process is viable

  9. Urinary tract infections in women: etiology and treatment options

    Directory of Open Access Journals (Sweden)

    Minardi D

    2011-04-01

    Full Text Available Daniele Minardi, Gianluca d'Anzeo, Daniele Cantoro, Alessandro Conti, Giovanni MuzzonigroDepartment of Clinical and Specialist Sciences, Urology, Polytechnic University of the Marche Medical School and United Hospitals, Ancona, ItalyAbstract: Urinary tract infections (UTI are common among the female population. It has been calculated that about one-third of adult women have experienced an episode of symptomatic cystitis at least once. It is also common for these episodes to recur. If predisposing factors are not identified and removed, UTI can lead to more serious consequences, in particular kidney damage and renal failure. The aim of this review was to analyze the factors more commonly correlated with UTI in women, and to see what possible solutions are currently used in general practice and specialized areas, as well as those still under investigation. A good understanding of the possible pathogenic factors contributing to the development of UTI and its recurrence will help the general practitioner to interview the patient, search for causes that would otherwise remain undiscovered, and to identify the correct therapeutic strategy.Keywords: urinary tract infection, women, etiology, diagnosis, treatment

  10. A neutronics study of LEU fuel options for the HFR-Petten

    International Nuclear Information System (INIS)

    Deen, J.R.; Snelgrove, J.L.

    1985-01-01

    The standard HEU fuel cycle characteristics are compared with those of several different LEU fuel cycles in the new vessel configuration. The primary design goals were to provide similar reactivity performance and neutron flux profiles with a minimal increase in 235 U loading. The fuel cycle advantages of Cd burnable absorbers over 10 B are presented. The LEU fuel cycle requirements were calculated also for an extended 32-day cycle and for a reload batch size reduction from six to five standard elements for the standard 26-day cycle. The effects of typical in-core experiments upon neutron flux profiles and fuel loading requirements are also presented. (author)

  11. Targeting metastatic colorectal cancer – present and emerging treatment options

    Directory of Open Access Journals (Sweden)

    Ciombor KK

    2014-07-01

    Full Text Available Kristen K Ciombor,1 Jordan Berlin21Division of Medical Oncology, Department of Medicine, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA; 2Division of Hematology/Oncology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Nashville, TN, USAAbstract: Metastatic colorectal cancer is a significant cause of morbidity and mortality in the US and around the world. While several novel cytotoxic and biologic therapies have been developed and proven efficacious in the past two decades, their optimal use in terms of patient selection, drug combinations, and regimen sequences has yet to be defined. Recent investigations regarding anti-epidermal growth factor receptor therapies include the comparison of single-agent panitumumab and cetuximab, the benefit of adding cetuximab to chemotherapy in the conversion therapy setting, the comparison of cetuximab and bevacizumab when added to first-line chemotherapy, and predictive biomarkers beyond KRAS exon 2 (codons 12 and 13 mutations. With respect to anti-vascular endothelial growth factor therapies, new data on continuing bevacizumab beyond disease progression on a bevacizumab-containing chemotherapy regimen, the addition of bevacizumab to triplet chemotherapy in the first-line setting, maintenance therapy with bevacizumab plus either capecitabine or erlotinib, the addition of aflibercept to chemotherapy, and regorafenib as monotherapy have emerged. Recent scientific and technologic advances in the field of metastatic colorectal cancer promise to elucidate the biological underpinnings of this disease and its therapies for the goal of improving personalized treatments for patients with metastatic colorectal cancer.Keywords: cetuximab, panitumumab, bevacizumab, aflibercept, regorafenib, biomarker

  12. Therapeutical options for the treatment of Cheyne-Stokes respiration.

    Science.gov (United States)

    Randerath, Winfried J

    2009-03-07

    The awareness of Cheyne-Stokes respiration (CSR) and of the co-existence of the obstructive sleep apnoea syndrome and central breathing disturbances has rapidly grown in recent years. CSR is defined by a waxing and waning pattern of the breathing amplitude. Sleep related breathing disorders in patients with heart failure are associated with impaired clinical outcome and survival. While continuous positive airway pressure treatment (CPAP) is widely used to treat CSR, it has failed to improve overall survival of heart failure patients. Nevertheless, it has been shown that CPAP reduces mortality if breathing disturbances were sufficiently eliminated. Therefore, optimal suppression of CSR is critical. While CPAP reduces CSR by 50% on average, adaptive servoventilation (ASV) normalises CSR in most patients. ASV devices apply different levels of pressure support: during periods of hypoventilation the inspiratory pressure is increased while it is reduced to the lowest possible level during hyperventilation. The devices deliver an expiratory pressure to overcome upper airways obstruction. Pressure support is defined by the difference between expiratory and inspiratory pressure. Thus, while pressure support is fixed in bilevel devices, it varies under ASV. However, the hypothesis that ASV might improve survival in CSR patients has to be proved in prospective studies in CPAP nonresponders. There is a lack of evidence on the use of bilevel devices in CSR. However, ASV has proven both to effectively treat CSR and to be superior to CPAP in respiratory and sleep parameters in short term and medium term studies. Nevertheless, data on the long term use and the influence on cardiac parameters are necessary.

  13. An integrated appraisal of energy recovery options in the United Kingdom using solid recovered fuel derived from municipal solid waste.

    Science.gov (United States)

    Garg, A; Smith, R; Hill, D; Longhurst, P J; Pollard, S J T; Simms, N J

    2009-08-01

    This paper reports an integrated appraisal of options for utilising solid recovered fuels (SRF) (derived from municipal solid waste, MSW) in energy intensive industries within the United Kingdom (UK). Four potential co-combustion scenarios have been identified following discussions with industry stakeholders. These scenarios have been evaluated using (a) an existing energy and mass flow framework model, (b) a semi-quantitative risk analysis, (c) an environmental assessment and (d) a financial assessment. A summary of results from these evaluations for the four different scenarios is presented. For the given ranges of assumptions; SRF co-combustion with coal in cement kilns was found to be the optimal scenario followed by co-combustion of SRF in coal-fired power plants. The biogenic fraction in SRF (ca. 70%) reduces greenhouse gas (GHG) emissions significantly ( approximately 2500 g CO(2) eqvt./kg DS SRF in co-fired cement kilns and approximately 1500 g CO(2) eqvt./kg DS SRF in co-fired power plants). Potential reductions in electricity or heat production occurred through using a lower calorific value (CV) fuel. This could be compensated for by savings in fuel costs (from SRF having a gate fee) and grants aimed at reducing GHG emission to encourage the use of fuels with high biomass fractions. Total revenues generated from coal-fired power plants appear to be the highest ( 95 pounds/t SRF) from the four scenarios. However overall, cement kilns appear to be the best option due to the low technological risks, environmental emissions and fuel cost. Additionally, cement kiln operators have good experience of handling waste derived fuels. The scenarios involving co-combustion of SRF with MSW and biomass were less favourable due to higher environmental risks and technical issues.

  14. An integrated appraisal of energy recovery options in the United Kingdom using solid recovered fuel derived from municipal solid waste

    International Nuclear Information System (INIS)

    Garg, A.; Smith, R.; Hill, D.; Longhurst, P.J.; Pollard, S.J.T.; Simms, N.J.

    2009-01-01

    This paper reports an integrated appraisal of options for utilising solid recovered fuels (SRF) (derived from municipal solid waste, MSW) in energy intensive industries within the United Kingdom (UK). Four potential co-combustion scenarios have been identified following discussions with industry stakeholders. These scenarios have been evaluated using (a) an existing energy and mass flow framework model, (b) a semi-quantitative risk analysis, (c) an environmental assessment and (d) a financial assessment. A summary of results from these evaluations for the four different scenarios is presented. For the given ranges of assumptions; SRF co-combustion with coal in cement kilns was found to be the optimal scenario followed by co-combustion of SRF in coal-fired power plants. The biogenic fraction in SRF (ca. 70%) reduces greenhouse gas (GHG) emissions significantly (∼2500 g CO 2 eqvt./kg DS SRF in co-fired cement kilns and ∼1500 g CO 2 eqvt./kg DS SRF in co-fired power plants). Potential reductions in electricity or heat production occurred through using a lower calorific value (CV) fuel. This could be compensated for by savings in fuel costs (from SRF having a gate fee) and grants aimed at reducing GHG emission to encourage the use of fuels with high biomass fractions. Total revenues generated from coal-fired power plants appear to be the highest ( Pounds 95/t SRF) from the four scenarios. However overall, cement kilns appear to be the best option due to the low technological risks, environmental emissions and fuel cost. Additionally, cement kiln operators have good experience of handling waste derived fuels. The scenarios involving co-combustion of SRF with MSW and biomass were less favourable due to higher environmental risks and technical issues.

  15. Comprehensive Genomic Profiling of Esthesioneuroblastoma Reveals Additional Treatment Options.

    Science.gov (United States)

    Gay, Laurie M; Kim, Sungeun; Fedorchak, Kyle; Kundranda, Madappa; Odia, Yazmin; Nangia, Chaitali; Battiste, James; Colon-Otero, Gerardo; Powell, Steven; Russell, Jeffery; Elvin, Julia A; Vergilio, Jo-Anne; Suh, James; Ali, Siraj M; Stephens, Philip J; Miller, Vincent A; Ross, Jeffrey S

    2017-07-01

    gene was TP53 (17%), and alterations in PIK3CA , NF1 , CDKN2A , or CDKN2C were identified in 7% of samples. Responses to treatment with the kinase inhibitors sunitinib, everolimus, and pazopanib are presented in conjunction with tumor genomics. © AlphaMed Press 2017.

  16. Using fine-scale fuel measurements to assess wildland fuels, potential fire behavior and hazard mitigation treatments in the southeastern USA

    International Nuclear Information System (INIS)

    Ottmar, Roger D.; Blake, John I.; Crolly, William T.

    2012-01-01

    The inherent spatial and temporal heterogeneity of fuelbeds in forests of the southeastern United States may require fine scale fuel measurements for providing reliable fire hazard and fuel treatment effectiveness estimates. In a series of five papers, an intensive, fine scale fuel inventory from the Savanna River Site in the southeastern United States is used for building fuelbeds and mapping fire behavior potential, evaluating fuel treatment options for effectiveness, and providing a comparative analysis of landscape modeled fire behavior using three different data sources including the Fuel Characteristic Classification System, LANDFIRE, and the Southern Wildfire Risk Assessment. The research demonstrates that fine scale fuel measurements associated with fuel inventories repeated over time can be used to assess broad scale wildland fire potential and hazard mitigation treatment effectiveness in the southeastern USA and similar fire prone regions. Additional investigations will be needed to modify and improve these processes and capture the true potential of these fine scale data sets for fire and fuel management planning.

  17. Economic potential of fuel recycling options: A lifecycle cost analysis of future nuclear system transition in China

    International Nuclear Information System (INIS)

    Gao, Ruxing; Choi, Sungyeol; Il Ko, Won; Kim, Sungki

    2017-01-01

    In today's profit-driven market, how best to pursue advanced nuclear fuel cycle technologies while maintaining the cost competitiveness of nuclear electricity is of crucial importance to determine the implementation of spent fuel reprocessing and recycling in China. In this study, a comprehensive techno-economic analysis is undertaken to evaluate the economic feasibility of ongoing national projects and the technical compatibility with China's future fuel cycle transition. We investigated the dynamic impacts of technical and economic uncertainties in the lifecycle of a nuclear system. The electricity generation costs associated with four potential fuel cycle transition scenarios were simulated by probabilistic and deterministic approaches and then compared in detail. The results showed that the total cost of a once-through system is lowest compared those of other advanced systems involving reprocessing and recycling. However, thanks to the consequential uncertainties caused by the further progress toward technology maturity, the economic potential of fuel recycling options was proven through a probabilistic uncertainty analysis. Furthermore, it is recommended that a compulsory executive of closed fuel cycle policy would pose some investment risk in the near term, though the execution of a series of R&D initiatives with a flexible roadmap would be valuable in the long run. - Highlights: • Real-time economic performance of the four scenarios of China's nuclear fuel cycle system transition until 2100. • Systematic assessments of techno-economic feasibility for ongoing national reprocessing projects. • Investigation the cost impact on nuclear electricity generation caused by uncertainties through probabilistic analysis. • Recommendation for sustainable implementation of fuel cycle R&D initiative ingrate with flexible roadmap in the long run.

  18. Spent fuel verification options for final repository safeguards in Finland. A study on verification methods, their feasibility and safety aspects

    International Nuclear Information System (INIS)

    Hautamaeki, J.; Tiitta, A.

    2000-12-01

    The verification possibilities of the spent fuel assemblies from the Olkiluoto and Loviisa NPPs and the fuel rods from the research reactor of VTT are contemplated in this report. The spent fuel assemblies have to be verified at the partial defect level before the final disposal into the geologic repository. The rods from the research reactor may be verified at the gross defect level. Developing a measurement system for partial defect verification is a complicated and time-consuming task. The Passive High Energy Gamma Emission Tomography and the Fork Detector combined with Gamma Spectrometry are the most potential measurement principles to be developed for this purpose. The whole verification process has to be planned to be as slick as possible. An early start in the planning of the verification and developing the measurement devices is important in order to enable a smooth integration of the verification measurements into the conditioning and disposal process. The IAEA and Euratom have not yet concluded the safeguards criteria for the final disposal. E.g. criteria connected to the selection of the best place to perform the verification. Measurements have not yet been concluded. Options for the verification places have been considered in this report. One option for a verification measurement place is the intermediate storage. The other option is the encapsulation plant. Crucial viewpoints are such as which one offers the best practical possibilities to perform the measurements effectively and which would be the better place in the safeguards point of view. Verification measurements may be needed both in the intermediate storages and in the encapsulation plant. In this report also the integrity of the fuel assemblies after wet intermediate storage period is assessed, because the assemblies have to stand the handling operations of the verification measurements. (orig.)

  19. Fuel cycle options for light water reactors and heavy water reactors. Proceedings of a technical committee meeting

    International Nuclear Information System (INIS)

    1999-11-01

    In the second half of the 20th century nuclear power has evolved from the research and development environment to an industry that supplies 16% of the world's electricity. By the end of 1997, over 8500 reactor-years of operating experience had been accumulated. Global environmental change, and the continuing increase in global energy supply required to provide increasing populations with an improving standard of living, make the contribution from nuclear energy even more important for the next century. For nuclear power to achieve its full potential and make its needed contribution, it must be safe, economical, reliable and sustainable. All of these factors can be enhanced by judicious choice and development of advanced fuel cycle options. The Technical Committee Meeting (TCM) on Fuel Cycle Options for Light Water Reactors and Heavy Water Reactors was hosted by Atomic Energy of Canada Limited (AECL) on behalf of the Canadian Government and was jointly conducted within the frame of activities of the IAEA International Working Group on Advanced Technologies for Light Water Reactors (IWG-LWR) and the IAEA International Working Group on Advanced Technologies for Heavy Water Reactors (IWG-HWR). The TCM provided the opportunity to have in-depth discussions on important technical topics which were highlighted in the International Symposium on Nuclear Fuel Cycle and Reactor Strategies: Adjusting to New Realities, held in Vienna, 3-6 June 1997. The main results and conclusions of the TCM were presented as input for discussion at the first meeting of the IAEA newly formed International Working Group on Fuel Cycle Options

  20. Moderator configuration options for a low-enriched uranium fueled Kilowatt-class Space Nuclear Reactor

    International Nuclear Information System (INIS)

    King, Jeffrey C.; Mencarini, Leonardo de Holanda; Guimaraes, Lamartine N. F.

    2015-01-01

    The Brazilian Air Force, through its Institute for Advanced Studies (Instituto de Estudos Avancados, IEAv/DCTA), and the Colorado School of Mines (CSM) are studying the feasibility of a space nuclear reactor with a power of 1-5 kW e and fueled with Low-Enriched Uranium (LEU). This type of nuclear reactor would be attractive to signatory countries of the Non-Proliferation Treaty (NPT) or commercial interests. A LEU-fueled space reactor would avoid the security concerns inherent with Highly Enriched Uranium (HEU) fuel. As an initial step, the HEU-fueled Kilowatt Reactor Using Stirling Technology (KRUSTY) designed by the Los Alamos National Laboratory serves as a basis for a similar reactor fueled with LEU fuel. Using the computational code MCNP6 to predict the reactor neutronics performance, the size of the resulting reactor fueled with 19.75 wt% enriched uranium-10 wt% molybdenum alloy fuel is adjusted to match the excess reactivity of KRUSTY. Then, zirconium hydride moderator is added to the core to reduce the size of the reactor. This work presents the preliminary results of the computational modeling, with special emphasis on the comparison between homogeneous and heterogeneous moderator systems, in terms of the core diameter required to meet a specific multiplication factor (k eff = 1.035). This comparison illustrates the impact of moderator configuration on the size and performance of a LEU-fueled kilowatt-class space nuclear reactor. (author)

  1. Moderator configuration options for a low-enriched uranium fueled Kilowatt-class Space Nuclear Reactor

    Energy Technology Data Exchange (ETDEWEB)

    King, Jeffrey C., E-mail: kingjc@mines.edu [Nuclear Science and Engineering Program, Colorado School of Mines (CSM), Golden, CO (United States); Mencarini, Leonardo de Holanda; Guimaraes, Lamartine N. F., E-mail: guimaraes@ieav.cta.br, E-mail: mencarini@ieav.cta.br [Instituto de Estudos Avancados (IEAV), Sao Jose dos Campos, SP (Brazil). Divisao de Energia Nuclear

    2015-07-01

    The Brazilian Air Force, through its Institute for Advanced Studies (Instituto de Estudos Avancados, IEAv/DCTA), and the Colorado School of Mines (CSM) are studying the feasibility of a space nuclear reactor with a power of 1-5 kW{sub e} and fueled with Low-Enriched Uranium (LEU). This type of nuclear reactor would be attractive to signatory countries of the Non-Proliferation Treaty (NPT) or commercial interests. A LEU-fueled space reactor would avoid the security concerns inherent with Highly Enriched Uranium (HEU) fuel. As an initial step, the HEU-fueled Kilowatt Reactor Using Stirling Technology (KRUSTY) designed by the Los Alamos National Laboratory serves as a basis for a similar reactor fueled with LEU fuel. Using the computational code MCNP6 to predict the reactor neutronics performance, the size of the resulting reactor fueled with 19.75 wt% enriched uranium-10 wt% molybdenum alloy fuel is adjusted to match the excess reactivity of KRUSTY. Then, zirconium hydride moderator is added to the core to reduce the size of the reactor. This work presents the preliminary results of the computational modeling, with special emphasis on the comparison between homogeneous and heterogeneous moderator systems, in terms of the core diameter required to meet a specific multiplication factor (k{sub eff} = 1.035). This comparison illustrates the impact of moderator configuration on the size and performance of a LEU-fueled kilowatt-class space nuclear reactor. (author)

  2. Municipal solid waste options : integrating organics management and residual disposal treatment : executive summary

    Energy Technology Data Exchange (ETDEWEB)

    Cant, M. (comp.) [Totten Sims Hubicki Associates Ltd., Calgary, AB (Canada); Van der Werf, P. [2cg Inc., Edmonton, AB (Canada); Kelleher, M. [Kelleher Environmental, Toronto, ON (Canada); Merriman, D. [MacViro Consultants, Markham, ON (Canada); Fitcher, K. [Gartner Lee Ltd., Toronto, ON (Canada); MacDonald, N. [CH2M Hill Engineering Ltd., Calgary, AB (Canada)

    2006-04-15

    The Municipal Solid Waste (MSW) Options Report explored different MSW management options for 3 community sizes: 20,000, 80,000 and 200,0000 people. It was released at a time when many communities were developing waste management plans to cost-effectively reduce environmental impacts and conserve landfill capacity. The purpose of this report was to provide a greater understanding on the environmental, social, economic, energy recovery/utilization and greenhouse gas (GHG) considerations of MSW management. The report also demonstrated the interrelationships between the management of organics and residuals. It was based on information from existing waste diversion and organics management options and emerging residual treatment technology options. The following organics management and residual treatment disposal options were evaluated: composting; anaerobic digestion; sanitary landfills; bioreactor landfills; and thermal treatment. Composting was examined with reference to both source separated organics (SSO) and mixed waste composting. SSO refers to the separation of materials suitable for composting solid waste from households, while mixed waste composting refers to the manual or mechanical removal of recyclable material from the waste, including compost. The composting process was reviewed along with available technologies such as non-reactor windrow; aerated static pile; reactor enclosed channel; and, container tunnel. An evaluation of SSO and mixed waste composting was then presented in terms of environmental, social, financial and GHG impacts. refs., tabs., figs.

  3. Treatment Options

    Science.gov (United States)

    About Us Mission & History Board of Directors & Staff Our Accomplishments Annual Reports Our Videos Quick Links Drug Watch Clinical Trials Physician ... Laotian Mongolian Spanish Turkish Vietnamese Subscribe Donate About Us Mission & History Board of Directors & Staff Our Accomplishments Annual Reports ...

  4. Treatment Options

    Science.gov (United States)

    ... counteract their perception and reaction to tinnitus. Sound masking can cover the sound of tinnitus, while more ... list ATA never sells, shares, or rents personal data Patient Stories There are as many experiences of ...

  5. Remediation options and the significance of water treatment at former uranium production sites in Eastern Germany

    International Nuclear Information System (INIS)

    Gatzweiler, R.; Jakubick, A.T.; Kiessig, G.

    2000-01-01

    The WISMUT remediation project in the States of Saxony and Thuringia, Germany, comprises several mine and mill sites including large volumes of production residues. Due to the climate, the intensive land use and the regulatory conditions, the water path is most important in evaluating remediation options. Water treatment is an integral part of mine flooding, mine dump and tailings remediation, and treatment costs represent a major portion of the overall costs of the project. Uncertainties in the estimations of quantities of mine and seepage waters, variations in quality from site to site, and changing conditions in time demand a strategic approach to the selection and optimization of water treatment methods. The paper describes options considered and experience gained including efforts to limit long-term treatment costs by developing and applying passive treatment systems and negotiating acceptable discharge limits. (author)

  6. Spallator and APEX nuclear fuel cycle: a new option for nuclear power

    International Nuclear Information System (INIS)

    Steinberg, M.

    1982-01-01

    A new nuclear fuel cycle is described which provides a long term supply of nuclear fuel for the thermal LWR nuclear power reactors and eliminates the need for long-term storage of radioactive waste. Fissile fuel is produced by the Spallator which depends on the production of spallation neutrons by the interaction of high-energy (1 to 2 GeV) protons on a heavy-metal target. The neutrons are absorbed in a surrounding natural-uranium or thorium blanket in which fissile Pu-239 to U-233 is produced. Advances in linear accelerator technology makes it possible to design and construct a high-beam-current continuous-wave proton linac for production purposes. The target is similar to a sub-critical reactor and produces heat which is converted to electricity for supplying the linac. The Spallator is a self-sufficient fuel producer, which can compete with the fast breeder. The APEX fuel cycle depends on recycling the transuranics and long-lived fission products while extracting the stable and short-lived fission products when reprocessing the fuel. Transmutation and decay within the fuel cycle and decay of short-lived fission products external to the fuel cycle eliminates the need for long-term geological age shortage of fission-product waste

  7. A Barrier Options Approach to Modeling Project Failure : The Case of Hydrogen Fuel Infrastructure

    NARCIS (Netherlands)

    Engelen, P.J.; Kool, C.J.M.; Li, Y.

    2016-01-01

    Hydrogen fuel cell vehicles have the potential to contribute to a sustainable transport system with zero tailpipe emissions. This requires the construction of a network of fuel stations, a long-term, expensive and highly uncertain investment. We contribute to the literature by including a knock-out

  8. Spallator and APEX nuclear fuel cycle: a new option for nuclear power

    Energy Technology Data Exchange (ETDEWEB)

    Steinberg, M.

    1982-01-01

    A new nuclear fuel cycle is described which provides a long term supply of nuclear fuel for the thermal LWR nuclear power reactors and eliminates the need for long-term storage of radioactive waste. Fissile fuel is produced by the Spallator which depends on the production of spallation neutrons by the interaction of high-energy (1 to 2 GeV) protons on a heavy-metal target. The neutrons are absorbed in a surrounding natural-uranium or thorium blanket in which fissile Pu-239 to U-233 is produced. Advances in linear accelerator technology makes it possible to design and construct a high-beam-current continuous-wave proton linac for production purposes. The target is similar to a sub-critical reactor and produces heat which is converted to electricity for supplying the linac. The Spallator is a self-sufficient fuel producer, which can compete with the fast breeder. The APEX fuel cycle depends on recycling the transuranics and long-lived fission products while extracting the stable and short-lived fission products when reprocessing the fuel. Transmutation and decay within the fuel cycle and decay of short-lived fission products external to the fuel cycle eliminates the need for long-term geological age shortage of fission-product waste.

  9. Assessment of options for the treatment of Sizewell PWR liquid effluent

    International Nuclear Information System (INIS)

    Hornby, J.; Allam, J.; Knibbs, R.H.

    1992-01-01

    This report describes the origins of PWR liquid waste streams, their composition and rates of arising. Data has been collected from operational PWRs and estimates obtained for Sizewell B PWR liquid waste streams. Current liquid waste treatment practices are reviewed and assessments made of established and novel treatment techniques which could be applicable to Sizewell B. A short list of treatment options is given and recommendations are made relating to established treatment technologies suitable for Sizewell B and also to development work on more novel treatments which could lead to a reduction in waste disposal volumes. (author)

  10. New Fathers' Perinatal Depression and Anxiety-Treatment Options: An Integrative Review.

    Science.gov (United States)

    O'Brien, Anthony P; McNeil, Karen A; Fletcher, Richard; Conrad, Agatha; Wilson, Amanda J; Jones, Donovan; Chan, Sally W

    2017-07-01

    More than 10% of fathers experience depression and anxiety during the perinatal period, but paternal perinatal depression (PPND) and anxiety have received less attention than maternal perinatal mental health problems. Few mainstream treatment options are available for men with PPND and anxiety. The aim of this literature review was to summarize the current understanding of PPND and the treatment programs specifically designed for fathers with perinatal depression. Eight electronic databases were searched using a predefined strategy, and reference lists were also hand searched. PPND and anxiety were identified to have a negative impact on family relationships, as well as the health of mothers and children. Evidence suggests a lack of support and tailored treatment options for men having trouble adjusting to the transition to fatherhood. Of the limited options available, cognitive behavioral therapy, group work, and blended delivery programs, including e-support approaches appear to be most effective in helping fathers with perinatal depression and anxiety. The review findings have important implications for the understanding of PPND and anxiety. Future research is needed to address the adoption of father-inclusive and father-specific models of care to encourage fathers' help-seeking behavior. Inclusion of male-specific requirements into support and treatment options can improve the ability of services to engage new fathers. Psychotherapeutic intervention could assist to address the cognitive differences and dissonance for men adjusting to the role of father, including male identity and role expectations.

  11. Biofeedback as complementary treatment in patients with epilepsy – an underestimated therapeutic option? Review, results, discussion

    Directory of Open Access Journals (Sweden)

    Uhlmann Carmen

    2016-12-01

    Full Text Available Background. Biofeedback methods represent side effect free complementary options in the treatment of epilepsy. In this paper we review the current status of these methods in terms of clinical study results and their evaluation by systematic review papers. Possible mechanisms of action in biofeedback methods are discussed.

  12. Split high-dose oral levothyroxine treatment as a successful therapy option in myxedema coma.

    Science.gov (United States)

    Charoensri, Suranut; Sriphrapradang, Chutintorn; Nimitphong, Hataikarn

    2017-10-01

    High-dose intravenous thyroxine (T4) is the preferable treatment for myxedema coma. We describe the clinical course of a 69-year-old man who presented with myxedema coma and received oral levothyroxine (LT4) therapy (1 mg) in a split dose. This suggests split high-dose oral LT4 as a therapeutic option in myxedema coma.

  13. Bronchiolitis obliterans after allo-SCT: clinical criteria and treatment options

    DEFF Research Database (Denmark)

    Uhlving, H H; Buchvald, F; Heilmann, C J

    2012-01-01

    Bronchiolitis obliterans (BO) following allogeneic haematopoietic SCT (HSCT) is a serious complication affecting 1.7-26% of the patients, with a reported mortality rate of 21-100%. It is considered a manifestation of chronic graft-versus-host disease, but our knowledge of aetiology and pathogenes...... treatment options for BO and presents the treatment results with HDPM in a paediatric national HSCT-cohort.Bone Marrow Transplantation advance online publication, 29 August 2011; doi:10.1038/bmt.2011.161....

  14. Interim spent-fuel storage options at commercial nuclear power plants

    International Nuclear Information System (INIS)

    Thakkar, A.R.; Hylko, J.M.

    1991-01-01

    Although spent fuel can be stored safely in waterfilled pools at reactor sites, some utilities may not possess sufficient space for life-of-plant storage capability. In-pool storage capability may be increased by reracking assemblies, rod consolidation, double tiering spent-fuel racks, and by shipping spent fuel to other utility-owned facilities. Long-term on-site storage capability for spent fuel may be provided by installing (dry-type) metal casks, storage and transportation casks, concrete casks, horizontal concrete modules, modular concrete vaults, or by constructing additional (pool-type) storage installations. Experience to date has provided valuable information regarding dry-type or pool-type installations, cask handling and staffing requirements, security features, decommissioning activities, and radiological issues

  15. Fuel Options for Vehicles in Korea and Role of Nuclear Energy

    International Nuclear Information System (INIS)

    Jeong, Yong Hoon; Chang, Soon Heung

    2005-01-01

    Nowadays, almost all vehicles in Korea are powered by gasoline or diesel and they are emitting about 25% of nationwide total carbon dioxide emission. With jetting up price of oil and concerns about global warming by use of fossil fuel, transition to the hydrogen economy gains more and more interest. As alternatives to the current fossil powered vehicles, hybrid, hydrogen, electricity powered vehicles are considered. In short term we will reduce dependence upon fossil fuel by using hybrid cars. However, in the long term, we have to escape from the dependence on fossil fuel. In this context, nuclear-driven hydrogen or electricity powered cars are the alternatives. In this study, we estimated the operation cost of cars powered by hydrogen and electricity from nuclear power and studied about the major blocks on the way to independence from fossil fuels. In the analysis, we put the capital cost of car aside

  16. Study on partitioning and transmutation as a possible option for spent fuel management within a nuclear phase-out scenario

    Energy Technology Data Exchange (ETDEWEB)

    Fazion, C.; Rineiski, A.; Salvatores, M.; Schwenk-Ferrero, A.; Romanello, V.; Vezzoni, B.; Gabrielli, F. [Karlsruhe Institute of Technology - KIT, Hermann-von-Helmholtz Platz 1, 76344 Eggenstein-Leopoldshafen (Germany)

    2013-07-01

    Most Partitioning and Transmutation (PT) studies implicitly presuppose the continuous use of nuclear energy. In this case the development of new facilities or the modification of the fuel cycle can be justified in the long-term as an important feature in order to improve sustainability by minimizing radioactive waste and reducing the burden at waste disposal. In the case of a country with nuclear energy phase-out policy, the PT option might have also an important role for what concerns the final disposal strategies of the spent fuel. In this work three selected scenarios are analyzed in order to assess the impact of PT implementation in a nuclear energy phase out option. The scenarios are: -) Scenario 1: Identification of Research/Development activities needs for a technological development of PT while postponing the decision of PT implementation; -) Scenario 2: Isolated application of PT in a phase-out context; and -) Scenario 3: Implementation of PT in a European context. In order to facilitate the discrimination among the 3 scenarios, a number of figures of indicators have been evaluated for each scenario. The selected indicators are: the mass of High Level Waste (HLW), Uranium inventory, thermal output of HLW, Radiotoxicity, Fuel cycle secondary waste associated to the PT operation, and Facility capacity/number requirements. The reduction, due to PT implementation, of high level wastes masses and their associated volumes can be significant. For what concerns the thermal output and radiotoxicity a significant impact can be also expected. However, when assessing these two indicators the contribution coming from already vitrified waste should also not be neglected. Moreover, an increase of secondary waste inventory is also expected. On the contrary, the increase of fission product inventories due to the operation of the transmutation system has a relatively limited impact on the fuel cycle.

  17. Investigation of economics of nuclear fuel cycle options in the Republic of Korea based on once-through - 5468

    International Nuclear Information System (INIS)

    Cho, S.K.; Yim, M.S.

    2015-01-01

    This study performs an economic evaluation of future nuclear fuel cycle options based on once-through strategy. Various factors of the future development in Korea are also considered including nuclear phase-out, continuous use of nuclear energy at varying growth rate, and the reunification of the Korean peninsula. A spreadsheet model is developed as part of the methodology of screening material flow and economic evaluation and results are discussed for policy planning for Korea as well as for nuclear developing countries. Results indicated that economics improves as the size of nuclear power system increases. We found some significant factors that affect LCOE (levelized cost of electricity) of the back end fuel cycle. Expanded nuclear power program with further construction of nuclear power plant (continuous use and/or the reunification) is a major political variable for LCOE. To keep the cost of nuclear power as low as possible, it is very important to have a proper strategy for the back-end fuel cycle including decommissioning. For continued use of nuclear energy, the Korea needs to develop soon a long-term policy for the back-end fuel cycle rather than taking the 'sit and watch' approach to make best out of the use of nuclear power into the future

  18. Treatment Options for Severe Obesity in the Pediatric Population: Current Limitations and Future Opportunities.

    Science.gov (United States)

    Ryder, Justin R; Fox, Claudia K; Kelly, Aaron S

    2018-06-01

    Severe obesity is the only obesity classification increasing in prevalence among children and adolescents. Treatment options that produce meaningful and sustained weight loss and comorbidity resolution are urgently needed. The purpose of this review is to provide a brief overview of the current treatment options for pediatric severe obesity and offer suggestions regarding future opportunities for accelerating the development and evaluation of innovative treatment strategies. At present, there are three treatment options for youth with severe obesity: lifestyle modification therapy, pharmacotherapy, and bariatric surgery. Lifestyle modification therapy can be useful for improving many chronic disease risk factors and comorbid conditions but often fails to achieve clinically meaningful and sustainable weight loss. Pharmacotherapy holds promise as an effective adjunctive treatment but remains in the primordial stages of development in the pediatric population. Bariatric surgery provides robust weight loss and risk factor/comorbidity improvements but is accompanied by higher risks and lower uptake compared to lifestyle modification therapy and pharmacotherapy. New areas worth pursuing include combination pharmacotherapy, device therapy, identification of predictors of response aimed at precision treatment, and interventions in the postbariatric surgical setting to improve long-term outcomes. Treating pediatric severe obesity effectively and safely is extremely challenging. Some progress has been made, but substantially more effort and innovation are needed in the future to combat this serious and ongoing medical and public health issue. © 2018 The Obesity Society.

  19. Application of spent fuel treatment technology to plutonium immobilization

    International Nuclear Information System (INIS)

    McPheeters, C.C.; Ackerman, J.P.; Gay, E.C., Johnson, G.K.

    1996-01-01

    The purpose of the electrometallurgical treatment technology being developed at Argonne National Laboratory (ANL) is to convert certain spent nuclear fuels into waste forms that are suitable for disposal in a geological repository for nuclear waste. The spent fuels of interest are those that cannot be safely stored for a long time in their current condition, and those that cannot be qualified for repository disposal. This paper explores the possibility of applying this electrometallurgical treatment technology to immobilization of surplus fissile materials, primarily plutonium. Immobilization of surplus fissile materials by electrometallurgical treatment could be done in the same facilities, at the same time. and in the same equipment as the proposed treatment of the present inventory of spent nuclear fuel. The cost and schedule savings of this simultaneous treatment scheme would be significant

  20. The role of nuclear power in the option zero emission technologies for fossil fuels

    International Nuclear Information System (INIS)

    Corak, Z.

    2006-01-01

    The energy sector is one of the main sources of greenhouse gas (GHG) emissions particularly carbon dioxide (CO2) increasing concerns due to their potential risk to induce global warming and climate change. The Parties having signed the Kyoto Protocol in December 1997, committed to decrease their GHG emissions. The Protocol states that countries shall undertake promotion, research, development and increased use of new and renewable forms of energy, of carbon dioxide sequestration technologies and of advanced and innovative environmentally sound technologies. The one significant option that is not specifically mentioned is nuclear energy which is essentially carbon-free. There are a number of technical options that could help reducing, or at least slowing the increase of, GHG emissions from the energy sector. The list of options includes: improving the efficiency of energy conversion and end-use processes; shifting to less carbon intensive energy sources (e.g. shifting from coal to natural gas); developing carbon-free or low-carbon energy sources; and carbon sequestration (e.g. planting forests or capturing and storing carbon dioxide). It must be pointed out that nuclear power is one of the few options that are currently available on the market, competitive in a number of countries, especially if global costs to society of alternative options are considered; practically carbon-free; and sustainable at large-scale deployment. The nuclear power could play significant role in alleviating the risk of global climate change. The main objective of the article is to present sequestration options, their cost evaluation as well as comparation with alternative possibilities of nuclear energy production. (author)